WorldWideScience

Sample records for meeting materials pharmaceutical

  1. Mixed Reality Meets Pharmaceutical Development.

    Science.gov (United States)

    Forrest, William P; Mackey, Megan A; Shah, Vivek M; Hassell, Kerry M; Shah, Prashant; Wylie, Jennifer L; Gopinath, Janakiraman; Balderhaar, Henning; Li, Li; Wuelfing, W Peter; Helmy, Roy

    2017-12-01

    As science evolves, the need for more efficient and innovative knowledge transfer capabilities becomes evident. Advances in drug discovery and delivery sciences have directly impacted the pharmaceutical industry, though the added complexities have not shortened the development process. These added complexities also make it difficult for scientists to rapidly and effectively transfer knowledge to offset the lengthened drug development timelines. While webcams, camera phones, and iPads have been explored as potential new methods of real-time information sharing, the non-"hands-free" nature and lack of viewer and observer point-of-view render them unsuitable for the R&D laboratory or manufacturing setting. As an alternative solution, the Microsoft HoloLens mixed-reality headset was evaluated as a more efficient, hands-free method of knowledge transfer and information sharing. After completing a traditional method transfer between 3 R&D sites (Rahway, NJ; West Point, PA and Schnachen, Switzerland), a retrospective analysis of efficiency gain was performed through the comparison of a mock method transfer between NJ and PA sites using the HoloLens. The results demonstrated a minimum 10-fold gain in efficiency, weighing in from a savings in time, cost, and the ability to have real-time data analysis and discussion. In addition, other use cases were evaluated involving vendor and contract research/manufacturing organizations. Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

  2. Radiation decontamination of pharmaceutical raw materials as an integral part of the good pharmaceutical manufacturing practice (GPMP)

    Energy Technology Data Exchange (ETDEWEB)

    Razem, D; Katusin-Razem, B [Institut Rudjer Boskovic, Zagreb (Yugoslavia); Starcevic, M; Galekovic, B [PLIVA Pharmaceutical Works, Zagreb (Yugoslavia)

    1990-01-01

    The microbiological quality of many raw materials used in the manufacture of pharmaceuticals and adjuvants often fails to meet the standards set by the pharmaceutical industry. Raw materials of biological provenience are particularly susceptible to contamination. This work describes the present situation regarding the microbial load of corn starch. Given the accepted microbiological criteria, irradiation treatment is proposed as integral to Good Pharmaceutical Manufacturing Practice (GPMP). The use of total viable count as a guide for specifying microbial limits for non-sterile materials is supported. Criteria for the choice of dose are discussed. (author).

  3. Radiation decontamination of pharmaceutical raw materials as an integral part of the good pharmaceutical manufacturing practice (GPMP)

    International Nuclear Information System (INIS)

    Razem, D.; Katusin-Razem, B.; Starcevic, M.; Galekovic, B.

    1990-01-01

    The microbiological quality of many raw materials used in the manufacture of pharmaceuticals and adjuvants often fails to meet the standards set by the pharmaceutical industry. Raw materials of biological provenience are particularly susceptible to contamination. This work describes the present situation regarding the microbial load of corn starch. Given the accepted microbiological criteria, irradiation treatment is proposed as integral to Good Pharmaceutical Manufacturing Practice (GPMP). The use of total viable count as a guide for specifying microbial limits for non-sterile materials is supported. Criteria for the choice of dose are discussed. (author)

  4. Pharmaceutical Applications of Polymeric Nano materials

    International Nuclear Information System (INIS)

    Wu, L.; Sun, L.

    2011-01-01

    With significant attention focused on nano science and nano technology in recent years, nano materials have been used in a wide variety of applications such as automotive, environmental, energy, catalysis, biomedical, drug delivery, and polymeric industries. Among those fields, the application of nano materials with pharmaceutical science is an emerging and rapidly growing field and has drawn increasing attention recently. Research and development in this field is mainly focused on several aspects such as the discoveries of novel functional nano materials, exploration on nanoparticles with controlled and targeted drug delivery characteristics, and investigation of bio functionalized and diagnostic nano materials. In this special issue, we have invited a few papers related to recent advances in pharmaceutical application of polymeric nano materials

  5. 76 FR 38668 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2011-07-01

    ...] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General.... In response to feedback during the April 13, 2010, Advisory Committee for Pharmaceutical Science and...

  6. 76 FR 38188 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2011-06-29

    ...] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General..., 2011, the committee will discuss current strategies for FDA's Office of Pharmaceutical Science...

  7. 75 FR 11551 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2010-03-11

    ...] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General... Pharmaceutical Science (OPS) on the regulatory challenges of drug-induced phospholipidosis (excessive...

  8. 78 FR 58315 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2013-09-23

    ...] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General... continuous manufacturing for pharmaceutical products. Speakers from the Agency, academia, and industry will...

  9. Prescribers and pharmaceutical representatives: why are we still meeting?

    Science.gov (United States)

    Fischer, Melissa A; Keough, Mary Ellen; Baril, Joann L; Saccoccio, Laura; Mazor, Kathleen M; Ladd, Elissa; Von Worley, Ann; Gurwitz, Jerry H

    2009-07-01

    Research suggests that pharmaceutical marketing influences prescribing and may cause cognitive dissonance for prescribers. This work has primarily been with physicians and physician-trainees. Questions remain regarding why prescribers continue to meet with pharmaceutical representatives (PRs). To describe the reasons that prescribers from various health professions continue to interact with PRs despite growing evidence of the influence of these interactions. Multi-disciplinary focus groups with 61 participants held in practice settings and at society meetings. Most prescribers participating in our focus groups believe that overall PR interactions are beneficial to patient care and practice health. They either trust the information from PRs or feel that they are equipped to evaluate it independently. Despite acknowledgement of study findings to the contrary, prescribers state that they are able to effectively manage PR interactions such that their own prescribing is not adversely impacted. Prescribers describe few specific strategies or policies for these interactions, and report that policies are not consistently implemented with all members of a clinic or institution. Some prescribers perceive an inherent contradiction between academic centers and national societies receiving money from pharmaceutical companies, and then recommending restriction at the level of the individual prescriber. Prescribers with different training backgrounds present a few novel reasons for these meetings. Despite evidence that PR detailing influences prescribing, providers from several health professions continue to believe that PR interactions improve patient care, and that they can adequately evaluate and filter information presented to them by PRs. Focus group comments suggest that cultural change is necessary to break the norms that exist in many settings. Applying policies consistently, considering non-physician members of the healthcare team, working with trainees, restructuring

  10. 78 FR 58314 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2013-09-23

    ...] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General... session, the Office of Pharmaceutical Science and the Office of Compliance will discuss with the committee...

  11. Coordinated research project on radiation sterilization and decontamination of pharmaceuticals and pharmaceutical raw materials. CRP report

    International Nuclear Information System (INIS)

    2005-01-01

    Radiation processing is a very convenient tool for imparting desirable effects in materials and it has been an area of enormous interest in the last few decades. Radiation processing of synthetic and natural polymers for improving their characteristics is largely used in laboratory and industrial scale. Radiation sterilization is a well developed and established technology for many products. It is especially useful for the treatment of pharmaceuticals due to flexibility of radiation processing to be carried out at any desired temperature, sterilizability of mixed products in kits, offering simultaneous sterilization and modification of polymer based formulations. The success of radiation technology for processing of synthetic and natural polymers and treatment of pharmaceuticals has been based, to a large extent, on empirical knowledge. But now, the applications of natural polymers are being sought in knowledge-demanding areas such as pharmacy and biotechnology. Reliable analytical methods are being developed for controlling of degradation effects of radiation on polymers. Procedures and chemical formulations are being investigated enhancing or preventing degradation effects depending on the desired application of the process. The Coordinated Research Project (CRP) on the use of radiation processing for sterilization or decontamination of pharmaceuticals and pharmaceutical raw materials has been completed in 2002. The overall objective of the CRP was to coordinate the research and development programmes carried out in different countries in use of radiation processing for sterilization or decontamination of pharmaceuticals and pharmaceutic raw materials. It has been concluded that in addition to well known advantages of radiation sterilization being a well developed and established technology requiring the control of only one parameter, dose, to achieve sterilization; it is especially useful for the treatment of pharmaceuticals due to flexibility of radiation

  12. Coordinated research project on radiation sterilization and decontamination of pharmaceuticals and pharmaceutical raw materials. CRP report

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2005-07-01

    Radiation processing is a very convenient tool for imparting desirable effects in materials and it has been an area of enormous interest in the last few decades. Radiation processing of synthetic and natural polymers for improving their characteristics is largely used in laboratory and industrial scale. Radiation sterilization is a well developed and established technology for many products. It is especially useful for the treatment of pharmaceuticals due to flexibility of radiation processing to be carried out at any desired temperature, sterilizability of mixed products in kits, offering simultaneous sterilization and modification of polymer based formulations. The success of radiation technology for processing of synthetic and natural polymers and treatment of pharmaceuticals has been based, to a large extent, on empirical knowledge. But now, the applications of natural polymers are being sought in knowledge-demanding areas such as pharmacy and biotechnology. Reliable analytical methods are being developed for controlling of degradation effects of radiation on polymers. Procedures and chemical formulations are being investigated enhancing or preventing degradation effects depending on the desired application of the process. The Coordinated Research Project (CRP) on the use of radiation processing for sterilization or decontamination of pharmaceuticals and pharmaceutical raw materials has been completed in 2002. The overall objective of the CRP was to coordinate the research and development programmes carried out in different countries in use of radiation processing for sterilization or decontamination of pharmaceuticals and pharmaceutic raw materials. It has been concluded that in addition to well known advantages of radiation sterilization being a well developed and established technology requiring the control of only one parameter, dose, to achieve sterilization; it is especially useful for the treatment of pharmaceuticals due to flexibility of radiation

  13. 75 FR 10488 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2010-03-08

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2010-N-0001] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General...

  14. 76 FR 3912 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2011-01-21

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2011-N-0002] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General...

  15. 78 FR 42966 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2013-07-18

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2013-N-0001] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General...

  16. 77 FR 41790 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2012-07-16

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2012-N-0001] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General...

  17. 77 FR 42746 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2012-07-20

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2012-N-0001] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General...

  18. 77 FR 1696 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2012-01-11

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2012-N-0001] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General...

  19. 75 FR 8368 - Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting

    Science.gov (United States)

    2010-02-24

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2010-N-0067] Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting AGENCY: Food and... of Committee: Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. General...

  20. Pattern of Duplicate Presentations at National Hematology-Oncology Meetings: Influence of the Pharmaceutical Industry.

    Science.gov (United States)

    Ramchandren, Radhakrishnan; Schiffer, Charles A

    2016-03-01

    The major large US hematology-oncology meetings sponsored by the American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) have specific guidelines in place discouraging submission of scientific information presented previously at other meetings. Nonetheless, duplicate submissions are frequent. The incidence and motivations for duplicate hematologic presentations and the influence of the pharmaceutical industry on this process have not been thoroughly analyzed. Therefore, were viewed four consecutive ASH and ASCO meetings to assess the frequency of duplicate abstract presentations. All abstracts presented at ASCO2010 in the area of malignant hematology were compared with abstracts from ASCO and ASH 2009 and ASH 2010, and funding sources were reviewed. More than half (54%) of all abstracts submitted to ASCO 2010 acknowledged pharmaceutical company support. Almost one third (31%) of ASCO 2010 abstracts were resubmitted in the 2-year time period, and it was notable that a high fraction (75%) of these duplicate abstracts had pharmaceutical industry sponsorship, compared with 42% of the abstracts that were submitted only once. Despite current guidelines prohibiting duplicate abstract presentation, a substantial proportion (31%) of abstracts at large international hematology-oncology meetings are duplicative, with potential negative consequences. In addition, a disproportionate percentage of the duplicate abstracts rely on pharmaceutical industry support (75%), suggesting that marketing strategies may be a motivation for some of these repetitive submissions.

  1. [The 10th Annual Meeting of the Japanese Society for Pharmaceutical Palliative Care and Sciences].

    Science.gov (United States)

    Shiokawa, Mitsuru; Kawamura, Kazumi

    2018-01-01

     The 10th Annual Meeting of the Japanese Society for Pharmaceutical Palliative Care and Sciences was held at Act City Hamamatsu, Japan, with a total of 2634 participants in attendance. The theme of the meeting was realized through a number of new concepts, such as a debate symposium, information sessions, nurses' workshops, and so on. The results obtained from the participation questionnaire (n=438), which were aggregated up to 1 month following the end of this year's meeting, revealed that 89% of the participants at considered it to have been appealing. In particular, 63% of the participants favored the adoption of a debate symposium whereby it was possible to ask and respond to questions in real time. In the free comments section of the questionnaire, the participants expressed how they felt the debate symposium made it easy to give their opinions, and that this element might be further developed in the future. They also stated that they found the introduction of the Clica system effective in terms of making the annual meeting an active learning place. One issue that was highlighted concerned the observation that the hall used to host the symposium was designed as a concert venue, which meant it was highly shielded from the outside environment, in addition to access to the internet being blocked. I hope that many of the projects from this Annual Meeting will serve to guide the future style of the Society's Annual Meetings.

  2. Clarke's Isolation and identification of drugs in pharmaceuticals, body fluids, and post-mortem material

    National Research Council Canada - National Science Library

    Clarke, E. G. C; Moffat, A. C; Jackson, J. V

    1986-01-01

    This book is intended for scientists faced with the difficult problem of identifying an unknown drug in a pharmaceutical product, in a sample of tissue or body fluid from a living patient, or in post-mortem material...

  3. Materials science tetrahedron--a useful tool for pharmaceutical research and development.

    Science.gov (United States)

    Sun, Changquan Calvin

    2009-05-01

    The concept of materials science tetrahedron (MST) concisely depicts the inter-dependent relationship among the structure, properties, performance, and processing of a drug. Similar to its role in traditional materials science, MST encompasses the development in the emerging field of pharmaceutical materials science and forms a scientific foundation to the design and development of new drug products. Examples are given to demonstrate the applicability of MST to both pharmaceutical research and product development. It is proposed that a systematic implementation of MST can expedite the transformation of pharmaceutical product development from an art to a science. By following the principle of MST, integration of research among different laboratories can be attained. The pharmaceutical science community as a whole can conduct more efficient, collaborative, and coherent research.

  4. Meeting Local Needs in Materials Writing

    Directory of Open Access Journals (Sweden)

    Rahma Al-Mahrooqi

    2010-01-01

    Full Text Available Textbooks are viewed as an essential tool in ELT. Despite the abundance of commercial textbooks, very few of them seem to meet the local needs of students and teachers in a certain context, owing to certain pitfalls in the materials. When a program adopts a certain commercial textbook the teachers soon realize that they have to supplement the materials to bridge the gap between what these materials offer and the local needs. Sometimes the supplementation yields greater volumes of materials than the book itself, causing teachers and learners to lose focus. An added complexity is the fact that there are always new, more attractive titles in the market, leaving the program in a dilemma of whether to keep their old, well supplemented textbooks or to replace them with new ones and start another cycle of supplementation. The ideal solution is for a program to produce its own teaching materials. However, writing quality local materials that can compete with commercial ones can be a real challenge. It requires clear vision, creativity, commitment and team work.

  5. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.

    Science.gov (United States)

    Stauffer, F; Vanhoorne, V; Pilcer, G; Chavez, P-F; Rome, S; Schubert, M A; Aerts, L; De Beer, T

    2018-06-01

    Active Pharmaceutical Ingredients (API) raw material variability is not always thoroughly considered during pharmaceutical process development, mainly due to low quantities of drug substance available. However, synthesis, crystallization routes and production sites evolve during product development and product life cycle leading to changes in physical material attributes which can potentially affect their processability. Recent literature highlights the need for a global approach to understand the link between material synthesis, material variability, process and product quality. The study described in this article aims at explaining the raw material variability of an API using extensive material characterization on a restricted number of representative batches using multivariate data analysis. It is part of a larger investigation trying to link the API drug substance manufacturing process, the resulting physical API raw material attributes and the drug product continuous manufacturing process. Eight API batches produced using different synthetic routes, crystallization, drying, delumping processes and processing equipment were characterized, extensively. Seventeen properties from seven characterization techniques were retained for further analysis using Principal Component Analysis (PCA). Three principal components (PCs) were sufficient to explain 92.9% of the API raw material variability. The first PC was related to crystal length, agglomerate size and fraction, flowability and electrostatic charging. The second PC was driven by the span of the particle size distribution and the agglomerates strength. The third PC was related to surface energy. Additionally, the PCA allowed to summarize the API batch-to-batch variability in only three PCs which can be used in future drug product development studies to quantitatively evaluate the impact of the API raw material variability upon the drug product process. The approach described in this article could be applied to any

  6. Materials for Pharmaceutical Dosage Forms: Molecular Pharmaceutics and Controlled Release Drug Delivery Aspects

    Directory of Open Access Journals (Sweden)

    Patrick P. DeLuca

    2010-09-01

    Full Text Available Controlled release delivery is available for many routes of administration and offers many advantages (as microparticles and nanoparticles over immediate release delivery. These advantages include reduced dosing frequency, better therapeutic control, fewer side effects, and, consequently, these dosage forms are well accepted by patients. Advances in polymer material science, particle engineering design, manufacture, and nanotechnology have led the way to the introduction of several marketed controlled release products and several more are in pre-clinical and clinical development.

  7. Division of Materials Science (DMS) meeting presentation

    Energy Technology Data Exchange (ETDEWEB)

    Cline, C.F.; Weber, M.J.

    1982-11-08

    Materials preparation techniques are listed. Materials preparation capabilities are discussed for making BeF/sub 2/ glasses and other materials. Materials characterization techniques are listed. (DLC)

  8. 37. annual meeting of the Institute of Nuclear Materials Management

    International Nuclear Information System (INIS)

    Anon.

    1996-01-01

    The following subjects were covered in this meeting: waste management; nuclear materials management -- safety and health; international safeguards; measurement control and statistics for nuclear materials management; material control and accountability; packaging and transportation; nonproliferation and arms control; and physical protection. Separate papers were prepared for 74 items of this meeting

  9. Introducing Students to Rheological Classification of Foods, Cosmetics, and Pharmaceutical Excipients Using Common Viscous Materials

    Science.gov (United States)

    Faustino, Ce´lia; Bettencourt, Ana F.; Alfaia, Anto´nio; Pinheiro, Lídia

    2015-01-01

    Rheological measurements are very important tools for the characterization of the flow and deformation of a material, as well as for optimization of the rheological parameters. The application and acceptance of pharmaceutical formulations, cosmetics, and foodstuffs depends upon their rheological characteristics, such as texture, consistency, or…

  10. Analytical methods for determination of terbinafine hydrochloride in pharmaceuticals and biological materials

    Directory of Open Access Journals (Sweden)

    Basavaiah Kanakapura

    2016-06-01

    Full Text Available Terbinafine is a new powerful antifungal agent indicated for both oral and topical treatment of mycosessince. It is highly effective in the treatment of determatomycoses. The chemical and pharmaceutical analysis of the drug requires effective analytical methods for quality control and pharmacodynamic and pharmacokinetic studies. Ever since it was introduced as an effective antifungal agent, many methods have been developed and validated for its assay in pharmaceuticals and biological materials. This article reviews the various methods reported during the last 25 years.

  11. Eutectics as improved pharmaceutical materials: design, properties and characterization.

    Science.gov (United States)

    Cherukuvada, Suryanarayan; Nangia, Ashwini

    2014-01-28

    Eutectics are a long known class of multi-component solids with important and useful applications in daily life. In comparison to other multi-component crystalline solids, such as salts, solid solutions, molecular complexes and cocrystals, eutectics are less studied in terms of molecular structure organization and bonding interactions. Classically, a eutectic is defined based on its low melting point compared to the individual components. In this article, we attempt to define eutectics not just based on thermal methods but from a structural organization view point, and discuss their microstructures and properties as organic materials vis-a-vis solid solutions and cocrystals. The X-ray crystal structure of a cocrystal is different from that of the individual components whereas the unit cell of a solid solution is similar to that of one of the components. Eutectics are closer to the latter species in that their crystalline arrangement is similar to the parent components but they are different with respect to the structural integrity. A solid solution possesses structural homogeneity throughout the structure (single phase) but a eutectic is a heterogeneous ensemble of individual components whose crystal structures are like discontinuous solid solutions (phase separated). Thus, a eutectic may be better defined as a conglomerate of solid solutions. A structural analysis of cocrystals, solid solutions and eutectics has led to an understanding that materials with strong adhesive (hetero) interactions between the unlike components will lead to cocrystals whereas those having stronger cohesive (homo/self) interactions will more often give rise to solid solutions (for similar structures of components) and eutectics (for different structures of components). We demonstrate that the same crystal engineering principles which have been profitably utilized for cocrystal design in the past decade can now be applied to make eutectics as novel composite materials, illustrated by

  12. Thermodynamics of water-solid interactions in crystalline and amorphous pharmaceutical materials.

    Science.gov (United States)

    Sacchetti, Mark

    2014-09-01

    Pharmaceutical materials, crystalline and amorphous, sorb water from the atmosphere, which affects critical factors in the development of drugs, such as the selection of drug substance crystal form, compatibility with excipients, dosage form selection, packaging, and product shelf-life. It is common practice to quantify the amount of water that a material sorbs at a given relative humidity (RH), but the results alone provide minimal to no physicochemical insight into water-solid interactions, without which pharmaceutical scientists cannot develop an understanding of their materials, so as to anticipate and circumvent potential problems. This research was conducted to advance the science of pharmaceutical materials by examining the thermodynamics of solids with sorbed water. The compounds studied include nonhygroscopic drugs, a channel hydrate drug, a stoichiometric hydrate excipient, and an amorphous excipient. The water sorption isotherms were measured over a range of temperature to extract the partial molar enthalpy and entropy of sorbed water as well as the same quantities for some of the solids. It was found that water-solid interactions spanned a range of energy and entropy as a function of RH, which was unique to the solid, and which could be valuable in identifying batch-to-batch differences and effects of processing in material performance. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association.

  13. Meeting the regulatory information needs of users of radioactive materials

    International Nuclear Information System (INIS)

    MacDurmon, G.W.

    1996-01-01

    The use of radioactive materials is one of the most regulated areas of research. Researchers face ever increasing regulatory requirements and issues involving the disposal of radioactive material, while meeting the demands of higher productivity. Radiation safety programs must maximize regulatory compliance, minimize barriers, provide services and solutions, and effectively communicate with users of radioactive materials. This talk will discuss methods by which a radiation safety program can meet the needs of both the research staff and regulatory compliance staff

  14. Meeting the regulatory information needs of users of radioactive materials

    Energy Technology Data Exchange (ETDEWEB)

    MacDurmon, G.W. [American Cyanamid Company, Princeton, NJ (United States)

    1996-10-01

    The use of radioactive materials is one of the most regulated areas of research. Researchers face ever increasing regulatory requirements and issues involving the disposal of radioactive material, while meeting the demands of higher productivity. Radiation safety programs must maximize regulatory compliance, minimize barriers, provide services and solutions, and effectively communicate with users of radioactive materials. This talk will discuss methods by which a radiation safety program can meet the needs of both the research staff and regulatory compliance staff.

  15. Comparison of solute-binding properties of plastic materials used as pharmaceutical product containers.

    Science.gov (United States)

    Jenke, Dennis; Couch, Tom; Gillum, Amy

    2010-01-01

    Material/water equilibrium binding constants (E(b)) were determined for 11 organic solutes and 2 plastic materials commonly used in pharmaceutical product containers (plasticized polyvinyl chloride and polyolefin). In general, solute binding by the plasticized polyvinyl chloride material was greater, by nearly an order of magnitude, than the binding by the polyolefin (on an equal weight basis). The utilization of the binding constants to facilitate container compatibility assessments (e.g., drug loss by container binding) for drug-containing products is discussed.

  16. Using compression calorimetry to characterize powder compaction behavior of pharmaceutical materials.

    Science.gov (United States)

    Buckner, Ira S; Friedman, Ross A; Wurster, Dale Eric

    2010-02-01

    The process by which pharmaceutical powders are compressed into cohesive compacts or tablets has been studied using a compression calorimeter. Relating the various thermodynamic results to relevant physical processes has been emphasized. Work, heat, and internal energy change values have been determined with the compression calorimeter for common pharmaceutical materials. A framework of equations has been proposed relating the physical processes of friction, reversible deformation, irreversible deformation, and inter-particle bonding to the compression calorimetry values. The results indicate that irreversible deformation dominated many of the thermodynamic values, especially the net internal energy change following the compression-decompression cycle. The relationships between the net work and the net heat from the complete cycle were very clear indicators of predominating deformation mechanisms. Likewise, the ratio of energy stored as internal energy to the initial work input distinguished the materials according to their brittle or plastic deformation tendencies. (c) 2009 Wiley-Liss, Inc. and the American Pharmacists Association.

  17. Adhesion of Pharmaceutical Binding Agents I-Adhesion to polymeric materials

    Directory of Open Access Journals (Sweden)

    Hossain Orafai

    1996-08-01

    Full Text Available Adhesion of three commonly used pharmaceutical binding agents, HPMC , PVP and Gelatin to five different polymeric sheet materials was studied. After conditioning, the bond strength of the specimens were measured by shear testing method using a suitablely designed apparatus. The results were correlated to the surface energies and the solubiiity parameters of the adherends. It is concluded that the thermodynamic properties and the solubility parameters are dominant when the mechanisms of adhesion are by adsorption and diffusion respectively.

  18. Evaluation of Extractables in Processed and Unprocessed Polymer Materials Used for Pharmaceutical Applications

    OpenAIRE

    Stults, Cheryl L. M.; Ansell, Jennifer M.; Shaw, Arthur J.; Nagao, Lee M.

    2014-01-01

    Polymeric materials are often used in pharmaceutical packaging, delivery systems, and manufacturing components. There is continued concern that chemical entities from polymeric components may leach into various dosage forms, particularly those that are comprised of liquids such as parenterals, injectables, ophthalmics, and inhalation products. In some cases, polymeric components are subjected to routine extractables testing as a control measure. To reduce the risk of discovering leachables du...

  19. Colorimetric determination of a paracetamole in raw material and in pharmaceutical dosage forms

    International Nuclear Information System (INIS)

    Usifoh, C.O; Adelusi, S.A.; Adebambo, R.F.

    2002-01-01

    A rapid, accurate and simple method is proposed for the determination of p-acetaminophen (paracetamole) in raw material, tablets and syrups. The method is based on measuring the intensity of the yellow color that developed when acute acetaminophen is allowed to react with p-dimethylaminobenzaldehyde in 2M HCl after heating. The color which absorbs in the visible region of gamma 450 nm is stable for several hours and the intensity is directly proportional to the concentration of the drug, that is, Beer lambert law is obeyed. The method can be used to analyse paracetamole in raw material and in pharmaceutical dosage forms. (author)

  20. Generic Pharmaceutical Association (GPhA) - 2015 Annual Meeting (February 9-11, 2015 - Miami Beach, Florida, USA).

    Science.gov (United States)

    Bowman, M

    2015-02-01

    The Generic Pharmaceutical Association (GPhA) chairman Craig Wheeler (Momenta Pharmaceuticals), welcomed attendees to the 2015 Annual Meeting by reflecting on the contributions of the generic industry over the past year and some of the challenges that lie ahead. In 2014, 86% of prescriptions dispensed in the U.S. were generic, contributing to the USD 1.4 trillion savings generated by the industry since its inception; however, there are still many challenges to face, including consolidation of customers, lag in Abbreviated New Drug Application (ANDA) approval timelines, restrictive Risk Evaluation and Mitigation Strategy (REMS) programs and labeling legislations. The continued drive into the branded business by many GPhA member companies has resulted in the association planning a structural division for companies involved in biologic and biosimilar products. During the 3-day meeting, attendees listened to expert panels discuss major business, regulatory and market trends developing in the generic industry, with insights from the U.S. Food and Drug Administration (FDA) and market analysts. The meeting also provided attendees with numerous opportunities to socialize and network with key decision makers in the industry. Copyright 2015 Prous Science, S.A.U. or its licensors. All rights reserved.

  1. Flow chemistry meets advanced functional materials.

    Science.gov (United States)

    Myers, Rebecca M; Fitzpatrick, Daniel E; Turner, Richard M; Ley, Steven V

    2014-09-22

    Flow chemistry and continuous processing techniques are beginning to have a profound impact on the production of functional materials ranging from quantum dots, nanoparticles and metal organic frameworks to polymers and dyes. These techniques provide robust procedures which not only enable accurate control of the product material's properties but they are also ideally suited to conducting experiments on scale. The modular nature of flow and continuous processing equipment rapidly facilitates reaction optimisation and variation in function of the products. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  2. Investigation of migrant-polymer interaction in pharmaceutical packaging material using the linear interaction energy algorithm.

    Science.gov (United States)

    Feenstra, Peter; Brunsteiner, Michael; Khinast, Johannes

    2014-10-01

    The interaction between drug products and polymeric packaging materials is an important topic in the pharmaceutical industry and often associated with high costs because of the required elaborative interaction studies. Therefore, a theoretical prediction of such interactions would be beneficial. Often, material parameters such as the octanol water partition coefficient are used to predict the partitioning of migrant molecules between a solvent and a polymeric packaging material. Here, we present the investigation of the partitioning of various migrant molecules between polymers and solvents using molecular dynamics simulations for the calculation of interaction energies. Our results show that the use of a model for the interaction between the migrant and the polymer at atomistic detail can yield significantly better results when predicting the polymer solvent partitioning than a model based on the octanol water partition coefficient. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

  3. Organizing Global IS Management to Meet Competitive Challenges: Experiences from the Pharmaceutical Industry

    OpenAIRE

    Bettina Schwarzer

    1995-01-01

    Despite the widely acknowledged importance information technology plays in multinational corporations, many companies lack an understanding of when and how to (re)organize global IS management. The issues of timing and organization of global IS management, however, seem to be of utmost importance in a company’s attempt to implement a new, global business strategy. Based on three case studies from the pharmaceutical industry, this paper analyzes the sequence in which business strategy, organ...

  4. On Identification of Critical Material Attributes for Compression Behaviour of Pharmaceutical Diluent Powders

    Directory of Open Access Journals (Sweden)

    Jianyi Zhang

    2017-07-01

    Full Text Available As one of the commonly-used solid dosage forms, pharmaceutical tablets have been widely used to deliver active drugs into the human body, satisfying patient’s therapeutic requirements. To manufacture tablets of good quality, diluent powders are generally used in formulation development to increase the bulk of formulations and to bind other inactive ingredients with the active pharmaceutical ingredients (APIs. For formulations of a low API dose, the drug products generally consist of a large fraction of diluent powders. Hence, the attributes of diluents become extremely important and can significantly influence the final product property. Therefore, it is essential to accurately characterise the mechanical properties of the diluents and to thoroughly understand how their mechanical properties affect the manufacturing performance and properties of the final products, which will build a sound scientific basis for formulation design and product development. In this study, a comprehensive evaluation of the mechanical properties of the widely-used pharmaceutical diluent powders, including microcrystalline cellulose (MCC powders with different grades (i.e., Avicel PH 101, Avicel PH 102, and DG, mannitol SD 100, lactose monohydrate, and dibasic calcium phosphate, were performed. The powder compressibility was assessed with Heckel and Kawakita analyses. The material elastic recovery during decompression and in storage was investigated through monitoring the change in the dimensions of the compressed tablets over time. The powder hygroscopicity was also evaluated to examine the water absorption ability of powders from the surroundings. It was shown that the MCC tablets exhibited continuous volume expansion after ejection, which is believed to be induced by (1 water absorption from the surrounding, and (2 elastic recovery. However, mannitol tablets showed volume expansion immediately after ejection, followed by the material shrinkage in storage. It is

  5. Modeling of the solution interaction properties of plastic materials used in pharmaceutical product container systems.

    Science.gov (United States)

    Jenke, Dennis; Couch, Tom; Gillum, Amy; Sadain, Salma

    2009-01-01

    Material/water equilibrium binding constants (Eb) were determined for 14 organic solutes and 17 plastic raw materials that could be used in pharmaceutical product container systems. Correlations between the measured binding constants and the organic solute's octanol/water and hexane/water partition coefficients were obtained. In general, while the materials examined exhibited a wide range of binding characteristics, the tested materials by and large fell within two broad classes: (1) those that were octanol-like in their binding characteristics, and (2) those that were hexane-like. Materials of the same class (e.g., polypropylenes) generally had binding models that were very similar. Rank ordering of the materials in terms of their magnitude of drug binding (least binding to most binding) was as follows: polypropylene < polyethylene < polyamide < styrene-ethylene-butylene-styrene < copolyester ether elastomer approximately equal to amine-terminated poly fatty acid amide polymer. The utilization of the developed models to estimate drug loss via sorption by the container is discussed.

  6. Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meet.

    Science.gov (United States)

    Helmlinger, Gabriel; Al-Huniti, Nidal; Aksenov, Sergey; Peskov, Kirill; Hallow, Karen M; Chu, Lulu; Boulton, David; Eriksson, Ulf; Hamrén, Bengt; Lambert, Craig; Masson, Eric; Tomkinson, Helen; Stanski, Donald

    2017-11-15

    Modeling & simulation (M&S) methodologies are established quantitative tools, which have proven to be useful in supporting the research, development (R&D), regulatory approval, and marketing of novel therapeutics. Applications of M&S help design efficient studies and interpret their results in context of all available data and knowledge to enable effective decision-making during the R&D process. In this mini-review, we focus on two sets of modeling approaches: population-based models, which are well-established within the pharmaceutical industry today, and fall under the discipline of clinical pharmacometrics (PMX); and systems dynamics models, which encompass a range of models of (patho-)physiology amenable to pharmacological intervention, of signaling pathways in biology, and of substance distribution in the body (today known as physiologically-based pharmacokinetic models) - which today may be collectively referred to as quantitative systems pharmacology models (QSP). We next describe the convergence - or rather selected integration - of PMX and QSP approaches into 'middle-out' drug-disease models, which retain selected mechanistic aspects, while remaining parsimonious, fit-for-purpose, and able to address variability and the testing of covariates. We further propose development opportunities for drug-disease systems models, to increase their utility and applicability throughout the preclinical and clinical spectrum of pharmaceutical R&D. Copyright © 2017 Elsevier B.V. All rights reserved.

  7. The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance.

    Science.gov (United States)

    Bergström, Richard

    2011-04-01

    The established market model for pharmaceutical products, as for most other products, is heavily dependent on sales volumes. Thus, it is a primary interest of the producer to sell large quantities. This may be questionable for medicinal products and probably most questionable for antibacterial remedies. For these products, treatment indications are very complex and encompass both potential patient benefits, possible adverse effects in the actual patient and, which is unique for this therapeutic class, consideration about what effects the drug use will have on the future therapeutic value of the drug. This is because bacteria are sure to develop resistance. The European Federation of Pharmaceutical Industries and Associations (EFPIA) agrees with the general description of the antibacterial resistance problem and wants to participate in measures to counteract antibacterial resistance. Stakeholders should forge an alliance that will address the need for and prudent use of new antibiotics. A variety of incentives probably have to be applied, but having all in common that the financial return has to be separated from the use of the product. Copyright © 2011. Published by Elsevier Ltd.

  8. Design of pharmaceutical products to meet future patient needs requires modification of current development paradigms and business models.

    Science.gov (United States)

    Stegemann, S; Baeyens, J-P; Becker, R; Maio, M; Bresciani, M; Shreeves, T; Ecker, F; Gogol, M

    2014-06-01

    Drugs represent the most common intervention strategy for managing acute and chronic medical conditions. In light of demographic change and the increasing age of patients, the classic model of drug research and development by the pharmaceutical industry and drug prescription by physicians is reaching its limits. Different stakeholders, e.g. industry, regulatory authorities, health insurance systems, physicians etc., have at least partially differing interests regarding the process of healthcare provision. The primary responsibility for the correct handling of medication and adherence to treatment schedules lies with the recipient of a drug-based therapy, i.e. the patient. It is thus necessary to interactively involve elderly patients, as well as the other stakeholders, in the development of medication and medication application devices, and in clinical trials. This approach will provide the basis for developing a strategy that better meets patients' needs, thus resulting in improved adherence to treatment schedules and better therapeutic outcomes.

  9. Viscoelastic characterization of compacted pharmaceutical excipient materials by analysis of frequency-dependent mechanical relaxation processes

    Science.gov (United States)

    Welch, K.; Mousavi, S.; Lundberg, B.; Strømme, M.

    2005-09-01

    A newly developed method for determining the frequency-dependent complex Young's modulus was employed to analyze the mechanical response of compacted microcrystalline cellulose, sorbitol, ethyl cellulose and starch for frequencies up to 20 kHz. A Debye-like relaxation was observed in all the studied pharmaceutical excipient materials and a comparison with corresponding dielectric spectroscopy data was made. The location in frequency of the relaxation peak was shown to correlate to the measured tensile strength of the tablets, and the relaxation was interpreted as the vibrational response of the interparticle hydrogen and van der Waals bindings in the tablets. Further, the measured relaxation strength, holding information about the energy loss involved in the relaxation processes, showed that the weakest material in terms of tensile strength, starch, is the material among the four tested ones that is able to absorb the most energy within its structure when exposed to external perturbations inducing vibrations in the studied frequency range. The results indicate that mechanical relaxation analysis performed over relatively broad frequency ranges should be useful for predicting material properties of importance for the functionality of a material in applications such as, e.g., drug delivery, drug storage and handling, and also for clarifying the origin of hitherto unexplained molecular processes.

  10. Evaluation of extractables in processed and unprocessed polymer materials used for pharmaceutical applications.

    Science.gov (United States)

    Stults, Cheryl L M; Ansell, Jennifer M; Shaw, Arthur J; Nagao, Lee M

    2015-02-01

    Polymeric materials are often used in pharmaceutical packaging, delivery systems, and manufacturing components. There is continued concern that chemical entities from polymeric components may leach into various dosage forms, particularly those that are comprised of liquids such as parenterals, injectables, ophthalmics, and inhalation products. In some cases, polymeric components are subjected to routine extractables testing as a control measure. To reduce the risk of discovering leachables during stability studies late in the development process, or components that may fail extractables release criteria, it is proposed that extractables testing on polymer resins may be useful as a screening tool. Two studies have been performed to evaluate whether the extractables profile generated from a polymer resin is representative of the extractables profile of components made from that same resin. The ELSIE Consortium pilot program examined polyvinyl chloride and polyethylene, and another study evaluated polypropylene and a copolymer of polycarbonate and acrylonitrile butadiene styrene. The test materials were comprised of polymer resin and processed resin or molded components. Volatile, semi-volatile, and nonvolatile chemical profiles were evaluated after headspace sampling and extraction with solvents of varying polarity and pH. The findings from these studies indicate that there may or may not be differences between extractables profiles obtained from resins and processed forms of the resin depending on the type of material, the compounds of interest, and extraction conditions used. Extractables testing of polymer resins is useful for material screening and in certain situations may replace routine component testing.

  11. European Pharmaceutical Pricing and Reimbursement--SMi's 21st Annual Meeting (October 5-6, 2015--London, UK).

    Science.gov (United States)

    Kibble, A; D'Souza, P

    2015-10-01

    Translating perceived market value for pharmaceutical products into a willingness to pay remains the key factor in ensuring market access and return on investment. How price is managed in the context of new market entrants or new approval settings can create complex challenges, and further complexity is added through diverse global reimbursement structures and the myriad of stakeholders involved at every step of value identification. SMi's 21st Annual Meeting on European Pricing and Reimbursement presented a program focused on the measures being taken by European healthcare systems as they seek to facilitate access to the latest treatments while delivering value for payers and patients. Supporting patient access to life-changing medicines is a challenge, and funders are responding in many different ways; however, while the pharma industry continues to focus its efforts on high cost drugs that treat diseases of the few, the disconnect will be not be resolved. The speakers and delegates at the annual meeting believe success is possible by focusing on value for patients, driven by provider experience, scale and learning. Instead of simply lowering costs, companies, providers and payers can more adequately contribute to the goals of funders as well as the treatment needs of patients. Copyright 2015 Prous Science, S.A.U. or its licensors. All rights reserved.

  12. Colorimetric humidity sensor based on liquid composite materials for the monitoring of food and pharmaceuticals.

    Science.gov (United States)

    Bridgeman, Devon; Corral, Javier; Quach, Ashley; Xian, Xiaojun; Forzani, Erica

    2014-09-09

    Using supported ionic-liquid membrane (SILM)-inspired methodologies, we have synthesized, characterized, and developed a humidity sensor by coating a liquid composite material onto a hygroscopic, porous substrate. Similar to pH paper, the sensor responds to the environment's relative humidity and changes color accordingly. The humidity indicator is prepared by casting a few microliters of low-toxicity reagents on a nontoxic substrate. The sensing material is a newly synthesized liquid composite that comprises a hygroscopic medium for environmental humidity capture and a color indicator that translates the humidity level into a distinct color change. Sodium borohydride was used to form a liquid composite medium, and DenimBlu30 dye was used as a redox indicator. The liquid composite medium provides a hygroscopic response to the relative humidity, and DenimBlu30 translates the chemical changes into a visual change from yellow to blue. The borate-redox dye-based humidity sensor was prepared, and then Fourier transform infrared spectroscopy, differential scanning calorimetry, and image analysis methods were used to characterize the chemical composition, optimize synthesis, and gain insight into the sensor reactivity. Test results indicated that this new sensing material can detect relative humidity in the range of 5-100% in an irreversible manner with good reproducibility and high accuracy. The sensor is a low-cost, highly sensitive, easy-to-use humidity indicator. More importantly, it can be easily packaged with products to monitor humidity levels in pharmaceutical and food packaging.

  13. Microbiological decontamination of botanical raw materials and corresponding pharmaceutical products by irradiation

    International Nuclear Information System (INIS)

    Katusin-Razem, B.; Novak, B.; Razem, D.

    2001-01-01

    Microbiological contamination typical of botanical raw materials used in the manufacture of pharmaceuticals decreases with the increasing level of processing, on going from flowers and leaves (10 4 -10 8 CFU/g), to fruits and seeds (10 2 -10 6 CFU/g), to liquid extracts (10 4 -10 6 CFU/g), and to dry extracts (10 2 -10 5 CFU/g). At the same time the resistivity of microflora to irradiation, expressed as a dose required for the first 90% reduction, increases along the same assortment as 2, 4, 5 and 5 kGy, respectively. This results in doses between 4 and 30 kGy required to treat typical contamination, or between 10 and 40 kGy for severe cases. The contamination of final products, phyto-therapeutic ointments (10 4 -10 7 CFU/g), is relatively sensitive to irradiation (D first90%red =1 kGy) and usually does not require doses higher than 8 kGy

  14. Meeting Materials for OECD Expert Meeting on Categorization of Manufactured Nanomaterials on September 17-19, 2014

    Science.gov (United States)

    Here are materials for the OECD Working Party on Nanomanufactured Materials Expert Meeting on Categorization of Nanomaterials (developing nanomaterial categories) took place on September 17-19, 2014 in Washington, D.C hosted by U.S. EPA.

  15. 78 FR 8202 - Meeting of the Joint ACRS Subcommittees on Thermal Hydraulic Phenomena and Materials, Metallurgy...

    Science.gov (United States)

    2013-02-05

    ... NUCLEAR REGULATORY COMMISSION Advisory Committee on Reactor Safeguards (ACRS) Meeting of the Joint ACRS Subcommittees on Thermal Hydraulic Phenomena and Materials, Metallurgy and Reactor Fuels; Notice of Meeting The Joint ACRS Subcommittees on Thermal Hydraulic Phenomena and Materials, Metallurgy and...

  16. Pharmaceutical Raw Material Identification Using Miniature Near-Infrared (MicroNIR) Spectroscopy and Supervised Pattern Recognition Using Support Vector Machine

    OpenAIRE

    Sun, Lan; Hsiung, Chang; Pederson, Christopher G.; Zou, Peng; Smith, Valton; von Gunten, Marc; O?Brien, Nada A.

    2016-01-01

    Near-infrared spectroscopy as a rapid and non-destructive analytical technique offers great advantages for pharmaceutical raw material identification (RMID) to fulfill the quality and safety requirements in pharmaceutical industry. In this study, we demonstrated the use of portable miniature near-infrared (MicroNIR) spectrometers for NIR-based pharmaceutical RMID and solved two challenges in this area, model transferability and large-scale classification, with the aid of support vector machin...

  17. Functional polyaniline/multiwalled carbon nanotube composite as an efficient adsorbent material for removing pharmaceuticals from aqueous media.

    Science.gov (United States)

    Dutra, Flávia Viana Avelar; Pires, Bruna Carneiro; Nascimento, Tienne Aparecida; Borges, Keyller Bastos

    2018-09-01

    The composite polyaniline/multiwalled carbon nanotube (PAni/MWCNT, 1:0.1 w/w) was developed with the intention of binding the adsorbent properties of two materials and using it to adsorb pharmaceuticals from aqueous media. PAni/MWCNT was characterized by scanning electron microscopy, thermogravimetry, infrared spectroscopy, pH at the point of zero charge, and the effect on the surface wettability of the material. As proof of concept, adsorption studies were carried out using meloxicam (MLX) as the pharmaceutical and it was evaluated as a function of pH, temperature, ionic strength, contact time and variation in concentration. Kinetics and isothermal models were applied to evaluate the mechanism of the adsorption process. The best MLX adsorption result was at pH 2 with 6 min of contact with PAni/MWCNT. The kinetics models that fitted the experimental data were pseudo-second order and Elovich and the kinetics model was the dual-site Langmuir-Freundlich. Both models suggest that the adsorption occurs by the chemical nature of the surface and in the pores of the energetically heterogeneous composite. The PAni/MWCNT presented an adsorption capacity of 221.2 mg g -1 , a very good value when compared with the literature and can be used to remove pharmaceuticals from aqueous environments. Copyright © 2018 Elsevier Ltd. All rights reserved.

  18. On-line and in-situ x-ray diffraction analysis of the crystallisation of important pharmaceutical materials

    International Nuclear Information System (INIS)

    Hastings, S.

    1999-01-01

    Full text: The crystallisation process is an important unit operation for the separation and purification of many chemical products, particularly in the pharmaceutical industry. Variations in the conditions of crystallisation can lead to the formation of different polymorphic forms which are often meta-stable phases which results in phase conversion at different rates to the stable form. Our group, in collaboration with many industrial sponsors, have developed a number of online techniques which help to optimise the processing conditions of many of these specialty materials. In particular, on-line and in-situ X-ray diffraction (XRD) has been used to monitor the crystallisation of pharmaceutical materials. Several novel in-situ X-ray cells have been developed, in particular; a solution cell, which allows us to control and hence optimise crystallographic conditions such as temperature and pH whilst monitoring the crystal structure of the sample as it crystallises from solution. In conjunction with XRD data information on turbidity (% light transmittance) is taken to analyse solvent-mediated crystallisation. This technique gives information on the temperatures at which the system crystallises and dissolves. From this the meta-stable zone width (MSZW) can be calculated and then directly related to the crystal structure of the particles formed. The current system being studied is the crystallisation of stearic acid, a common pharmaceutical excipient, in various polar and non-polar solvents in order to ascertain the effect that the polarity of the solvent has on the polymorphic form crystallised. By combining such kinetic assessment with measurements of resulting particle structure the potential to optimise the process to produce optimal particle properties is obtainable. Copyright (1999) Australian X-ray Analytical Association Inc

  19. Technical meeting on materials for in-vessel components of ITER

    International Nuclear Information System (INIS)

    Kalinin, G.; Barabash, V.

    2000-01-01

    The Technical meeting on materials for in-vessel components of ITER was held at the ITER Joint Work Site in Garching from 31 January to 4 February. The main objectives of the meetings were: 1. to summarize the requirements, 2. to review new data, 3. to discuss in detail the R and D program and to discuss the material assessment report

  20. 78 FR 65265 - Materials Technical Advisory Committee; Notice of Open Meeting

    Science.gov (United States)

    2013-10-31

    .... Report on regime-based activities. 7. SHUTDOWN Feedback. 8. Public Comments and New Business. The open...; Notice of Open Meeting The Materials Technical Advisory Committee will meet on November 14, 2013, 10:00 a... materials and related technology. Agenda Open Session 1. Opening Remarks and Introductions. 2. Remarks from...

  1. Pharmaceutical Raw Material Identification Using Miniature Near-Infrared (MicroNIR) Spectroscopy and Supervised Pattern Recognition Using Support Vector Machine.

    Science.gov (United States)

    Sun, Lan; Hsiung, Chang; Pederson, Christopher G; Zou, Peng; Smith, Valton; von Gunten, Marc; O'Brien, Nada A

    2016-05-01

    Near-infrared spectroscopy as a rapid and non-destructive analytical technique offers great advantages for pharmaceutical raw material identification (RMID) to fulfill the quality and safety requirements in pharmaceutical industry. In this study, we demonstrated the use of portable miniature near-infrared (MicroNIR) spectrometers for NIR-based pharmaceutical RMID and solved two challenges in this area, model transferability and large-scale classification, with the aid of support vector machine (SVM) modeling. We used a set of 19 pharmaceutical compounds including various active pharmaceutical ingredients (APIs) and excipients and six MicroNIR spectrometers to test model transferability. For the test of large-scale classification, we used another set of 253 pharmaceutical compounds comprised of both chemically and physically different APIs and excipients. We compared SVM with conventional chemometric modeling techniques, including soft independent modeling of class analogy, partial least squares discriminant analysis, linear discriminant analysis, and quadratic discriminant analysis. Support vector machine modeling using a linear kernel, especially when combined with a hierarchical scheme, exhibited excellent performance in both model transferability and large-scale classification. Hence, ultra-compact, portable and robust MicroNIR spectrometers coupled with SVM modeling can make on-site and in situ pharmaceutical RMID for large-volume applications highly achievable. © The Author(s) 2016.

  2. Specialists meeting on properties of primary circuit structural materials including environmental effects

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1977-07-01

    The Specialists Meeting on Properties of Primary Circuit Structural Materials of LMFBRs covered the following topics: overview of materials program in different countries; mechanical properties of materials in air; fracture mechanics studies - component related activities; impact of environmental influences on mechanical properties; relationship of material properties and design methods. The purpose of the meeting was to provide a forum for exchange of information on structural materials behaviour in primary circuit of fast breeder reactors. Special emphasis was placed on environmental effects such as influence of sodium and irradiation on mechanical properties of reactor materials.

  3. Specialists meeting on properties of primary circuit structural materials including environmental effects

    International Nuclear Information System (INIS)

    1977-01-01

    The Specialists Meeting on Properties of Primary Circuit Structural Materials of LMFBRs covered the following topics: overview of materials program in different countries; mechanical properties of materials in air; fracture mechanics studies - component related activities; impact of environmental influences on mechanical properties; relationship of material properties and design methods. The purpose of the meeting was to provide a forum for exchange of information on structural materials behaviour in primary circuit of fast breeder reactors. Special emphasis was placed on environmental effects such as influence of sodium and irradiation on mechanical properties of reactor materials

  4. PHARMACEUTICAL AMORPHOUS ORGANIC MATERIALS CHARACTERIZATION BY USING THE DIFFERENTIAL SCANNING CALORIMETRY AND DYNAMIC MECHANICAL ANALYSIS

    Directory of Open Access Journals (Sweden)

    Ion Dranca

    2011-12-01

    Full Text Available This research has been carried out in order to demonstrate the use of differential scanning calorimetry (DSC in detecting and measuring α- and β-relaxation processes in amorphous pharmaceutical systems. DSC has been employed to study amorphous samples of poly (vinylpyrrolidone (PVP, indomethacin (InM, and ursodeoxycholic acid (UDA that are annealed at temperature (Ta around 0.8 of their glass transition temperature (Tg. Dynamic mechanical analysis (DMA is used to measure β- relaxation in PVP. Yet, the DSC has been used to study the glassy indomethacin aged at 0 and -10 oC for periods of time up to 109 and 210 days respectively. The results demonstrate the emergence of a small melting peak of the α-polymorph after aging for 69 days at 0°C and for 147 days at -10°C (i.e., ~55°C below the glass transition temperature that provides evidence of nucleation occurring in the temperature region of the β-relaxation.

  5. Pharmaceutical films made from the waste material from the preparation of propolis extracts: development and characterization

    Directory of Open Access Journals (Sweden)

    Lucas de Alcântara Sica de Toledo

    2015-12-01

    Full Text Available abstract This study investigated the development and characterized the physicochemical properties of films obtained from by-products (BP from the preparation of propolis extracts. Films were produced in the presence and absence of a polymeric adjuvant (gelatin or ethylcellulose and propylene glycol by a solvent casting method. Density, surface topography by scanning electron microscopy, mechanical properties (folding endurance, tensile strength and percentage elongation, water vapour permeability (WVP, moisture uptake capacity, thermogravimetry, differential scanning calorimetry and Fourier transform infrared spectroscopy (FTIR were determined. The films were a transparent, light greenish-yellow colour, with a uniform surface, and were flexible and easy to handle. The thickness and density of the preparations indicated that the compounds were homogeneously dispersed throughout the film. Mechanical properties were influenced by the film composition; films containing gelatin were more resistant to stress, while those containing ethylcellulose were more flexible. Increasing the adjuvant concentration decreased the elasticity and the rupture resistance, but increased the moisture uptake capacity and WVP of the formulations. BP was thermally stable as were the films. FTIR tests suggested interactions between BP and the adjuvants. This work could contribute to the utilization of BP to prepare films for food and pharmaceutical uses

  6. Materials Characterization Center meeting on impact testing of waste forms. Summary report

    International Nuclear Information System (INIS)

    Merz, M.D.; Atteridge, D.; Dudder, G.

    1981-10-01

    A meeting was held on March 25-26, 1981 to discuss impact test methods for waste form materials to be used in nuclear waste repositories. The purpose of the meeting was to obtain guidance for the Materials Characterization Center (MCC) in preparing the MCC-10 Impact Test Method to be approved by the Materials Review Board. The meeting focused on two essential aspects of the test method, namely the mechanical process, or impact, used to effect rapid fracture of a waste form and the analysis technique(s) used to characterize particulates generated by the impact

  7. Pharmaceutical virtue.

    Science.gov (United States)

    Martin, Emily

    2006-06-01

    In the early history of psychopharmacology, the prospect of developing technologically sophisticated drugs to alleviate human ills was surrounded with a fervor that could be described as religious. This paper explores the subsequent history of the development of psychopharmacological agents, focusing on the ambivalent position of both the industry and its employees. Based on interviews with retired pharmaceutical employees who were active in the industry in the 1950s and 1960s when the major breakthroughs were made in the development of MAOIs and SSRIs, the paper explores the initial development of educational materials for use in sales campaigns. In addition, based on interviews with current employees in pharmaceutical sales and marketing, the paper describes the complex perspective of contemporary pharmaceutical employees who must live surrounded by the growing public vilification of the industry as rapacious and profit hungry and yet find ways to make their jobs meaningful and dignified. The paper will contribute to the understudied problem of how individuals function in positions that require them to be part of processes that on one description constitute a social evil, but on another, constitute a social good.

  8. International Materials Research Meeting in the Greater Region: “Current Trends in the Characterisation of Materials and Surface Modification”

    Science.gov (United States)

    2017-10-01

    Preface Dear ladies and gentlemen, On 6th and 7th of April 2017 took place the “International Materials Research Meeting in the Greater Region” at the Saarland University, Saarbrücken, Germany. This meeting corresponded to the 9th EEIGM International Conference on Advanced Materials Research and it was intended as a meeting place for researchers of the Greater Region as well as their partners of the different cooperation activities, like the EEIGM program, the ‘Erasmus Mundus’ Advanced Materials Science and Engineering Master program (AMASE), the ‘Erasmus Mundus’ Doctoral Program in Materials Science and Engineering (DocMASE) and the CREATe-Network. On this meeting, 72 participants from 15 countries and 24 institutions discussed and exchanged ideas on the latest trends in the characterization of materials and surface modifications. Different aspects of the material research of metals, ceramics, polymers and biomaterials were presented. As a conclusion of the meeting, the new astronaut of the European Space Agency Dr. Matthias Maurer, who is an alumni of the Saarland University and the EEIGM, held an exciting presentation about his activities. Following the publication of selected papers of the 2009 meeting in Volume 5 and 2012 meeting in Volume 31 of this journal, it is a great pleasure to present this selection of 9 articles to the readers of the IOP Conference Series: Materials Science and Engineering. The editors are thankful to all of the reviewers for reviewing the papers. Special praise is also given to the sponsors of the conference: European Commission within the program Erasmus Mundus (AMASE and DocMASE), Erasmus+ (AMASE), and Horizon2020 (CREATe-Network, Grant agreement No 644013): the DAAD (Alumni Program), and the German-French University (PhD-Track). List of Author signatures, Conference topics, Organization, Conference impressions and list of the participants are available in this PDF.

  9. Vermicomposting of herbal pharmaceutical industry waste: earthworm growth, plant-available nutrient and microbial quality of end materials.

    Science.gov (United States)

    Singh, Deepika; Suthar, Surindra

    2012-05-01

    Efforts were made to decompose herbal pharmaceutical industrial waste (HPIW) spiked with cow dung (CD) using Eisenia fetida. A total of five vermibeds: T(1) - HPIW (0%+CD 100%, control), T(2) - HPIW (25%), T(3) - HPIW (50%), T(4) - HPIW (75%) and T(5) - HPIW (100%) were used for vermicomposting. The changes in biology and chemistry of vermibeds were measured after ten days interval. E. fetida showed high growth and cocoon production rate in all vermibeds. The vermicomposted material contained great population of fungi 6.0-40.6 (CFU × 10(5)g(-1)), bacteria 220-1276.0 (CFU × 10(8)g(-1)) and actinomycetes 410.0-2962.0 (CFU × 10(5)g(-1)) than initial material. Vermicomposted material was rich in plant-available forms of nutrients (N-NO(3)(-),PO(4)(3-),available K and SO(4)(-2)). Results suggested that noxious industrial waste can be converted into valuable product for sustainable soil fertility programme. Copyright © 2012 Elsevier Ltd. All rights reserved.

  10. 78 FR 16044 - Hazardous Materials Packaging-Composite Cylinder Standards; Public Meeting

    Science.gov (United States)

    2013-03-13

    ... Toughiry, Engineering and Research Division, Office of Hazardous Materials Safety, Pipeline and Hazardous... the HMR, ISO 11119 Parts-1, -2 and -3, contain design, construction and testing requirements that are.../permits-approvals/special-permits . II. Public Meeting Topics During this public meeting, PHMSA will...

  11. Technical Meeting on Liquid Metal Reactor Concepts: Core Design and Structural Materials. Presentations

    International Nuclear Information System (INIS)

    2013-01-01

    The objective of the Technical Meeting is to present and discuss innovative liquid metal fast reactor (LMFR) core designs with special focus on the choice, development, testing and qualification of advanced reactor core structural materials

  12. The contribution of material control to meeting performance requirements

    International Nuclear Information System (INIS)

    Rivers, J.D.

    1989-01-01

    The U.S. Dept. of Energy (DOE) is in the process of implementing a set of performance requirements for material control and accountability (MC ampersand A). These graded requirements set a uniform level of performance for similar materials at various facilities with respect to the threat of an insider adversary stealing special nuclear material (SNM). These requirements are phrased in terms of detecting the theft of a goal quantity of SNM within a specified time period and with a probability greater than or equal to a specified value and include defense in-depth requirements

  13. Materials Meets Concepts in Molecule-Based Electronics

    KAUST Repository

    Ortmann, Frank

    2014-10-14

    In this contribution, molecular materials are highlighted as an important topic in the diverse field of condensed matter physics, with focus on their particular electronic and transport properties. A better understanding of their performance in various applications and devices demands for an extension of basic theoretical approaches to describe charge transport in molecular materials, including the accurate description of electron-phonon coupling. Starting with the simplest case of a molecular junction and moving on to larger aggregates of bulk organic semiconductors, charge-transport regimes from ballistic motion to incoherent hopping, which are frequently encountered in molecular systems under respective conditions, are discussed. Transport features of specific materials are described through ab initio material parameters whose determination is addressed. © 2014 Wiley-VCH Verlag GmbH & Co. KGaA.

  14. Materials Meets Concepts in Molecule-Based Electronics

    KAUST Repository

    Ortmann, Frank; Radke, K. Sebastian; Gü nther, Alrun; Kasemann, Daniel; Leo, Karl; Cuniberti, Gianaurelio

    2014-01-01

    In this contribution, molecular materials are highlighted as an important topic in the diverse field of condensed matter physics, with focus on their particular electronic and transport properties. A better understanding of their performance

  15. IAEA advisory group meeting on: Critical assessment of tritium retention in fusion reactor materials. Summary report

    International Nuclear Information System (INIS)

    Janev, R.K.; Federici, G.; Roth, J.

    1999-07-01

    The proceedings, conclusions and recommendations of the IAEA Advisory Group Meeting on 'Critical Assessment of Tritium Retention in Fusion Reactor Materials', held on June 7-8, 1999 at the IAEA Headquarters in Vienna, Austria, are briefly described. The report contains a summary of the presentations of meeting participants, a review of the data status (availability and needs) for the fusion most relevant bulk and mixed materials, and recommendations to the IAEA regarding its future activity in this data area. (author)

  16. Hydroxyapatites enriched in silicon–Bioceramic materials for biomedical and pharmaceutical applications

    Institute of Scientific and Technical Information of China (English)

    Katarzyna Szurkowska; Joanna Kolmas

    2017-01-01

    Hydroxyapatite (Ca10(PO4)6(OH)2, abbreviated as HA) plays a crucial role in implantology, dentistry and bone surgery. Due to its considerable similarity to the inorganic fraction of the mineralized tissues (bones, enamel and dentin), it is used as component in many bone substitutes, coatings of metallic implants and dental materials. Biomaterial engineering often takes advantage of HA capacity for partial ion substitution because the incorporation of different ions in the HA structure leads to materials with improved biological or physico-chemical properties. The objective of the work is to provide an overview of current knowledge about apatite materials substituted with silicon ions. Although the exact mechanism of action of silicon in the bone formation process has not been fully elucidated, research has shown beneficial effects of this element on bone matrix mineralization as well as on collagen type I synthesis and stabilization. The paper gives an account of the functions of silicon in bone tissue and outlines the present state of research on synthetic HA containing silicate ions (Si-HA). Finally, methods of HA production as well as potential and actual applications of HA materials modified with silicon ions are discussed.

  17. Hydroxyapatites enriched in silicon – Bioceramic materials for biomedical and pharmaceutical applications

    Directory of Open Access Journals (Sweden)

    Katarzyna Szurkowska

    2017-08-01

    Full Text Available Hydroxyapatite (Ca10(PO46(OH2, abbreviated as HA plays a crucial role in implantology, dentistry and bone surgery. Due to its considerable similarity to the inorganic fraction of the mineralized tissues (bones, enamel and dentin, it is used as component in many bone substitutes, coatings of metallic implants and dental materials. Biomaterial engineering often takes advantage of HA capacity for partial ion substitution because the incorporation of different ions in the HA structure leads to materials with improved biological or physicochemical properties. The objective of the work is to provide an overview of current knowledge about apatite materials substituted with silicon ions. Although the exact mechanism of action of silicon in the bone formation process has not been fully elucidated, research has shown beneficial effects of this element on bone matrix mineralization as well as on collagen type I synthesis and stabilization. The paper gives an account of the functions of silicon in bone tissue and outlines the present state of research on synthetic HA containing silicate ions (Si-HA. Finally, methods of HA production as well as potential and actual applications of HA materials modified with silicon ions are discussed.

  18. Proton Conducting Fuel Cells where Electrochemistry Meets Material Science

    DEFF Research Database (Denmark)

    Li, Qingfeng

    Fuel cells are electrochemical devices which directly convert the chemical energy of fuels into electrical energy. They are featured of high energy conversion efficiency and minimized pollutant emission. Proton conducting electrolytes are primarily used as separator materials for low and intermed...... science point of view including novel proton conducting materials and non-precious metal catalysts. The discussion will be made with highlights of DTU´s recent research and of course addressing a diverse technical audience.......Fuel cells are electrochemical devices which directly convert the chemical energy of fuels into electrical energy. They are featured of high energy conversion efficiency and minimized pollutant emission. Proton conducting electrolytes are primarily used as separator materials for low...... followed by a review of the state-of-the-art in terms of performance, lifetime and cost. Technically faced challenges are then outlined on a system level and traced back to fundamental issues of the proton conducting mechanisms and materials. Perspectives and future research are sketched from a materials...

  19. Investigating the Effects of Loading Factors on the In Vitro Pharmaceutical Performance of Mesoporous Materials as Drug Carriers for Ibuprofen

    Directory of Open Access Journals (Sweden)

    Junmin Lai

    2017-02-01

    Full Text Available The aim of the study was to investigate the effects of the loading factors, i.e., the initial drug loading concentration and the ratio of the drug to carriers, on the in vitro pharmaceutical performance of drug-loaded mesoporous systems. Ibuprofen (IBU was used as a model drug, and two non-ordered mesoporous materials of commercial silica Syloid® 244FP (S244FP and Neusilin® US2 (NS2 were selected in the study. The IBU-loaded mesoporous samples were prepared by a solvent immersion method with a rotary evaporation drying technique and characterized by polarized light microscopy (PLM, Fourier transform infrared (FTIR spectroscopy, X-ray powder diffraction (XRPD and differential scanning calorimetry (DSC. Dissolution experiments were performed in simulated gastric media at 37 °C under non-sink conditions. The concentration of IBU in solution was determined by HPLC. The study showed that the dissolution rate of IBU can be improved significantly using the mesoporous S224FP carriers due to the conversion of crystalline IBU into the amorphous form. Both of the loading factors affected the IBU dissolution kinetics. Due to the molecular interaction between the IBU and NS2 carriers, the loading factors had little effects on the drug release kinetics with incomplete drug desorption recovery and insignificant dissolution enhancement. Care and extensive evaluation must therefore be taken when mesoporous materials are chosen as carrier delivery systems.

  20. Application of the Materials Requirement Planning (MRP in the Pharmaceutical Laboratory Oriente

    Directory of Open Access Journals (Sweden)

    Elena Saumell–Fonseca

    2015-12-01

    Full Text Available In the logistics management of any business organization the allocation of material resources is very important, both for its dynamic approach to the internal processes of the company, as the pursuit of customer satisfaction, enabling the fulfillment of their goals efficiently and effectively. In this context, are used with effective results the models of Material’s Requirements Planning (MRP which allow to plan and control the demands for materials and production capacities in companies, conjugating with orders’s delivery dates, so is a tool proven effective, especially in the conditions of the Cuban economy. The present work has as objective to apply a MRP model in drugs manufacturing in the Company Laboratory Oriente in Santiago de Cuba, based on a theoretical and practical analysis for application of MRP tool using the WinQSB software. 

  1. Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018.

    Science.gov (United States)

    Rutter, Victoria; Chan, Amy Hai Yan; Tuck, Chloe; Bader, Lina; Babar, Zaheer-Ud-Din; Bates, Ian

    2018-01-01

    The biennial Commonwealth Heads of Government Meeting (CHOGM) this year is based around four key themes: prosperity, fairness, sustainability and security. This is an opportune time to consider the role of pharmacists in healthcare delivery, and particularly their contribution to achieving the United Nations Sustainable Development Goals (SDGs). As a member of the Commonwealth Health Professions Alliance (CHPA), the Commonwealth Pharmacists Association (CPA) has been working to ensure that pharmacy-related aspects of health are represented in the advocacy papers submitted by Civil Society. Echoing the CHPA's priorities around SDG 3 (health) and the attainment of sustainable universal health coverage (UHC), the CPA has been raising the profile of key priorities for our members, including: addressing the shortage of healthcare workers (with an emphasis on pharmacists); need for access to quality medicines and medicines information; tackling anti-microbial resistance and substandard/falsified medicines; and championing the role of digitalisation and partnerships. This editorial discusses how the work of the CPA links with the themes of CHOGM, the CPA's input into this meeting and the direction of travel 'Towards a Common Future' for health and pharmacy in the Commonwealth.

  2. Stability-indicating spectrofluorimetric method for determination of itopride hydrochloride in raw material and pharmaceutical formulations.

    Science.gov (United States)

    Walash, Mohamed I; Ibrahim, Fawzia; Eid, Manal I; El Abass, Samah Abo

    2013-11-01

    A simple, sensitive and rapid spectrofluorimetric method for determination of itopride hydrochloride in raw material and tablets has been developed. The proposed method is based on the measurement of the native fluorescence of the drug in water at 363 nm after excitation at 255 nm. The relative fluorescence intensity-concentration plot was rectilinear over the range of 0.1-2 μg/mL (2.5 × 10(-7)-5.06 × 10(-6) mole/L), with good correlation (r = 0.9999), limit of detection of 0.015 μg/mL and a lower limit of quantification of 0.045 μg/mL. The described method was successfully applied for the determination of itopride hydrochloride in its commercial tablets with average percentage recovery of 100.11 ± 0.32 without interference from common excipients. Additionally, the proposed method can be applied for determination of itopride in combined tablets with rabeprazole or pantoprazole without prior separation. The method was extended to stability study of itopride. The drug was exposed to acidic, alkaline, oxidative and photolytic degradation according to ICH guidelines. Moreover, the method was utilized to investigate the kinetics of the alkaline, acidic and oxidative degradation of the drug. A proposal for the degradation pathways was postulated.

  3. 77 FR 16264 - Manufacturer of Controlled Substances, Notice of Registration; Johnson Matthey Pharmaceutical...

    Science.gov (United States)

    2012-03-20

    ..., Notice of Registration; Johnson Matthey Pharmaceutical Materials Inc. By Notice dated November 18, 2011... Pharmaceutical Materials Inc., Pharmaceutical Service, 25 Patton Road, Devens, Massachusetts 01434, made... Matthey Pharmaceutical Materials Inc. to manufacture the listed basic classes of controlled substances is...

  4. Rapid limit tests for metal impurities in pharmaceutical materials by X-ray fluorescence spectroscopy using wavelet transform filtering.

    Science.gov (United States)

    Arzhantsev, Sergey; Li, Xiang; Kauffman, John F

    2011-02-01

    We introduce a new method for analysis of X-ray fluorescence (XRF) spectra based on continuous wavelet transform filters, and the method is applied to the determination of toxic metals in pharmaceutical materials using hand-held XRF spectrometers. The method uses the continuous wavelet transform to filter the signal and noise components of the spectrum. We present a limit test that compares the wavelet domain signal-to-noise ratios at the energies of the elements of interest to an empirically determined signal-to-noise decision threshold. The limit test is advantageous because it does not require the user to measure calibration samples prior to measurement, though system suitability tests are still recommended. The limit test was evaluated in a collaborative study that involved five different hand-held XRF spectrometers used by multiple analysts in six separate laboratories across the United States. In total, more than 1200 measurements were performed. The detection limits estimated for arsenic, lead, mercury, and chromium were 8, 14, 20, and 150 μg/g, respectively.

  5. Technical committee meeting on material-coolant interactions and material movement and relocation in liquid metal fast reactors

    International Nuclear Information System (INIS)

    1994-01-01

    The Technical Committee Meeting on Material-Coolant Interactions and Material Movement and Relocation in Liquid Metal Fast Reactors was sponsored by the International Working Group on Fast Reactors (IWGFR), International Atomic Energy Agency (IAEA) and hosted by PNC, on behalf of the Japanese government. A broad range of technical subjects was discussed in the TCM, covering entire aspects of material motion and interactions relevant to the safety of LMFRs. Recent achievement and current status in research and development in this area were presented including European out-of-pile test of molten material movement and relocation; molten material-sodium interaction; molten fuel-coolant interaction; core disruptive accidents; sodium boiling; post accident material relocation, heat removal and relevant experiments already performed or planned

  6. Technical committee meeting on material-coolant interactions and material movement and relocation in liquid metal fast reactors

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1994-07-01

    The Technical Committee Meeting on Material-Coolant Interactions and Material Movement and Relocation in Liquid Metal Fast Reactors was sponsored by the International Working Group on Fast Reactors (IWGFR), International Atomic Energy Agency (IAEA) and hosted by PNC, on behalf of the Japanese government. A broad range of technical subjects was discussed in the TCM, covering entire aspects of material motion and interactions relevant to the safety of LMFRs. Recent achievement and current status in research and development in this area were presented including European out-of-pile test of molten material movement and relocation; molten material-sodium interaction; molten fuel-coolant interaction; core disruptive accidents; sodium boiling; post accident material relocation, heat removal and relevant experiments already performed or planned.

  7. Good analytical practice in the analysis of IAEA materials for certification. Report of a consultants' meeting

    International Nuclear Information System (INIS)

    1999-01-01

    The purpose of this Consultant's Meeting report was to provide basic guidelines to the analysts involved in IAEA certification analysis for IAEA-392 and IAEA-393 Algae Reference Materials and to harmonise the analytical approach. The experience of this exercise will be combined with the requirements of ISO Guide 34 and 35 and should be the basis for a planned guide book on this topic. The Meeting was focused on on the practical implementation of the quality requirements for Reference Material analysis and certification procedures from ISO Guide 34 and ISO Guide 35

  8. Specialists' meeting on high temperature metallic materials for application in gas-cooled reactors

    International Nuclear Information System (INIS)

    At the meeting overviews of current programmes for the development of high temperature materials in Japan, F.R. Germany and the United States of America were presented. Some papers were presented dealing with various aspects of microstructural studies, surface reactions and the changes of microstructure and dimensions due mainly to the associated interfacial material transports, protective surface coatings for HTGR and AGR applications. Other topics presented were mechanical properties of materials and also the influence of materials' properties data on design at temperatures in the creep region where time dependent behaviour must be considered

  9. IAEA consultants' meeting on thermal response of plasma facing materials and components

    International Nuclear Information System (INIS)

    Janev, R.K.

    1990-07-01

    The present Summary Report contains brief proceedings and the main conclusions and recommendations of the IAEA Consultants' Meeting on ''Thermal Response of Plasma Facing Materials and Components'', which was organized by the IAEA Atomic and Molecular Data Unit and held on June 11-13, 1990, in Vienna, Austria. The Report also includes a categorization and assessment of currently studied plasma facing materials, a classification scheme of material properties data, required in fusion reactor design, and a survey of the urgently needed material properties data. (author)

  10. Behaviour of LWR core materials under accident conditions. Proceedings of a technical committee meeting

    International Nuclear Information System (INIS)

    1996-12-01

    At the invitation of the Government of the Russian Federation, following a proposal of the International Working Group on Water Reactor Fuel Performance and Technology, the IAEA convened a Technical Committee Meeting on Behaviour of LWR Core Materials Under Accident Conditions from 9 to 13 October 1995 in Dimitrovgrad to analyze and evaluate the behaviour of LWR core materials under accident conditions with special emphasis on severe accidents. In-vessel severe accidents phenomena were considered in detail, but specialized thermal hydraulic aspects as well as ex-vessel phenomena were outside the scope of the meeting. Forty participants representing eight countries attended the meeting. Twenty-three papers were presented and discussed during five sessions. Refs, figs, tabs

  11. Proceedings, annual meeting - Institute of Nuclear Materials Management, 21st, 1980

    International Nuclear Information System (INIS)

    Anon.

    1980-01-01

    This meeting proceedings contains 84 papers by various authors. Some of the topics discussed are: safeguards today and tomorrow; physical protection-requirements and rules; safeguards measurement technology; nonproliferation and international safeguards; analysis and interpretation of materials accounting data; physical protection; safeguards evaluation methodologies; public information; emergency response for accounting and physical security systems; materials control and accountability systems; and safeguards measurements technology. 78 papers are separately indexed

  12. Assessment of core structural materials and surveillance programme of research reactors. Report of the consultants meeting. Working material

    International Nuclear Information System (INIS)

    2009-01-01

    A series of presentations on the assessment of core structural components and materials at their facilities were given by the experts. The different issues related to degradation mechanisms were discussed. The outputs include a more thorough understanding of the specific challenges related to Research Reactors (RRs) as well as proposals for activities which could assist RR organizations in their efforts to address the issues involved. The experts recommend that research reactor operators consider implementation of surveillance programs for materials of core structural components, as part of ageing management program (TECDOC-792 and DS-412). It is recognised by experts that adequate archived structural material data is not available for many RRs. Access to this data and extension of existing material databases could help many operating organisations extend the operation of their RRs. The experts agreed that an IAEA Technical Meeting (TM) on Assessment of Core Structural Materials should be organised in December 2009 (IAEA HQ Vienna). The proposed objectives of the TM are: (i) exchange of detailed technical information on the assessment and ageing management of core structural materials, (ii) identification of materials of interest for further investigation, (iii) proposal for a new IAEA CRP on Assessment of Core Structural Materials, and (iv) identification of RRs prepared to participate in proposed CRP. Based on the response to a questionnaire prepared for the 2008 meeting of the Technical Working Group for Research Reactors, the number of engineering capital projects related to core structural components is proportionally lower than those related to,for example, I and C or electrical power systems. This implies that many operating research reactors will be operating longer using their original core structural components and justifies the assessment and evaluation programmes and activities proposed in this report. (author)

  13. Distribution of bacterial contamination in non-sterile pharmaceutical materials and assessment of its risk to the health of the final consumers quantitatively

    Directory of Open Access Journals (Sweden)

    Mostafa Essam Eissa

    2016-09-01

    Full Text Available Bacterial contamination control in pharmaceutical products is a critical aspect in the field of drug manufacturing industry due to the encountered risk to the patients' health and possibly their life. The application of commercial bacterial identification system is crucial to identify the type of contamination and its source to anticipate the impact of bioburden on the products and setting corrective and preventive actions. During the period of one year, random samples from raw materials and final products were tested according to United States Pharmacopeia, and those that showed suspect results for specified microorganisms and/or out-of-specification limits or showed out-of-trend results were subjected to further identification by using miniaturized biochemical identification system after performing Gram stain. From the total bacterial isolates of the investigated products, more than 60% were primarily belonging to Micrococcaceae 16.98% (empty hard gelatin capsules, Enterobacteriaceae 18.86% (vaginal cream applicator, plastic caps for bottles, Sorbitol solution, finished hard gelatin capsule product, topical cream and oral suspension and Bacillaceae 24.53% (Talc powder, liquid oral preparation and finished hard gelatin capsule product. Gram Positive and Negative samples were 56.60% and 41.51% respectively from the total investigated sample products and materials. Finished pharmaceutical products constituted 53.33% and 68.18% from Gram-positive and Gram-negative microorganisms respectively. An approach to quantitative risk assessment for pharmaceutical products was conducted on selected medicinal items and showed that Enterobacteriaceae followed by Burkholderiaceae contributed by more than 80% to the major hazard that could be delivered to patients through drugs. The applied risk can be used as a milestone for setting goals by pharmaceutical companies to improve the safety of medicinal products microbiologically and to identify the major sources

  14. Report of the research co-ordination meeting on reference materials for microanalytical nuclear techniques

    International Nuclear Information System (INIS)

    1994-01-01

    Many microanalytical procedure require specific natural-matrix reference materials containing very low levels of trace elements and having a high degree of homogeneity. This proposed CRP will specifically address the question of quality control materials for these techniques. The participants of the meeting discussed the requirements for certified reference materials to by used in microanalysis with particular emphasis on the homogeneity issues. This publication contains summary of the discussions along with conclusions and recommendations made by the participants. The publication also contains 13 individual presentations delivered by the participants. Each of the individual papers has been provided with an abstract and indexed separately

  15. Meeting of socialist conntries' representatives on problems of nuclear materials analyses

    International Nuclear Information System (INIS)

    Pacak, P.; Moravec, J.; Krtil, J.; Sus, F.

    1982-01-01

    A meeting of representatives of the socialist countries was held in Prague from May 18 to 22, 1981, to discuss cooperation in the field of analytical control of nuclear materials. The Czechoslovak delegation informed the participants of the extent and results of the work of the Central Control Laboratory of the Nuclear Research Institute in Rez. A brief survey is given of the nondestructive methods of measuring the physical parameters of nuclear fuel, the methods of destructive determination of uranium and plutonium and the methods of preparation of standard materials for mass spectrometry which the Central Control Laboratory has introduced and verified for securing analytical control of nuclear materials. (B.S.)

  16. Report of the research co-ordination meeting on reference materials for microanalytical nuclear techniques

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1994-07-01

    Many microanalytical procedure require specific natural-matrix reference materials containing very low levels of trace elements and having a high degree of homogeneity. This proposed CRP will specifically address the question of quality control materials for these techniques. The participants of the meeting discussed the requirements for certified reference materials to by used in microanalysis with particular emphasis on the homogeneity issues. This publication contains summary of the discussions along with conclusions and recommendations made by the participants. The publication also contains 13 individual presentations delivered by the participants. Each of the individual papers has been provided with an abstract and indexed separately.

  17. Nuclear power plant diagnostics - Safety aspects and licensing. Report of a technical committee meeting. Working material

    International Nuclear Information System (INIS)

    1997-01-01

    The aim of the Technical Committee Meeting (TCM) was to review developed systems and methods in diagnostics in the scope of their impacts and importance to the safety of Nuclear Power Plants. Papers presented on TCM came from different sources, from developers, from manufacturers, from licensing authorities and from NPP personal. They reflect up to date status in the given subject. Participants of TCM formulated three working groups to elaborate different questions which were raised during the discussions. Their results are reflected in the three chapter titles of the given material. Annex 1 to this document contains presentations made at the Technical Committee Meeting. Refs, figs, tabs

  18. Cracking in LWR RPV head penetrations. Working material. Proceedings of a specialists meeting

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-12-31

    The IAEA Specialists` Meeting on Cracking in LWR RPV Head Penetrations was held at the ASTM Headquarters, Philadelphia, Pennsylvania, on May 2-4, 1995. It was attended by 39 participants from 12 countries. The meeting was held in the framework of the IAEA International Working Group on Life Management of Nuclear Power Plants (IWG-LMNPP) and was organized and sponsored by the Oak Ridge National Laboratory and the U.S. Nuclear Regulatory Commission. The purpose of the meeting was to review experience in the field for ensuring adequate performance of reactor pressure vessel (RPV) heads and penetrations. Presentations were aimed at achieving a better understanding of the behaviour of reactor component materials, providing guidance and recommendations to assure reliability and adequate performance, and proposing directions for further investigations. Refs, figs and tabs.

  19. Cracking in LWR RPV head penetrations. Working material. Proceedings of a specialists meeting

    International Nuclear Information System (INIS)

    1995-01-01

    The IAEA Specialists' Meeting on Cracking in LWR RPV Head Penetrations was held at the ASTM Headquarters, Philadelphia, Pennsylvania, on May 2-4, 1995. It was attended by 39 participants from 12 countries. The meeting was held in the framework of the IAEA International Working Group on Life Management of Nuclear Power Plants (IWG-LMNPP) and was organized and sponsored by the Oak Ridge National Laboratory and the U.S. Nuclear Regulatory Commission. The purpose of the meeting was to review experience in the field for ensuring adequate performance of reactor pressure vessel (RPV) heads and penetrations. Presentations were aimed at achieving a better understanding of the behaviour of reactor component materials, providing guidance and recommendations to assure reliability and adequate performance, and proposing directions for further investigations. Refs, figs and tabs

  20. Report on the material committee meetings in fiscal 1987; 1987 nendo zairyo iinkai hokokusho

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1988-03-01

    The material committee has held two meetings in this fiscal year. The first committee meeting (September 25, 1987) was held for the major agenda of (1) the development of a centrifugal slurry pump for liquefaction plants, and as the research and development in fiscal 1987, the in-plant tests on new materials and the development a let-down valve, which were reported and deliberated. The major agenda of the second committee meeting (February 24, 1988) were, as the summarized achievements in fiscal 1987, (2) development of a technology to manufacture hydrogen by utilizing coal, (3) in-plant tests on new materials, and (4) development of a let-down valve, which were reported and deliberated. In Item (1), wear in the shaft seal of the centrifugal slurry pump was discussed regarding its cause from the result of a contraction flow test. In Item (2), it was verified that picrochloromite and chromia are integrated as an electromelting aggregate for the atmospheric stability of refractories used in a gasification furnace, and that the test conditions for the refractories call for the refractories to be tested under severe conditions. In Item (3), how to proceed the tests in the future was verified on such items as corrosion patterns, tested materials, coal types, and the degree of corrosion. In Item (4), kinds and temperatures were verified on slurries used in the water-slurry wear test and the fretting corrosion test. (NEDO)

  1. Meeting

    Indian Academy of Sciences (India)

    July 1989 No.19 Newsletter of the Indian Academy of Sciences. 55th Annual. Meeting ... in the world, keeping alive atthe same time his research interests, abreast .... theory made a comeback with many new ideas and with the success of the ...

  2. Control assembly materials for water reactors: Experience, performance and perspectives. Proceedings of a technical committee meeting

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2000-02-01

    The safe, reliable and economic operation of water cooled nuclear power reactors depends to a large extent upon the reliable operation of control assemblies for the regulation and shutdown of the reactors. These consist of neutron absorbing materials clad in stainless steel or zirconium based alloys, guide tubes and guide cards, and other structural components. Current designs have worked extremely well in normal conditions, but less than ideal behaviour limits the lifetimes of control materials, imposing an economic penalty which acts as a strong incentive to produce improved materials and designs that are more reliable. Neutron absorbing materials currently in use include the ceramic boron carbide, the high melting point metal hafnium and the low melting point complex alloy Ag-In-Cd. Other promising neutron absorbing materials, such as dysprosium titanate, are being evaluated in the Russian Federation. These control materials exhibit widely differing mechanical, physical and chemical properties, which must be understood in order to be able to predict the behaviour of control rod assemblies. Identification of existing failure mechanisms, end of life criteria and the implications of the gradual introduction of extended burnup, mixed oxide (MOX) fuels and more complex fuel cycles constitutes the first step in a search for improved materials and designs. In the early part of this decade, it was recognized by the International Working Group on Fuel Performance and Technology (IWGFPT) that international conferences, symposia and published reviews on the materials science aspects of control assemblies were few and far between. Consequently, the IWGFPT recommended that the IAEA should rectify this situation with a series of Technical Committee meetings (TCMs) devoted entirely to the materials aspects of reactor control assemblies. The first was held in 1993 and in the intervening five years considerable progress has been made. In bringing together experts in the

  3. Control assembly materials for water reactors: Experience, performance and perspectives. Proceedings of a technical committee meeting

    International Nuclear Information System (INIS)

    2000-02-01

    The safe, reliable and economic operation of water cooled nuclear power reactors depends to a large extent upon the reliable operation of control assemblies for the regulation and shutdown of the reactors. These consist of neutron absorbing materials clad in stainless steel or zirconium based alloys, guide tubes and guide cards, and other structural components. Current designs have worked extremely well in normal conditions, but less than ideal behaviour limits the lifetimes of control materials, imposing an economic penalty which acts as a strong incentive to produce improved materials and designs that are more reliable. Neutron absorbing materials currently in use include the ceramic boron carbide, the high melting point metal hafnium and the low melting point complex alloy Ag-In-Cd. Other promising neutron absorbing materials, such as dysprosium titanate, are being evaluated in the Russian Federation. These control materials exhibit widely differing mechanical, physical and chemical properties, which must be understood in order to be able to predict the behaviour of control rod assemblies. Identification of existing failure mechanisms, end of life criteria and the implications of the gradual introduction of extended burnup, mixed oxide (MOX) fuels and more complex fuel cycles constitutes the first step in a search for improved materials and designs. In the early part of this decade, it was recognized by the International Working Group on Fuel Performance and Technology (IWGFPT) that international conferences, symposia and published reviews on the materials science aspects of control assemblies were few and far between. Consequently, the IWGFPT recommended that the IAEA should rectify this situation with a series of Technical Committee meetings (TCMs) devoted entirely to the materials aspects of reactor control assemblies. The first was held in 1993 and in the intervening five years considerable progress has been made. In bringing together experts in the

  4. Automated Solid Phase Extraction (SPE) LC/NMR Applied to the Structural Analysis of Extractable Compounds from a Pharmaceutical Packaging Material of Construction.

    Science.gov (United States)

    Norwood, Daniel L; Mullis, James O; Davis, Mark; Pennino, Scott; Egert, Thomas; Gonnella, Nina C

    2013-01-01

    The structural analysis (i.e., identification) of organic chemical entities leached into drug product formulations has traditionally been accomplished with techniques involving the combination of chromatography with mass spectrometry. These include gas chromatography/mass spectrometry (GC/MS) for volatile and semi-volatile compounds, and various forms of liquid chromatography/mass spectrometry (LC/MS or HPLC/MS) for semi-volatile and relatively non-volatile compounds. GC/MS and LC/MS techniques are complementary for structural analysis of leachables and potentially leachable organic compounds produced via laboratory extraction of pharmaceutical container closure/delivery system components and corresponding materials of construction. Both hyphenated analytical techniques possess the separating capability, compound specific detection attributes, and sensitivity required to effectively analyze complex mixtures of trace level organic compounds. However, hyphenated techniques based on mass spectrometry are limited by the inability to determine complete bond connectivity, the inability to distinguish between many types of structural isomers, and the inability to unambiguously determine aromatic substitution patterns. Nuclear magnetic resonance spectroscopy (NMR) does not have these limitations; hence it can serve as a complement to mass spectrometry. However, NMR technology is inherently insensitive and its ability to interface with chromatography has been historically challenging. This article describes the application of NMR coupled with liquid chromatography and automated solid phase extraction (SPE-LC/NMR) to the structural analysis of extractable organic compounds from a pharmaceutical packaging material of construction. The SPE-LC/NMR technology combined with micro-cryoprobe technology afforded the sensitivity and sample mass required for full structure elucidation. Optimization of the SPE-LC/NMR analytical method was achieved using a series of model compounds

  5. Technical committee meeting on evaluation of radioactive materials release and sodium fires in fast reactors

    International Nuclear Information System (INIS)

    1996-01-01

    The objectives of the Technical Committee Meeting was to review the activities of research on radioactive materials release and sodium fires in fast reactors in each of the participating countries. It covered: out-of-pile experiments and analysis codes on source term; in-pile experiments on source term; core disruptive accidents; sodium leak experience in liquid metal fast reactors; evaluation of sodium fire; and aerosol behaviour

  6. Technical committee meeting on evaluation of radioactive materials release and sodium fires in fast reactors

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-07-01

    The objectives of the Technical Committee Meeting was to review the activities of research on radioactive materials release and sodium fires in fast reactors in each of the participating countries. It covered: out-of-pile experiments and analysis codes on source term; in-pile experiments on source term; core disruptive accidents; sodium leak experience in liquid metal fast reactors; evaluation of sodium fire; and aerosol behaviour.

  7. Technical Meeting on Liquid Metal Reactor Concepts: Core Design and Structural Materials. Working Material

    International Nuclear Information System (INIS)

    2013-01-01

    The objective of the TM on “Liquid metal reactor concept: core design and structural materials” was to present and discuss innovative liquid metal fast reactor (LMFR) core designs with special focus on the choice, development, testing and qualification of advanced reactor core structural materials. Main results arising from national and international R&D programmes and projects in the field were reviewed, and new activities to be carried out under the IAEA aegis were identified on the basis of the analysis of current research and technology gaps

  8. Characterization and testing of materials for nuclear reactors. Proceedings of a technical meeting

    International Nuclear Information System (INIS)

    2007-03-01

    Nuclear techniques in general and neutrons based methods in particular have played and will continue to play an important role in research in materials science and technology. Today the world is looking at nuclear fission and nuclear fusion as the main sources of energy supply for the future. Research reactors have played a key role in the development of nuclear technology. A materials development programme will thus play a major role in the design and development of new nuclear power plants, for the extension of the life of operating reactors as well as for fusion reactors. Against this background, the IAEA had organized a Technical Meeting on Development, Characterization and Testing of Materials - With Special Reference to the Energy Sector under the activity on specific applications of research reactors. The meeting was held in Vienna, May 29- June 2, 2006. There was also participation by experts in techniques, complementary to neutrons. The participants for the technical meeting were experts in the utilization of nuclear techniques namely the high flux and medium flux research reactors, fusion research and positron annihilation. They presented the design, development and utilization of the facilities at their respective centres for materials characterization with main focus on materials for nuclear energy, both fission and fusion. In core irradiation of materials, development of instrument for residual stress measurement in large and / or irradiated specimen, neutron radiography for inspection of irradiated fuel, work on oxide dispersion strengthened (ODS) steels and SiC composites, relevant to future power systems were cited as application of nuclear techniques in fission reactors. The use of neutron scattering for helium bubbles in steel, application of positron annihilation to study helium bubbles in Cu, Ti-stabilized stainless steel and voidswelling studies etc. show that these techniques have an important role in the development of materials for energy

  9. Neutron reflectometry: A probe for materials surfaces. Proceedings of a technical meeting

    International Nuclear Information System (INIS)

    2006-01-01

    Research reactors play an important role in delivering the benefits of nuclear science and technology. The IAEA, through its project on the effective utilization of research reactors, has been providing technical support to Member States and promotes activities related to specific applications. Neutron beam research is one of the main components in materials science studies. Neutron reflectometry is extremely useful for characterizing thin films and layered structures, polymers, oxide coatings on metals and biological membranes. The neutron has been a major probe for investigating magnetic materials. Development of magnetic multilayers is important for diverse applications in sensors, memory devices, etc. The special nature of the interaction of the neutron with matter makes it an important tool to locate low z elements in the presence of high z elements, which is useful in biology and polymer science. The role of neutron reflectometry in research and development in materials science and technology was discussed in a consultants meeting held in 2003. Following this, a technical meeting was organized from 16 to 20 August 2004 in Vienna to discuss the current status of neutron reflectometry, including the instrumentation, data acquisition, data analysis and applications. Experts in the field of neutron reflectometry presented their contributions, after which there was a brainstorming session on various aspects of the technique and its applications. This publication is the outcome of deliberations during the meeting and the presentations by the participants. This publication will be of use to scientists planning to develop a neutron reflectometer at research reactors. It will also help disseminate knowledge and information to material scientists, biologists and chemists working towards characterizing and developing new materials

  10. Report of the consultants' meeting on traceability of IAEA-AQCS reference materials to SI-units

    International Nuclear Information System (INIS)

    2002-01-01

    The purpose of the meeting was to discuss the present Agency's Analytical Quality Control Services (AQCS) procedure for the characterization of reference materials and to identify necessary improvements or changes needed to fulfill the requirements on traceability and uncertainty related to the property value of IAEA reference materials. This publication contains a summary of the discussions held at the meeting as well as specific recommendations made by the consultants. It also contains draft reports of two previous meetings and individual papers presented by the consultants at the meeting. These reports and papers have been provided with abstracts and indexed separately

  11. Design of training centres for nuclear power plants. Working material. Proceedings of a specialists` meeting

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-11-01

    The purpose of this meeting was to provide an international forum for presentation and discussion of experiences in the design and operation of training centres for nuclear power plant personnel. The term ``training centre``, as used during this meeting, includes both those facilities that are dedicated to provide training for an individual nuclear power plants, and that are often located near that plant, as well as facilities that provide training for multiple NPPs, and which are operated by vendors or by utility organizations that are not directly controlled by the NPP organizations which they serve. The topic, ``design of training centres`` was used in its broadest sense to include not only facilities (such as classrooms, laboratories and simulators), but also design of: training organizations; training programmes and materials; and examination/evaluation methods. Refs, figs, tabs.

  12. Design of training centres for nuclear power plants. Working material. Proceedings of a specialists' meeting

    International Nuclear Information System (INIS)

    1996-01-01

    The purpose of this meeting was to provide an international forum for presentation and discussion of experiences in the design and operation of training centres for nuclear power plant personnel. The term ''training centre'', as used during this meeting, includes both those facilities that are dedicated to provide training for an individual nuclear power plants, and that are often located near that plant, as well as facilities that provide training for multiple NPPs, and which are operated by vendors or by utility organizations that are not directly controlled by the NPP organizations which they serve. The topic, ''design of training centres'' was used in its broadest sense to include not only facilities (such as classrooms, laboratories and simulators), but also design of: training organizations; training programmes and materials; and examination/evaluation methods. Refs, figs, tabs

  13. Measurement of residual stress in materials using neutrons. Proceedings of a technical meeting

    International Nuclear Information System (INIS)

    2005-06-01

    One of the objectives of the IAEA's project on effective utilization of research reactors is to promote the use of the existing research reactors based on their capabilities and is implemented through workshops and technical meetings. Measurement of residual stress is one of the techniques that find wide applications in materials development and testing. The Technical Meeting on Measurement of Residual Stress Using Neutrons was organized to meet this objective. This publication is the outcome of the deliberations during the meeting and the presentations by the participants and is addressed to the research reactor managers, users and designers of facilities for reactor utilization. It will especially benefit those seeking to develop new facilities or upgrade the existing ones to enhance the utilization of their research reactors. Experts with a long experience in developing and using neutron beam instruments in high flux and medium flux research reactors participated in this technical meeting. They presented the design, development and utilization of the facilities at their respective centres and reviewed the current status of the residual stress measurements using neutron beams from research reactors. The sessions included brainstorming on the methodology and data analysis, characterization and standardization of the equipment and identifying the scope for further development. This publication refers to the determination of residual and/or applied stresses in polycrystalline materials using neutron diffraction technique. Stress is developed during the synthesis and use of materials such as alloys and compounds. Measurement of residual stress is essential to improve the quality of synthesized materials and diagnosis of failure and/or reliability of fabricated components. Neutron scattering has played an important role in studying structure and dynamics of condensed matter. Neutron scattering is a non-destructive technique and is useful for testing large samples. The

  14. IAEA technical meeting on fissile material strategies for sustainable nuclear energy

    International Nuclear Information System (INIS)

    Ganguly, Chaitanyamoy; Koyama, Kazutoshi

    2005-01-01

    A Technical Meeting (TM) on 'Fissile Material Management Strategies for Sustainable Nuclear Energy' was organized by the International Atomic Energy Agency (IAEA) in Vienna from 12 to 15 September 2005. Prior to the TM, three Working Groups (WG) composed of experts from 10 countries prepared Key Issues papers on: 1) Uranium Demand and Supply through 2050; 2) Back-end Fuel Cycle Options; and 3) Sustainable Nuclear Energy beyond 2050: Cross-cutting Issues. Some 36 papers, including 3 key issue papers, were presented during the TM in 3 different sessions. The present paper summarizes the deliberations of the TM. (author)

  15. PREFACE: 2nd International Meeting for Researchers in Materials and Plasma Technology

    Science.gov (United States)

    Niño, Ely Dannier V.

    2013-11-01

    These proceedings present the written contributions of the participants of the 2nd International Meeting for Researchers in Materials and Plasma Technology, 2nd IMRMPT, which was held from February 27 to March 2, 2013 at the Pontificia Bolivariana Bucaramanga-UPB and Santander and Industrial - UIS Universities, Bucaramanga, Colombia, organized by research groups from GINTEP-UPB, FITEK-UIS. The IMRMPT, was the second version of biennial meetings that began in 2011. The three-day scientific program of the 2nd IMRMPT consisted in 14 Magisterial Conferences, 42 Oral Presentations and 48 Poster Presentations, with the participation of undergraduate and graduate students, professors, researchers and entrepreneurs from Colombia, Russia, France, Venezuela, Brazil, Uruguay, Argentina, Peru, Mexico, United States, among others. Moreover, the objective of IMRMPT was to bring together national and international researchers in order to establish scientific cooperation in the field of materials science and plasma technology; introduce new techniques of surface treatment of materials to improve properties of metals in terms of the deterioration due to corrosion, hydrogen embrittlement, abrasion, hardness, among others; and establish cooperation agreements between universities and industry. The topics covered in the 2nd IMRMPT include New Materials, Surface Physics, Laser and Hybrid Processes, Characterization of Materials, Thin Films and Nanomaterials, Surface Hardening Processes, Wear and Corrosion / Oxidation, Modeling, Simulation and Diagnostics, Plasma Applications and Technologies, Biomedical Coatings and Surface Treatments, Non Destructive Evaluation and Online Process Control, Surface Modification (Ion Implantation, Ion Nitriding, PVD, CVD). The editors hope that those interested in the are of materials science and plasma technology, enjoy the reading that reflect a wide range of topics. It is a pleasure to thank the sponsors and all the participants and contributors for

  16. Meeting of the Technical Working Group on Fast Reactors (TWG-FR) (41st Annual Meeting). Working Material

    International Nuclear Information System (INIS)

    2008-01-01

    The objectives of the meeting were to: - Exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); - Review the progress since the 40th TWG-FR Annual Meeting, including the status of the actions; - Consider meeting arrangements for 2008, 2009, 2010 and beyond; - Review the IAEA’s ongoing information exchange and coordinated research activities in the technical fields relevant to the TWG-FR (FRs and ADS), as well as coordination of the TWG-FR’s activities with other organizations and international initiatives; - Discuss future joint activities in view of IAEA’s Programme and Budget Cycles beyond 2008-2009

  17. Seminar Cum Meeting Report: Codata Task Group for Exchangeable Material Data Representation to Support Research and Education

    Directory of Open Access Journals (Sweden)

    T Ashino

    2008-11-01

    Full Text Available On March 4-5, 2008, the CODATA Task Group for Exchangeable Material Data Representation to Support Research and Education held a two day seminar cum meeting at the National Physical Laboratory (NPL, New Delhi, India, with NPL materials researchers and task group members representing material activities and databases from seven countries: European Union (The Czech Republic, France, and the Netherlands, India, Korea, Japan, and the United States. The NPL seminar included presentations about the researchers' work. The Task Group meeting included presentations about current data related activities of the members. Joint discussions between NPL researchers and CODATA task group members began an exchange of viewpoints among materials data producers, users, and databases developers. The seminar cum meeting included plans to continue and expand Task Group activities at the 2008 CODATA 21st Meeting in Kyiv, Ukraine.

  18. 1st IAEA research co-ordination meeting on 'plasma-material interaction data for mixed plasma facing materials in fusion reactors'. Summary report

    International Nuclear Information System (INIS)

    Janev, R.K.; Longhurst, G.

    1998-12-01

    The proceedings and conclusions of the 1st IAEA Research Co-ordination Meeting on 'Plasma-Material Interaction Data for Mixed Plasma Facing Materials in Fusion Reactors', held on December 19 and 20, 1998 at the IAEA Headquarters in Vienna, are briefly described. This report includes a summary of the presentations made by meeting participants, a review of the data availability and data needs in the areas from the scope of the Co-ordinated Research Project (CRP) on the subject of the meeting, and recommendations regarding the future work within this CRP. (author)

  19. Effects of Coating Materials and Processing Conditions on Flow Enhancement of Cohesive Acetaminophen Powders by High-Shear Processing With Pharmaceutical Lubricants.

    Science.gov (United States)

    Wei, Guoguang; Mangal, Sharad; Denman, John; Gengenbach, Thomas; Lee Bonar, Kevin; Khan, Rubayat I; Qu, Li; Li, Tonglei; Zhou, Qi Tony

    2017-10-01

    This study has investigated the surface coating efficiency and powder flow improvement of a model cohesive acetaminophen powder by high-shear processing with pharmaceutical lubricants through 2 common equipment, conical comil and high-shear mixer. Effects of coating materials and processing parameters on powder flow and surface coating coverage were evaluated. Both Carr's index and shear cell data indicated that processing with the lubricants using comil or high-shear mixer substantially improved the flow of the cohesive acetaminophen powder. Flow improvement was most pronounced for those processed with 1% wt/wt magnesium stearate, from "cohesive" for the V-blended sample to "easy flowing" for the optimally coated sample. Qualitative and quantitative characterizations demonstrated a greater degree of surface coverage for high-shear mixing compared with comilling; nevertheless, flow properties of the samples at the corresponding optimized conditions were comparable between 2 techniques. Scanning electron microscopy images demonstrated different coating mechanisms with magnesium stearate or l-leucine (magnesium stearate forms a coating layer and leucine coating increases surface roughness). Furthermore, surface coating with hydrophobic magnesium stearate did not retard the dissolution kinetics of acetaminophen. Future studies are warranted to evaluate tableting behavior of such dry-coated pharmaceutical powders. Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

  20. On the role of API in determining porosity, pore structure and bulk modulus of the skeletal material in pharmaceutical tablets formed with MCC as sole excipient.

    Science.gov (United States)

    Ridgway, Cathy; Bawuah, Prince; Markl, Daniel; Zeitler, J Axel; Ketolainen, Jarkko; Peiponen, Kai-Erik; Gane, Patrick

    2017-06-30

    The physical properties and mechanical integrity of pharmaceutical tablets are of major importance when loading with active pharmaceutical ingredient(s) (API) in order to ensure ease of processing, control of dosage and stability during transportation and handling prior to patient consumption. The interaction between API and excipient, acting as functional extender and binder, however, is little understood in this context. The API indomethacin is combined in this study with microcrystalline cellulose (MCC) at increasing loading levels. Tablets from the defined API/MCC ratios are made under conditions of controlled porosity and tablet thickness, resulting from different compression conditions, and thus compaction levels. Mercury intrusion porosimetry is used to establish the accessible pore volume, pore size distribution and, adopting the observed region of elastic intrusion-extrusion at high pressure, an elastic bulk modulus of the skeletal material is recorded. Porosity values are compared to previously published values derived from terahertz (THz) refractive index data obtained from exactly the same tablet sample sets. It is shown that the elastic bulk modulus is dependent on API wt% loading under constant tablet preparation conditions delivering equal dimensions and porosity. The findings are considered of novel value in respect to establishing consistency of tablet production and optimisation of physical properties. Copyright © 2017 Elsevier B.V. All rights reserved.

  1. Doctors and pharmaceutical industry.

    Science.gov (United States)

    Beran, Roy G

    2009-09-01

    The pharmaceutical industry is seen as seducing doctors by providing expensive gifts, subsidising travel and underwriting practice expenses in return for those doctors prescribing products that otherwise they would not use. This paints doctors in a very negative light; suggests doctors are available to the highest bidder; implies doctors do not adequately act as independent agents; and that doctors are driven more by self-interest than by patient needs. Similar practices, in other industries, are accepted as normal business behaviour but it is automatically assumed to be improper if the pharmaceutical industry supports doctors. Should the pharmaceutical industry withdraw educational grants then there would be: fewer scientific meetings; reduced attendance at conferences; limited post graduate education; and a depreciated level of maintenance of professional standards. To suggest that doctors prescribe inappropriately in return for largesse maligns their integrity but where there is no scientific reason to choose between different treatments then there can be little argument against selecting the product manufactured by a company that has invested in the doctor and the question arises as to whether this represents bad medicine? This paper will examine what constitutes non-professional conduct in response to inducements by the pharmaceutical industry. It will review: conflict of interest; relationships between doctors and pharma and the consequences for patients; and the need for critical appraisal before automatically decrying this relationship while accepting that there remain those who do not practice ethical medicine.

  2. Meeting of the Technical Working Group on Fast Reactors (TWG-FR) (39th annual meeting). Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2007-07-01

    The 39th Annual Meeting of the Technical Working Group on Fast Reactors (TWG FR) was held from 15-19 May 2006 in Beijing, China, at the invitation of the China Institute of Atomic Energy (CIAEA). The meeting was attended by TWG-FR Members and Advisers from the following Member States (MS): Belgium (observer), Brazil, China, France, Germany, India, Italy, Japan, the Republic of Kazakhstan, the Republic of Korea, the Russian Federation, Sweden (observer), the United Kingdom, and the United States. Belarus, Switzerland, the European Commission, and OECD/NEA were unable to participate. Moreover, Prof. Carlo Rubbia, CERN director general emeritus, participated, upon IAEA invitation, in the meeting as distinguished scientist and IAEA expert. Mr. S.C. Chetal, from India (Indira Gandhi Centre for Atomic Research, IGCAR), was appointed chairman. The objectives of the meeting were to: - Exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); - Review the progress since the 38th TWG-FR Annual Meeting, including the status of the actions; - Consider meeting arrangements for 2006 and 2007; - Reviewed the Agency's ongoing information exchange and co-ordinated research activities in the technical fields relevant to the TWG-FR (FRs and ADS), as well as co-ordination of the TWG-FR's activities with other organizations; - Discuss future joint activities in view of the Agency's Programme and Budget Cycle 2008-2009 (and beyond)

  3. Pharmaceutical Cocrystals

    OpenAIRE

    Korotkova, Elena I.; Kratochvíl, B.

    2014-01-01

    Cocrystals are very interesting and useful product. In this paper the main information about cocrystals is presented. It is shown that cocrystals are solid substances, which consist of few components mixed together. There are a lot of ways of cocrystals production and application. It is shown that cocrystals can be applied in medicine and pharmaceutical industry for improving different properties such as dissolution rate, melting point, solubility, chemical stability etc. Another way of cocry...

  4. Report of the consultants meeting on proper use of reference and control materials

    International Nuclear Information System (INIS)

    2002-01-01

    Quality control in analytical laboratories as a basis of a complete quality system needs still to be developed in many Member States. To support the dissemination of information in this field a consultants meeting on 'Proper Use of Reference and Quality Control Materials' was held at the IAEA Headquarters, Vienna, from 13 to 17 August 2001. The experts convened with the objective to prepare a TECDOC to advise analytical laboratories in Member States on the correct use of Certified Reference Materials (CRMs) for Quality Control purposes and give practical recommendations to expand this concept to in-house Quality Control Materials (QCMs). In view of the existing literature in this field an urgent need for a practical guidebook for the preparation and application of cost effective and matrix matching QCMs was identified and the experts tried to fill this gap from their relevant experience. One and a half days of lecturing was followed by intensive discussion and brain storming to create a list of key words, which were structured in a logical order to provide a frame for the projected document. Responsibilities were assigned and deadlines fixed for the submission of the full text. (author)

  5. Report of the consultants meeting on proper use of reference and control materials

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2002-07-01

    Quality control in analytical laboratories as a basis of a complete quality system needs still to be developed in many Member States. To support the dissemination of information in this field a consultants meeting on 'Proper Use of Reference and Quality Control Materials' was held at the IAEA Headquarters, Vienna, from 13 to 17 August 2001. The experts convened with the objective to prepare a TECDOC to advise analytical laboratories in Member States on the correct use of Certified Reference Materials (CRMs) for Quality Control purposes and give practical recommendations to expand this concept to in-house Quality Control Materials (QCMs). In view of the existing literature in this field an urgent need for a practical guidebook for the preparation and application of cost effective and matrix matching QCMs was identified and the experts tried to fill this gap from their relevant experience. One and a half days of lecturing was followed by intensive discussion and brain storming to create a list of key words, which were structured in a logical order to provide a frame for the projected document. Responsibilities were assigned and deadlines fixed for the submission of the full text. (author)

  6. Institute of Nuclear Materials Management 36. annual meeting: Proceedings. Volume 24

    International Nuclear Information System (INIS)

    Anon.

    1995-01-01

    The sessions at this meeting covered the following topics: international safeguards; physical protection; material control and accountability (MC and A) training; waste overview; nonproliferation and arms control -- US/former Soviet Union; MC and A/physical protection -- SNM storage; spent fuel storage; physical protection -- intrusion sensors and access delay; MC and A -- gamma ray and holdup measurements; MC and A -- neutron based measurements; MC and A/nonproliferation and arms control -- fissile materials disposition; low level waste; packaging and transportation; international safeguards and nonproliferation and arms control -- IAEA verification in the US; international safeguards and physical protection -- video systems; poster and demonstrations; international safeguards and physical protection -- T.I.D.'s, tags and seals; high level wastes and mixed waste; MC and A -- bulk measurements; MC and A and physical protection -- policy; nonproliferation and arms control -- detection and monitoring techniques; nonproliferation and arms control -- US-Russian lab-to-lab safeguards cooperation; MC and A -- information systems; physical protection and MC and A -- vulnerability assessments; waste management -- measurement; international safeguards -- integrated and remote monitoring systems; MC and A -- material control and accountability and indicators; nonproliferation and arms control -- treaties and analysis; nonproliferation and arms control -- plutonium/HEU nonproliferation; MC and A -- measurement control and verification; and international safeguards and nonproliferation and arms control -- environmental monitoring and export control. Separate abstracts were prepared for some of the papers in this volume

  7. 78 FR 19017 - Manufacturer of Controlled Substances; Notice of Application; Johnson Matthey Pharmaceutical...

    Science.gov (United States)

    2013-03-28

    ... DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Johnson Matthey Pharmaceutical Materials, Inc. Pursuant to Sec. 1301.33(a), Title... Matthey Pharmaceutical Materials, Inc., Pharmaceutical Service, 25 Patton Road, Devens, Massachusetts...

  8. Technical meeting on 'Review of solid and mobile fuels for partitioning and transmutation systems'. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2003-07-01

    The topics covered during the Meeting were divided into two Sessions. Session 1 - Qualification of Solid and Mobile Fuels delt with: Neutronic, fuel and material properties of a molten salt transmuter; and Preliminary analysis of transmutation fuels for KALIMER. Session 2 - Reactor Physics and Safety Characteristics of Transmutation Systems based on Solid and Mobile Fuel Types included the following: Activity in NEA for P and T area; IAEA activities in the area of partitioning and transmutation; The R and D activity in Brazil: A conceptual fast energy amplifier ADS cooled by helium double stata Th/U fuel cycle; Closed fuel cycle and contemporary tendencies of the nuclear facilities development; Current Russian activities in P and T area; Pyrochemical reprocessing and nuclear spent fuel disposal project; Fuel selection criteria specific for double stratum minor actinide burners.

  9. Supramolecular Pharmaceutical Sciences: A Novel Concept Combining Pharmaceutical Sciences and Supramolecular Chemistry with a Focus on Cyclodextrin-Based Supermolecules.

    Science.gov (United States)

    Higashi, Taishi; Iohara, Daisuke; Motoyama, Keiichi; Arima, Hidetoshi

    2018-01-01

    Supramolecular chemistry is an extremely useful and important domain for understanding pharmaceutical sciences because various physiological reactions and drug activities are based on supramolecular chemistry. However, it is not a major domain in the pharmaceutical field. In this review, we propose a new concept in pharmaceutical sciences termed "supramolecular pharmaceutical sciences," which combines pharmaceutical sciences and supramolecular chemistry. This concept could be useful for developing new ideas, methods, hypotheses, strategies, materials, and mechanisms in pharmaceutical sciences. Herein, we focus on cyclodextrin (CyD)-based supermolecules, because CyDs have been used not only as pharmaceutical excipients or active pharmaceutical ingredients but also as components of supermolecules.

  10. IAEA technical meeting on atomic and plasma-material interaction data for fusion science technology. Summary report

    International Nuclear Information System (INIS)

    Clark, R.E.H.

    2003-10-01

    The proceedings and conclusions of the Technical Meeting on 'Atomic and Plasma- Material Interaction Data for Fusion Science Technology' held in Juelich, Germany on October 28-31 are summarized. During the course of the meetings working groups were formed to review the status of specific areas of atomic, molecular and material physics of relevance to fusion and to make recommendations on data needs in fusion from these areas. The reports of those working groups are summarized and the complete reports included as appendices. This meeting brought together over fifty leading scientists in fusion related data. Results of research in a number of topics were presented and very useful discussions were held. The meeting was extremely successful. (author)

  11. The use of atomic spectroscopy in the pharmaceutical industry for the determination of trace elements in pharmaceuticals.

    Science.gov (United States)

    Lewen, Nancy

    2011-06-25

    The subject of the analysis of various elements, including metals and metalloids, in the pharmaceutical industry has seen increasing importance in the last 10-15 years, as modern analytical instrumentation has afforded analysts with the opportunity to provide element-specific, accurate and meaningful information related to pharmaceutical products. Armed with toxicological data, compendial and regulatory agencies have revisited traditional approaches to the testing of pharmaceuticals for metals and metalloids, and analysts have begun to employ the techniques of atomic spectroscopy, such as flame- and graphite furnace atomic absorption spectroscopy (FAAS, Flame AA or FAA and GFAAS), inductively coupled plasma-atomic emission spectroscopy (ICP-AES) and inductively coupled plasma-mass spectrometry (ICP-MS), to meet their analytical needs. Newer techniques, such as laser-induced breakdown spectroscopy (LIBS) and Laser Ablation ICP-MS (LAICP-MS) are also beginning to see wider applications in the analysis of elements in the pharmaceutical industry.This article will provide a perspective regarding the various applications of atomic spectroscopy in the analysis of metals and metalloids in drug products, active pharmaceutical ingredients (API's), raw materials and intermediates. The application of atomic spectroscopy in the analysis of metals and metalloids in clinical samples, nutraceutical, metabolism and pharmacokinetic samples will not be addressed in this work. Copyright © 2010 Elsevier B.V. All rights reserved.

  12. Advanced fuel pellet materials and designs for water cooled reactors. Proceedings of a technical committee meeting

    International Nuclear Information System (INIS)

    2004-10-01

    This meeting was the second IAEA meeting on this subject. The first was held in 1996 in Tokyo, Japan. They are all part of a cooperative effort through the Technical Working Group on Water Reactor Fuel Performance and Technology (TWGFPT) of IAEA, with a series of three further meetings organized by CEA, France and co-sponsored by the IAEA and OECD/NEA. In the seven years since the first meeting took place, the demands on fuel duties have increased, with higher burnup, longer fuel cycles and higher temperatures. This places additional demands on fuel performance to comply with safety requirements. Criteria relative to fuel components, i.e. pellets and fuel rod column, require limiting of fission gas release and pellet-cladding interaction (PCI). This means that fuel components should maintain the composite of rather contradictory properties from the beginning until the end of its in-pile operation. Fabrication and design tools are available to influence, and to some extent, to ensure desirable in-pile fuel properties. Discussion of these tools was one of the objectives of the meeting. The second objective was the analysis of fuel characteristics at high burnup and the third and last objective was the discussion of specific feature of MOX and urania gadolinia fuels. Sixty specialists in the field of fuel fabrication technology attended the meeting from 18 countries. Twenty-five papers were presented in five sessions covering all relevant topics from the practices and modelling of fuel fabrication technology to its optimization. Eight papers were presented in session 'Optimization of fuel fabrication technology' which all were devoted to fuel fabrication technology. They mostly treated methods for optimizing fuel manufacturing processes, but gave also a good overview on nuclear fabrication needs and capabilities in different countries. During Session 'UO 2 , MOX and UO 2 -Gd 2 O 3 pellets with additives', six papers were presented in this session, which dealt mainly

  13. Effects and detection of raw material variability on the performance of near-infrared calibration models for pharmaceutical products.

    Science.gov (United States)

    Igne, Benoit; Shi, Zhenqi; Drennen, James K; Anderson, Carl A

    2014-02-01

    The impact of raw material variability on the prediction ability of a near-infrared calibration model was studied. Calibrations, developed from a quaternary mixture design comprising theophylline anhydrous, lactose monohydrate, microcrystalline cellulose, and soluble starch, were challenged by intentional variation of raw material properties. A design with two theophylline physical forms, three lactose particle sizes, and two starch manufacturers was created to test model robustness. Further challenges to the models were accomplished through environmental conditions. Along with full-spectrum partial least squares (PLS) modeling, variable selection by dynamic backward PLS and genetic algorithms was utilized in an effort to mitigate the effects of raw material variability. In addition to evaluating models based on their prediction statistics, prediction residuals were analyzed by analyses of variance and model diagnostics (Hotelling's T(2) and Q residuals). Full-spectrum models were significantly affected by lactose particle size. Models developed by selecting variables gave lower prediction errors and proved to be a good approach to limit the effect of changing raw material characteristics. Hotelling's T(2) and Q residuals provided valuable information that was not detectable when studying only prediction trends. Diagnostic statistics were demonstrated to be critical in the appropriate interpretation of the prediction of quality parameters. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association.

  14. 2nd (final) IAEA research co-ordination meeting on 'plasma-material interaction data for mixed plasma facing materials in fusion reactors'. Summary report

    International Nuclear Information System (INIS)

    Clark, R.E.H.

    2001-11-01

    The proceedings and conclusions of the 2nd Research Co-ordination Meeting on 'Plasma-Material Interaction Data for Mixed Plasma Facing Materials in Fusion Reactors', held on October 16 and 17, 2000 at the IAEA Headquarters in Vienna, are briefly described. This report includes a summary of the presentations made by the meeting participants and a review of the accomplishments of the Co-ordinated Research Project (CRP). In addition, short summaries from the participants are included indicating the specific research completed in support of this CRP. (author)

  15. Proceedings of the specialists' meeting on reliability of the ultrasonic inspection of austenitic materials

    International Nuclear Information System (INIS)

    1980-01-01

    The contributions of this meeting addressed several topics: the fundamentals of ultrasonic examination of austenitic materials (effect of anisotropy on propagation, improvement of ultrasonic testing to thick bimetallic welds, aspects of the ultrasonic testing of austenitic steel structures, utilization of a Fisher linear discriminant function in intergranular stress corrosion cracking or IGSCC detection, case of coarse grain austenitic welds, efforts of the Argonne National Laboratory), instruments and methods (longitudinal wave ultrasonic inspection, Grass echo suppression technique during the ultrasonic inspection of fuel cladding tubes, inspections of fillet and butt welds, improvement by signal averaging techniques, multiple bearing angle crack detector for cladded pipes examinations, flow-to-grain echo enhancement by split-spectrum processing, ultrasonic imaging techniques, ultrasonic inspection of pipe weldments for IGSCC), industrial practice (ultrasonic testing techniques for fabrication and in-service inspection, experiences in ultrasonic examination of austenitic steel components, experience and practice on nuclear piping in Spain, detection of underclad defects, sizing of cracks perpendicular to stainless overlay), and reliability (survey of ultrasonic testing in austenitic weld material, examination of electron beam welds, factors affecting the reliability of ultrasonic examination, detectability of IGSCC, ultrasonic inspection reliability for primary piping systems)

  16. Proceedings of the specialists' meeting on reliability of the ultrasonic inspection of austenitic materials

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1980-07-01

    The contributions of this meeting addressed several topics: the fundamentals of ultrasonic examination of austenitic materials (effect of anisotropy on propagation, improvement of ultrasonic testing to thick bimetallic welds, aspects of the ultrasonic testing of austenitic steel structures, utilization of a Fisher linear discriminant function in intergranular stress corrosion cracking or IGSCC detection, case of coarse grain austenitic welds, efforts of the Argonne National Laboratory), instruments and methods (longitudinal wave ultrasonic inspection, Grass echo suppression technique during the ultrasonic inspection of fuel cladding tubes, inspections of fillet and butt welds, improvement by signal averaging techniques, multiple bearing angle crack detector for cladded pipes examinations, flow-to-grain echo enhancement by split-spectrum processing, ultrasonic imaging techniques, ultrasonic inspection of pipe weldments for IGSCC), industrial practice (ultrasonic testing techniques for fabrication and in-service inspection, experiences in ultrasonic examination of austenitic steel components, experience and practice on nuclear piping in Spain, detection of underclad defects, sizing of cracks perpendicular to stainless overlay), and reliability (survey of ultrasonic testing in austenitic weld material, examination of electron beam welds, factors affecting the reliability of ultrasonic examination, detectability of IGSCC, ultrasonic inspection reliability for primary piping systems)

  17. Using a home blood pressure monitor: do accompanying instructional materials meet low literacy guidelines?

    Science.gov (United States)

    Wallace, Lorraine S; Keenum, Amy J

    2008-08-01

    To evaluate the readability and related features of English language Quick Reference Guides (QRGs) and User Manuals (UMs) accompanying home blood pressure monitors (HBPMs). We evaluated QRGs and UMs for 22 HBPMs [arm (n=12); wrist (n=10)]. Using established criteria, we evaluated reading grade level, language availability, dimensions, text point size, use of illustrations, layout/formatting characteristics, and emphasis of key points of English-language patient instructions accompanying HBPMs. Readability was calculated using McLaughlin's Simplified Measure of Gobbledygoop. Items from the Suitability of Materials Assessment and User-Friendliness Tool were used to assess various layout features. Simplified Measure of Gobbledygoop scores of both QRGs (mean+/-SD=9.1+/-0.8) and UMs (9.3+/-0.8) ranged from 8th to 10th grade. QRGs and UMs presented steps in chronological order, used active voice throughout, avoided use of specialty fonts, focused on need to know, and used realistic illustrations. Seven sets of instructions included all seven key points related to proper HPBM use, whereas three sets of instructions included less than or equal to three key points (mean=4.8+/-1.9). Although most QRGs and UMs met at least some recommended low-literacy formatting guidelines, all instructional materials should be developed and tested to meet the needs of the patient population at large. Key points related to proper HBPM use should not only be included within these instructions, but highlighted to emphasize their importance.

  18. Chemometric analysis for identification of botanical raw materials for pharmaceutical use: a case study using Panax notoginseng.

    Science.gov (United States)

    Zhu, Jieqiang; Fan, Xiaohui; Cheng, Yiyu; Agarwal, Rajiv; Moore, Christine M V; Chen, Shaw T; Tong, Weida

    2014-01-01

    The overall control of the quality of botanical drugs starts from the botanical raw material, continues through preparation of the botanical drug substance and culminates with the botanical drug product. Chromatographic and spectroscopic fingerprinting has been widely used as a tool for the quality control of herbal/botanical medicines. However, discussions are still on-going on whether a single technique provides adequate information to control the quality of botanical drugs. In this study, high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC), capillary electrophoresis (CE) and near infrared spectroscopy (NIR) were used to generate fingerprints of different plant parts of Panax notoginseng. The power of these chromatographic and spectroscopic techniques to evaluate the identity of botanical raw materials were further compared and investigated in light of the capability to distinguishing different parts of Panax notoginseng. Principal component analysis (PCA) and clustering results showed that samples were classified better when UPLC- and HPLC-based fingerprints were employed, which suggested that UPLC- and HPLC-based fingerprinting are superior to CE- and NIR-based fingerprinting. The UPLC- and HPLC- based fingerprinting with PCA were able to correctly distinguish between samples sourced from rhizomes and main root. Using chemometrics and its ability to distinguish between different plant parts could be a powerful tool to help assure the identity and quality of the botanical raw materials and to support the safety and efficacy of the botanical drug products.

  19. Chemometric analysis for identification of botanical raw materials for pharmaceutical use: a case study using Panax notoginseng.

    Directory of Open Access Journals (Sweden)

    Jieqiang Zhu

    Full Text Available The overall control of the quality of botanical drugs starts from the botanical raw material, continues through preparation of the botanical drug substance and culminates with the botanical drug product. Chromatographic and spectroscopic fingerprinting has been widely used as a tool for the quality control of herbal/botanical medicines. However, discussions are still on-going on whether a single technique provides adequate information to control the quality of botanical drugs. In this study, high performance liquid chromatography (HPLC, ultra performance liquid chromatography (UPLC, capillary electrophoresis (CE and near infrared spectroscopy (NIR were used to generate fingerprints of different plant parts of Panax notoginseng. The power of these chromatographic and spectroscopic techniques to evaluate the identity of botanical raw materials were further compared and investigated in light of the capability to distinguishing different parts of Panax notoginseng. Principal component analysis (PCA and clustering results showed that samples were classified better when UPLC- and HPLC-based fingerprints were employed, which suggested that UPLC- and HPLC-based fingerprinting are superior to CE- and NIR-based fingerprinting. The UPLC- and HPLC- based fingerprinting with PCA were able to correctly distinguish between samples sourced from rhizomes and main root. Using chemometrics and its ability to distinguish between different plant parts could be a powerful tool to help assure the identity and quality of the botanical raw materials and to support the safety and efficacy of the botanical drug products.

  20. Imaging of Crystalline and Amorphous Surface Regions Using Time-of-Flight Secondary-Ion Mass Spectrometry (ToF-SIMS): Application to Pharmaceutical Materials.

    Science.gov (United States)

    Iuraş, Andreea; Scurr, David J; Boissier, Catherine; Nicholas, Mark L; Roberts, Clive J; Alexander, Morgan R

    2016-04-05

    The structure of a material, in particular the extremes of crystalline and amorphous forms, significantly impacts material performance in numerous sectors such as semiconductors, energy storage, and pharmaceutical products, which are investigated in this paper. To characterize the spatial distribution for crystalline-amorphous forms at the uppermost molecular surface layer, we performed time-of-flight secondary-ion mass spectroscopy (ToF-SIMS) measurements for quench-cooled amorphous and recrystallized samples of the drugs indomethacin, felodipine, and acetaminophen. Polarized light microscopy was used to localize crystallinity induced in the samples under controlled conditions. Principal component analysis was used to identify the subtle changes in the ToF-SIMS spectra indicative of the amorphous and crystalline forms for each drug. The indicators of amorphous and crystalline surfaces were common in type across the three drugs, and could be explained in general terms of crystal packing and intermolecular bonding, leading to intramolecular bond scission in the formation of secondary ions. Less intramolecular scission occurred in the amorphous form, resulting in a greater intensity of molecular and dimer secondary ions. To test the generality of amorphous-crystalline differentiation using ToF-SIMS, a different recrystallization method was investigated where acetaminophen single crystals were recrystallized from supersaturated solutions. The findings indicated that the ability to assign the crystalline/amorphous state of the sample using ToF-SIMS was insensitive to the recrystallization method. This demonstrates that ToF-SIMS is capable of detecting and mapping ordered crystalline and disordered amorphous molecular materials forms at micron spatial resolution in the uppermost surface of a material.

  1. Specialists' meeting on correlation between material properties and thermohydraulics conditions in LMFRs

    International Nuclear Information System (INIS)

    1994-01-01

    In a liquid metal fast reactor (LMFR), temperature fluctuations in the fluid close to a structure occur in many areas: core outlet zone, lower part of hot pool, free surface of pool, IHX outlet, secondary circuit, water steam interface in steam generators. In some conditions, these temperature fluctuations can lead to mechanical damage to structures. Consequently, knowledge of temperature fluctuations and induced thermomechanical damage to structures is essential to support design and maintenance during the plant life-time. In response to a recommendation from the IWGFR, the IAEA convened a Specialist Meeting on 'Correlation between material properties and thermohydraulics conditions in LMFRs' in November 1994. The purpose of the meeting was to exchange information on the state of the art on thermalhydraulic aspects of temperature fluctuations (mixing jet phenomena, temperature gradient fluctuations, transfer of fluctuations from the fluid to the wall), and associated thermomechanical studies (thermal striping, thermal ratchetting, high strain fatigue) as well as design criteria to avoid damage. The main areas discussed by the delegates were: thermalhydraulics and thermomechanics. The objective of thermalhydraulic activities is the characterization of the temperature fluctuations on the wall. Three main items can be identified, for which both the experimental and calculational approaches were considered: identification of the areas where the fluctuations may occur; characterization of the fluctuations in the fluid; and transfer of the fluid fluctuations to the walls. For thermomechanical studies, which cover the effect of the fluctuations in the structures, the following subjects are of great importance: determination of the damage modes induced by thermal loadings in structures (thermal striping, ratchetting, high strain fatigue), and study of all damage modes so as to take them into account in the design criteria and to provide rules for avoiding failure of the

  2. Specialists' meeting on correlation between material properties and thermohydraulics conditions in LMFRs

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1994-07-01

    In a liquid metal fast reactor (LMFR), temperature fluctuations in the fluid close to a structure occur in many areas: core outlet zone, lower part of hot pool, free surface of pool, IHX outlet, secondary circuit, water steam interface in steam generators. In some conditions, these temperature fluctuations can lead to mechanical damage to structures. Consequently, knowledge of temperature fluctuations and induced thermomechanical damage to structures is essential to support design and maintenance during the plant life-time. In response to a recommendation from the IWGFR, the IAEA convened a Specialist Meeting on 'Correlation between material properties and thermohydraulics conditions in LMFRs' in November 1994. The purpose of the meeting was to exchange information on the state of the art on thermalhydraulic aspects of temperature fluctuations (mixing jet phenomena, temperature gradient fluctuations, transfer of fluctuations from the fluid to the wall), and associated thermomechanical studies (thermal striping, thermal ratchetting, high strain fatigue) as well as design criteria to avoid damage. The main areas discussed by the delegates were: thermalhydraulics and thermomechanics. The objective of thermalhydraulic activities is the characterization of the temperature fluctuations on the wall. Three main items can be identified, for which both the experimental and calculational approaches were considered: identification of the areas where the fluctuations may occur; characterization of the fluctuations in the fluid; and transfer of the fluid fluctuations to the walls. For thermomechanical studies, which cover the effect of the fluctuations in the structures, the following subjects are of great importance: determination of the damage modes induced by thermal loadings in structures (thermal striping, ratchetting, high strain fatigue), and study of all damage modes so as to take them into account in the design criteria and to provide rules for avoiding failure of the

  3. Technical meeting on 'Primary coolant pipe rupture event in liquid metal cooled fast reactors'. Working material

    International Nuclear Information System (INIS)

    2003-01-01

    In Liquid Metal cooled Fast Reactors (LMFR) or in accelerator driven sub-critical systems (ADS) with LMFR like sub-critical cores, the primary coolant pipes (PCP) connect the primary coolant pumps to the grid plate. A rupture in one of these pipes could cause significant loss of coolant flow to the core with severe consequences. In loop type reactors, all primary pipelines are provided with double envelopes and inter-space coolant leak monitoring systems that permit leak detection before break. Thus, the PCP rupture event can be placed in the beyond design basis event (BDBE) category. Such an arrangement is difficult to incorporate for pool type reactors, and hence it could be argued that the PCP rupture event needs to be analysed in detail as a design basis event (DBE, category 4 event). The primary coolant pipes are made of ductile austenitic stainless steel material and operate at temperatures of the cold pool and at comparatively low pressures. For such low stressed piping with negligible creep and embrittlement effects, it is of interest to discuss under what design provisions, for pool type reactors, the guillotine rupture of PCP could be placed in the BDBE category. The topical Technical Meeting (TM) on 'Primary Coolant Pipe Rupture Event in Liquid Metal Cooled Reactors' was called to enable the specialists to present the philosophy and analyses applied on this topic in the various Member States for different LMFRs. The scope of the Technical Meeting was to provide a global forum for information exchange on the philosophy applied in the various participating Member States and the analyses performed for different LMFRs with regard to the primary coolant pipe rupture event. More specifically, the objectives of the Technical Meeting were to review the safety philosophy for the PCP rupture event in pool type LMFR, to assess the structural reliability of the PCP and the probability of rupture under different conditions (with/without in-service inspection), to

  4. Development of a new ferulic acid certified reference material for use in clinical chemistry and pharmaceutical analysis

    Directory of Open Access Journals (Sweden)

    Dezhi Yang

    2015-05-01

    Full Text Available This study compares the results of three certified methods, namely differential scanning calorimetry (DSC, the mass balance (MB method and coulometric titrimetry (CT, in the purity assessment of ferulic acid certified reference material (CRM. Purity and expanded uncertainty as determined by the three methods were respectively 99.81%, 0.16%; 99.79%, 0.16%; and 99.81%, 0.26% with, in all cases, a coverage factor (k of 2 (P=95%. The purity results are consistent indicating that the combination of DSC, the MB method and CT provides a confident assessment of the purity of suitable CRMs like ferulic acid.

  5. Development of a new ferulic acid certified reference material for use in clinical chemistry and pharmaceutical analysis.

    Science.gov (United States)

    Yang, Dezhi; Wang, Fengfeng; Zhang, Li; Gong, Ningbo; Lv, Yang

    2015-05-01

    This study compares the results of three certified methods, namely differential scanning calorimetry (DSC), the mass balance (MB) method and coulometric titrimetry (CT), in the purity assessment of ferulic acid certified reference material (CRM). Purity and expanded uncertainty as determined by the three methods were respectively 99.81%, 0.16%; 99.79%, 0.16%; and 99.81%, 0.26% with, in all cases, a coverage factor (k) of 2 (P=95%). The purity results are consistent indicating that the combination of DSC, the MB method and CT provides a confident assessment of the purity of suitable CRMs like ferulic acid.

  6. Division of Development and Technology Plasma/Materials Interaction and High Heat Flux Materials and Components Task Groups: Report on the joint meeting, July 9, 1986

    International Nuclear Information System (INIS)

    Watson, R.D.

    1986-09-01

    This paper contains a collection of viewgraphs from a joint meeting of the Division of Development and Technology Plasma/Materials Interaction and High Heat Flux Materials and Components Task Groups. A list of contributing topics is: PPPL update, ATF update, Los Alamos RFP program update, status of DIII-D, PMI graphite studies at ORNL, PMI studies for low atomic number materials, high heat flux materials issues, high heat flux testing program, particle confinement in tokamaks, helium self pumping, self-regenerating coatings technical planning activity and international collaboration update

  7. Container-content compatibility studies: a pharmaceutical team's integrated approach.

    Science.gov (United States)

    Laschi, Alda; Sehnal, Natacha; Alarcon, Antoine; Barcelo, Beatrice; Caire-Maurisier, François; Delaire, Myriam; Feuilloley, Marc; Genot, Stéphanie; Lacaze, Catherine; Pisarik, Luc; Smati, Christophe

    2009-01-01

    Container-content compatibility studies are required as part of the submission of a new product market authorization file or for a change relating to the primary product-contact packaging. Many regulatory publications and guidances are available in the USA, Europe, and Japan. However these publications and guidances are not sufficiently precise enough to allow for consistent interpretation and implementation of the technical requirements. A working group has been formed by the French Society of Pharmaceutical Science and Technology (SFSTP) in order to propose guidance for container-content interaction studies that meet both European and US requirements, and allows consistent and standardized information to be presented by the industry to the regulators. When a pharmaceutical drug product remains in prolonged contact with a material, the two critical points to consider are the drug product's quality and safety. A pharmaceutical evaluation of the container-content relationship should be done based on the knowledge of the contact material (e.g., type, physicochemical properties), its manufacturing processes (e.g., the type of sterilization that could potentially alter the interactions), and the formulation components involved in contact with this material (e.g., physicochemical properties, pharmaceutical presentation, route of administration). Quality is evaluated using the stability study performed on the product. Safety is partially evaluated with the stability study and is analyzed in conjunction with toxicity testing, specifically with cytotoxicity testing. The toxicity aspect is the key point of the container-content compatibility study and of patient safety. Migration tests are conducted when an interaction is suspected, or found based on previous results, to identify the component responsible for this interaction and to help select a new material if needed. Therefore, such tests are perhaps not the best ones to use for the purpose of safety evaluation

  8. Meeting of the Chemical Societies: Almanac of the contributions of the fifty-third meeting of the chemical societies, Vol. 3

    International Nuclear Information System (INIS)

    Toelgyessy, J.

    2001-09-01

    The publication has been set up as the abstracts of the meeting dealing with different chemical problems. The book (Vol. 3) consists of the sections: (F) Chemistry of polymers, organic materials, textile, fibres, foil materials (63 papers); (I) Organic and pharmaceutical chemistry (59 papers); (J) Food chemistry and biotechnology (26 papers); (M) Environment, Toxicology (51 papers)

  9. Materials Substitution and Recycling. Proceedings of the Meeting of the Structures and Materials Panel (57th) Held at Vimeiro, Portugal on 14-19 October 1983.

    Science.gov (United States)

    1984-04-01

    No.356 MATERIALS SUBSTITUTION AND RECYCLING Papers presented at the 5 7th Meeting of the Structures and Materials Panel in Vimneiro, Portupi. 19 -14...nation. The mission of AGARD is carried out through the Panels which are composed of experts appointed by the National Delegates, the Consultant and...composition. The quality heat treatment for monocrystalline alloys such as CMSX2 normally consists of a 3-stage process, viz., Stage 1 2-3 hours @ 1260°C

  10. ELWIRA "Plants, wood, steel, concrete - a lifecycle as construction materials": University meets school - science meets high school education

    Science.gov (United States)

    Strauss-Sieberth, Alexandra; Strauss, Alfred; Kalny, Gerda; Rauch, Hans Peter; Loiskandl, Willibald

    2016-04-01

    The research project "Plants, wood, steel, concrete - a lifecycle as construction materials" (ELWIRA) is in the framework of the Sparkling Science programme performed by the University of Natural Resources and Life Sciences together with the Billroth Gymnasium in Vienna. The targets of a Sparkling Science project are twofold (a) research and scientific activities should already be transferred in the education methods of schools in order to fascinate high school students for scientific methods and to spark young people's interest in research, and (b) exciting research questions not solved and innovative findings should be addressed. The high school students work together with the scientists on their existing research questions improve the school's profile and the high school student knowledge in the investigated Sparkling Science topic and can lead to a more diverse viewing by the involvement of the high school students. In the project ELWIRA scientists collaborate with the school to quantify and evaluate the properties of classical building materials like concrete and natural materials like plants and woodlogs in terms of their life cycle through the use of different laboratory and field methods. The collaboration with the high school students is structured in workshops, laboratory work and fieldworks. For an efficient coordination/communication, learning and research progress new advanced electronic media like "Moodle classes/courses" have been used and utilized by the high school students with great interest. The Moodle classes are of high importance in the knowledge transfer in the dialogue with the high school students. The research project is structured into four main areas associated with the efficiencies of building materials: (a) the aesthetic feeling of people in terms of the appearance of materials and associated structures will be evaluated by means of jointly developed and collected questionnaires. The analysis, interpretation and evaluation are carried

  11. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.

    Science.gov (United States)

    Gohel, Mukesh C; Sumitra G, Manhapra

    2002-02-19

    The objective of the present study was to obtain programmed drug delivery from hard gelatin capsules containing a hydrophilic plug (HPMC or guar gum). The significance of factors such as type of plug (powder or tablet), plug thickness and the formulation of fill material on the release pattern of diltiazem HCl, a model drug, was investigated. The body portion of the hard gelatin capsules was cross-linked by the combined effect of formaldehyde and heat treatment. A linear relationship was observed between weight of HPMC K15M and log % drug released at 4 h from the capsules containing the plug in powder form. In order to accelerate the drug release after a lag time of 4 h, addition of an effervescent blend, NaHCO(3) and citric acid, in the capsules was found to be essential. The plugs of HPMC in tablet form, with or without a water soluble adjuvant (NaCl or lactose) were used for obtaining immediate drug release after the lag time. Sodium chloride did not cause significant influence on drug release whereas lactose favourably affected the drug release. The capsules containing HPMC K15M tablet plug (200 mg) and 35 mg effervescent blend in body portion of the capsule met the selection criteria of less than 10% drug release in 4 h and immediate drug release thereafter. It is further shown that the drug release was also dependant on the type of swellable hydrophilic agent (HPMC or guar gum) and molecular weight of HPMC (K15M or 20 cPs). The results reveal that programmed drug delivery can be obtained from hard gelatin capsules by systemic formulation approach.

  12. Advanced Fuel Pellet Materials and Fuel Rod Design for Water Cooled Reactors. Proceedings of a Technical Committee Meeting

    International Nuclear Information System (INIS)

    2010-10-01

    The economics of current nuclear power plants have improved through increased fuel burnup and longer fuel cycles, i.e. increasing the effective time that fuel remains in the reactor core and the amount of energy it generates. Efficient consumption of fissile material in the fuel element before it is discharged from the reactor means that less fuel is required over the reactor's life cycle, which results in lower amounts of fresh fuel, lower spent fuel storage costs, and less waste for ultimate disposal. Better utilization of fissile nuclear materials, as well as more flexible power manoeuvring, place challenging operational demands on materials used in reactor components, and first of all, on fuel and cladding materials. It entails increased attention to measures ensuring desired in-pile fuel performance parameters that require adequate improvements in fuel material properties and fuel rod designs. These are the main reasons that motivated the IAEA Technical Working Group on Fuel Performance and Technology (TWG-FPT) to recommend the organization of a Technical Committee Meeting on Advanced Fuel Pellet Materials and Fuel Rod Designs for Power Reactors. The proposal was supported by the IAEA TWGs on Advanced Technologies for Light and Heavy Water-Cooled Reactors (TWG-LWR and TWG-HWR), and the meeting was held at the invitation of the Government of Switzerland at the Paul Scherrer Institute in Villigen, from 23 to 26 November 2009. This was the third IAEA meeting on these subjects (the first was held in 1996 in Tokyo, Japan, and the second in 2003 in Brussels, Belgium), which reflects the continuous interest in the above issues among Member States. The purpose of the meeting was to review the current status in the development of fuel pellet materials and to explore recent improvements in fuel rod designs for light and heavy water cooled power reactors. The meeting was attended by 45 specialists representing fuel vendors, nuclear utilities, research and development

  13. Proceedings of a specialists' meeting on application of the concepts of exclusion, exemption and clearance: Implications for the management of radioactive materials. Working material

    International Nuclear Information System (INIS)

    1997-01-01

    The international principles developed to help in the regulation and deregulation of low-activity materials require elaboration, and there is a need for guidance regarding their practical application. The objectives of the meeting, organized by the Agency were: To provide a forum in which concerns and issues concerned with the regulatory management of materials containing very low levels of radioactivity can be discussed; to develop strategies for resolving the issues through international action; to develop advice for Agency work in drafting guidance material for safety standards

  14. Pharmaceutical powder compaction technology

    National Research Council Canada - National Science Library

    Çelik, Metin

    2011-01-01

    "Revised to reflect modern pharmaceutical compacting techniques, this Second Edition guides pharmaceutical engineers, formulation scientists, and product development and quality assurance personnel...

  15. International Working Group on Life Management of Nuclear Power Plants regular meeting. Working material

    International Nuclear Information System (INIS)

    1994-01-01

    The aim of this meeting is to review the IWG activities in 1992-1993, other relevant activities, national programmes, projects of international organizations and provide recommendations of the Agency's activities, forward programmes in this area, priority scope and content of publications and meetings to be organized and sponsored by the Agency. Refs, figs and tabs

  16. Report of the 2nd research co-ordination meeting on reference materials for microanalytical nuclear techniques

    International Nuclear Information System (INIS)

    2002-01-01

    Many microanalytical procedure require specific natural-matrix reference materials containing very low levels of trace elements and having a high degree of homogeneity. This proposed CRP will specifically address the question of quality control materials for these techniques. The participants of the meeting discussed the requirements for certified reference materials to by used in microanalysis with particular emphasis on the homogeneity issues. This publication contains summary of the discussions along with conclusions and recommendations made by the participants. The publication also contains ten individual presentations delivered by the participants. Each of the individual papers has been provided with an abstract and indexed separately

  17. Data for Erosion and Tritium Retention in Beryllium Plasma-Facing Materials. Summary Report of the First Research Coordination Meeting

    International Nuclear Information System (INIS)

    Braams, B.J.

    2013-04-01

    Nine experts in the field of plasma-wall interaction on beryllium surfaces together with IAEA staff met at IAEA Headquarters 26-28 September 2012 for the First Research Coordination Meeting of an IAEA Coordinated Research Project on data for erosion and tritium retention in beryllium plasma-facing materials. They described their on-going research, reviewed the main data needs and made plans for coordinated research during the remaining years of the project. The proceedings of the meeting are summarized in this report. (author)

  18. Technical Meeting on Fast Reactors and Related Fuel Cycle Facilities with Improved Economic Characteristics. Working Material

    International Nuclear Information System (INIS)

    2013-01-01

    In recent years, engineering oriented work, rather than basic research and development (R&D), has led to significant progress in improving the economics of innovative fast reactors and associated fuel cycle facilities, while maintaining and even enhancing the safety features of these systems. Optimization of plant size and layout, more compact designs, reduction of the amount of plant materials and the building volumes, higher operating temperatures to attain higher generating efficiencies, improvement of load factor, extended core lifetimes, high fuel burnup, etc. are good examples of achievements to date that have improved the economics of fast neutron systems. The IAEA, through its Technical Working Group on Fast Reactors (TWG-FR) and Technical Working Group on Nuclear Fuel Cycle Options and Spent Fuel Management (TWG-NFCO), devotes many of its initiatives to encouraging technical cooperation and promoting common research and technology development projects among Member States with fast reactor and advanced fuel cycle development programmes, with the general aim of catalysing and accelerating technology advances in these fields. In particular the theme of fast reactor deployment, scenarios and economics has been largely debated during the recent IAEA International Conference on Fast Reactors and Related Fuel Cycles: Safe Technologies and Sustainable Scenarios, held in Paris in March 2013. Several papers presented at this conference discussed the economics of fast reactors from different national and regional perspectives, including business cases, investment scenarios, funding mechanisms and design options that offer significant capital and energy production cost reductions. This Technical Meeting on Fast Reactors and Related Fuel Cycle Facilities with Improved Economic Characteristics addresses Member States’ expressed need for information exchange in the field, with the aim of identifying the main open issues and launching possible initiatives to help and

  19. Procedures for Evaluation of Atomic, Molecular and Plasma-Material Interaction Data for Fusion. Summary Report of an IAEA Consultants' Meeting

    International Nuclear Information System (INIS)

    Chung, Hyun-Kyung

    2012-05-01

    This report summarizes the proceedings of the IAEA Consultants' Meeting on 'Procedures for Evaluation of Atomic, Molecular and Plasma-Material Interaction Data for Fusion' on 7-9 February 2012. Fourteen participants from 8 Institutes of 3 Member States attended the three-day meeting held at the National Institute for Fusion Science, Toki in Japan. The report includes discussions on data evaluation activities, meeting conclusions and recommendations and the abstracts of presentations presented in the meeting. (author)

  20. [Fortieth Annual] Meeting of the Technical Working Group on Fast Reactors (TWG-FR). Working Material

    International Nuclear Information System (INIS)

    2008-01-01

    The objectives of the meeting were to: - Exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); - Review the progress since the 39th TWG-FR Annual Meeting, including the status of the actions; - Consider meeting arrangements for 2007, 2008 and 2009; - Review the Agency’s ongoing information exchange and co-ordinated research activities in the technical fields relevant to the TWG-FR (FRs and ADS), as well as coordination of the TWG-FR’s activities with other organizations; - Discuss future joint activities in view of the Agency’s Programme and Budget Cycle 2008–2009 (and beyond)

  1. Basic pharmaceutical technology

    OpenAIRE

    Angelovska, Bistra; Drakalska, Elena

    2017-01-01

    The lecture deals with basics of pharmaceutical technology as applied discipline of pharmaceutical science, whose main subject of study is formulation and manufacture of drugs. In a broad sense, pharmaceutical technology is science of formulation, preparation, stabilization and determination of the quality of medicines prepared in the pharmacy or in pharmaceutical industry

  2. Horizon Scanning for Pharmaceuticals

    DEFF Research Database (Denmark)

    Lepage-Nefkens, Isabelle; Douw, Karla; Mantjes, GertJan

    for a joint horizon scanning system (HSS).  We propose to create a central “horizon scanning unit” to perform the joint HS activities (a newly established unit, an existing HS unit, or a third party commissioned and financed by the collaborating countries). The unit will be responsible for the identification...... and filtration of new and emerging pharmaceutical products. It will maintain and update the HS database, organise company pipeline meetings, and disseminate the HSS’s outputs.  The HS unit works closely together with the designated national HS experts in each collaborating country. The national HS experts...... will collect country-specific information, liaise between the central HS unit and country-specific clinical and other experts, coordinate the national prioritization process (to select products for early assessment), and communicate the output of the HSS to national decision makers.  The outputs of the joint...

  3. Joint EC-IAEA topical meeting on development of new structural materials for advanced fission and fusion reactor systems. PowerPoint presentations

    International Nuclear Information System (INIS)

    2009-01-01

    The key topics of the meeting are the following: Radiation damage phenomena and modelling of material properties under irradiation; On-going challenges in radiation materials science; Key material parameters and operational conditions of selected reactor designs; Microstructures and mechanical properties of nuclear structural materials; Pathways to development of new structural materials; Qualification of new structural materials; Advanced microstructure probing methods; Special emphasis is given to the application of nuclear techniques in the development and qualification of new structural materials.

  4. PREFACE Surface Modifications of Diamond and Related Materials (Session D, E-MRS Spring Meeting)

    Science.gov (United States)

    Nebel, Christoph E.

    2010-11-01

    This special issue contains selected papers which were presented at the E-MRS Symposium BIOMATERIALS, SENSORS & SURFACES, D: 'Surface modifications of diamond and related materials' which was held on 7-9 June 2010 in Strasbourg (France). With about 54 oral and poster presentations given from teams all over the world it was a very interesting, dense and lively meeting. The symposium focused on chemical modifications applied to graft surfaces of diamond, nano-diamond particles, diamond-like carbon, graphene, graphite and carbon nano-tubes with linker molecular layers for realization of bio-sensors, bio-markers, separation techniques, and switchable chemical links. Presented techniques span spontaneous bonding to photo-chemical attachment, electrochemical modifications, to Suzuki-coupling of aryl molecules. Special attention was drawn to mechanisms driving bonding kinetics such as electron transfer reactions, hydrogen cleavage reactions by nucleophilic molecules and growths schemas which vary from correlated two-dimensional chain reactions to three-dimensional cross polymerization. Hydrogen terminations, surface defects, surface roughness and atomic arrangements of surface carbon atoms were of interest to elucidate bonding mechanisms. In addition, bonding stability, either of linker molecules or of complex functionalized surfaces with DNA, proteins and enzymes was discussed by several speakers as well as details of the electronic interfaces between solid transducers and bio-layers. Here the characterization of surface and interface defect densities, of Fermi level pinning and of electron transfer rates was a major topic. Miniaturization of sensor area and application of new detection schemas was discussed. Diamond nano-particles which are increasingly used as biomarkers in drug delivery experiments also attracted attention. The organizers express our gratitude to the international members of the scientific committee who actively contributed to ensure an attractive

  5. Research Reactor Application for Materials under High Neutron Fluence. Proceedings of an IAEA Technical Meeting (TM-34779)

    International Nuclear Information System (INIS)

    2011-05-01

    Research reactors (RRs) have played, and continue to play, a key role in the development of the peaceful uses of nuclear energy and technology. The role of the IAEA is to assist Member States in the effective utilization of these technologies in various domains of research such as fundamental and applied science, industry, human health care and environmental studies, as well as nuclear energy applications. In particular, material testing reactors (MTRs), serve as unique tools in scientific and technological development and they have quite a wide variety of applications. Today, a large range of different RR designs exist when compared with power reactors and they also have different operating modes, producing high neutron fluxes, which may be steady or pulsed. Recently, an urgent need has arisen for the development of new advanced materials, for example in the nuclear industry, where RRs offer capacities for irradiation programmes. Besides the scientific and research activities and commercial applications, RRs are also used extensively for educational training activities for scientists and engineers. This report is a compilation of outputs of an IAEA Technical Meeting (TM-34779) held on Research Reactor Application for Materials under High Neutron Fluence. The overall objective of the meeting was to review typical applications of small and medium size RRs, such as material characterization and testing, neutron physics and beam research, neutron radiography and imaging as well as isotope production and other types of non-nuclear applications. Several issues were discussed during the meeting, in particular: (1) recent development of irradiation facilities, specific irradiation programmes and their implementation; (2) effective and optimal RR operation regimes for irradiation purposes; (3) sharing of best practices and existing technical knowledge; and (4) fostering of advanced or innovative technologies, e.g. information exchange and effective collaboration. This

  6. In-Pile Testing and Instrumentation for Development of Generation-IV Fuels and Materials. Proceedings of a Technical Meeting

    International Nuclear Information System (INIS)

    2013-12-01

    For many years, the increase in efficiency in the production of nuclear electricity has been an economic challenge in many countries which have developed this kind of energy. The increase in fuel burnup and fuel residence time leads to a reduction in the volume of fresh fuel loaded and spent fuel discharged, respectively. More demanding nuclear fuel cycle parameters are combined with a need to operate nuclear power plants with maximal availability and load factors, in load-follow mode and with longer fuel cycles. In meeting these requirements, fuel has to operate in a demanding environment of high radiation fields, high temperatures, high mechanical stresses and high coolant flow. Requirements of increased fuel reliability and minimal fuel failures also remain in force. Under such circumstances, continuous development of more radiation resistant fuel materials, especially advanced cladding, careful and incremental examinations, and improved understanding and modelling of high burnup fuel behaviour are required. Following a recommendation of the IAEA Technical Working Group on Fuel Performance and Technology, the Technical Meeting on In-pile Testing and Instrumentation for Development of Generation-IV Fuels and Materials was held in Halden, Norway, on 21-24 August 2012. The purpose of the meeting was to review the current status and the progress in methods and technologies used for the in-pile testing of nuclear fuel achieved since the previous IAEA meeting on In-core Instrumentation and Reactor Core Assessment, also held in Halden in 2007. Emphasis was placed on advanced techniques applied for the understanding of high burnup fuel behaviour of water cooled power reactors that represent the vast majority of the current nuclear reactor fleet. However, the meeting also included papers and discussion on testing techniques applied or developed specifically for new fuel and structural materials considered for Generation-IV systems. The meeting was attended by 43

  7. Methodology for pressurized thermal shock evaluation. Proceedings of the IAEA specialists meeting. Working material

    International Nuclear Information System (INIS)

    1997-01-01

    The meeting was held within the scope of activities of the International Working Group, recognizing that the importance of the PTS phenomena and advances in the subject require regular information exchange in this field. The purpose of the meeting was to provide an opportunity to exchange information as well as new results in research and development, concentrating on the total PTS calculation and including PTS evaluation and application in RPV life time and integrity assessment. The papers presented at the meeting covered problems of thermohydraulics, RPV temperature-stress fields calculations, fracture mechanics approach to integrity assessment as well as discussions on PTS modeling, general procedures for RPV life assessment and mitigation methods other than RPV annealing. Refs, figs, tabs

  8. Methodology for pressurized thermal shock evaluation. Proceedings of the IAEA specialists meeting. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-09-01

    The meeting was held within the scope of activities of the International Working Group, recognizing that the importance of the PTS phenomena and advances in the subject require regular information exchange in this field. The purpose of the meeting was to provide an opportunity to exchange information as well as new results in research and development, concentrating on the total PTS calculation and including PTS evaluation and application in RPV life time and integrity assessment. The papers presented at the meeting covered problems of thermohydraulics, RPV temperature-stress fields calculations, fracture mechanics approach to integrity assessment as well as discussions on PTS modeling, general procedures for RPV life assessment and mitigation methods other than RPV annealing. Refs, figs, tabs.

  9. Irradiation effects and mitigation. Proceedings of the IAEA Specialists Meeting. Working material

    International Nuclear Information System (INIS)

    1997-01-01

    The IAEA Specialists Meeting on Irradiation Effects and Mitigation organised in co-operation with the Russian Research Centre 'Kurchatov Institute' was held at Vladimir, Russian Federation from 15 to 19 September 1997. Topics of the Meeting covered a number of problems including mechanisms of radiation damage, results of surveillance programmes and their analysis, effects of operating parameters, fracture mechanics tests and evaluation, annealing and optimisation of the process and reembrittlement after annealing. Specialists from 17 countries presented 31 paper, published in this proceedings each with a separate abstract

  10. IAEA Technical Meeting on Innovative Heat Exchanger and Steam Generator Designs for Fast Reactors. Working Material

    International Nuclear Information System (INIS)

    2011-01-01

    The IAEA, within the framework of its Nuclear Energy Department’s Technical Working Group on Fast Reactors (TWG-FR), assists Member States activities in fast reactors technology development areas by providing an umbrella for information exchange [topical Technical Meetings (TMs), Workshops and large Conferences] and collaborative R&D [Coordinated Research Projects (CRPs)]. The Technical meeting on “Innovative Heat Exchanger and Steam Generator Designs for Fast Reactors” was held from 21 – 22 December 2011 in Vienna, addressing Member States’ expressed needs of information exchange in the field of advanced fast reactor design features, with particular attention to innovative heat exchangers and steam generators. The Objective of the TM is to provide a global forum for in-depth information exchange and discussion on the most advanced concepts of heat exchangers and steam generators for fast reactors. More specifically, the objectives are: · Review of the status of advanced fast reactor development activities with special emphasis on design and performance of heat exchangers and steam generators; · Discuss requirements for innovative heat exchangers and steam generators; · Present results of studies and conceptual designs for innovative heat exchangers and steam generators; · Provide recommendations for international collaboration under the IAEA aegis. The meeting agenda of the meeting is in Annex I

  11. 77 FR 21592 - Proposal Review Panel for Materials Research; Notice of Meeting: Correction

    Science.gov (United States)

    2012-04-10

    .... This notice is to correct the ending time of the meeting on April 24, 2012 being held at the Pennsylvania State University, College Station, PA. Correction On page 19362, column 2, under Dates & Times.... Open-Poster Session''. Dated: April 5, 2012. Susanne Bolton, Committee Management Officer. [FR Doc...

  12. Technical meeting on decommissioning of fast reactors after sodium draining. Working material

    International Nuclear Information System (INIS)

    2005-01-01

    The objective of the technical meeting was to provide a forum for in-depth scientific and technical exchange on topics related to the decommissioning experience with fast reactors, in particular with regard to the decommissioning of components after sodium draining. Accordingly, the scope of the meeting covers the review and analyses of the experience gained from the decommissioning of both active sodium loops and sodium cooled fast reactors (e.g., KNK II, Superphenix, RAPSODIE, EBR-II, FERMI, BN-350, BR-10). It is expected that the outcome of the meeting will contribute to the Agency initiative to preserve fast reactor data and knowledge. The main focus of the technical meeting was given on the decommissioning of both active loop and reactor components (e.g., the primary vessel of a sodium-cooled reactor) that have been drained of sodium, but that still conserve some residual amounts of sodium (e.g., films covering the entire surface of the component, or particular sodium heels that cannot be drained)

  13. Use of PSA in the regulatory process. Report of the specialist's meeting. Working material

    International Nuclear Information System (INIS)

    1994-01-01

    The objective of this meeting was to focus on the role of the regulator in relation to PSA, to give a picture of the present status, and near term plans, of the requirements placed on licensees and of the uses, formal and informal, made of PSA in regulatory decision making. One such use, in which there is currently much interest, is known as Risk-Based Regulation. This term has various connotations but essentially refers to a more flexible and efficient application of Technical Specifications in the interests of gains in both economy and safety. The position in many countries is one of change in the use of PSA by regulators, and hence any report can only give a snapshot in time. It has to be noted that a number of countries, with important nuclear power programmes, were not represented at the meeting, and so the overall picture is not as comprehensive as might have been hoped. The field of the discussion in the meeting was divided into three areas, progressed in three working groups, namely: Regulatory requirements related to PSA, Regulatory uses of PSA, and Risk-Based Regulation. The outcomes are covered in the next three sections. The fifth section of this report gives the overall conclusions of the meeting and the final section makes some recommendations for future IAEA activities in these areas. Refs, figs, tabs

  14. Meeting of the Chemical Societies: Almanac of the contributions of the fifty-first meeting of the chemical societies. Vol. 3

    International Nuclear Information System (INIS)

    Uher, M.; Benes, P.; Carsky, J.; Ctrnactova, H.; Fecenko, J.; Fellner, P.; Hodul, P.; Koprda, V.; Kratochvil, B.; Krkoska, P.; Kuruc, J.; Lehotay, J.; Matousek, J.; Milichovsky, P.; Omastova, M.; Petrus, L. jr.; Petrus, L. sr.; Schwendt, P.; Silny, P.; Sevcik, P.; Toma, S.; Uherova, R.; Zachar, P.

    1999-09-01

    The publication has been set up as an abstracts of the meeting dealing with different chemical problems. The book (Vol. 3) consists of the sections: (E) Wood, pulp, paper (15 papers); (G) Macromolecular chemistry (42 papers); (H) Organic chemistry, bio-organic chemistry and pharmaceutical chemistry (96 Papers); (I) Food chemistry and biochemistry; (J) Textile, fibres and foil materials

  15. Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review.

    Science.gov (United States)

    Alkhaled, Lina; Kahale, Lara; Nass, Hala; Brax, Hneine; Fadlallah, Racha; Badr, Kamal; Akl, Elie A

    2014-07-01

    Pharmaceutical company representatives likely influence the prescribing habits and professional behaviour of physicians. The objective of this study was to systematically review the effects of interventions targeting practising physicians' interactions with pharmaceutical companies. We included observational studies, non-randomised controlled trials (non-RCTs) and RCTs evaluating legislative, educational, policy or other interventions targeting the interactions between physicians and pharmaceutical companies. The search strategy included an electronic search of MEDLINE and EMBASE. Two reviewers performed duplicate and independent study selection, data abstraction and assessment of risk of bias. We assessed the risk of bias in each included study. We summarised the findings narratively because the nature of the data did not allow a meta-analysis to be conducted. We assessed the quality of evidence by outcome using the GRADE methodology. Of 11 189 identified citations, one RCT and three observational studies met the eligibility criteria. All four studies specifically targeted one type of interaction with pharmaceutical companies, that is, interactions with drug representatives. The RCT provided moderate quality evidence of no effect of a 'collaborative approach' between the pharmaceutical industry and a health authority. The three observational studies provided low quality evidence suggesting a positive effect of policies aiming to reduce interaction between physicians and pharmaceutical companies (by restricting free samples, promotional material, and meetings with pharmaceutical company representatives) on prescription behaviour. We identified too few studies to allow strong conclusions. Available evidence suggests a potential impact of policies aiming to reduce interaction between physicians and drug representatives on physicians' prescription behaviour. We found no evidence concerning interventions affecting other types of interaction with pharmaceutical

  16. Applications of Research Reactors Towards Research on Materials for Nuclear Fusion Technology. Proceedings of a Technical Meeting

    International Nuclear Information System (INIS)

    2013-11-01

    of materials under development for Generation IV concepts. International collaboration among MTRs and specialized facilities has been identified as integral to progress in fusion development as well as enhancing reactor utilization. This publication specifies which areas of research remain in the qualification of structural materials and components, and has detailed the characteristics of many research reactors and devices that can accomplish an important portion of these necessary studies. This publication is the outcome of two recent IAEA sponsored meetings under its programme to enhance the utilization and collaboration of research reactor and material test facilities: - Consultancy meeting on Role of Research Reactors in Materials Research for Nuclear Fusion Technology, 13-15 December 2010, IAEA, Vienna; - Technical meeting on Materials under High Energy and High Intensity Neutron Fluxes for Nuclear Fusion Technology, 27-29 June 2011, IAEA, Vienna. These meetings brought together representatives from MTRs, spallation neutron sources, multiple beam irradiation facilities, material scientists as well as fusion community representatives to discuss the current state of fusion research and to plot necessary studies and modes of research collaboration

  17. Materials of 4. international meeting on pulse investigations in physics, chemistry and biology. PULS'94

    International Nuclear Information System (INIS)

    1994-01-01

    4. International Meeting on Pulse Investigations in Physics, Chemistry and Biology, PULS'94 has been organized in honor of Professor Jerzy Kroh, the precursor of radiation chemistry in Poland. The meeting has been divided into three sessions: the historical session (H) with four review lectures, lecture session (L) collected 23 papers and poster session (P) with 39 posters. The fundamental studies on early stages of radiolysis have been presented for different systems being irradiated. The pulse radiolysis and flash photolysis methods has been predominantly used in reported experimental works. The reaction of intermediate products of radiolysis and photolysis such a trapped and solvated electrons, ions and radicals has been extensively studied. The reaction mechanisms and kinetics have been also discussed

  18. Status of national programmes on fast reactors 1998/99. 32nd annual meeting. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-07-01

    Over the past 32 years, the IAEA has actively encouraged and advocated international cooperation in fast reactor technology. The present publication contains information on the status of fast reactor development and on worldwide activities in this advanced nuclear power technology during 1998/1999, as reported at the 32. annual meeting of the International Working Group on Fast Reactors. It is intended to provide information regarding the current status of LMFR development in IAEA Member States.

  19. Status of national programmes on fast reactors 1998/99. 32nd annual meeting. Working material

    International Nuclear Information System (INIS)

    1999-01-01

    Over the past 32 years, the IAEA has actively encouraged and advocated international cooperation in fast reactor technology. The present publication contains information on the status of fast reactor development and on worldwide activities in this advanced nuclear power technology during 1998/1999, as reported at the 32. annual meeting of the International Working Group on Fast Reactors. It is intended to provide information regarding the current status of LMFR development in IAEA Member States

  20. Technical Meeting on the Implementation of Fast Reactor Data Retrieval and Knowledge Preservation Activities. Working Material

    International Nuclear Information System (INIS)

    2008-01-01

    The current Technical Meeting was convened to foster the development of the FRKP initiative, in general, and, more specifically, to advance the development of the FRKP Portal. Its objectives were therefore: 1. To review the implementation status of the FRKP Portal prototype; 2. To review the availability of FR-related document collections made accessible through the FRKP Portal; 3. To locate sources of FR-related digital items to be made accessible through the FRKP portal

  1. Technical Meeting on Impact of Fukushima Event on Current and Future Fast Reactor Designs. Working Material

    International Nuclear Information System (INIS)

    2012-01-01

    The overall purpose of the Technical Meeting was to recognize and analyse the implications of the accident occurred at the Fukushima Dai-ichi Nuclear Power Station on current and future fast neutron systems design and operation. The aim was to provide a global forum for discussing the principal lessons learned from this event, and thus to review safety principles and characteristics of existing and future fast neutron concepts, especially in relation with extreme natural events which potentially may lead to severe accident scenarios. The participants also presented and discussed innovative technical solutions, design features and countermeasures for design extension conditions - including earthquakes, tsunami and other extreme natural hazards - which can enhance the safety level of existing and future fast neutron systems. Furthermore, the meeting gave the opportunity to present advanced methods for the evaluation of the robustness of plants against design extension conditions. Another important goal of this TM was to discuss how to harmonize safety approaches and goals for next generation’s fast reactors. Finally, the meeting was intended to identify areas where further research and development in nuclear safety, technology and engineering in the light of the Fukushima accident are needed. In the frame of the implementation of its Nuclear Safety Action Plan endorsed by all Member States, the IAEA will consider these areas as potential technical topics for new Coordinated Research Projects, to be launched in the near future

  2. Technical Meeting on Passive Shutdown Systems for Liquid Metal-Cooled Fast Reactors. Working Material

    International Nuclear Information System (INIS)

    2015-01-01

    A major focus of the design of modern fast reactor systems is on inherent and passive safety. Specific systems to improve reactor safety performance during accidental transients have been developed in nearly all fast reactor programs, and a large number of proposed systems have reached various stages of maturity. This Technical Meeting on Passive Shutdown Systems for Fast Reactors, which was recommended by the Technical Working Group on Fast Reactors (TWG-FR), addressed Member States’ expressed need for information exchange on projects and programs in the field, as well as for the identification of priorities based on the analysis of technology gaps to be covered through R&D activities. This meeting was limited to shutdown systems only, and did not include other passive features such as natural circulation decay heat removal systems etc.; however the meeting catered to passive shutdown safety devices applicable to all types of fast neutron systems. It was agreed to initiate a new study and produce a Nuclear Energy Series (NES) Technical Report to collect information about the existing operational systems as well as innovative concepts under development. This will be a useful source for member states interested in gaining technical expertise to develop passive shutdown systems as well as to highlight the importance and development in this area

  3. Advisory group meeting on design and performance of reactor and subcritical blanket systems with lead and lead-bismuth as coolant and/or target material. Working material

    International Nuclear Information System (INIS)

    2001-01-01

    The purpose of the IAEA Advisory Group Meeting (AGM) on Design and Performance of Reactor and Sub-critical Blanket Systems with Lead and Lead-Bismuth as Coolant and/or Target Material was to provide a forum for international information exchange on all the topics relevant to Pb and Pb/Bi cooled critical and sub-critical reactors. In addition, the AGM aimed at: (1) finding ways and means to improve international co-ordination efforts in this area; (2) obtaining advice from the Member States with regard to the activities to be implemented in this area by the IAEA, in order to best meet their needs; and (3) laying out the plans for an effective co-ordination and support of the R and D activities in this area. The AGM stressed that nuclear energy is a realistic solution to satisfy the energy demand, considering the limited resources of fossil fuel, its uneven distribution in the world and the impact of its use on the planet, and taking into account the expected doubling of the world population in the 21st century and tripling of the electricity demand (especially in the developing countries). However, the AGM concluded that the development of an innovative nuclear technology meeting the following requirements must be pursued: (a) deterministic exclusion of any severe accident; (b) proliferation resistance; (c) cost competitiveness with alternative energy sources; (d) sustainable fuel supply; and (e) solution of the radioactive waste management problem

  4. Imidazopyridines as a source of biological activity and their pharmacological potentials-Infrared and Raman spectroscopic evidence of their content in pharmaceuticals and plant materials.

    Science.gov (United States)

    Dymińska, Lucyna

    2015-09-15

    Derivatives of imidazopyridine are used in medicinal chemistry due to their biological and pharmaceutical properties. This review article presents imidazopyridine pharmacological activity as antiinflammatory, anticancer, antiviral, antiosteoporotic, antiparasitic, and antihypertensive agents by studying its various synthesized derivatives. Some of compounds with imidazopyridine skeleton are used in psychiatry and autoimmune disorders. The presented data suggest that IR and Raman spectra measurements are a good methods for identification and characterization of the compounds containing imidazopyridine core. Two stretching vibrations: νas(Φ) and νs(Φ) are of a diagnostic importance. The appearance of these bands in the IR and Raman spectra of some plants, tissues and pharmaceuticals confirms the presence of imidazopyridine skeleton in these substances. Copyright © 2015 Elsevier Ltd. All rights reserved.

  5. 3rd International Meeting for Researchers in Materials and Plasma Technology (IMRMPT) and 1st Symposium on Nanoscience and Nanotechnology

    International Nuclear Information System (INIS)

    2016-01-01

    These proceedings present the written contributions of the participants of the 3rd International Meeting for Researchers in Materials and Plasma Technology (3rd IMRMPT) and the 1st Symposium on Nanoscience and Nanotechnology which was held from 4 to May 9, 2015 at the Dann Carlton Hotel Bucaramanga, Colombia, organized by the faculty of science of the Universidad Industrial de Santander (UIS) and the basic science department of the Universidad Pontificia Bolivariana. This was the third version of biennial meetings that began in 2011. The five-day scientific program of the 3rd IMRMPT consisted of 24 Magisterial Conferences, 70 Oral Presentations, 185 Poster Presentations, 3 Courses and 1 Discussion Panel with the participation of undergraduate and graduate students, professors, researchers and entrepreneurs from Colombia, Russia, Germany, France, Spain, England, United States, Mexico, Argentina, Uruguay, Brazil, Venezuela, among others. Moreover, the objective of IMRMPT was to bring together national and international researchers in order to establish a network of scientific cooperation with a global impact in the area of the science and the technology of materials; to promote the exchange of creative ideas and the effective transfer of scientific knowledge, from fundamental research to innovation applied to industrial solutions and to advances in the development of new research allowing to increase the lifetime of the materials used in the industry by means of efficient transference of the knowledge between sectors academia and industry. The topics covered in the 3rd IMRMPT include New Materials, Surface Physics, Structural Integrity, Renewable Energy, Online Process Control, Non Destructive Evaluation, Characterization of Materials, Laser and Hybrid Processes, Thin Films and Nanomaterials, Surface Hardening Processes, Wear and Corrosion/Oxidation, Plasma Applications and Technologies, Modelling, Simulation and Diagnostics, Biomedical Coatings, Surface Treatments

  6. Technical Meeting on Existing and Proposed Experimental Facilities for Fast Neutron Systems. Working Material

    International Nuclear Information System (INIS)

    2013-01-01

    The discussion which followed the different presentations highlighted the following points: • All the Member States representatives participating in the technical meeting welcomed this IAEA initiative and expressed their potential interest in contributing to the catalogue; • Not all the countries with a fast reactor programme were represented at the meeting. In particular, it was noted that there was no participation from China, the Russian Federation and the USA. Even contribution from Sweden and Spain would be beneficial. It will be a task of the IAEA Secretariat to try involving also these countries in the preparation of the catalogue; • The catalogue will focus only on experimental facilities supporting development of liquid metal cooled fast reactors (Sodium, Lead and Lead-Bismuth). For the time being, facilities in support of GFR and MSR research will not be included; • As for countries involved in HLM technology research, only European countries were participating at the meeting, i.e. Belgium, France, Italy and Germany. In order to avoid duplication of the work performed within the European project ADRIANA, representatives from these countries underlined that a condition for their contribution to the IAEA catalogue is the involvement of non-European countries with HLM research programmes; • The advice from the Member States is fundamental to clearly define scope, objectives and content of the catalogue. The plan for its drafting has also to be further discussed with Member States representatives; • The catalogue is also intended to identify gaps and future needs that require further R&D initiatives; • The catalogue will be a useful tool to set up international collaboration

  7. Advances in control assembly materials for water reactors. Proceedings of a technical committee meeting held in Vienna, 29 November - 2 December 1993

    International Nuclear Information System (INIS)

    1995-07-01

    To obtain an overall picture of the current usage of control materials, research under way on new materials and to identify areas where materials are necessary to improve the safety, reliability and/or economics of water reactors, the IAEA convened a Technical Committee Meeting on Advances in Control Materials for Water Reactors. This meeting was recommended by the International Working Group on Fuel Performance and Technology and was held in Vienna from 29 November to 2 December 1993. Twenty-seven participants from twelve different countries attended the meeting and twelve papers were presented and are reproduced in these proceedings together with a summary of the meeting. A separate abstract was prepared for each of the papers. Refs, figs and tabs

  8. Critical and strategic materials proceedings of the laboratory study group meeting

    International Nuclear Information System (INIS)

    1983-06-01

    These Proceedings serve to identify the appropriate role for the DOE-BES-DMS Laboratory program concerning critical and strategic materials, identify and articulate high priority DOE-BES-DMS target areas so as to maximize programmatic responsiveness to national needs concerning critical and strategic materials, and identify research, expertise, and resources (including Collaborative Research Centers) that are relevant to critical and strategic materials that is either underway or in place under the DOE-BES-DMS Laboratory program. Laboratory statements of collaborative research are given

  9. Final IAEA research coordination meeting on plasma-interaction induced erosion of fusion reactor materials. October 9-11, 1995, Vienna, Austria. Summary report

    International Nuclear Information System (INIS)

    Langley, R.A.

    1995-12-01

    The proceedings and results of the Final IAEA Research Coordination Meeting on ''Plasma-interaction Induced Erosion of Fusion Reactor Materials'' held on October 9, 10 and 11, 1995 at the IAEA Headquarters in Vienna are briefly described. This report includes a summary of presentations made by the meeting participants, the results of a data survey and needs assessment for the erosion of plasma facing components and in-vessel materials, and recommendations regarding future work. (author). Refs, figs, tabs

  10. Meeting Radiation Protection Requirements and Reducing Spacecraft Mass - A Multifunctional Materials Approach

    Science.gov (United States)

    Atwell, William; Koontz, Steve; Reddell, Brandon; Rojdev, Kristina; Franklin, Jennifer

    2010-01-01

    Both crew and radio-sensitive systems, especially electronics must be protected from the effects of the space radiation environment. One method of mitigating this radiation exposure is to use passive-shielding materials. In previous vehicle designs such as the International Space Station (ISS), materials such as aluminum and polyethylene have been used as parasitic shielding to protect crew and electronics from exposure, but these designs add mass and decrease the amount of usable volume inside the vehicle. Thus, it is of interest to understand whether structural materials can also be designed to provide the radiation shielding capability needed for crew and electronics, while still providing weight savings and increased useable volume when compared against previous vehicle shielding designs. In this paper, we present calculations and analysis using the HZETRN (deterministic) and FLUKA (Monte Carlo) codes to investigate the radiation mitigation properties of these structural shielding materials, which includes graded-Z and composite materials. This work is also a follow-on to an earlier paper, that compared computational results for three radiation transport codes, HZETRN, HETC, and FLUKA, using the Feb. 1956 solar particle event (SPE) spectrum. In the following analysis, we consider the October 1989 Ground Level Enhanced (GLE) SPE as the input source term based on the Band function fitting method. Using HZETRN and FLUKA, parametric absorbed doses at the center of a hemispherical structure on the lunar surface are calculated for various thicknesses of graded-Z layups and an all-aluminum structure. HZETRN and FLUKA calculations are compared and are in reasonable (18% to 27%) agreement. Both codes are in agreement with respect to the predicted shielding material performance trends. The results from both HZETRN and FLUKA are analyzed and the radiation protection properties and potential weight savings of various materials and materials lay-ups are compared.

  11. International Atomic Energy Agency consultants' group meeting on C-14 reference materials for radiocarbon laboratories

    International Nuclear Information System (INIS)

    Rozanski, K.

    2001-01-01

    This publication describes the 14 C intercomparison study co-ordinated by the IAEA. Five intercomparison materials have been prepared and distributed among 137 participating laboratories. By February 20, 1991, results have been received from 69 laboratories (39 of them representing liquid scintillation counting, 25 - gas counting, and 6 - accelerator mass spectrometry). This publication presents measurement results and their discussion along with description of the materials and methodology

  12. PREFACE: E-MRS 2012 Spring Meeting, Symposium M: More than Moore: Novel materials approaches for functionalized Silicon based Microelectronics

    Science.gov (United States)

    Wenger, Christian; Fompeyrine, Jean; Vallée, Christophe; Locquet, Jean-Pierre

    2012-12-01

    More than Moore explores a new area of Silicon based microelectronics, which reaches beyond the boundaries of conventional semiconductor applications. Creating new functionality to semiconductor circuits, More than Moore focuses on motivating new technological possibilities. In the past decades, the main stream of microelectronics progresses was mainly powered by Moore's law, with two focused development arenas, namely, IC miniaturization down to nano scale, and SoC based system integration. While the microelectronics community continues to invent new solutions around the world to keep Moore's law alive, there is increasing momentum for the development of 'More than Moore' technologies which are based on silicon technologies but do not simply scale with Moore's law. Typical examples are RF, Power/HV, Passives, Sensor/Actuator/MEMS or Bio-chips. The More than Moore strategy is driven by the increasing social needs for high level heterogeneous system integration including non-digital functions, the necessity to speed up innovative product creation and to broaden the product portfolio of wafer fabs, and the limiting cost and time factors of advanced SoC development. It is believed that More than Moore will add value to society on top of and beyond advanced CMOS with fast increasing marketing potentials. Important key challenges for the realization of the 'More than Moore' strategy are: perspective materials for future THz devices materials systems for embedded sensors and actuators perspective materials for epitaxial approaches material systems for embedded innovative memory technologies development of new materials with customized characteristics The Hot topics covered by the symposium M (More than Moore: Novel materials approaches for functionalized Silicon based Microelectronics) at E-MRS 2012 Spring Meeting, 14-18 May 2012 have been: development of functional ceramics thin films New dielectric materials for advanced microelectronics bio- and CMOS compatible

  13. Treatment of mixed F006 contaminated material to meet the new EPA debris rule at the Savannah River Site

    International Nuclear Information System (INIS)

    Pickett, J.B.; Diener, G.A.; Carroll, S.J.; Steingard, J.M.

    1993-01-01

    The Westinghouse Savannah River Company (WSRC), as the operating contractor for the Department of Energy (DOE) at the Savannah River Site (SRS) has demonstrated a procedure to clean mixed (radioactive/hazardous) materials to meet the criteria in the recently promulgated Land Disposal Restrictions ''debris'' rule. The material was equipment (steel piping, transfer pumps valves) which had been used in industrial wastewater treatment facility to transfer listed F006 wastewater treatment plating line sludges to a RCRA storage tank complex. When the equipment needed to be replaced/repaired, it was concluded that the resulting debris would have to be managed as a mixed waste, due to the fact that the solid waste ''contained'' the listed hazardous waste

  14. Topical study on IRS events involving foreign material intrusion in plant systems. First issue. Report of a consultants meeting. Working material

    International Nuclear Information System (INIS)

    1997-01-01

    Recent exchange of operational safety experience among countries, within the framework of the IRS, revealed a noticeable increase in incidents involving foreign material intrusion (FMI) in nuclear power plant systems. These incidents appeared to have safety impact, sometimes widespread, on many systems and components, including the reactor core, control rods, the secondary side, and other support systems such as the electrical, air, and water systems. Notwithstanding the economic penalties and the operational problems that can arise from the FMI, many events indicated severe component damages, challenges to safety systems and to fuel integrity. Difficulties encountered with the removal of foreign material present further challenges due to the long term effects of such material remaining in the system and interacting with either fuel cladding, with the potential of releasing fission products in coolant systems, or with the system pressure boundary with the potential for material wear and sudden failure of the pressure boundary. The FMI topic was, therefore, one of a number of topics that was recommended by the TCM in 1996 for investigation. A consultant meeting was held at the IAEA during the period 14-18 April 1997 to address this topic. Figs

  15. Removal of Pharmaceutical Compounds from Hospital Wastewaters Using Nanomaterials: A Review

    Directory of Open Access Journals (Sweden)

    Hasan Bagheri

    2016-06-01

    Full Text Available Over the past few years, residual pharmaceuticals (antibiotics, anticonvulsants, antipyretics drugs, hormones have begun to be considered as emerging environmental pollutants due to their continuous input and persistence to aquatic ecosystem even at low concentrations. Therefore, the development of efficient, cost-effective, and stable methods and materials for the wastewaters treatment have gained more recognition in recent years. In the path of meeting these developments, nanomaterials have attracted much attention as economical, convenient and ecofriendly tools for removing of pharmaceuticals from the hospital wastewaters because of their unique properties. The present review deals with recent advances in removal and/or destruction of residual pharmaceutical in wastewater samples using nanomaterials including metal nanoparticles, carbon nanotubes and nanofilters. In spite of using a variety of nanomaterials to remove the residual of pharmaceuticals, there is still a dearth of successful applicability of them in industrial processes. Therefore, some defects of nanomaterials to be used for the removal of pharmaceutical contaminate in environmental samples and their impacts on human health and environment is briefly discussed.

  16. Forty-Fifth Annual Meeting of the Technical Working Group on Fast Reactors (TWG-FR). Working Material

    International Nuclear Information System (INIS)

    2012-01-01

    The objectives of the meeting were to: • Exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); • Review the progress since the 44 th TWG-FR Annual Meeting, including the status of the actions; • Consider topical technical meeting arrangements for 2012-2013, as well as review FR-related activities included in the IAEA Programme & Budget (P&B) biennium 2012-2013; • Review the IAEA’s concluded, on-going and planned coordinated research projects in the technical fields relevant to the TWG-FR (FRs and ADS), as well as coordination of the TWG-FR’s activities with other organizations and international initiatives (GIF, INPRO, NEA, ESNII, etc.). The 45th Meeting of the TWG-FR reached the following conclusions/recommendations: • The participants expressed satisfaction and appreciation for the large amount of new information on on-going activities carried out by the Member States in the field of FR and ADS exchanged during the meeting; • Also the organizations which have participated to the TWG-FR meeting for the first time expressed their appreciation for the lively discussion and the results and thanked the IAEA for inviting them at the meeting; • The meeting was very useful in particular for collecting inputs and advice in view of the preparation of the IAEA Programme & Budget 2014-2015 (and then 2016-2017) in the area of FR and ADS technology development; • The TWG-FR remains an unique international forum for information exchange in the field of fast neutron systems and for promoting RT&D activities in this area; • Due to the increasing interest in FR and in view of the forthcoming realizations, it would be advisable to increase the involvement of industries, regulators and other R&D organizations; • The annual TWG-FR meeting should focused on exchange of information on national and international programmes, avoiding duplications or overlapping’s with other IAEA initiatives in the field;

  17. When biomolecules meet graphene: from molecular level interactions to material design and applications.

    Science.gov (United States)

    Li, Dapeng; Zhang, Wensi; Yu, Xiaoqing; Wang, Zhenping; Su, Zhiqiang; Wei, Gang

    2016-12-01

    Graphene-based materials have attracted increasing attention due to their atomically-thick two-dimensional structures, high conductivity, excellent mechanical properties, and large specific surface areas. The combination of biomolecules with graphene-based materials offers a promising method to fabricate novel graphene-biomolecule hybrid nanomaterials with unique functions in biology, medicine, nanotechnology, and materials science. In this review, we focus on a summarization of the recent studies in functionalizing graphene-based materials using different biomolecules, such as DNA, peptides, proteins, enzymes, carbohydrates, and viruses. The different interactions between graphene and biomolecules at the molecular level are demonstrated and discussed in detail. In addition, the potential applications of the created graphene-biomolecule nanohybrids in drug delivery, cancer treatment, tissue engineering, biosensors, bioimaging, energy materials, and other nanotechnological applications are presented. This review will be helpful to know the modification of graphene with biomolecules, understand the interactions between graphene and biomolecules at the molecular level, and design functional graphene-based nanomaterials with unique properties for various applications.

  18. Technical Meeting on Fast Reactors and Related Fuel Cycle Facilities with Improved Economic Characteristics. Working Material

    International Nuclear Information System (INIS)

    2013-01-01

    The objectives of the meeting were: - To identify the main issues and technical features that affect capital and energy production costs of fast reactors and related fuel cycle facilities; - To present fast reactor concepts and designs with enhanced economic characteristics, as well as innovative technical solutions (components, subsystems, etc.) that have the potential to reduce the capital costs of fast reactors and related fuel cycle facilities; - To present energy models and advanced tools for the cost assessment of innovative fast reactors and associated nuclear fuel cycles; - To discuss the results of studies and on-going R&D activities that address cost reduction and the future economic competitiveness of fast reactors; and - To identify research and technology development needs in the field, also in view of new IAEA initiatives to help and support Member States in improving the economic competitiveness of fast reactors and associated nuclear fuel cycles

  19. In situ leach uranium mining. Proceedings of a technical committee meeting. Working material

    International Nuclear Information System (INIS)

    2002-03-01

    mutual interest between specialists who developed and employ the technology in the two areas. The Technical Committee Meeting on In Situ Leach Uranium Mining was held in Almaty, Kazakhstan in the Hall of Science of the National Academy of Science from 9-12 September 1996. It was attended by 61 participants from 15 countries and one non-governmental international organization (Uranium Institute). Organizational support for the meeting was provided on behalf of the Government of the Republic of Kazakhstan by the National Joint Stock Company of Atomic Energy and Industry 'KATEP', the state enterprise responsible for uranium production in the Republic of Kazakhstan. This meeting provided the first ever opportunity for specialists from throughout the world to meet in central Asia and discuss ISL technology with emphasis on its development and use in the region. The site visit to the Number 6 Mining Company in south central Kazakhstan provided an opportunity for participants to observe and discuss an operating ISL facility

  20. Gas-cooled reactor technology safety and siting. Report of a technical committee meeting. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1990-07-01

    At the invitation of the Government of the Union of Soviet Socialist Republics, the Eleventh International Conference on the HTGR and the IAEA Technical Committee Meeting on Gas-Cooled Reactor Technology, Safety and Siting were held in Dimitrovgrad, USSR, on June 21-23, 1989. The Technical Committee Meeting provided the Soviet delegates with an opportunity to display the breadth of their program on HTGRs to an international audience. Nearly one-half of the papers were presented by Soviet participants. Among the highlights of the meeting were the following: the diverse nature and large magnitude of the Soviet research and development program on high temperature gas-cooled reactors; the Government approval of the budget for the construction of the 30 MWt High Temperature Test Reactor (HTTR) in Japan (The schedule contemplates a start of construction in spring 1990 on a site at the Oarai Research Establishment and about a five year construction period.); disappointment in the announced plans to shutdown both the Fort St. Vrain (FSV) plant in the United States (US) and the Thorium High Temperature Reactor (THTR-300) in Germany (These two reactors presently represent the only operating HTGRs in the world since the AVR plant in Juelich, Germany, was also shutdown at the end of 1988.); the continuing negotiations between Germany and the USSR on the terms of the co-operation between the two countries for the construction of a HTR Module supplemented by joint research and development activities aimed at increasing coolant outlet temperatures from 750 deg. C to 950 deg. C; the continued enthusiasm displayed by both the US and German representatives for the potential of the small modular designs under development in both countries and the ability for these designs to meet the stringent requirements demanded for the future expansion of nuclear power; the combining of the HTGR technology interest of ABB-Atom and Siemens in Germany into a joint enterprise, HTR GmbH, in May 1989

  1. Gas-cooled reactor technology safety and siting. Report of a technical committee meeting. Working material

    International Nuclear Information System (INIS)

    1990-01-01

    At the invitation of the Government of the Union of Soviet Socialist Republics, the Eleventh International Conference on the HTGR and the IAEA Technical Committee Meeting on Gas-Cooled Reactor Technology, Safety and Siting were held in Dimitrovgrad, USSR, on June 21-23, 1989. The Technical Committee Meeting provided the Soviet delegates with an opportunity to display the breadth of their program on HTGRs to an international audience. Nearly one-half of the papers were presented by Soviet participants. Among the highlights of the meeting were the following: the diverse nature and large magnitude of the Soviet research and development program on high temperature gas-cooled reactors; the Government approval of the budget for the construction of the 30 MWt High Temperature Test Reactor (HTTR) in Japan (The schedule contemplates a start of construction in spring 1990 on a site at the Oarai Research Establishment and about a five year construction period.); disappointment in the announced plans to shutdown both the Fort St. Vrain (FSV) plant in the United States (US) and the Thorium High Temperature Reactor (THTR-300) in Germany (These two reactors presently represent the only operating HTGRs in the world since the AVR plant in Juelich, Germany, was also shutdown at the end of 1988.); the continuing negotiations between Germany and the USSR on the terms of the co-operation between the two countries for the construction of a HTR Module supplemented by joint research and development activities aimed at increasing coolant outlet temperatures from 750 deg. C to 950 deg. C; the continued enthusiasm displayed by both the US and German representatives for the potential of the small modular designs under development in both countries and the ability for these designs to meet the stringent requirements demanded for the future expansion of nuclear power; the combining of the HTGR technology interest of ABB-Atom and Siemens in Germany into a joint enterprise, HTR GmbH, in May 1989

  2. Diagnostic systems in nuclear power plants. Proceedings of a technical committee meeting. Working material

    International Nuclear Information System (INIS)

    1998-01-01

    Nuclear power industry has a quite long tradition in on-line diagnostic of mechanical components and a considerable effort was put in developing diagnostic systems which are able to detect arising mechanical problems at an early stage. Computers are increasingly exploited to provide higher level information on process behaviour such as: early indication of the process deviation from normal conditions; rapid identification of the cause of any disturbance; prediction of the evolution of a disturbance; operator aid through computerized help. Following the recommendation of Several Member States to strengthen the activity in this field two divisions of IAEA established in 1995 the International Task Force on Nuclear Power Plant Diagnostics. The scope of the task force cover both technological developments and safety/licensing aspects of diagnostics. This report contains papers presented at the last in the series of Technical Committee Meetings on the Diagnostic Systems in Nuclear Power Plants organized in the framework of International Task Force

  3. Diagnostic systems in nuclear power plants. Proceedings of a technical committee meeting. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-12-31

    Nuclear power industry has a quite long tradition in on-line diagnostic of mechanical components and a considerable effort was put in developing diagnostic systems which are able to detect arising mechanical problems at an early stage. Computers are increasingly exploited to provide higher level information on process behaviour such as: early indication of the process deviation from normal conditions; rapid identification of the cause of any disturbance; prediction of the evolution of a disturbance; operator aid through computerized help. Following the recommendation of Several Member States to strengthen the activity in this field two divisions of IAEA established in 1995 the International Task Force on Nuclear Power Plant Diagnostics. The scope of the task force cover both technological developments and safety/licensing aspects of diagnostics. This report contains papers presented at the last in the series of Technical Committee Meetings on the Diagnostic Systems in Nuclear Power Plants organized in the framework of International Task Force Refs, figs, tabs

  4. Energy Materials Coordinating Committee (EMACC) contractors meeting on problems and opportunities in structural ceramics

    International Nuclear Information System (INIS)

    1983-04-01

    This report consists mainly of viewographs and summaries of DOE and other programs on structural ceramics. Applications include heat engines, fusion reactors, solar absorbers, heat exchangers, coal conversion, turbines, material substitution, etc. Research centers and their capabilities are described. Panel discussions on fabrication reliability, market, ceramic producers and engine manufacturers, and conclusions are summarized

  5. Smart Materials Meet Multifunctional Biomedical Devices: Current and Prospective Implications for Nanomedicine

    Directory of Open Access Journals (Sweden)

    Giada Graziana Genchi

    2017-12-01

    Full Text Available With the increasing advances in the fabrication and in monitoring approaches of nanotechnology devices, novel materials are being synthesized and tested for the interaction with biological environments. Among them, smart materials in particular provide versatile and dynamically tunable platforms for the investigation and manipulation of several biological activities with very low invasiveness in hardly accessible anatomical districts. In the following, we will briefly recall recent examples of nanotechnology-based materials that can be remotely activated and controlled through different sources of energy, such as electromagnetic fields or ultrasounds, for their relevance to both basic science investigations and translational nanomedicine. Moreover, we will introduce some examples of hybrid materials showing mutually beneficial components for the development of multifunctional devices, able to simultaneously perform duties like imaging, tissue targeting, drug delivery, and redox state control. Finally, we will highlight challenging perspectives for the development of theranostic agents (merging diagnostic and therapeutic functionalities, underlining open questions for these smart nanotechnology-based devices to be made readily available to the patients in need.

  6. Symposium II: Mechanochemistry in Materials Science, MRS Fall Meeting, Nov 30-Dec 4, 2009, Boston, MA

    Science.gov (United States)

    2010-09-02

    30 AM�.1 Mechanochemistry of Carbon Tribo Materials. Michael Moseler, Tribosimulation and Multiscale Modelling, Fraunhofer Institute for...years. These compounds are usually formed by the reaction of mercury salts (some examples are: mercury - nitrate , iodide, chloride or cyanide) with

  7. Summary of workshop 'Theory Meets Industry' - the impact of ab initio solid state calculations on industrial materials research

    International Nuclear Information System (INIS)

    Wimmer, E

    2008-01-01

    A workshop, 'Theory Meets Industry', was held on 12-14 June 2007 in Vienna, Austria, attended by a well balanced number of academic and industrial scientists from America, Europe, and Japan. The focus was on advances in ab initio solid state calculations and their practical use in industry. The theoretical papers addressed three dominant themes, namely (i) more accurate total energies and electronic excitations (ii) more complex systems, and (iii) more diverse and accurate materials properties. Hybrid functionals give some improvements in energies, but encounter difficulties for metallic systems. Quantum Monte Carlo methods are progressing, but no clear breakthrough is on the horizon. Progress in order-N methods is steady, as is the case for efficient methods for exploring complex energy hypersurfaces and large numbers of structural configurations. The industrial applications were dominated by materials issues in energy conversion systems, the quest for hydrogen storage materials, improvements of electronic and optical properties of microelectronic and display materials, and the simulation of reactions on heterogeneous catalysts. The workshop is a clear testimony that ab initio computations have become an industrial practice with increasingly recognized impact

  8. Summary of workshop 'Theory Meets Industry'—the impact of ab initio solid state calculations on industrial materials research

    Science.gov (United States)

    Wimmer, E.

    2008-02-01

    A workshop, 'Theory Meets Industry', was held on 12-14 June 2007 in Vienna, Austria, attended by a well balanced number of academic and industrial scientists from America, Europe, and Japan. The focus was on advances in ab initio solid state calculations and their practical use in industry. The theoretical papers addressed three dominant themes, namely (i) more accurate total energies and electronic excitations, (ii) more complex systems, and (iii) more diverse and accurate materials properties. Hybrid functionals give some improvements in energies, but encounter difficulties for metallic systems. Quantum Monte Carlo methods are progressing, but no clear breakthrough is on the horizon. Progress in order-N methods is steady, as is the case for efficient methods for exploring complex energy hypersurfaces and large numbers of structural configurations. The industrial applications were dominated by materials issues in energy conversion systems, the quest for hydrogen storage materials, improvements of electronic and optical properties of microelectronic and display materials, and the simulation of reactions on heterogeneous catalysts. The workshop is a clear testimony that ab initio computations have become an industrial practice with increasingly recognized impact.

  9. The history of theoretical, material and computational mechanics mathematics meets mechanics and engineering

    CERN Document Server

    2014-01-01

    This collection of 23 articles is the output of lectures in special sessions on “The History of Theoretical, Material and Computational Mechanics” within the yearly conferences of the GAMM in the years 2010 in Karlsruhe, Germany, 2011 in Graz, Austria, and in 2012 in Darmstadt, Germany; GAMM is the “Association for Applied Mathematics and Mechanics”, founded in 1922 by Ludwig Prandtl and Richard von Mises. The contributions in this volume discuss different aspects of mechanics. They are related to solid and fluid mechanics in general and to specific problems in these areas including the development of numerical solution techniques. In the first part the origins and developments of conservation principles in mechanics and related variational methods are treated together with challenging applications from the 17th to the 20th century. Part II treats general and more specific aspects of material theories of deforming solid continua and porous soils. and Part III presents important theoretical and enginee...

  10. 10th meeting of the International Conference on Protection of Materials and Structures from Space Environment

    CERN Document Server

    Tagawa, Masahito; Kimoto, Yugo; Protection of Materials and Structures From the Space Environment

    2013-01-01

    The goals of the 10th International Space Conference on “Protection of Materials and Structures from Space Environment” ICPMSE-10J, since its inception in 1992, have been to facilitate exchanges between members of the various engineering and science disciplines involved in the development of space materials, including aspects of LEO, GEO and Deep Space environments, ground-based qualification, and in-flight experiments and lessons learned from operational vehicles that are closely interrelated to disciplines of the atmospheric sciences, solar-terrestrial interactions and space life sciences. The knowledge of environmental conditions on and around the Moon, Mars, Venus and the low Earth orbit as well as other possible candidates for landing such as asteroids have become an important issue, and protecting both hardware and human life from the effects of space environments has taken on a new meaning in light of the increased interest in space travel and colonization of other planets.  And while many materia...

  11. PHARMACEUTICALS AND PERSONAL CARE PRODUCTS ...

    Science.gov (United States)

    Modern sanitary practices result in large volumes of human waste, as well as domestic and industrial sewage, being collected and treated at common collection points, wastewater treatment plants (WWTP). In recognition of the growing use of sewage sludges as a fertilizers and as soilamendments, and the scarcity of current data regarding the chemical constituents in sewage sludges, the United States National Research Council (NRC) in 2002 produced a report on sewage sludges. Among the NRC's recommendations was the need for investigating the occurrence of pharmaceuticals and personal care products (PPCPs) in sewage sludges. PPCPsare a diverse array of non-regulated contaminants that had not been studied in previous sewage sludges surveys but which are likely to be present. The focus of this paper will be to review the current analytical methodologies available for investigating whether pharmaceuticals are present in WWTP-produced sewage sludges, to summarize current regulatory practices regarding sewage sludges, and to report on the presence of pharmaceuticals in sewage sludges. The research focused on in the subtasks is the development and application of state-of the-art technologies to meet the needs of the public, Office of Water, and ORD in the area of Water Quality. Located In the subtasks are the various research projects being performed in support of this Task and more in-depth coverage of each project. Briefly, each project's objective is stated below.Subta

  12. Pharmaceutical cocrystals:formation mechanisms, solubility behaviour and solid-state properties

    OpenAIRE

    Alhalaweh, Amjad

    2012-01-01

    The primary aim of pharmaceutical materials engineering is the successful formulation and process development of pharmaceutical products. The diversity of solid forms available offers attractive opportunities for tailoring material properties. In this context, pharmaceutical cocrystals, multicomponent crystalline materials with definite stoichiometries often stabilised by hydrogen bonding, have recently emerged as interesting alternative solid forms with potential for improving the physical a...

  13. Consultants Group Meeting on Genetic Sexing and Population Genetics of Screwworms. Working Material

    International Nuclear Information System (INIS)

    2000-01-01

    A Thematic Plan on SIT for Screwworms developed in 1999 by IPC and TC identified certain R and D bottlenecks to the expansion of this technology into new agricultural areas. This consultant's meeting was held to review these conclusions and to advise the Agency on the need, or otherwise, of initiating a CRP to address the bottlenecks identified in the Thematic Plan. In 2001 it is expected that the New World Screwworm, Cochliomyia hominivorax, will have been eradicated from all of Central America, including Panama where a sterile release barrier will be established to prevent re-invasion from South America. This barrier will need to be maintained indefinitely with its associated costs. The use of an all-male strain in the production facility would have very positive impact on the cost/benefit analysis of the programme. The Director of the Screwworm Programme in Central America made this point very strongly during the Thematic Plan discussions and at a subsequent technical meeting in Tuxtla Gutierrez. Interest to expand the programme into South America is now being shown by certain countries in the region where the economic feasibility of implementing an SIT programme might depend on producing sterile flies more economically and here again the use of a genetic sexing strain could play an important role. For the Old World Screwworm, Chrysomya bezziana the Australian authorities have just completed a successful small field trial of the SIT in Malaysia and it is proposed that more extensive field tests be carried out in the region. For both the New World Screwworm in South America and the Old World Screwworm, in Asia there is virtually no information regarding the population structure in relation to the implementation of an SIT programme. Is the Old World Screwworm a single species over its very wide distribution and are the populations of New World Screwworm in South America the same as in Central America and related to each other? Are the populations isolated? These

  14. Does brand differentiate pharmaceuticals?

    Science.gov (United States)

    Bednarik, Josef

    2005-12-01

    Role of marketing in pharmaceutical industry is increasing and inspiration by successful brands known from consumer goods market influenced pharmaceutical companies enough to switch their attention to branding initiatives. Still there is little evidence that pharmaceutical brands represent anything more than product only. This study aims to explore the area of branding in pharmaceutical industry. Central hypothesis of the research has been that brand and its emotional content differentiate pharmaceuticals as well as rational data derived from clinical studies. It has been tested by extensive review of available literature as well as by primary research focused on drivers of physicians' attitudes towards products and their influence on prescribing behavior. The research has been conducted in the sample of psychiatrists in the Czech Republic. No evidence about pharmaceutical brand exceeding value of product has been found in reviewed literature. Nevertheless, the primary research conducted in the sample of Czech psychiatrists indicates that emotional brand in pharmaceutical industry exists and enables author to draw a model of Customer/product life cycle that describes likely impact of functional, emotional and self-expressive benefits throughout pharmaceutical product's market presence. Pharmaceutical brand is likely to develop differently than the same of consumer goods products--it seems to be built predominantly on long-term positive experience. Marketing role in this process should lie in finding relevant product position and building brand identity compliant with real product capabilities.

  15. IAEA Technical Meeting on Status of IAEA Fast Reactor Knowledge Preservation Initiative. Working Material

    International Nuclear Information System (INIS)

    2013-01-01

    In response to needs expressed by Member States and within a broader IAEA-wide effort in nuclear knowledge preservation, the IAEA has been carrying out a dedicated initiative on Fast Reactor Data Knowledge Preservation (FRKP). The main objectives of the FRKP initiative are to: • Halt the on-going loss of information related to Fast Reactors (FR); • Collect, retrieve, preserve and make accessible already existing data and information on FR. These objectives require the implementation of activities supporting digital document archival, exchange, search and retrieval and facilitating, by developing and using suitable standards and IT tools, the knowledge preservation over the next decades. To this purpose the IAEA has developed the Fast Reactor Knowledge Organization System (FRKOS), a web-based application employing IAEA methodology and approach for categorization of FR knowledge domain, which allows creating a comprehensive and well-structured international inventory of fast reactor data and information provided by different Member States. The resulting Web Portal is established and maintained by the IAEA. The IAEA knowledge preservation initiatives and tools in the field of fast neutron systems - which were presented and very well received during the recent IAEA Fast Reactor and Related Fuel Cycles Conference (FR13) - are supposed to be of interest for national nuclear authorities, regulators, scientific and research organizations, commercial companies and all other stakeholders involved in fast reactor activities at national or international level. The objectives of the technical meeting were to: • Exchange information between the member states/international organizations on national and international initiatives addressing knowledge preservation and data retrieval/collection in the field of fast neutron systems; • Present and discuss the member states’/international organizations’ policies and conditions for releasing to the IAEA both publicly

  16. Symposium on Energy Storage Materials Energy and Fuel Division, 246th ACS National Meeting

    Science.gov (United States)

    2015-04-17

    similar chemical reactivity as Li+ and surface selectivity due to their much larger  ionic  radii than Li+. Chemical and local structure information is...interest in developing organic­inorganic  oligomeric  materials for use as electrolyte in lithium ion batteries. Polyphosphazenes are inorganic...Small functionalized linear oligophosphazenes were also synthesized. All of these viscous  liquids  showed low glass transition temperatures. This

  17. The roles of energy and material efficiency in meeting steel industry CO2 targets.

    Science.gov (United States)

    Milford, Rachel L; Pauliuk, Stefan; Allwood, Julian M; Müller, Daniel B

    2013-04-02

    Identifying strategies for reducing greenhouse gas emissions from steel production requires a comprehensive model of the sector but previous work has either failed to consider the whole supply chain or considered only a subset of possible abatement options. In this work, a global mass flow analysis is combined with process emissions intensities to allow forecasts of future steel sector emissions under all abatement options. Scenario analysis shows that global capacity for primary steel production is already near to a peak and that if sectoral emissions are to be reduced by 50% by 2050, the last required blast furnace will be built by 2020. Emissions reduction targets cannot be met by energy and emissions efficiency alone, but deploying material efficiency provides sufficient extra abatement potential.

  18. Planning meeting to form the CMSN Team: Building a unified computational model for the resonant X-ray scattering of strongly correlated materials. Final report

    International Nuclear Information System (INIS)

    van Veenendaal, M.

    2008-01-01

    The planning meeting was held May 21-23 2008 at Argonne National Laboratory (ANL). The purpose of the meeting was to establish a network on building computational model for resonant elastic and inelastic x-ray scattering. This course of action was recommended by program officer Dale Koelling after the initial submission of a proposal for a Computational Materials Science Network to Basic Energy Sciences. The meeting consisted of talks and discussion. At the end of the meeting three subgroups were formed. After the successful formation of the team, a new proposal was written which was funded by BES. Since this was a planning meeting there were no proceedings. The program and titles of talks are given.

  19. Proceedings of a specialist meeting on regulatory approaches for the control of environmental residues containing naturally occurring radioactive material. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2005-07-01

    approaches are used nationally and a review of the regulation of NORM is timely. The mining and milling of uranium and thorium ores and the management of the waste generated from such activities is the subject of several safety documents of the IAEA. An assessment of occupational protection conditions in workplaces with high levels of exposure to natural radiation was made through an IAEA Technical Committee Meeting held in 2001. The findings of this meeting are forming the basis for a work plan for future activities in this area and for a Safety Guide on occupational radiation protection in mining and processing of raw material, as well as two related safety reports. However, there is a range of radiation protection issues, arising from the mining, processing, utilisation and disposal of NORM, which have not yet been covered in IAEA safety documents. These include impacts on the public and the environment of the processing of NORM and the associated generation of waste.

  20. Proceedings of a specialist meeting on regulatory approaches for the control of environmental residues containing naturally occurring radioactive material. Working material

    International Nuclear Information System (INIS)

    2005-01-01

    approaches are used nationally and a review of the regulation of NORM is timely. The mining and milling of uranium and thorium ores and the management of the waste generated from such activities is the subject of several safety documents of the IAEA. An assessment of occupational protection conditions in workplaces with high levels of exposure to natural radiation was made through an IAEA Technical Committee Meeting held in 2001. The findings of this meeting are forming the basis for a work plan for future activities in this area and for a Safety Guide on occupational radiation protection in mining and processing of raw material, as well as two related safety reports. However, there is a range of radiation protection issues, arising from the mining, processing, utilisation and disposal of NORM, which have not yet been covered in IAEA safety documents. These include impacts on the public and the environment of the processing of NORM and the associated generation of waste

  1. Report on the joint meeting of the Division of Development and Technology Plasma Wall Interaction and High Heat Flux Materials and Components task groups

    International Nuclear Information System (INIS)

    Nygren, R.E.

    1992-04-01

    The Plasma/Wall Interaction and High Heat Flux Materials and Components Task Groups typically hold a joint meeting each year to provide a forum for discussion of technical issues of current interest as well as an opportunity for program reviews by the Department of Energy (DOE). At the meeting in September 1990, reported here, research programs in support of the International Thermonuclear Experimental Reactor (ITER) were highlighted. The first part of the meeting was devoted to research and development (R ampersand D) for ITER on plasma facing components plus introductory presentations on some current projects and design studies. The balance of the meeting was devoted to program reviews, which included presentations by most of the participants in the Small Business Innovative Research (SBIR) Programs with activities related to plasma wall interactions. The Task Groups on Plasma/Wall Interaction and on High Heat Flux Materials and Components were chartered as continuing working groups by the Division of Development and Technology in DOE's Magnetic Fusion Program. This report is an addition to the series of ''blue cover'' reports on the Joint Meetings of the Plasma/Wall Interaction and High Heat Flux Materials and Components Task Groups. Among several preceding meetings were those in October 1989 and January 1988

  2. Laser Materials and Laser Spectroscopy - A Satellite Meeting of IQEC '88

    Science.gov (United States)

    Wang, Zhijiang; Zhang, Zhiming

    1989-03-01

    The Table of Contents for the book is as follows: * Laser Materials * Laser Site Spectroscopy of Transition Metal Ions in Glass * Spectroscopy of Chromium Doped Tunable Laser Materials * Spectroscopic Properties of Nd3+ Ions in LaMgAl11O19 Crystal * Spectral Study and 2.938 μm Laser Emission of Er3+ in the Y3Al5O12 Crystal * Raman-infrared Spectra and Radiationless Relaxation of Laser Crystal NdAl3(BO3)4 * A Study on HB and FLN in BaFCl0.5Br0.5:Sm2+ at 77K * Pair-pumped Upconversion Solid State Lasers * CW Upconversion Laser Action in Neodymium and Erbium doped Solids * Ultra-high Sensitive Upconversion Fluorescence of YbF3 Doped with Trace Tm3+ and Er3+ * The Growth and Properties of NYAB and EYAB Multifunctional Crystal * Study on Fluorescence and Laser Light of Er3+ in Glass * Growth and Properties of Single Crystal Fibers for Laser Materials * A Study on the Quality of Sapphire, Ruby and Ti3+ Doped Sapphire Grown by Temperature Gradient Technique (TGT) and Czochralski Technique (CZ) * The Measurement of Output Property of Ti3+ Al2O3 Laser Crystal * An Xα Study of the Laser Crystal MgF2 : V2+ * Q-switched NAB Laser * Miniature YAG Lasers * Study of High Efficiency {LiF}:{F}^-_2 Color Center Crystals * Study on the Formation Conditions and Optical Properties of (F2+)H Color Center in NaCl:OH- Crystals * Novel Spectroscopic Properties of {LiF}:{F}^+_3 - {F}_2 Mixed Color Centers Laser Crystals * Terraced Substrate Visible GaAlAs Semiconductor Lasers with a Large Optical Cavity * The Temperature Dependence of Gain Spectra, Threshold Current and Auger Recombination in InGaAsP-InP Double Heterojunction Laser diode * Time-resolved Photoluminescence and Energy Transfer of Bound Excitons in GaP:N Crystals * Optical Limiting with Semiconductors * A Critical Review of High-efficiency Crystals for Tunable Lasers * Parametric Scattering in β - BaB2O4 Crystal Induced by Picosecond Pulses * Generation of Picosecond Pulses at 193 nm by Frequency Mixing in β - BaB2O4

  3. Marketing concepts for pharmaceutical service development.

    Science.gov (United States)

    Grauer, D W

    1981-02-01

    Marketing concepts as a mechanism to help pharmacy develop, communicate, and sell future pharmaceutical services to consumers are discussed. Pharmacy as a profession must define itself broadly to take advantage of future growth opportunities. These growth opportunities will be realized from unmet health-care needs and changing consumer life style trends and values. New services must therefore be oriented toward consumers (i.e., patients, health professionals, and third-party agencies) to gain acceptance. Dispensing and drug-knowledge-distribution pharmaceutical services are reviewed by a product life cycle analysis of sales profits versus time. A marketing mix for new pharmaceutical services is developed consisting of service, price, distribution, and promotion strategies. Marketing can encompass those key elements necessary to meet the organizational goals of pharmacy and provide a systematic, disciplined approach for presenting a new service to consumers.

  4. Analytical tools for determination of new oral antidiabetic drugs, glitazones, gliptins, gliflozins and glinides, in bulk materials, pharmaceuticals and biological samples

    Directory of Open Access Journals (Sweden)

    Gumieniczek Anna

    2016-01-01

    Full Text Available The review presents analytical methods for determination of new oral drugs for the treatment of type 2 diabetes mellitus (T2DM, focusing on peroxisome proliferator-activated receptor gamma agonists (glitazones, dipeptidyl peptidase 4 inhibitors (gliptins and sodium/glucose co-transporter 2 inhibitors (gliflozins. Drugs derived from prandial glucose regulators, such as glinides, are considered because they are present in some new therapeutic options. The review presents analytical procedures suitable for determination of the drugs in bulk substances, such as pharmaceuticals and biological samples, including HPLC-UV, HPLC/LC-MS, TLC/HPTLC, CE/CE-MS, spectrophotometric (UV/VIS, spectrofluorimetric and electrochemical methods, taken from the literature over the past ten years (2006-2016. Some new procedures for extraction, separation and detection of the drugs, including solid phase extraction with molecularly imprinted polymers (SPE-MIP, liquid phase microextraction using porous hollow fibers (HP-LPME, HILIC chromatography, micellar mobile phases, ion mobility spectrometry (IMS and isotopically labeled internal standards, are discussed.

  5. 78 FR 46373 - Manufacturer of Controlled Substances; Notice of Registration; Johnson Matthey Pharmaceutical...

    Science.gov (United States)

    2013-07-31

    ...; Notice of Registration; Johnson Matthey Pharmaceutical Materials, Inc. By Notice dated March 20, 2013, and published in the Federal Register on March 28, 2013, 78 FR 19017, Johnson Matthey Pharmaceutical Materials, Inc., Pharmaceutical Services, 25 Patton Road, Devens, Massachusetts 01434, made application by...

  6. Pharmaceutical cocrystals: an overview.

    Science.gov (United States)

    Qiao, Ning; Li, Mingzhong; Schlindwein, Walkiria; Malek, Nazneen; Davies, Angela; Trappitt, Gary

    2011-10-31

    Pharmaceutical cocrystals are emerging as a new class of solid drugs with improved physicochemical properties, which has attracted increased interests from both industrial and academic researchers. In this paper a brief and systematic overview of pharmaceutical cocrystals is provided, with particular focus on cocrystal design strategies, formation methods, physicochemical property studies, characterisation techniques, and recent theoretical developments in cocrystal screening and mechanisms of cocrystal formations. Examples of pharmaceutical cocrystals are also summarised in this paper. Copyright © 2011 Elsevier B.V. All rights reserved.

  7. Diagnostic and therapeutic radio pharmaceutical capsules

    International Nuclear Information System (INIS)

    Haney, T.A.; Wedeking, P.W.; Morcos, N.A.

    1981-01-01

    An improved pharmaceutical radioactive capsule consisting of a non-toxic, water soluble material adapted to being ingested and rapidly disintegrating on contact with fluids of the gastro-intestinal tract is described. Each capsule is provided with filler material supporting a pharmaceutically useful radioactive compound absorbable from the gastro-intestinal tract. The capsule is preferably of gelatin, methyl cellulose or polyvinyl alcohol and the filler is a polyethylene glycol. The radioactive compound may be iodine e.g. sodium radioiodide I-131 or 123. The capsule may also contain a reducing agent e.g. sodium thiosulphate, sulphite, or bisulphite. (author)

  8. Report on the joint meeting of the Division of Development and Technology Plasma/Wall Interaction and High Heat Flux Materials and Components Task Groups

    International Nuclear Information System (INIS)

    Wilson, K.L.

    1985-10-01

    This report of the Joint Meeting of the Division of Development and Technology Plasma/Wall Interaction and High Heat Flux Materials and Components Task Groups contains contributing papers in the following areas: Plasma/Materials Interaction Program and Technical Assessment, High Heat Flux Materials and Components Program and Technical Assessment, Pumped Limiters, Ignition Devices, Program Planning Activities, Compact High Power Density Reactor Requirements, Steady State Tokamaks, and Tritium Plasma Experiments. All these areas involve the consideration of High Heat Flux on Materials and the Interaction of the Plasma with the First Wall. Many of the Test Facilities are described as well

  9. Data Evaluation for Atomic, Molecular and Plasma Material Interaction Processes in Fusion. Summary Report of a Joint IAEA-NFRI Technical Meeting

    International Nuclear Information System (INIS)

    Chung, Hyun-Kyung

    2012-12-01

    This report summarizes the proceedings of the Joint IAEA-NFRI Technical Meeting on 'Data Evaluation for Atomic, Molecular and Plasma Material Interaction Processes in Fusion' on 4-7 September 2012. Twenty five participants from 10 Member States and two from the IAEA attended the four-day meeting held at the Daejeon Convention Center in Daejeon, Republic of Korea hosted by the National Fusion Research Institute (NFRI) in conjunction with the 8th International Symposium on Standard Reference Data. The report includes discussions on the issues of the critical assessment of fundamental data required for fusion and plasma applications, meeting conclusions and recommendations. The abstracts of presentations presented in the meeting are attached in the Appendix. (author)

  10. EU pharmaceutical expenditure forecast

    OpenAIRE

    Urbinati, Duccio; Rémuzat, Cécile; Kornfeld, Åsa; Vataire, Anne-Lise; Cetinsoy, Laurent; Aballéa, Samuel; Mzoughi, Olfa; Toumi, Mondher

    2014-01-01

    Background and Objectives: With constant incentives for healthcare payers to contain their pharmaceutical budgets, forecasting has become critically important. Some countries have, for instance, developed pharmaceutical horizon scanning units. The objective of this project was to build a model to assess the net effect of the entrance of new patented medicinal products versus medicinal products going off-patent, with a defined forecast horizon, on selected European Union (EU) Member States’ ph...

  11. Progress report on nuclear science and technology in China (Vol.1). Proceedings of academic annual meeting of China Nuclear Society in 2009, No.4--nuclear material

    International Nuclear Information System (INIS)

    2010-11-01

    Progress report on nuclear science and technology in China (Vol. 1) includes 889 articles which are communicated on the first national academic annual meeting of China Nuclear Society. There are 10 books totally.This is the fourth one, the content is about nuclear materials, isotope separation, nuclear chemistry and radiological chemistry.

  12. Selected Peer-Reviewed Articles from The International Meeting on Developments in Materials, Processes and Applications of Nanotechnology (MPA 2008), UK

    NARCIS (Netherlands)

    Ali, Nasar; De Hosson, Jeff. Th. M.; Ahmed, W.

    The International Meeting on Developments in Materials, Processes and Applications of Nanotechnology (MPA 2008) held at Robinson College, University of Cambridge, UK was the second event of the MPA conference series. The first MPA-2007, held at the University of Ulster, UK officially launched the

  13. Technical committee meeting on Liquid Metal Fast Reactor (LMFR) developments. 33rd annual meeting of the International Working Group on Fast Reactors (IWG-FR). Working material

    International Nuclear Information System (INIS)

    2000-01-01

    Over the past 33 years, the IAEA has actively encouraged and advocated international cooperation in fast reactor technology. The present publication contains information on the status of fast reactor development and on worldwide activities in this advanced nuclear power technology during 1999/2000, as reported at the 33. annual meeting of the International Working Group on Fast Reactors. It is intended to provide information regarding the current status of LMFR development in IAEA Member States

  14. Radiosterilization of medical products, pharmaceuticals and bioproducts

    International Nuclear Information System (INIS)

    1967-01-01

    A Panel on the Radiosterilization of Medical Products, Pharmaceuticals and Bioproducts was convened by the International Atomic Energy Agency on 17-19 January 1966 at its headquarters in Vienna. The purpose of the meeting was to survey the activities of the Member States in this field with a view to preparing the way for an international code of practice for the radiosterilization of medical products, in conformity with existing legal international rules. Refs, figs and tabs

  15. Cheese whey. Waste or raw material useful for foods, cosmetics and pharmaceuticals specialities?; Il siero di latte. Rifiuto o materia prima per prodotti alimentari, cosmetici e farmaceutici?

    Energy Technology Data Exchange (ETDEWEB)

    Pizzichini, M. [ENEA, Divisione Biotecnologie e Agricoltura, Centro Ricerche Casaccia, S. Maria di Galeria, Rome (Italy); Montani, R.; Russo, C. [Inteam Srl, Genoa (Italy)

    2001-07-01

    In Italy the waste whey (7 million tons/year), coming from cheese farms (2,500) is mainly employed as pigs fodder, or discharged in illegal manner into rivers or soils. It is well known that whey represents a serious environmental problem in relation with its high pollution charge (COD=70,000 O{sub 2} ppm). On the other hand, the whey's organic components as proteins, lactose, vitamins and salts, show an high commercial interest because they are used as food additives in souses, pasta, biscuits, chocolate, beverage, baby foods, etc., in cosmetics, as creams and shampoos, and also in pharmaceutical field, especially as food integrators for body builders. The application of membrane technology, as ultrafiltration (UF), nanofiltration (NF) and reverse osmosis (RO) permitted the recovery of the whey solute (proteins, lactose, mineral salts) and solvent as purified water. In this paper an industrial treatment process of 60 m{sup 3}/day, and the procedure for upgrading the biochemical properties of whey proteins, and consequently its commercial values, are discussed. It is also reported an economic process evaluation, obtained on the base of product recovery and process costs. [Italian] In Italia si producono circa 7 milioni di ton/anno di siero grezzo dagli oltre 2.500 caseifici sparsi sul territorio nazionale. Mentre al Nord il siero grezzo e' impiegato per l'alimentazione dei suini, al Centro-Sud viene smaltito illegalmente nei fiumi e sul terreno. Il siero di latte costituisce un problema importante del settore lattiero caseario poiche' ha una carica inquinante molto alta (COD 70.000 ppm di O{sub 2}). Il siero puo' rappresentare una fonte di sostanze nobili come proteine ad alto valore biologico, lattosio, vitamine sali minerali che trovano largo impiego nell'industria alimentare (salse, pasta, biscotti, cioccolato, bevande, baby foods, ecc., nell'industria cosmetica come creme idratanti o detergenti e nell

  16. Forty-Second Meeting of the Technical Working Group on Fast Reactors (TWG-FR). Working Material

    International Nuclear Information System (INIS)

    2009-01-01

    The objectives of the meeting were to: - Exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); - Review the progress since the 41st TWG-FR Annual Meeting, including the status of the actions; - Consider topical technical meetings meeting arrangements for 2009, 2010, 2011 and beyond; - Review the IAEA’s ongoing information exchange and coordinated research activities in the technical fields relevant to the TWG-FR (FRs and ADS), as well as coordination of the TWG-FR’s activities with other organizations and international initiatives; - Discuss future joint activities in view of IAEA’s Programme and Budget Cycles beyond 2010-2011

  17. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.

    Directory of Open Access Journals (Sweden)

    Aldo De Ferrari

    Full Text Available BACKGROUND: The interaction between physicians and the pharmaceutical industry influences physicians' attitudes and prescribing behavior. Although largely studied in the US, this topic has not been well studied in resource-poor settings, where a close relationship between physicians and industry still exists. OBJECTIVE: To describe physician interactions with and attitudes towards the pharmaceutical industry in a public general hospital in Lima, Peru. DESIGN: Descriptive, cross-sectional study through an anonymous, self-filled questionnaire distributed among faculty and trainee physicians of five different clinical departments working in a Peruvian public general hospital. A transcultural validation of an existing Spanish questionnaire was performed. Exposure to marketing activities, motivations to contact pharmaceutical representatives and attitudes towards industry were studied. Collected data was analyzed by degree of training, clinical department, gender and teaching status. Attitudes were measured on a four-point LIKERT scale. RESULTS: 155 physicians completed the survey, of which 148 were included in the study sample. 94.5% of attending physicians reported ongoing encounters with pharmaceutical representatives. The most common industry-related activities were receiving medical samples (91.2%, promotional material (87.8% and attending meetings in restaurants (81.8%. Respondents considered medical samples and continuing medical education the most ethically acceptable benefits. We found significant differences between attendings and residents, and teaching and non-teaching attendings. An association between the amount of encounters with pharmaceutical representatives, and attitudes towards industry and acceptance of medical samples was found. CONCLUSIONS: A close physician-industry relationship exists in the population under study. The contact is established mainly through pharmaceutical representatives. Medical samples are the most received

  18. ASTM and ASME-BPE Standards--Complying with the Needs of the Pharmaceutical Industry.

    Science.gov (United States)

    Huitt, William M

    2011-01-01

    Designing and building a pharmaceutical facility requires the owner, engineer of record, and constructor to be knowledgeable with regard to the industry codes and standards that apply to this effort. Up until 1997 there were no industry standards directed at the needs and requirements of the pharmaceutical industry. Prior to that time it was a patchwork effort at resourcing and adopting nonpharmaceutical-related codes and standards and then modifying them in order to meet the more stringent requirements of the Food and Drug Administration (FDA). In 1997 the American Society of Mechanical Engineers (ASME) published the first Bioprocessing Equipment (BPE) Standard. Through harmonization efforts this relatively new standard has brought together, scrutinized, and refined industry accepted methodologies together with FDA compliance requirements, and has established an American National Standard that provides a comprehensive set of standards that are integral to the pharmaceutical industry. This article describes various American National Standards, including those developed and published by the American Society for Testing and Materials (ASTM), and how they apply to the pharmaceutical industry. It goes on to discuss the harmonization effort that takes place between the various standards developers in an attempt to prevent conflicts and omissions between the many standards. Also included are examples of tables and figures taken from the ASME-BPE Standard. These examples provide the reader with insight to the relevant content of the ASME-BPE Standard. Designing and building a pharmaceutical facility requires the owner, engineer of record, and constructor to be knowledgeable with regard to the industry codes and standards that apply to this effort. Up until 1997 there were no industry standards directed at the needs and requirements of the pharmaceutical industry. Prior to that time it was a patchwork effort at resourcing and adopting nonpharmaceutical-related codes and

  19. The impact of hot melt extrusion and spray drying on mechanical properties and tableting indices of materials used in pharmaceutical development.

    Science.gov (United States)

    Iyer, Raman; Hegde, Shridhar; Zhang, Yu-E; Dinunzio, James; Singhal, Dharmendra; Malick, A; Amidon, Gregory

    2013-10-01

    The impact of melt extrusion (HME) and spray drying (SD) on mechanical properties of hypromellose acetate succinate (HPMCAS), copovidone, and their formulated blends was studied and compared with that of reference excipients. Tensile strength (TS), compression pressure (CP), elastic modulus (E), and dynamic hardness (Hd ) were determined along with Hiestand indices using compacts prepared at a solid fraction of ∼0.85. HPMCAS and copovidone exhibited lower Hd , lower CP, and lower E than the reference excipients and moderate TS. HPMCAS was found to be highly brittle based on brittle fracture index values. The CP was 24% and 61% higher for HPMCAS after SD and HME, respectively, than for unprocessed material along with a higher Hd . Furthermore, the TS of HPMCAS and copovidone decreased upon HME. Upon blending melt-extruded HPMCAS with plastic materials such as microcrystalline cellulose, the TS increased. These results suggest that SD and HME could impact reworkability by reducing deformation of materials and in case of HME, likely by increasing density due to heating and shear stress in a screw extruder. A somewhat similar effect was observed for the dynamic binding index (BId ) of the excipients and formulated blends. Such data can be used to quantitate the impact of processing on mechanical properties of materials during tablet formulation development. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association.

  20. Microbiological quality of pharmaceutical products in Bangladesh: current research perspective

    OpenAIRE

    Rashed Noor; Nagma Zerin; Kamal Kanta Das

    2015-01-01

    Pharmaceutical industrialization in Bangladesh, both by multinational and local companies, has increased significantly in the last two decades. Most of the pharmaceutical products are found to be therapeutically competent to meet the demands of general population satisfactorily. However, complaints regarding the compromised quality of the products stored in markets are also reported very often. In order to ensure the overall drug user safety, the present review discussed the pr...

  1. The Korean Pharmaceutical Industry and the Expansion of the General Pharmaceuticals Market in the 1950-1960s

    Directory of Open Access Journals (Sweden)

    Kyu-Hwan SIHN

    2015-12-01

    Full Text Available After the Liberation, the Korean economy was dependent on relief supplies and aid after the ruin of the colonial regime and war. The pharmaceutical business also searched for their share in the delivery of military supplies and the distribution of relief supplies. The supply-side pharmaceutical policy made the pharmaceutical market a wholesale business. The gravity of the situation led to an increased importation of medical supplies, and wholesalers took the lead in establishing the distribution structure, whereas consumers and pharmaceutical business were relatively intimidated. The aid provided by the International Cooperation Administration (ICA marked a turning point in the Korean pharmaceutical industry after the middle of the 1950s. ICA supplied raw materials and equipment funds, while the pharmaceutical business imported advanced technology and capital. The government invited the local production of medical substances, whereas pharmaceutical businesses replaced imported medical substances with locally produced antibiotics. After the 1960s, the production of antibiotics reached saturation. Pharmaceutical businesses needed new markets to break through the stalemate, so they turned their attention to vitamins and health tonics as general pharmaceuticals, as these were suitable for mass production and mass consumption. The modernized patent medicine market after the Opening of Korea was transformed into the contemporized general pharmaceuticals market equipped with the up-to-date facilities and technology in 1960s. Pharmaceutical businesses had to advertise these new products extensively and reform the distribution structure to achieve high profits. With the introduction of TV broadcasting, these businesses invested in TV advertising and generated sizable sales figures. They also established retail pharmacy and chain stores to reform the distribution structure. The end result was a dramatic expansion of the general pharmaceuticals market. The

  2. [The Korean Pharmaceutical Industry and the Expansion of the General Pharmaceuticals Market in the 1950-1960s].

    Science.gov (United States)

    Sihn, Kyu-Hwan

    2015-12-01

    After the Liberation, the Korean economy was dependent on relief supplies and aid after the ruin of the colonial regime and war. The pharmaceutical business also searched for their share in the delivery of military supplies and the distribution of relief supplies. The supply-side pharmaceutical policy made the pharmaceutical market a wholesale business. The gravity of the situation led to an increased importation of medical supplies, and wholesalers took the lead in establishing the distribution structure, whereas consumers and pharmaceutical business were relatively intimidated. The aid provided by the International Cooperation Administration (ICA) marked a turning point in the Korean pharmaceutical industry after the middle of the 1950s. ICA supplied raw materials and equipment funds, while the pharmaceutical business imported advanced technology and capital. The government invited the local production of medical substances, whereas pharmaceutical businesses replaced imported medical substances with locally produced antibiotics. After the 1960s, the production of antibiotics reached saturation. Pharmaceutical businesses needed new markets to break through the stalemate, so they turned their attention to vitamins and health tonics as general pharmaceuticals, as these were suitable for mass production and mass consumption. The modernized patent medicine market after the Opening of Korea was transformed into the contemporized general pharmaceuticals market equipped with the up-to-date facilities and technology in 1960s. Pharmaceutical businesses had to advertise these new products extensively and reform the distribution structure to achieve high profits. With the introduction of TV broadcasting, these businesses invested in TV advertising and generated sizable sales figures. They also established retail pharmacy and chain stores to reform the distribution structure. The end result was a dramatic expansion of the general pharmaceuticals market. The market for

  3. Process Analytical Technology for Crystallization of Active Pharmaceutical Ingredients

    DEFF Research Database (Denmark)

    Malwade, Chandrakant Ramkrishna; Qu, Haiyan

    2018-01-01

    Background: Pharmaceutical industry is witnessing increased pressure to introduce innovative and efficient processes for manufacturing of Active Pharmaceutical Ingredients (APIs) in order to be competitive as well as to meet the stringent product quality requirements set by regulatory authorities...... parameters and their impact on quality of APIs and subsequently the drug products assume great significance for pharmaceutical industry. Methods: This review paper focuses on application of PAT tools, an integral part of Quality by Design (QbD) approach, for better understanding, control, and design...

  4. Concept of the Ural pharmaceutical cluster formation

    Directory of Open Access Journals (Sweden)

    Aleksandr Petrovich Petrov

    2011-06-01

    Full Text Available This paper substantiates the necessity of cluster organization of the pharmaceutical industry in the region. The estimation of the state and prospects of development of such structures in the domestic economy is given. Sverdlovsk region was chosen as the object of study on the possibility of forming a pharmaceutical cluster. Objective prerequisites for the organization of a cluster of pharmaceutical production in Sverdlovsk region are considered, among these were distinguished: capacious and fast-growing market for pharmaceutical products, availability of potential development of the pharmaceutical industry in the territory and the key success factors for enterprises - potential participants of the cluster. Indicated key success factors are: presence of a creative team and close interaction between business and government, high level of cooperation among the enterprises of the cluster and commercialization of products, implementation of research and development expenditures etc. Thus, it was substantiated that in there all references and resources for the formation of a pharmaceutical cluster. The concept of formation and development of the Ural pharmaceutical cluster was elaborated. Inside the concept, the goals, objectives, processing, product and organizational priorities for cluster formation are identified. Architecture of this structure with a justification of its members and certain forms of interaction between them is proposed. The stages of formation and development of the Ural pharmaceutical cluster on the basis of a ten-year settlement period for the full range of activities for this project are substantiated. At each stage, a set of key objectives and results of the cluster was defined. The choice of phases was carried out on the basis of investment programs of cluster's enterprises strategic position on the mastering of markets and infrastructure development. An assessment of socio-economic efficiency of the Ural pharmaceutical

  5. 2nd IAEA research coordination meeting on collection and evaluation of reference data for thermo-mechanical properties of fusion reactor plasma facing materials. Summary report

    International Nuclear Information System (INIS)

    Langley, R.A.

    1996-08-01

    The proceedings and results of the 2nd IAEA Research Coordination Meeting on ''Collection and Evaluation of Reference Data for Thermo-mechanical Properties of Fusion Reactor Plasma Facing Materials'' held on March 25, 26 and 27, 1996 at the IAEA Headquarters in Vienna are briefly described. This report includes a summary of presentations made by the meeting participants, the results of discussions amongst the participants regarding the status of data, publication of a multi-author review paper and recommendations regarding future work. (author). 1 tab

  6. Summary report of the IAEA advisory group meeting on nuclear data for neutron multiplication in fusion-reactor first-wall and blanket materials

    International Nuclear Information System (INIS)

    Muir, D.W.; Pashchenko, A.B.

    1992-09-01

    The present Report contains the Summary of the IAEA Advisory Group Meeting on Nuclear Data for Neutron Multiplication in Fusion-Reactor First-Wall and Blanket Materials, which was hosted by the Southwest Institute of Nuclear physics and Chemistry (SWINPC) at Chengdu, China and held from 19-21 November 1990. This AGM was organized by the IAEA Nuclear Data Section (NDS), with the cooperation and assistance of local organizers at the SWINPC. The papers which the participants prepared for and presented at the meeting will be published as an INDC report. (author)

  7. Book of abstracts of the joint EC-IAEA topical meeting on development of new structural materials for advanced fission and fusion reactor systems

    International Nuclear Information System (INIS)

    2009-01-01

    Materials performance and reliability are key issues for the safety and competitiveness of future nuclear installations: Generation IV nuclear systems for increased sustainability, advanced systems for non-electrical uses of nuclear energy, partitioning and transmutation systems, as well as thermo-nuclear fusion systems. These systems will have to feature high thermal efficiency and optimized utilization of fuel combined with minimized nuclear waste. For the sustainability of the nuclear option, there is a renewed interest worldwide in new reactor systems, closed fuel cycle research and technology development, and nuclear process heat applications. This requires the development and qualification of new high temperature structural materials with improved radiation and corrosion resistance. To achieve the challenging materials performance parameters, focused research and targeted testing of new candidate materials are necessary. Recent developments regarding new classes of materials with improved microstructural features, such as fibre-reinforced ceramic composite materials, oxide dispersion strengthened steels or advanced ferritic-martensitic steels are promising since they combine good radiation resistance and corrosion properties with high-temperature strength and toughness. In view of a successful and timely implementation of design parameters, in particular for primary circuits, new structural materials have to be qualified during the next decade. To this end an international R and D effort is being undertaken. Recent progress in materials science, supported by computer modelling and advanced materials characterisation techniques, has the potential to accelerate the process of new structural materials development. The scope of the meeting is information exchange and cross-fertilisation of various disciplines, including an overview of recent status of world-wide R and D activities. A comprehensive review of the designs of fission as well as fusion reactor systems

  8. Pharmaceutical care: the PCNE definition 2013.

    Science.gov (United States)

    Allemann, Samuel S; van Mil, J W Foppe; Botermann, Lea; Berger, Karin; Griese, Nina; Hersberger, Kurt E

    2014-06-01

    Twenty-three years after Hepler and Strand published their well-known definition of Pharmaceutical Care (PhC), confusion remains about what the term includes and how to differentiate it from other terms. The board of the Pharmaceutical Care Network Europe (PCNE) felt the need to redefine PhC and to answer the question: "What is Pharmaceutical Care in 2013". The aims of this paper were to review existing definitions of PhC and to describe the process of developing a redefined definition. A literature search was conducted in the MEDLINE database (1964-January 2013). Keywords included "Pharmaceutical Care", "Medication (Therapy) Management", "Medicine Management", and "Pharmacist Care" in the title or abstract together with the term "defin*". To ease comparison between definitions, we developed a standardised syntax to paraphrase the definitions. During a dedicated meeting, a moderated discussion about the definition of PhC was organised. The initial literature search produced 186 hits, with eight unique PhC definitions. Hand searching identified a further 11 unique definitions. These 19 definitions were paraphrased using the standardised syntax (provider, recipient, subject, outcome, activities). Fourteen members of PCNE and 10 additional experts attended the moderated discussion. Working groups of increasing size developed intermediate definitions, which had similarities and differences to those retrieved in the literature search. At the end of the session, participants reached a consensus on a "PCNE definition of Pharmaceutical Care" reading: "Pharmaceutical Care is the pharmacist's contribution to the care of individuals in order to optimize medicines use and improve health outcomes". It was possible to paraphrase definitions of PhC using a standardised syntax focusing on the provider, recipient, subject, outcomes, and activities included in PhC practice. During a one-day workshop, experts in PhC research agreed on a definition, intended to be applicable for the

  9. Summary reports on the meetings held in the period May 1999 - April 2000, background material, and some room documents in preparation of the 33rd IWG-FR annual meeting, IAEA Headquarters, Vienna 16-18 May 2000. Working material

    International Nuclear Information System (INIS)

    2000-01-01

    This publication contains a brief overview of the activities performed in the period May 1999-April 2000 in the Nuclear Power Technology Development Section relating to the work scope of the International Working Group (IWG) on Fast Reactors. It includes the following reports as well: report on the 32nd Annual Meeting of the IWG on Liquid Metal Cooled Fast Reactor Developments; report on the Advisory Group Meeting on National Accelerator Driven System Programs; report on the Research Coordination Meeting of the CRP on Use of Thorium-Based Fuel Cycle in Accelerator Driven Systems to incinerate Plutonium and to reduce Long-term Waste Toxicities; report on Advisory Group Meeting on Evaluation of Fast Reactor Core Physics test; report on the Research Coordination Meeting of CRP on Updated Codes and Methods to Reduce the Calculational Uncertainties of the Liquid Metal Cooled Fast Reactor Reactivity Effects; report on the Consultancy on Proposals for New CRP on Accelerator Driven Systems; report on the Peer review meeting on the Performance and Assessment System Evaluation of Sub-Program A.2; and a list of IAEA documents of the IWG on fast reactors published since 1968

  10. [Fourcroy and pharmaceutical journals].

    Science.gov (United States)

    Bonnemain, Bruno

    2011-04-01

    Cadet de Gassicourt wrote a brief Eloge of Fourcroy in January 1810 as he died in December of 1809. Fourcroy had a major role concerning the new ideas on the place of pharmacy at the beginning of the 19th century. Fourcroy has had a key influence for the start of several pharmaceutical journals that wanted to emphasize the link between the new chemistry and pharmacy. None of these journals created with him will survive and one has to wait for 1909 to see the creation, without Fourcroy, of a new pharmaceutical journal, the "Journal de Pharmacie" that will become "Journal de Pharmacie et des Sciences accessoires", then "Journal de Pharmacie et de Chimie", before taking the name of"Annales Pharmaceutiques Françaises", the present official journal of the French Academy of Pharmacy. In spite of the essential role of Fourcroy at the start of pharmaceutical journals, Cadet did not even mention it in his Eloge of 1810.

  11. Rheology in Pharmaceutical Sciences

    DEFF Research Database (Denmark)

    Aho, Johanna; Hvidt, Søren; Baldursdottir, Stefania

    2016-01-01

    Rheology is the science of flow and deformation of matter. Particularly gels and non-Newtonian fluids, which exhibit complex flow behavior, are frequently encountered in pharmaceutical engineering and manufacturing, or when dealing with various in vivo fluids. Therefore understanding rheology......, together with the common measurement techniques and their practical applications. Examples of the use of rheological techniques in the pharmaceutical field, as well as other closely related fields such as food and polymer science, are also given....... is important, and the ability to use rheological characterization tools is of great importance for any pharmaceutical scientist involved in the field. Flow can be generated by shear or extensional deformations, or a combination of both. This chapter introduces the basics of both shear and extensional rheology...

  12. On-the-job training and qualification of nuclear power plant personnel. Proceedings of a specialists' meeting. Working material

    International Nuclear Information System (INIS)

    1996-01-01

    The topic of this meeting , on-the-job training, was selected by the International Working Group on Training and Qualification of Nuclear Power Plant Personnel, during their most recent meeting in 1994. This International Working Group is made up of representatives from all Member States who have operating nuclear power plants. This Group felt that there was a need to provide a forum for exchange of information among specialists from Member States on the topic of on-the-job training, and further that the Agency should publish the proceedings of this meeting for the use of those specialists who were not able to attend. Refs, figs, tabs

  13. Advanced control systems to improve nuclear power plant reliability and efficiency. Working material. Report of an advisory group meeting held in Vienna, 13-17 March, 1995

    International Nuclear Information System (INIS)

    1995-01-01

    The Advisory Group Meeting as a consequence of the recommendations of the IAEA International Working Group on Nuclear Power Plant Control and Instrumentation to produce a practical guidance on the application of the advanced control systems available for nuclear power plant operation. The objective of the IAEA advisory group meeting were: To provide an international forum of exchange of ideas and views for the purpose of enhancement of nuclear power plant reliability and efficiency by adopting advanced control technologies; to develop a scope, table of content, and extended outlines for an IAEA technical document on the subject. The present volume contains summary report, materials prepared by the meeting, and reports presented by national delegates. Refs, figs and tabs

  14. Reference and intercomparison materials for stable isotopes of light elements. Proceedings of a consultants meeting held in Vienna, 1-3 December 1993

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-09-01

    The stable isotope composition of elements varies in natural compounds as a consequence of the slightly different physico-chemical behaviour of isotopes. The possibility of measuring the stable isotope relative variations with high precision, using mass spectrometry, promoted the rise of new fields of research in geochemistry and hydrology and, more recently, in environmental studies. The steady growth of these investigations and of their practical applications has emphasized the need for high quality isotopic standards and intercomparison samples, with well determined isotopic composition, for the intercalibration of analytical techniques and results among laboratories. The organization of the Consultants Meeting on Stable Isotope Standards and Intercomparison Materials held in Vienna from 1 to 3 December 1993, the fifth of this type (the previous meetings took place in 1966, 1976, 1983 and 1985), called for a review and a discussion of the characteristics, quality and availability of the existing standards and intercalibration materials, and for an assessment of needs for new materials, in view of recent developments and applications. A large part of the discussions was devoted to the new materials prepared for sulphur isotope analysis and the analytical requirements for highly precise isotopic analysis of CO{sub 2}. The papers presented at the meeting are assembled in this volume. Refs, figs and tabs.

  15. Reference and intercomparison materials for stable isotopes of light elements. Proceedings of a consultants meeting held in Vienna, 1-3 December 1993

    International Nuclear Information System (INIS)

    1995-09-01

    The stable isotope composition of elements varies in natural compounds as a consequence of the slightly different physico-chemical behaviour of isotopes. The possibility of measuring the stable isotope relative variations with high precision, using mass spectrometry, promoted the rise of new fields of research in geochemistry and hydrology and, more recently, in environmental studies. The steady growth of these investigations and of their practical applications has emphasized the need for high quality isotopic standards and intercomparison samples, with well determined isotopic composition, for the intercalibration of analytical techniques and results among laboratories. The organization of the Consultants Meeting on Stable Isotope Standards and Intercomparison Materials held in Vienna from 1 to 3 December 1993, the fifth of this type (the previous meetings took place in 1966, 1976, 1983 and 1985), called for a review and a discussion of the characteristics, quality and availability of the existing standards and intercalibration materials, and for an assessment of needs for new materials, in view of recent developments and applications. A large part of the discussions was devoted to the new materials prepared for sulphur isotope analysis and the analytical requirements for highly precise isotopic analysis of CO 2 . The papers presented at the meeting are assembled in this volume. Refs, figs and tabs

  16. Conceptualizing Pharmaceutical Plants

    DEFF Research Database (Denmark)

    Larsen, Bent Dalgaard; Jensen, Klaes Ladeby; Gjøl, Mikkel

    2006-01-01

    In the conceptual design phase of pharmaceutical plants as much as 80%-90% of the total cost of a project is committed. It is therefore essential that the chosen concept is viable. In this design process configuration and 3D models can help validate the decisions made. Designing 3D models...... is a complex task and requires skilled users. We demonstrate that a simple 2D/3D configuration tool can support conceptualizing of pharmaceutical plants. Present paper reports on preliminary results from a full scale implementation project at a Danish engineering company....

  17. Technical meeting to 'Review of national programmes on fast reactors and accelerator driven systems (ADS)'. Working material

    International Nuclear Information System (INIS)

    2002-01-01

    The 35th Annual Meeting of the Technical Working Group on Fast Reactors TWG-FR, previously International Working Group on Fast Reactors (IWG-FR, created in 1967), was hosted by the Forschungszentrum Karlsruhe (FZK) and was attended by TWG-FR members and advisers from the following Member States: Brazil, China, France, Germany, India, Japan, the Republic of Kazakhstan, the Republic of Korea, the Russian Federation, and the United States of America. The objectives of the meeting were: to exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); to review the progress since the 34th TWG-FR Annual Meeting, including the status of the actions; to consider meeting arrangements for 2002 and 2003; to review the Agency's co-ordinated research activities in the field of FRs and ADS, as well as co-ordination of the TWG-FR's activities with other organizations

  18. Technical meeting to 'Review of national programmes on fast reactors and accelerator driven systems (ADS)'. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2002-07-01

    The 35th Annual Meeting of the Technical Working Group on Fast Reactors TWG-FR, previously International Working Group on Fast Reactors (IWG-FR, created in 1967), was hosted by the Forschungszentrum Karlsruhe (FZK) and was attended by TWG-FR members and advisers from the following Member States: Brazil, China, France, Germany, India, Japan, the Republic of Kazakhstan, the Republic of Korea, the Russian Federation, and the United States of America. The objectives of the meeting were: to exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); to review the progress since the 34th TWG-FR Annual Meeting, including the status of the actions; to consider meeting arrangements for 2002 and 2003; to review the Agency's co-ordinated research activities in the field of FRs and ADS, as well as co-ordination of the TWG-FR's activities with other organizations.

  19. Technical meeting to 'Review of national programmes on fast reactors and accelerator driven systems (ADS)'. Working material

    International Nuclear Information System (INIS)

    2003-01-01

    36th Annual Meeting of the Technical Working Group on Fast Reactors, the IAEA Technical Meeting (TM) on 'Review of National Programmes on Fast Reactors and Accelerator Driven Systems (ADS)', hosted by the Korean Atomic Energy Research Institute (KAERI) was attended by TWG-FR Members and Advisers from the following Member States (MS) and International Organizations: Brazil, France, Germany, India, Japan, the Republic of Kazakhstan, the Republic of Korea, the Russian Federation, the United Kingdom, the United States of America, and the OECD/NEA. The objectives of the meeting were to: 1) exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); 2) review the progress since the 35th TWG-FR Annual Meeting, including the status of the actions; 3) consider meeting arrangements for 2003 and 2004; 4) review the Agency's co-ordinated research activities in the field of FRs and ADS, as well as co-ordination of the TWG-FR's activities with other organizations. The participants made presentations on the status of the respective national programmes on FR and ADS development. A summary of the highlights for the period since the 35th TWG-FR Annual Meeting

  20. Proceedings of the twenty fourth annual general meeting of Materials Research Society of India and theme symposium on advanced materials for energy applications: abstract and souvenir book

    International Nuclear Information System (INIS)

    2013-01-01

    Materials science and engineering plays a crucial role in the development of advanced technologies that include development of materials that can withstand high temperatures and intense neutron dose, development of advanced sensors and radiochemical processing methodologies. The contributed papers in the symposium were focussed on energy materials: thermoelectrics, photovoltaics; nuclear materials: alloys and glasses; oxides and ceramics; alloys and intermetallics; fictionalised nanomaterials and applications; thin films; soft matter and bio materials etc. Papers relevant to INIS are indexed separately

  1. Pharmaceutical packaging handbook

    National Research Council Canada - National Science Library

    Bauer, Edward J

    2009-01-01

    ... of the modern world. Pharmaceutical products and health care in developing countries and remote parts of the world seems like magic. Diseases that were once fatal and chronic conditions that destroyed lives have slowly been conquered by modern medicine. Views of the body, unimaginable for most of the last century with X rays, are now possible with new i...

  2. Data Evaluation and the Establishment of a Standard Library of Atomic, Molecular and Plasma-Material Interaction Data for Fusion. Summary Report of an IAEA Consultants' Meeting

    International Nuclear Information System (INIS)

    Braams, B.J.

    2012-08-01

    Seven experts in the field of atomic, molecular and plasma-material interaction (A+M+PMI) data and data evaluation for fusion plasma physics met with IAEA A+M Data Unit staff at IAEA Headquarters to provide advice towards the establishment of an evaluated and recommended library of A+M+PMI data for fusion. The proceedings and conclusions of the meeting are summarized here. (author)

  3. Third meeting of the advisory group for the comprehensive review of the IAEA regulations for the safe transport of radioactive materials, Vienna, 7-11 November 1983

    International Nuclear Information System (INIS)

    Rawl, R.R.

    This meeting was the third and final planned stage in the process to revise the Agency's Regulations for the Safe Transport of Radioactive Materials, Safety Series No. 6. Its task was to consider comments which had been submitted in response to the Agency's circulation of the third draft revision of Safety Series No. 6 and to make any necessary changes to the draft that the Advisory Group felt were necessary

  4. The Effectiveness of Pharmaceutical Marketing

    NARCIS (Netherlands)

    E.R. Kappe

    2011-01-01

    textabstractPharmaceutical marketing effectiveness comprises the measurement of marketing efforts of pharmaceutical firms towards doctors and patients. These firms spend billions of dollars yearly to promote their prescription drugs. This dissertation provides empirical analyses and methods to

  5. Adsorptive removal of selected pharmaceuticals by mesoporous silica SBA-15

    International Nuclear Information System (INIS)

    Bui, Tung Xuan; Choi, Heechul

    2009-01-01

    The removal of five selected pharmaceuticals, viz., carbamazepine, clofibric acid, diclofenac, ibuprofen, and ketoprofen was examined by batch sorption experiments onto a synthesized mesoporous silica SBA-15. SBA-15 was synthesized and characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), N 2 adsorption-desorption measurement, and point of zero charge (PZC) measurement. Pharmaceutical adsorption kinetics was rapid and occurred on a scale of minutes, following a pseudo-second-order rate expression. Adsorption isotherms were best fitted by the Freundlich isotherm model. High removal rates of individual pharmaceuticals were achieved in acidic media (pH 3-5) and reached 85.2% for carbamazepine, 88.3% for diclofenac, 93.0% for ibuprofen, 94.3% for ketoprofen, and 49.0% for clofibric acid at pH 3 but decreased with increase in pH. SBA-15 also showed high efficiency for removal of a mixture of 5 pharmaceuticals. Except for clofibric acid (35.6%), the removal of pharmaceuticals in the mixture ranged from 75.2 to 89.3%. Based on adsorption and desorption results, the mechanism of the selected pharmaceuticals was found to be a hydrophilic interaction, providing valuable information for further studies to design materials for the purpose. The results of this study suggest that mesoporous-silica-based materials are promising adsorbents for removing pharmaceuticals from not only surface water but also wastewater of pharmaceutical industrial manufactures.

  6. Adsorptive removal of selected pharmaceuticals by mesoporous silica SBA-15

    Energy Technology Data Exchange (ETDEWEB)

    Bui, Tung Xuan, E-mail: bxtung@gist.ac.kr [Department of Environmental Science and Engineering, Gwangju Institute of Science and Technology (GIST), 261 Cheomdan-gwagiro, Buk-gu, Gwangju 500-712 (Korea, Republic of); Choi, Heechul, E-mail: hcchoi@gist.ac.kr [Department of Environmental Science and Engineering, Gwangju Institute of Science and Technology (GIST), 261 Cheomdan-gwagiro, Buk-gu, Gwangju 500-712 (Korea, Republic of)

    2009-09-15

    The removal of five selected pharmaceuticals, viz., carbamazepine, clofibric acid, diclofenac, ibuprofen, and ketoprofen was examined by batch sorption experiments onto a synthesized mesoporous silica SBA-15. SBA-15 was synthesized and characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), N{sub 2} adsorption-desorption measurement, and point of zero charge (PZC) measurement. Pharmaceutical adsorption kinetics was rapid and occurred on a scale of minutes, following a pseudo-second-order rate expression. Adsorption isotherms were best fitted by the Freundlich isotherm model. High removal rates of individual pharmaceuticals were achieved in acidic media (pH 3-5) and reached 85.2% for carbamazepine, 88.3% for diclofenac, 93.0% for ibuprofen, 94.3% for ketoprofen, and 49.0% for clofibric acid at pH 3 but decreased with increase in pH. SBA-15 also showed high efficiency for removal of a mixture of 5 pharmaceuticals. Except for clofibric acid (35.6%), the removal of pharmaceuticals in the mixture ranged from 75.2 to 89.3%. Based on adsorption and desorption results, the mechanism of the selected pharmaceuticals was found to be a hydrophilic interaction, providing valuable information for further studies to design materials for the purpose. The results of this study suggest that mesoporous-silica-based materials are promising adsorbents for removing pharmaceuticals from not only surface water but also wastewater of pharmaceutical industrial manufactures.

  7. Computerized reactor protection and safety related systems in nuclear power plants. Proceedings of a specialists' meeting. Working material

    International Nuclear Information System (INIS)

    1998-01-01

    Though the majority of existing control and protection systems in nuclear power plants use old analogue technology and design philosophy, the use of computers in safety and safety related systems is becoming a current practice. The Specialists Meeting on ''Computerized Reactor Protection and Safety Related Systems in Nuclear Power Plants'' was organized by IAEA (jointly by the Division of Nuclear Power and the Fuel Cycle and the Division of Nuclear Installation Safety), in co-operation with Paks Nuclear Power Plant in Hungary and was held from 27-29 October 1997 in Budapest, Hungary. The meeting focused on computerized safety systems under refurbishment, software reliability issues, licensing experiences and experiences in implemented computerized safety and safety related systems. Within a meeting programme a technical visit to Paks NPP was organized. The objective of the meeting was to provide an international forum for the presentation and discussion on R and D, in-plant experiences in I and C important to safety, backfits and arguments for and reservations against the digital safety systems. The meeting was attended by 70 participants from 16 countries representing NPPs and utility organizations, design/engineering, research and development, and regulatory organizations. In the course of 4 sessions 25 technical presentations were made. The present volume contains the papers presented by national delegates and the conclusions drawn from the final general discussion

  8. 4th meeting on advanced pulsed-neutron research on quantum functions in nano-scale materials

    International Nuclear Information System (INIS)

    2006-07-01

    Toward the worldwide realization of high-intensity pulsed neutron source, KEK (High Energy Accelerator Research Organization) proceeds the research by composing 6 research groups as neutron science initiation base to initiate new neutron science. The papers generalizing the researches for 2 years were presented at this meeting. KENS (Neutron Science Laboratory, KEK) shut down on March 22nd in 2006, and KEK will continue the research utilizing the pulsed neutron by using foreign facilities until the completion of J-PARC from now on. At international session in this meeting, the accomplishments and future prospects about the Japan-United Kingdom science and technology collaboration project, and about the research collaboration projects with IPNS (Intense Pulsed Neutron Source, ANL) and LANSCE (Los Alamos Neutron Science Center) were presented. Especially in the latter projects, the first accomplishment was reported under the present agreement. In addition, Meeting on structural study of proteins in aqueous solutions' and 'Meeting on hydrogen quantum atomics study' were held as satellite meetings. (J.P.N)

  9. Annual meeting 1996 'Nondestructive materials testing'. German, Austrian and Swiss nondestructive materials testing standards as mirrored by international standardization. Vol. 1. Lectures

    International Nuclear Information System (INIS)

    1996-01-01

    The volume contains 45 lectures which were given at the annual meeting of the German Society for Nondestructive Testing on May 13-15, 1996 at Lindau. The main subjects were: Standardization of nondestructive testing, irradiation testing, ultrasonic testing and electromagnetic processes. 13 individual articles were included in the ENERGY database. (MM) [de

  10. Annual meeting 1996 'Nondestructive material testing'. German, Austrian and Swiss nondestructive materials testing standards as mirrored by international standardization. Vol. 2. Posters

    International Nuclear Information System (INIS)

    1996-01-01

    The volume contains 49 poster articles which were presented at the Annual Meeting of the German Society for Nondestructive Testing at Lindau on May 13-15, 1996. The main subjects were: Standardization of nondestructive testing, irradiation testing, ultrasonic testing and electromagnetic processes. 16 individual articles were included in the ENERGY databank. (MM) [de

  11. Tropical Journal of Pharmaceutical Research

    African Journals Online (AJOL)

    Journal Homepage Image. We seek to encourage pharmaceutical and allied research of tropical and international relevance and to foster multidisciplinary research and collaboration among scientists, the pharmaceutical industry and the healthcare professionals. We publish articles in pharmaceutical sciences and related ...

  12. Forty-Fourth Meeting of the Technical Working Group on Fast Reactors (TWG-FR). Working Material

    International Nuclear Information System (INIS)

    2011-01-01

    The objectives of the meeting were to: - Exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); - Review the progress since the 43rd TWG-FR Annual Meeting, including the status of the actions; - Consider topical technical meeting arrangements for 2012-2013, as well as review FR-related activities included in the IAEA Project&Budget (P&B) biennium 2012-2013; - Review the IAEA’s ongoing information exchange and coordinated research projects in the technical fields relevant to the TWG-FR (FRs and ADS), as well as coordination of the TWG-FR’s activities with other organizations and international initiatives (GIF, INPRO, NEA, ESNII, etc.)

  13. Care ideologies reflected in 4 conceptions of pharmaceutical care.

    Science.gov (United States)

    Björkman, Ingeborg K; Bernsten, Cecilia B; Sanner, Margareta A

    2008-12-01

    Different ways to practice pharmaceutical care have been developed. One expression of this fact is the existence of many different classification systems to document drug-related problems (DRPs). Evidence suggests that classification systems have different characteristics and that these characteristics reflect different conceptions of pharmaceutical care. To increase the understanding of conceptions of pharmaceutical care, underlying values and beliefs (ideologies) can be explored. To explore various conceptions of pharmaceutical care to identify the care ideologies on which these conceptions are based. Representatives of 4 selected conceptions of pharmaceutical care were interviewed in face-to-face meetings. During the interviews, 4 basic questions were asked. Three were focused on pharmaceutical care and 1 on DRPs. Interview transcripts were analyzed by an inductive method inspired by grounded theory. The conceptions studied were Strand, Granada-II, PCNE v5.0, and Apoteket. In Strand, patients are given a more active role in the pharmaceutical care process, as compared to Granada-II, PCNE v5.0, and Apoteket. Pharmacists in all the conceptions of pharmaceutical care assume they have special knowledge that patients benefit from. However, they use their knowledge in different ways in the various pharmaceutical care conceptions. In Strand, individual goals of drug therapy are established together with the patient, whereas in Granada-II, PCNE, and Apoteket goals are not explicitly discussed. The identified differences correspond to different care ideologies. The pharmaceutical care conceptions are based on different care ideologies. The ideology is expressed in how therapy goals are set and patient needs defined. Strand is based on a patient-centered ideology; patient therapy goals and needs are defined by the patient together with the practitioners. Granada-II, PCNE, and Apoteket are based on an evidence-based medicine approach; patient therapy goals and needs are

  14. [Written pharmaceutical advertising--still unreliable?].

    Science.gov (United States)

    Gladsø, Kristin Haugen; Garberg, Hedda Rosland; Spigset, Olav; Slørdal, Lars

    2014-09-02

    Marketing by the pharmaceutical industry affects doctors' prescribing habits. All pharmaceutical advertising received by nine doctors in two GP offices over a period of three months was collected. The advertising material was sorted by compound. For each compound, the advert with the highest number of references was selected. The cited references were obtained, and the claims in the adverts were assessed in terms of their consistency with the source data based on the provisions in the Norwegian regulations on pharmaceuticals. The references were also assessed with regard to the incidence of conflicts of interest among authors. The doctors received a total of 270 shipments of advertising for 46 different compounds. Altogether 95% of the 173 references cited in the 46 selected adverts could be obtained. The adverts contained a total of 156 claims. Of these, 56% were assessed as correct when compared to the source data and as having clinical relevance. Altogether 75% of the journal articles reported relevant conflicts of interest for the authors. About half the claims in the adverts were found to be correct and clinically relevant. These results concur with those from a methodologically identical study based on advertising material collected in 2004. The cited literature was of varying quality and often funded by the pharmaceutical companies. The findings indicate that the target group should be sceptical of this type of marketing.

  15. EU pharmaceutical expenditure forecast.

    Science.gov (United States)

    Urbinati, Duccio; Rémuzat, Cécile; Kornfeld, Åsa; Vataire, Anne-Lise; Cetinsoy, Laurent; Aballéa, Samuel; Mzoughi, Olfa; Toumi, Mondher

    2014-01-01

    With constant incentives for healthcare payers to contain their pharmaceutical budgets, forecasting has become critically important. Some countries have, for instance, developed pharmaceutical horizon scanning units. The objective of this project was to build a model to assess the net effect of the entrance of new patented medicinal products versus medicinal products going off-patent, with a defined forecast horizon, on selected European Union (EU) Member States' pharmaceutical budgets. This model took into account population ageing, as well as current and future country-specific pricing, reimbursement, and market access policies (the project was performed for the European Commission; see http://ec.europa.eu/health/healthcare/key_documents/index_en.htm). In order to have a representative heterogeneity of EU Member States, the following countries were selected for the analysis: France, Germany, Greece, Hungary, Poland, Portugal, and the United Kingdom. A forecasting period of 5 years (2012-2016) was chosen to assess the net pharmaceutical budget impact. A model for generics and biosimilars was developed for each country. The model estimated a separate and combined effect of the direct and indirect impacts of the patent cliff. A second model, estimating the sales development and the risk of development failure, was developed for new drugs. New drugs were reviewed individually to assess their clinical potential and translate it into commercial potential. The forecast was carried out according to three perspectives (healthcare public payer, society, and manufacturer), and several types of distribution chains (retail, hospital, and combined retail and hospital). Probabilistic and deterministic sensitivity analyses were carried out. According to the model, all countries experienced drug budget reductions except Poland (+€41 million). Savings were expected to be the highest in the United Kingdom (-€9,367 million), France (-€5,589 million), and, far behind them

  16. CATEGORY MANAGEMENT IN THE MANAGEMENT OF MINIMUM ASSORTMENT OF THE PHARMACEUTICAL ORGANIZATION

    Directory of Open Access Journals (Sweden)

    I. F. Samoshchenkova

    2017-01-01

    Full Text Available The main principle of the category management is the management of product category as a separate business unit. Category management directs the activities of the pharmaceutical organization to meet the consumer requirements and to provide customers with maximum benefits, which are expressed in the improved assortment,the attractive prices, the reduction of cases of lack of necessary goods, the simplifiedpurchase process. In article the structure of the category management and its role inthe minimum pharmaceutical assortment, a complex of the theoretical and practical issues affecting interrelation of the list of vital and essential medicines and the minimum range of medicines are considered. A number of the new elements supplementing the concept of category management is offered, and the corresponding generalizations are made. The objective of the research is to study the influence of category management on the structure in management of the minimum assortment of medicines of the pharmaceutical organization. Materials and methods. In the course of the solution of the set tasks, the methods of marketing and economic-mathematical analysis were used. Results and discussion. In the analysis of the assortment list of medicines for medical application, which is obligatory for the pharmaceutical enterprises of all forms of ownership, it was revealed that this assortment list is based on the List of Vital Essential and Necessary (VEN Drugs. The results of the analysis of the obligatory assortment list from the position of internal category management showed that 77.45% are medicines of the list of VEN Drugs; 46.08% are medicines of non-prescription dispensing. Proceeding from this it follows that the worthy, profitable price policy can be conducted only with 22.55% of the list; to develop standards of merchandising with 46.05%. The category management gives an opportunity to the pharmaceutical organization to specify its competitive strategy and to

  17. Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.

    Directory of Open Access Journals (Sweden)

    Marta Makowska

    Full Text Available This article aims to describe how Polish physicians cooperate with the pharmaceutical industry and show how this relationship may pose a threat to public health.It considers the results of an online survey of 379 physicians. The survey was hosted by surveymonkey.com with links from a Polish physicians' website (Medycyna Praktyczna between 29 October 2013 and 31 December 2013. The sample was purposive, respondents having to be physicians working in Poland.The majority of respondents (96.8% said that they had talked with pharmaceutical sales representatives (PSRs in their practice, with 85% saying that they had had regular contact with them. Despite the existing legal ban in Poland, 35% of respondents admitted that they had usually met with PSRs in their office during working hours. As many as 81.8% of surveyed doctors said that they had taken part in an educational meeting organized by the pharmaceutical industry at least once during the 12 months preceding the study. A majority of the respondents (72.3% said they trusted the information provided by PSRs. Over one third of respondents (36.4% claimed that Polish doctors accepted gifts of a type that they should not accept according to Polish law.The study showed that Polish physicians cooperate in different ways with pharmaceutical companies and have frequent contact with them. This can influence their knowledge and doctors whose knowledge of drugs is based mainly on information from pharmaceutical industry materials may prescribe medicines in a biased way, possibly exposing their patients to sub-optimal treatments and burdening both their patients and the state budget with unnecessary costs. Lack of trust in doctors and pharmaceutical companies have other implications too: there may be a decline of faith in the efficacy of therapy and patients may be encouraged to engage in self-diagnosis and self-treatment. For these reasons it is necessary to increase transparency and strengthen the ethical

  18. Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.

    Science.gov (United States)

    Makowska, Marta

    2017-01-01

    This article aims to describe how Polish physicians cooperate with the pharmaceutical industry and show how this relationship may pose a threat to public health. It considers the results of an online survey of 379 physicians. The survey was hosted by surveymonkey.com with links from a Polish physicians' website (Medycyna Praktyczna) between 29 October 2013 and 31 December 2013. The sample was purposive, respondents having to be physicians working in Poland. The majority of respondents (96.8%) said that they had talked with pharmaceutical sales representatives (PSRs) in their practice, with 85% saying that they had had regular contact with them. Despite the existing legal ban in Poland, 35% of respondents admitted that they had usually met with PSRs in their office during working hours. As many as 81.8% of surveyed doctors said that they had taken part in an educational meeting organized by the pharmaceutical industry at least once during the 12 months preceding the study. A majority of the respondents (72.3%) said they trusted the information provided by PSRs. Over one third of respondents (36.4%) claimed that Polish doctors accepted gifts of a type that they should not accept according to Polish law. The study showed that Polish physicians cooperate in different ways with pharmaceutical companies and have frequent contact with them. This can influence their knowledge and doctors whose knowledge of drugs is based mainly on information from pharmaceutical industry materials may prescribe medicines in a biased way, possibly exposing their patients to sub-optimal treatments and burdening both their patients and the state budget with unnecessary costs. Lack of trust in doctors and pharmaceutical companies have other implications too: there may be a decline of faith in the efficacy of therapy and patients may be encouraged to engage in self-diagnosis and self-treatment. For these reasons it is necessary to increase transparency and strengthen the ethical guidelines

  19. Polish physicians’ cooperation with the pharmaceutical industry and its potential impact on public health

    Science.gov (United States)

    2017-01-01

    Objective This article aims to describe how Polish physicians cooperate with the pharmaceutical industry and show how this relationship may pose a threat to public health. Methods It considers the results of an online survey of 379 physicians. The survey was hosted by surveymonkey.com with links from a Polish physicians’ website (Medycyna Praktyczna) between 29 October 2013 and 31 December 2013. The sample was purposive, respondents having to be physicians working in Poland. Results The majority of respondents (96.8%) said that they had talked with pharmaceutical sales representatives (PSRs) in their practice, with 85% saying that they had had regular contact with them. Despite the existing legal ban in Poland, 35% of respondents admitted that they had usually met with PSRs in their office during working hours. As many as 81.8% of surveyed doctors said that they had taken part in an educational meeting organized by the pharmaceutical industry at least once during the 12 months preceding the study. A majority of the respondents (72.3%) said they trusted the information provided by PSRs. Over one third of respondents (36.4%) claimed that Polish doctors accepted gifts of a type that they should not accept according to Polish law. Conclusions The study showed that Polish physicians cooperate in different ways with pharmaceutical companies and have frequent contact with them. This can influence their knowledge and doctors whose knowledge of drugs is based mainly on information from pharmaceutical industry materials may prescribe medicines in a biased way, possibly exposing their patients to sub-optimal treatments and burdening both their patients and the state budget with unnecessary costs. Lack of trust in doctors and pharmaceutical companies have other implications too: there may be a decline of faith in the efficacy of therapy and patients may be encouraged to engage in self-diagnosis and self-treatment. For these reasons it is necessary to increase transparency

  20. 21. Lecture meeting, ''Long-term performance of heat-resistant steels and high-temperature materials''. Thermal stresses

    International Nuclear Information System (INIS)

    1999-01-01

    The proceedings contains 15 papers presented at the lecture meeting of Arbeitsgemeinschaft fuer warmfeste Staehle and Arbeitsgemeinschaft fuer Hochtemperaturwerkstoffe, held on 27 November 1998 in Duesseldorf/Germany. Ten of the papers have been selected for subject analysis and indexing, and for separate rerieval from the ENERGY database. (orig./CB) [de

  1. ETHICAL ASPECTS OF THE COOPERATION BETWEEN PHYSICIAN AND PHARMACEUTICAL INDUSTRY

    Directory of Open Access Journals (Sweden)

    Jože Drinovec

    2001-09-01

    Full Text Available Background. It is not possible to isolated ethical aspects and norms in the work of physician from the professional and scientific ones. The physician will not act contrary to ethical principles if he will work for the interests of the patient and in accordance with scientific knowledge.Present situation and possible solutions. Every physician, especially if working in university institution is co-operating with pharmaceutical industry, at least he is makes the prescriptions and chooses one drug of the possible ones. There are also other aspects of co-operation: clinical trials, writing expertise and lectures at scientific meetings, sponsored by pharmaceutical industry. There are guidelines and codex in Western countries for more than ten years, which regulate the relation between physician and pharmaceutical industry. The most important ones are those from World Health Organisation, European Federation of Pharmaceutical Industries’ Associations’, and International Federation of Pharmaceutical Manufacturers Associations’. Scientific independence of lecturers and writers is tried to be achieved by disclosure of relevant financial relation with pharmaceutical corporation in advance.Conclusions. Physician working with pharmaceutical industry has o follow the guidelines of international professional associations. He/she has to be independent relaying only upon scientific and professional principles seeing primary the benefit of the patient.

  2. [New research on the significance of polymers in pharmaceutical formulations].

    Science.gov (United States)

    Amighi, K

    2001-01-01

    During these last few decades, a lot of work has been made in pharmaceutical area in order to control the drug delivery from various pharmaceutical dosage forms. The use of polymers in pharmaceutical technology have led to the development of the first drug delivery systems proposed in order to prolong or to delay the drug delivery, or to enhance drug release for drugs showing bioavailability shortcomings. The wide range of polymers available for pharmaceutical use, their low reactivity towards drugs and other formulation ingredients and their safe nature, have permitted a widespread use of polymers to improve manufacturing processes or for the formulation of pharmaceutical dosage forms for various administration routes. More over, the preparation of new polymeric materials by the synthesis of new polymers with unique properties or by the modification of available natural or synthetic polymers, offer to the formulator a wide range of applications in order to optimise the drug delivery for each specific case.

  3. Pharmaceutical market in Serbia

    Directory of Open Access Journals (Sweden)

    Veselin Tima Dickov

    2012-02-01

    Full Text Available Marketing concept formed around the focus on the consumers, their needs, wants and demands, evolves in the case of pharmaceutical into a care of the complex interest of constituents generating demand on this market and #8211; pres scribers whose role is to select therapies, pharmacists who dispense drugs within a specialized distribution channel to the final consumer -patient, alongside the payers and #8211; the state and or insurance companies refund a part of or total costs of the pharmaceutical product. A special challenge that the subject raises is the existence of controversy generated from two sources. Marketing controversy stems from criticism leveled at the effectiveness and efficiency of marketing activities and the debatable ethical code of conduct. [J Intercult Ethnopharmacol 2012; 1(1.000: 44-51

  4. Pharmaceutical Research Strategies

    OpenAIRE

    Phlippen, Sandra; Vermeersch, Ad

    2008-01-01

    textabstractThis study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of successful research projects. We provide clear evidence that externally sourced projects and projects involving biotechnologies perform better than internal projects and chemical projects, respectively. Controlling for these effects, we find that big pharma should either build a critical mass of disease area knowledge or diversify projects over different DA’s in or...

  5. Analytical protocol for the sensitive determination of mannitol, sorbitol and glucose containing powders in pharmaceutical workplaces by ion chromatography using a pulsed amperometric detector.

    Science.gov (United States)

    Butler, Owen; Forder, James; Saunders, John

    2015-03-15

    Workers in the pharmaceutical industry can potentially be exposed to airborne dusts and powders that can contain potent active pharmaceutical ingredients (API). Occupational hygienists and health and safety professionals need to assess and ultimately minimise such inhalation and dermal exposure risks. Containment of dusts at source is the first line of defence but the performance of such technologies needs to be verified, for which purpose the good practice guide: assessing the particulate containment performance of pharmaceutical equipment, produced by the International Society for Pharmaceutical Engineering (ISPE), is a widely used reference document. This guide recommends the use of surrogate powders that can be used to challenge the performance of such containment systems. Materials such as lactose and mannitol are recommended as their physical properties (adhesion, compactability, dustiness, flow characteristics and particle sizes) mimic those of API-containing materials typically handled. Furthermore they are safe materials to use, are available in high purity and can be procured at a reasonable cost. The aim of this work was to develop and validate a sensitive ion-chromatography based analytical procedure for the determination of surrogate powders collected on filter samples so as to meet analytical requirements set out in this ISPE guide. Crown Copyright © 2014. Published by Elsevier B.V. All rights reserved.

  6. The pharmaceutical quality revolution

    Directory of Open Access Journals (Sweden)

    Jordi Botet

    2016-01-01

    Full Text Available Pharmaceutical products are patient-oriented. If they had a deficient quality they might put live at risk. Ensuring their quality is not, however, a straightforward task and this is why different approaches have been used along the way. This article analyzes them and shows how our present approach, if well implemented, is very effective in ensuring quality.Methods. This article analyzes the current pharmaceutical quality system as described by international guidances in the light of practical experience gathered by the author as an international GMP-consultant.Result. Nowadays we have come to understand that as quality is a global concept in terms of time and of requirements, it has to be assured in a global way too. This is why quality assurance is a permanent process that starts during the development of a product and goes on during its manufacturing life. Manufacturing should be performed within a pharmaceutical quality system which ensures GMP compliance. Decisions should be science and risk-based. Products and processes are monitored by means of critical variables.Conclusions. The approach followed in the 21st century for ensuring quality is very effective and allows for a progressive reduction of the level of quality risk. However, this quality system is either comprehensive or there is no quality

  7. Knowledge and practice of pharmaceutical care by community ...

    African Journals Online (AJOL)

    There is a global strategy to improve health through prompt identification and treatment of diseases. The pharmacy profession has remodelled its roles in an attempt to meet these global expectations through pharmaceutical care. The objective of this study was therefore to assess the knowledge and practice of ...

  8. Report of second FAO/IAEA research coordination meeting on in vitro techniques for selection of radiation-induced mutants adapted to adverse environmental conditions. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-07-01

    The meeting was attended by scientists from nine countries: Bangladesh, China P.R., Colombia, Egypt, Ghana, India, Pakistan, Peru and United States of America. The participants in this Research Coordination Meeting are working on the improvement of potato, sweet potato, garlic, sugarcane, pineapple and alfalfa by combining in vitro techniques with induced mutagenesis to select for resistance to salinity, freezing, heat, drought, and water-logging depending upon adverse condition prevailing in their region. The participants reported results of their experiments on the radio-sensitivity tests on in vitro cultured plant material, such as micropropagated plants and organogenic or embryogenic callus cultures. In addition, reports on the modifications of culture media required to regenerate and multiply local varieties and to carry out in vitro selection for specific stress conditions were presented. Refs, figs, tabs.

  9. Report of second FAO/IAEA research coordination meeting on in vitro techniques for selection of radiation-induced mutants adapted to adverse environmental conditions. Working material

    International Nuclear Information System (INIS)

    1997-07-01

    The meeting was attended by scientists from nine countries: Bangladesh, China P.R., Colombia, Egypt, Ghana, India, Pakistan, Peru and United States of America. The participants in this Research Coordination Meeting are working on the improvement of potato, sweet potato, garlic, sugarcane, pineapple and alfalfa by combining in vitro techniques with induced mutagenesis to select for resistance to salinity, freezing, heat, drought, and water-logging depending upon adverse condition prevailing in their region. The participants reported results of their experiments on the radio-sensitivity tests on in vitro cultured plant material, such as micropropagated plants and organogenic or embryogenic callus cultures. In addition, reports on the modifications of culture media required to regenerate and multiply local varieties and to carry out in vitro selection for specific stress conditions were presented. Refs, figs, tabs

  10. International Working Group on Water Reactor Fuel Performance and Technology. Summary report of the 14. plenary meeting. Working material

    International Nuclear Information System (INIS)

    1997-01-01

    The fourteenth Plenary Meeting of the International Working Group on Water Reactor Fuel Performance and Technology (IWGFPT) was held at IAEA Headquarters, Vienna, from 21 to 23 May 1997. Twenty-seven participants, from twenty two Member States and two international organizations, attended the meeting. These presentations generally gave: The general situation of the nuclear industry in the country; Fuel fabrication; Fuel performance, high burnup fuel (including MOX) operational experience; Status and trends in fuel research programmes directed to achievement sufficient safety margins at high burnups with regard to normal and transient operational conditions. Majority of countries reported on the stable situation of the nuclear fuel industry, i.e. without significant additions/cuts in nuclear power plant and fuel fabrication plant (NPP) capacities. Refs, figs, tabs

  11. International Working Group on Water Reactor Fuel Performance and Technology. Summary report of the 14. plenary meeting. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-12-01

    The fourteenth Plenary Meeting of the International Working Group on Water Reactor Fuel Performance and Technology (IWGFPT) was held at IAEA Headquarters, Vienna, from 21 to 23 May 1997. Twenty-seven participants, from twenty two Member States and two international organizations, attended the meeting. These presentations generally gave: The general situation of the nuclear industry in the country; Fuel fabrication; Fuel performance, high burnup fuel (including MOX) operational experience; Status and trends in fuel research programmes directed to achievement sufficient safety margins at high burnups with regard to normal and transient operational conditions. Majority of countries reported on the stable situation of the nuclear fuel industry, i.e. without significant additions/cuts in nuclear power plant and fuel fabrication plant (NPP) capacities. Refs, figs, tabs.

  12. The assessment of soil conservation technologies for sustainable agricultural production. Report of the FAO/IAEA consultants meeting. Working material

    International Nuclear Information System (INIS)

    2001-01-01

    A Consultants' Meeting on 'The assessment of soil conservation technologies for sustainable agricultural production' was held in Vienna at the IAEA Headquarters from May 28-30, 2001. The consultants' presentations reviewed recent advances in the use of fallout radionuclides to measure soil erosion as well as approaches and technologies applied for soil conservation worldwide. Also, activities and experiences of FAO and UNEP in the field of land degradation, soil conservation and related issues were presented. Based on the information provided by the Scientific Secretary, a full project proposal was prepared during the second part of the Consultants' Meeting. The consultants also provided recommendations on the formulation and implementation of a future CRP on the subject

  13. International Working Group on Life Management of Nuclear Power Plants. (IWG-LMNPP). Regular meeting. Working material. V. 2

    International Nuclear Information System (INIS)

    1998-01-01

    National programs of Hungary, Japan, Korea, Russian Federation, Bulgaria, Slovenia, Sweden, Switzerland, Ukraine, United Kingdom and USA, related to nuclear power plants life management presented at the Technical Committee Meeting are published in this volume. The main features of the reports are oriented towards extension of NPP lifetime and conditions indispensable to achieve in order to fulfil the safety requirements including testing the mechanical properties of relevant reactor components

  14. International Working Group on Life Management of Nuclear Power Plants. (IWG-LMNPP). Regular meeting. Working material. V. 1

    International Nuclear Information System (INIS)

    1998-01-01

    National programs of Argentina, Brazil, Belgium, Czech Republic, Canada, France and Germany related to nuclear power plants life management presented at the Technical Committee Meeting are published in this volume. Finnish report VTT-TIED-1843 included in this volume was already included separately in the INIS Database. The main features of the reports are oriented towards extension of NPP lifetime and conditions indispensable to achieve in order to fulfil the safety requirements including testing the mechanical properties of relevant reactor components

  15. Forty-Sixth Meeting of the Technical Working Group on Fast Reactors (TWG-FR). Working Material

    International Nuclear Information System (INIS)

    2013-01-01

    The objectives of the meeting were to: • Review the current status and the progress since the 45th TWG-FR meeting of FR and ADS technology development activities in IAEA Member States; • Review the activities (past, present and planned) of the IAEA’s project 1.1.5.3, “Support for fast reactor research, technology development and deployment” to ensure that they remain relevant to the needs of Member States; • Provide the experts group with updates to advise the IAEA on FR and ADS activities, including on proposals for relevant studies and reviews; • Serve as a means for exchanging information on national and international FR and ADS programmes; • Review the main achievements and outcomes of the “International Conference on Fast Reactors and Related Fuel Cycle: Safe Technologies and Sustainable Scenarios – FR13”, held on 4 – 7 March 2013 in Paris, France; • Promote the exchange of technical information by proposing topics for, and assisting in the organization of, IAEA Workshops and Technical Meetings for 2014-2015 and further, and • Review the IAEA’s concluded, on-going and planned coordinated research projects (CRPs) in the technical fields relevant to the TWG-FR (FRs and ADS), as well as coordination of the TWG-FR’s activities with other organizations and international initiatives (GIF, INPRO, NEA, Euratom, etc.)

  16. Reflective and refractive optical materials for earth and space applications; Proceedings of the Meeting, Orlando, FL, Apr. 4, 5, 1991

    Science.gov (United States)

    Riedl, Max J.; Hale, Robert R.; Parsonage, Thomas B.

    The present conference discusses beryllium mirror design and fabrication, production of aspheric beryllium optical surfaces by HIP consolidation, the control of thermally induced porosity for the fabrication of beryllium optics, fine-grained beryllium optical coatings, light-absorbing beryllium baffle materials, and advanced broadband baffle materials. Also discussed are radiation-resistant optical glasses, a catalog of IR and cryooptical properties of selected materials, durable metal-dielectric mirror coatings, the optical stability of diffuse reflectance materials, and optical filters for space applications.

  17. ORIGINS AND RAMIFICATIONS OF PHARMACEUTICALS & ...

    Science.gov (United States)

    There is no abstract available for this product. If further information is requested, please refer to the bibliographic citation and contact the person listed under Contact field. The research focused on in the subtasks is the development and application of state-of the-art technologies to meet the needs of the public, Office of Water, and ORD in the area of Water Quality. Located In the subtasks are the various research projects being performed in support of this Task and more in-depth coverage of each project. Briefly, each project's objective is stated below.Subtask 1: To integrate state-of-the-art technologies (polar organic chemical integrative samplers, advanced solid-phase extraction methodologies with liquid chromatography/electrospray/mass spectrometry) and apply them to studying the sources and fate of a select list of PPCPs. Application and improvement of analytical methodologies that can detect non-volatile, polar, water-soluble pharmaceuticals in source waters at levels that could be environmentally significant (at concentrations less than parts per billion, ppb). IAG with USGS ends in FY05. APM 20 due in FY05.Subtask 2: Coordination of interagency research and public outreach activities for PPCPs. Participate on NSTC Health and Environment subcommittee working group on PPCPs. Web site maintenance and expansion, invited technical presentations, invited articles for peer-reviewed journals, interviews for media, responding to public inquiries. S

  18. Combinatorial nanodiamond in pharmaceutical and biomedical applications.

    Science.gov (United States)

    Lim, Dae Gon; Prim, Racelly Ena; Kim, Ki Hyun; Kang, Eunah; Park, Kinam; Jeong, Seong Hoon

    2016-11-30

    One of the newly emerging carbon materials, nanodiamond (ND), has been exploited for use in traditional electric materials and this has extended into biomedical and pharmaceutical applications. Recently, NDs have attained significant interests as a multifunctional and combinational drug delivery system. ND studies have provided insights into granting new potentials with their wide ranging surface chemistry, complex formation with biopolymers, and combination with biomolecules. The studies that have proved ND inertness, biocompatibility, and low toxicity have made NDs much more feasible for use in real in vivo applications. This review gives an understanding of NDs in biomedical engineering and pharmaceuticals, focusing on the classified introduction of ND/drug complexes. In addition, the diverse potential applications that can be obtained with chemical modification are presented. Copyright © 2016 Elsevier B.V. All rights reserved.

  19. The argument for pharmaceutical policy.

    Science.gov (United States)

    Traulsen, Janine Morgall; Almarsdóttir, Anna Birna

    2005-02-01

    Pharmaceutical policy is a global concern. It has become a hot political topic in most countries--developed as well as developing--and can be found on the agenda of international organizations such as WHO, OECD, EU, WTO and even the World Bank. Pharmaceutical policy affects everyone in the world of pharmacy and it is therefore imperative that it be understood, discussed and debated within the pharmacy profession and included in the curriculum of schools of pharmacy. This, the first article in a series, argues for the importance of the academic discipline of pharmaceutical policy analysis and the involvement of pharmacists in this endeavour. The aim of the authors is to stimulate an informed and critical appreciation of this field. The authors begin with an introduction to the field of pharmaceutical policy, introducing several important concepts and current trends including: medicines regulation; how pharmaceutical policy is made; pharmaceutical policy as a dynamic process; and the new public health as a global issue. The article ends with a short description of the remaining five articles in the series which will deal with important aspects of pharmaceutical policy. The topics include: economic pressures on health care systems; drug utilization from the clinical viewpoint (rational use of medicines); the impact of pharmaceutical policy on patients and the patient impact on pharmaceutical policy; the professional perspective; and finally the last article which deals with studying and evaluating pharmaceutical policy.

  20. [Logistics in the pharmaceutical service].

    Science.gov (United States)

    Stanko, P; Fulmeková, M

    2005-11-01

    The conception of the field of pharmaceutical service defines pharmaceutical service as the basic part of pharmacy, the principal task of which is to provide pharmaceutical care as an inseparable part of providing health care. It represents a set of professional activities of the pharmacist oriented to securing human and veterinary pharmaceutical products and health care products and to optimising effective, safe and quality pharmacotherapy. Technically, pharmaceutical service is an applied discipline, as it makes use of knowledge gained in other pharmaceutical, medical, psychological, social, and economic sciences. Because of its interdisciplinary character it is necessary to extend the theory of pharmaceutical service in such a way so that it may reflect all aspects of its sphere of activity. One of the possibilities is to define the pharmacy premises as an independent functional unit which operates on the basis of valid legal standards in such a way that on the one hand it secures the provision of health (pharmaceutical) care, and on the other hand it maintains its cost-effectiveness. To keep the quality of care of the patient and the economic aspect in balance, it is necessary to define the term pharmaceutical logistics also under the conditions of Slovak (Czech) pharmacy as early satisfaction of the requirements of the patient (client) in the pharmacy premises, which means that the appropriate pharmaceutical product or health care product and the appropriate information must be at the right time in the required amount and required quality in the right place.

  1. Window and dome technologies and materials; Proceedings of the Meeting, Orlando, FL, Mar. 27-29, 1989

    Science.gov (United States)

    Klocek, Paul

    1989-09-01

    Papers on window and dome technologies and methodologies are presented, covering the processing and application of window and dome materials such as polycrystalline MgAl2O4 spinel, yttria and lanthana-doped yttria, transparent aluminum oxynitride, sapphire materials, fluoride glass, zinc sulfide, and germanium materials. Other topics include high modulus layers as protective coatings for window materials, ultrahard coatings for IR materials, IR applications of GeC thin filems, CVD diamond for IR applications, amorphic diamond films grown with a laser-ion source, dome cooling, microwave shielding effectiveness of electrically conductive coated optical windows, and the window evaluation program for an airborne FLIR system. In addition, papers are presented on modeling optical properties of window materials, lattice symmetries and thermal expansion, rain damage protection for IR materials, optical window materials for hypersonic flow, the IR emission due to aerodynamic heating of missile domes, a ZnS window for the IR instrumentation system, hypersonic aerooptical effects, optical and semiconductor properties of lead telluride coatings, boron phosphide for coating IR transparencies, and the measurement of high out-of-band filter rejection characteristics.

  2. INAA of polyacrylic hydrogels of pharmaceutical grade

    International Nuclear Information System (INIS)

    Ponta, C.; Salagean, M.; Pantelica, A.; Georgescu, I.I.

    1998-01-01

    Polyacrylic acid (PA) and its salts are promising biomaterials used in the pharmaceutical industry. They could be used as pharmaceutical additives, as a burn dressing and also in the slow released implants or trans-derma patch formulations. Polyacrylic acid of pharmaceutical grade can be obtained by gamma irradiation polymerization. The influence of the raw materials and of the technological procedure on the final product purity has been investigated by Instrumental Neutron Activation Analysis (INAA) method. The following materials have been analyzed by INAA: 1) acrylic acid of technical grade; 2) acrylic acid purified by double crystallisation; 3) NaOH of analytical grade; 4) CaCl-2·6H 2 O of pharmaceutical grade; 5) CaCl 2 ·2H 2 O of analytical grade; 6) granulated PANa; 7) ungranulated PANa; 8) ungranulated PANaCa; 9) PANaCa granulated by milling in IFIN-HH using the mill nr. 1; 10) PANaCa granulated by milling in Institute of Chemical and Pharmaceutical Research (ICPR); 11) PANaCa granulated by milling in IFIN-HH using the mill nr. 2. The first five samples, marked from 1 to 5, are raw materials and the other six samples, marked from 6 to 11, are the final polyacrylic structures processed by various technological procedures. The samples together with the appropriate reference materials have been irradiated at WWR-S reactor in a neutron flux of 2.5·10 12 cm -2 s -1 and the induced radioactivity was registered by a HPGe detector (EG/G ORTEC) of 30% efficiency and 2.1 keV resolution. The concentrations of As, Br, Ce, Co, Cr, Fe, La, Sb, Sc, Zn have been determined. For the final polyacrylic structures, except for granulated PANa (sample 6), only the elements Co, Cr, Fe, Sc, Zn were found at the following concentration levels: tens of ppm (Co), ppm (Zn), hundreds of ppb (Cr), tens of ppb (Co), ppb (Co, Sc), 10 -1 ppb (Sc). In the granulated PANa, in comparison with the other analyzed final products, similar concentration values were found for Fe, Sc and Zn

  3. Advisory group meeting on safeguards related to final disposal of nuclear material in waste and spent fuel

    International Nuclear Information System (INIS)

    1988-07-01

    This paper is primarily concerned with Section 11 of INFCIRC/153 which provides for the possible termination of safeguards based on a determination that the nuclear material in question has been consumed, has been diluted, or has become practicably irrecoverable. Two distinctly different categories of nuclear material have been suggested for possible termination of safeguards based on a determination that the nuclear material has become practicably irrecoverable: One relates to a variety of low concentration waste materials, meaning thereby materials which the State or plant operator considers to be of questionable economic recoverability and the other relates to the spent fuel placed in facilities described as ''permanent repositories'' which are at least claimed to represent ''final disposal'' facilities and are candidates for a possible determination of practicably irrecoverable. 26 refs, tabs

  4. Electrostatics of Pharmaceutical Aerosols for Pulmonary Delivery.

    Science.gov (United States)

    Lip Kwok, Philip Chi

    2015-01-01

    This paper provides a review on key research findings in the rapidly developing area of pharmaceutical aerosol electrostatics. Solids and liquids can become charged without electric fields, the former by contact or friction and the latter by flowing or spraying. Therefore, charged particles and droplets carrying net charges are produced from pharmaceutical inhalers (e.g. dry powder inhalers, metered dose inhalers, and nebulisers) due to the mechanical processes involved in aerosolisation. The charging depends on many physicochemical factors, such as formulation composition, solid state properties, inhaler material and design, and relative humidity. In silico, in vitro, and limited in vivo studies have shown that electrostatic charges may potentially influence particle deposition in the airways. However, the evidence is not yet conclusive. Furthermore, there are currently no regulatory requirements on the characterisation and control of the electrostatic properties of inhaled formulations. Besides the need for further investigations on the relationship between physicochemical factors and charging characteristics of the aerosols, controlled and detailed in vivo studies are also required to confirm whether charges can affect particle deposition in the airways. Since pharmaceutical aerosol electrostatics is a relatively new research area, much remains to be explored. Thus there is certainly potential for development. New findings in the future may contribute to the advancement of pharmaceutical aerosol formulations and respiratory drug delivery.

  5. Nano spray drying for encapsulation of pharmaceuticals.

    Science.gov (United States)

    Arpagaus, Cordin; Collenberg, Andreas; Rütti, David; Assadpour, Elham; Jafari, Seid Mahdi

    2018-05-17

    Many pharmaceuticals such as pills, capsules, or tablets are prepared in a dried and powdered form. In this field, spray drying plays a critical role to convert liquid pharmaceutical formulations into powders. In addition, in many cases it is necessary to encapsulate bioactive drugs into wall materials to protect them against harsh process and environmental conditions, as well as to deliver the drug to the right place and at the correct time within the body. Thus, spray drying is a common process used for encapsulation of pharmaceuticals. In view of the rapid progress of nanoencapsulation techniques in pharmaceutics, nano spray drying is used to improve drug formulation and delivery. The nano spray dryer developed in the recent years provides ultrafine powders at nanoscale and high product yields. In this paper, after explaining the concept of nano spray drying and understanding the key elements of the equipment, the influence of the process parameters on the final powders properties, like particle size, morphology, encapsulation efficiency, drug loading and release, will be discussed. Then, numerous application examples are reviewed for nano spray drying and encapsulation of various drugs in the early stages of product development along with a brief overview of the obtained results and characterization techniques. Copyright © 2018 Elsevier B.V. All rights reserved.

  6. Impacts of international sanctions on Iranian pharmaceutical market.

    Science.gov (United States)

    Cheraghali, Abdol Majid

    2013-07-31

    Iran in recent decade faced several regional and international sanctions in foreign trade, financial and banking services. Iran national pharmaceutical industry has always played a major role in providing medicines to the Iranian patients. However, following the sanctions it has faced profound difficulties for importing of both finished products and pharmaceutical raw materials. Although medicines are exempted from sanctions, due to restriction on money transaction and proper insurance Iranian pharmaceutical companies have to pay cash in advance for imports of medicines and raw materials or to secure offshore funds at very high risks. Current situation in Iran pharmaceutical market confirms that the sanctions against Iran are affecting ordinary citizens and national health sector which resulted to reduction of availability of lifesaving medicines in the local market and has caused increasing pain and suffering for Iranian patients.

  7. Experience in monitoring ageing phenomena for improving nuclear power plant availability. Proceedings of a specialists' meeting. Working material

    International Nuclear Information System (INIS)

    1992-01-01

    For more than thirty years nuclear power plants have been supplying electricity to national grids. Today, the nuclear power community is facing great challenges. The safe, reliable operation of existing nuclear power plants (NPPs) must continue to be ensured. From an economic viewpoint, because of the long lead times associated with bringing new plants into service, securing the continued operation of existing plants for their planned lifetimes and possible life extension will be very important in the near term for meeting electrical power demands. The IAEA programmes in nuclear power plant ageing and life extension and in control and instrumentation promote technical information exchange between Member States with new programmes, offers assistance to Member States with an interest in reliability of NPP components, in-service inspection methods and programmes using on-line techniques, component monitoring and special technological topics of nuclear reactors. Significant experience already exists in the nuclear industry in developing and applying the monitoring techniques for different nuclear power plant applications, especially in monitoring of ageing phenomena for improving NPP availability. The purpose of this Specialists' Meeting was to bring together experts from operations, design, research and development and licensing to share their experience in: ageing mechanics of key structural components, methods of monitoring such ageing, tools for cost-effective implementation of the methods and methodologies, life management approaches and examples from current reactors, future direction for monitoring of key structural components in nuclear power plants. The meeting was organized by the IAEA International Working Groups on Life Management of Nuclear Power Plants (IWG-LMNPP) and Nuclear Power Plant Control and Instrumentation (TWG-NPPCI) in co-operation with the Czechoslovak Atomic Energy Commission and Skoda concern. Around 40 participants from 10 countries

  8. The Potential for Genetic Control of Malaria-Transmitting Mosquitoes. Report of a Consultants Group Meeting. Working Material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1993-07-01

    Since the beginning of the Joint FAO/IAEA Division Programme on the research and development of insect pest control methodology, emphasis has been placed on the basic and applied aspects of implementing the Sterile Insect Technique (SIT). Special emphasis has always been directed at the assembly of technological progress into workable systems that can be implemented in developing countries. The general intention is to solve problems associated with insect pests that have an adverse impact on public health and the production of food and fibre. For certain insects, SIT has proven to be a powerful method for control, but for a variety of reasons this technology has not been tried on an operational scale for most of the pest species of insects that exact a toll on the endeavors of humans. The Joint FAO/IAEA Division convened a Consultants Group Meeting to examine 'The Potential for Genetic Control of Malaria-Transmitting Mosquitoes', with emphasis to be placed on the SIT. A group of five scientists met, 26-30 April 1993, to examine the current status and the future potential of genetic control for malaria mosquitoes. In most of the tropical, developing countries, and to some extent in temperate regions of the world, Anopheles mosquitoes cause havoc by transmitting malaria, a dreaded disease that causes high mortality amongst children and diminishes productivity of adults. The importance of malaria as a deterrent to further economic growth in a large part of the world cannot be over-emphasized. Malaria is a severe problem because there are inadequacies in the technology available for control. As a result of the deliberations at the meeting, the consultants prepared a list of recommendations concerning the consensus opinions about the development of genetic control for malaria vector control. This report presents the findings and recommendations of the Consultants Group Meeting.

  9. Experience in monitoring ageing phenomena for improving nuclear power plant availability. Proceedings of a specialists' meeting. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1992-07-01

    For more than thirty years nuclear power plants have been supplying electricity to national grids. Today, the nuclear power community is facing great challenges. The safe, reliable operation of existing nuclear power plants (NPPs) must continue to be ensured. From an economic viewpoint, because of the long lead times associated with bringing new plants into service, securing the continued operation of existing plants for their planned lifetimes and possible life extension will be very important in the near term for meeting electrical power demands. The IAEA programmes in nuclear power plant ageing and life extension and in control and instrumentation promote technical information exchange between Member States with new programmes, offers assistance to Member States with an interest in reliability of NPP components, in-service inspection methods and programmes using on-line techniques, component monitoring and special technological topics of nuclear reactors. Significant experience already exists in the nuclear industry in developing and applying the monitoring techniques for different nuclear power plant applications, especially in monitoring of ageing phenomena for improving NPP availability. The purpose of this Specialists' Meeting was to bring together experts from operations, design, research and development and licensing to share their experience in: ageing mechanics of key structural components, methods of monitoring such ageing, tools for cost-effective implementation of the methods and methodologies, life management approaches and examples from current reactors, future direction for monitoring of key structural components in nuclear power plants. The meeting was organized by the IAEA International Working Groups on Life Management of Nuclear Power Plants (IWG-LMNPP) and Nuclear Power Plant Control and Instrumentation (TWG-NPPCI) in co-operation with the Czechoslovak Atomic Energy Commission and Skoda concern. Around 40 participants from 10 countries.

  10. The Potential for Genetic Control of Malaria-Transmitting Mosquitoes. Report of a Consultants Group Meeting. Working Material

    International Nuclear Information System (INIS)

    1993-01-01

    Since the beginning of the Joint FAO/IAEA Division Programme on the research and development of insect pest control methodology, emphasis has been placed on the basic and applied aspects of implementing the Sterile Insect Technique (SIT). Special emphasis has always been directed at the assembly of technological progress into workable systems that can be implemented in developing countries. The general intention is to solve problems associated with insect pests that have an adverse impact on public health and the production of food and fibre. For certain insects, SIT has proven to be a powerful method for control, but for a variety of reasons this technology has not been tried on an operational scale for most of the pest species of insects that exact a toll on the endeavors of humans. The Joint FAO/IAEA Division convened a Consultants Group Meeting to examine 'The Potential for Genetic Control of Malaria-Transmitting Mosquitoes', with emphasis to be placed on the SIT. A group of five scientists met, 26-30 April 1993, to examine the current status and the future potential of genetic control for malaria mosquitoes. In most of the tropical, developing countries, and to some extent in temperate regions of the world, Anopheles mosquitoes cause havoc by transmitting malaria, a dreaded disease that causes high mortality amongst children and diminishes productivity of adults. The importance of malaria as a deterrent to further economic growth in a large part of the world cannot be over-emphasized. Malaria is a severe problem because there are inadequacies in the technology available for control. As a result of the deliberations at the meeting, the consultants prepared a list of recommendations concerning the consensus opinions about the development of genetic control for malaria vector control. This report presents the findings and recommendations of the Consultants Group Meeting.

  11. Use of probabilistic safety assessment in the regulatory process. Report of the technical committee meeting. Working material

    International Nuclear Information System (INIS)

    1994-01-01

    A Technical Committee Meeting (TCM) was organized between 5-8 December 1994 to discuss and review the international situation in connection with the use made, whether formally or informally, by regulatory bodies of probabilistic safety assessment (PSA) in the course of their work, and the related question of the use and value of adopting probabilistic safety criteria (PSC) as an aid to judging the results of PSAs. The document includes the output from the four working groups, as well as 11 papers from the 12 papers presented to the TCM. A separate abstract was prepared for each paper. Refs, figs, tabs

  12. Intercomparison of analysis methods for seismically isolated nuclear structures. Papers and working materials presented at the 3. research coordination meeting

    International Nuclear Information System (INIS)

    1998-01-01

    The Coordinated research program on Intercomparison of analysis methods for seismically isolated nuclear structures involved participants from Italy, Japan, Republic of Korea, Russia, United Kingdom, USA, EC. The purpose of the meeting was to review the progress on the finite element prediction of the force-deformation behaviour of seismic isolators and to discuss the first set of analytical results for the prediction of the response of base-oscillated structures to earthquake inputs. The intercomparison of predictions of bearing behaviour has identified important unexpected issues requiring deeper investigation

  13. Recent developments in materials and detectors for the infrared; Proceedings of the Meeting, Cannes, France, November 25, 26, 1985

    Science.gov (United States)

    Morten, F. D. (Editor); Seeley, John S. (Editor)

    1986-01-01

    The present conference on advancements in IR-sensitive materials and detector technologies employing them gives attention to thermal detectors, focal plane array processing detectors, novel detector designs, general properties of IR optics materials, and preparation methods for such materials. Specific topics encompass the fabrication of InSb MIS structures prepared by photochemical vapor deposition, IR heterodyne detectors employing cadmium mercury telluride, low microphony pyroelectric arrays, IR detection based on minority carrier extrusion, longwave reststrahl in IR crystals, and molecular beam techniques for optical thin film fabrication.

  14. Editorial Nano structures for Medicine and Pharmaceuticals

    International Nuclear Information System (INIS)

    Xing-Jie, L.; Kumar, A.; Donglu, S.; Daxiang, C.

    2012-01-01

    The rapid developments in nano structured materials and nano technology will have profound impact in many areas of biomedical applications including delivery of drugs and biomolecules, tissue engineering, detection of bio markers, cancer diagnosis, cancer therapy, and imaging. This field is expanding quickly, and a lot of work is ongoing in the design, characterization, synthesis, and application of materials, for controlling shape and size at nanometer scale to develop highly advanced materials for biomedical application and even to design better pharmaceutical products. In recent years, novel nano structure with multi functionalities has been focused on the use of nano structures toward solving problems of biology and medicine. The main scope of this special issue is to demonstrate the latest achievement of nano technology and its application in nano medicine particularly in new approaches for drug delivery such as targeted drug delivery system, nano structure for drug storage, nano materials for tissue engineering, medical diagnosis and treatment, and generation of new kinds of materials from biological sources. Therefore, many critical issues in nano structured materials, particularly their applications in biomedicine, must be addressed before clinical applications. This special issue devotes several review and research articles encompassing various aspects of nano materials for medicine and pharmaceuticals.

  15. 3. Radioactive pharmaceutical medications

    International Nuclear Information System (INIS)

    2006-01-01

    In the chapter common definitions of for radio-pharmacy are given. Radio-pharmacy medications are pharmacy medications which contain minor amount of one or several radionuclides (radioactive tracers), those radiation ability is applying in diagnostic or therapeutic purposes. At the same time radionuclides with more short life time, which are ether gamma-radiators or beta-radiators are applying. The following items for such radioisotopes production; radionuclides applying in nuclear medicine; radio-pharmaceutics; radio-toxicity; quality insurance; order for 18 F-PDG production; radionuclide analysis are considered

  16. Regulation of Pharmaceutical Prices

    DEFF Research Database (Denmark)

    Kaiser, Ulrich; Mendez, Susan J.; Rønde, Thomas

    On April 1, 2005, Denmark changed the way references prices, a main determinant of reimbursements for pharmaceutical purchases, are calculated. The previous reference prices, which were based on average EU prices, were substituted to minimum domestic prices. Novel to the literature, we estimate...... the joint eects of this reform on prices and quantities. Prices decreased more than 26 percent due to the reform, which reduced patient and government expenditures by 3.0 percent and 5.6 percent, respectively, and producer revenues by 5.0 percent. The prices of expensive products decreased more than...

  17. Electrochemical biosensors in pharmaceutical analysis

    OpenAIRE

    Gil, Eric de Souza; Melo, Giselle Rodrigues de

    2010-01-01

    Given the increasing demand for practical and low-cost analytical techniques, biosensors have attracted attention for use in the quality analysis of drugs, medicines, and other analytes of interest in the pharmaceutical area. Biosensors allow quantification not only of the active component in pharmaceutical formulations, but also the analysis of degradation products and metabolites in biological fluids. Thus, this article presents a brief review of biosensor use in pharmaceutical analysis, fo...

  18. Pharmaceuticals labelled with stable isotopes

    International Nuclear Information System (INIS)

    Krumbiegel, P.

    1986-11-01

    The relatively new field of pharmaceuticals labelled with stable isotopes is reviewed. Scientific, juridical, and ethical questions are discussed concerning the application of these pharmaceuticals in human medicine. 13 C, 15 N, and 2 H are the stable isotopes mainly utilized in metabolic function tests. Methodical contributions are given to the application of 2 H, 13 C, and 15 N pharmaceuticals showing new aspects and different states of development in the field under discussion. (author)

  19. Design of experiments (DoE) in pharmaceutical development.

    Science.gov (United States)

    N Politis, Stavros; Colombo, Paolo; Colombo, Gaia; M Rekkas, Dimitrios

    2017-06-01

    At the beginning of the twentieth century, Sir Ronald Fisher introduced the concept of applying statistical analysis during the planning stages of research rather than at the end of experimentation. When statistical thinking is applied from the design phase, it enables to build quality into the product, by adopting Deming's profound knowledge approach, comprising system thinking, variation understanding, theory of knowledge, and psychology. The pharmaceutical industry was late in adopting these paradigms, compared to other sectors. It heavily focused on blockbuster drugs, while formulation development was mainly performed by One Factor At a Time (OFAT) studies, rather than implementing Quality by Design (QbD) and modern engineering-based manufacturing methodologies. Among various mathematical modeling approaches, Design of Experiments (DoE) is extensively used for the implementation of QbD in both research and industrial settings. In QbD, product and process understanding is the key enabler of assuring quality in the final product. Knowledge is achieved by establishing models correlating the inputs with the outputs of the process. The mathematical relationships of the Critical Process Parameters (CPPs) and Material Attributes (CMAs) with the Critical Quality Attributes (CQAs) define the design space. Consequently, process understanding is well assured and rationally leads to a final product meeting the Quality Target Product Profile (QTPP). This review illustrates the principles of quality theory through the work of major contributors, the evolution of the QbD approach and the statistical toolset for its implementation. As such, DoE is presented in detail since it represents the first choice for rational pharmaceutical development.

  20. Metabolic engineering: the ultimate paradigm for continuous pharmaceutical manufacturing.

    Science.gov (United States)

    Yadav, Vikramaditya G; Stephanopoulos, Gregory

    2014-07-01

    Research and development (R&D) expenditures by pharmaceutical companies doubled over the past decade, yet candidate attrition rates and development times rose markedly during this period. Understandably, companies have begun downsizing their pipelines and diverting investments away from R&D in favor of manufacturing. It is estimated that transitioning to continuous manufacturing could enable companies to compete for a share in emerging markets. Accordingly, the model for continuous manufacturing that has emerged commences with the conversion of late-stage intermediates into the active pharmaceutical ingredient (API) in a series of continuous flow reactors, followed by continuous solid processing to form finished tablets. The use of flow reactions for API synthesis will certainly generate purer products at higher yields in shorter times compared to equivalent batch reactions. However, transitioning from batch to flow configuration simply alleviates transport limitations within the reaction milieu. As the catalogue of reactions used in flow syntheses is a subset of batch-based chemistries, molecules such as natural products will continue to evade drug prospectors. Also, it is uncertain whether flow synthesis can deliver improvements in the atom and energy economies of API production at the scales that would achieve the levels of revenue growth targeted by companies. Instead, it is argued that implementing metabolic engineering for the production of oxidized scaffolds as gateway molecules for flow-based addition of electrophiles is a more effective and scalable strategy for accessing natural product chemical space. This new paradigm for manufacturing, with metabolic engineering as its engine, would also permit rapid optimization of production variables and allow facile scale-up from gram to ton scale to meet material requirements for clinical trials, thus recasting manufacturing as a tool for discovery. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  1. The assessment of occupational protection conditions in workplaces with high levels of exposure to natural radiation. Report from a technical committee meeting. Working material

    International Nuclear Information System (INIS)

    2002-01-01

    Occupational exposure from natural radiation is, in the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) 2000 Report, estimated to contribute to more than 80 percent of the world-wide annual collective dose from occupational exposure, uranium mining excluded. The Agency's Radiation Safety Standards Series, the Requirements, and the Safety Guides (jointly sponsored by the Agency and the International Labour Office), address the control of occupational exposures from natural sources of radiation. In addition, some Safety Reports on specific issues are in the process of being finalized. Following upon recommendations to the Agency from its Member States to provide further guidance on the control of occupational exposure to natural radiation, a Technical Committee Meeting on Assessment of Occupational Radiation Protection Conditions in Workplaces with High Levels of Exposure to Natural Radiation was held in Vienna from 7 to 11 May 2001. The objective of the meeting was to produce an inventory of problem areas, make an assessment of the problem and propose a draft work plan for the Agency, This IAEA Working Material includes the report from the meeting, including the presentations made. Based on the recommendations made by the Technical Committee, a work plan is being initiated, implying that more attention will be paid to occupational exposure from natural radiation sources in the Occupational Radiation Protection programme

  2. The pharmaceutical death-ride of dihydroartemisinin.

    Science.gov (United States)

    Jansen, Frans Herwig

    2010-07-22

    In the 2010 second edition of WHO's guidelines for the treatment of malaria, the relatively new fixed dose combination dihydroartemisinin-piperaquine is included as one of the recommended artemisinin combination therapies. However, experimental testing demonstrates that, due to its intrinsic chemical instability, dihydroartemisinin is not suitable to be used in pharmaceutical formulations. In addition, data show that the currently available dihydroartemisinin preparations fail to meet the internationally accepted stability requirements. At a time when many efforts aim to ban counterfeit and substandard drugs from the malaria market, the obvious question rises how WHO and public-private partnerships, such as Medicine for Malaria venture (MMV), can support the production and marketing of anti-malarial drugs that do not even meet the International Pharmacopoeia requirements?

  3. The pharmaceutical death-ride of dihydroartemisinin

    Directory of Open Access Journals (Sweden)

    Jansen Frans

    2010-07-01

    Full Text Available Abstract In the 2010 second edition of WHO's guidelines for the treatment of malaria, the relatively new fixed dose combination dihydroartemisinin-piperaquine is included as one of the recommended artemisinin combination therapies. However, experimental testing demonstrates that, due to its intrinsic chemical instability, dihydroartemisinin is not suitable to be used in pharmaceutical formulations. In addition, data show that the currently available dihydroartemisinin preparations fail to meet the internationally accepted stability requirements. At a time when many efforts aim to ban counterfeit and substandard drugs from the malaria market, the obvious question rises how WHO and public-private partnerships, such as Medicine for Malaria venture (MMV, can support the production and marketing of anti-malarial drugs that do not even meet the International Pharmacopoeia requirements?

  4. Chitin and Chitosan as Direct Compression Excipients in Pharmaceutical Applications

    Science.gov (United States)

    Badwan, Adnan A.; Rashid, Iyad; Al Omari, Mahmoud M.H.; Darras, Fouad H.

    2015-01-01

    Despite the numerous uses of chitin and chitosan as new functional materials of high potential in various fields, they are still behind several directly compressible excipients already dominating pharmaceutical applications. There are, however, new attempts to exploit chitin and chitosan in co-processing techniques that provide a product with potential to act as a direct compression (DC) excipient. This review outlines the compression properties of chitin and chitosan in the context of DC pharmaceutical applications. PMID:25810109

  5. Chitin and Chitosan as Direct Compression Excipients in Pharmaceutical Applications

    Directory of Open Access Journals (Sweden)

    Adnan A. Badwan

    2015-03-01

    Full Text Available Despite the numerous uses of chitin and chitosan as new functional materials of high potential in various fields, they are still behind several directly compressible excipients already dominating pharmaceutical applications. There are, however, new attempts to exploit chitin and chitosan in co-processing techniques that provide a product with potential to act as a direct compression (DC excipient. This review outlines the compression properties of chitin and chitosan in the context of DC pharmaceutical applications.

  6. Effluent treatment plant for pharmaceutical unit at Bahipheru - case study

    International Nuclear Information System (INIS)

    Hayat, A.

    1997-01-01

    This project has been awarded to environ (Pvt) Ltd., on turnkey basis, and is an integrated waste treatment facility for pharmaceuticals companies, manufacturing paracetamole, aspirin and various pharmaceuticals intermediates, from phenol as basic raw material. A highly toxic waste water, containing high concentrations of phenolics and sulfate ions is generated at this plant and has to be treatment before final disposal into an irrigation channel. (author)

  7. Summary Report for the Technical Interchange Meeting on Development of Baseline Material Properties and Design Guidelines for In-Space Manufacturing Activities

    Science.gov (United States)

    Prater, T. J.; Bean, Q. A.; Werkheiser, N. J.; Johnston, M. M.; Ordonez, E. A.; Ledbetter, F. E.; Risdon, D. L.; Stockman, T. J.; Sandridge, S. K. R.; Nelson, G. M.

    2016-01-01

    NASA Marshall Space Flight Center (MSFC) and the Agency as a whole are currently engaged in a number of in-space manufacturing (ISM) activities that have the potential to reduce launch costs, enhance crew safety, and provide the capabilities needed to undertake long-duration spaceflight. The recent 3D Printing in Zero-G experiment conducted on board the International Space Station (ISS) demonstrated that parts of acrylonitrile butadiene styrene (ABS) plastic can be manufactured in microgravity using fused deposition modeling (FDM). This project represents the beginning of the development of a capability that is critical to future NASA missions. Current and future ISM activities will require the development of baseline material properties to facilitate design, analysis, and certification of materials manufactured using in-space techniques. The purpose of this technical interchange meeting (TIM) was to bring together MSFC practitioners and experts in materials characterization and development of baseline material properties for emerging technologies to advise the ISM team as we progress toward the development of material design values, standards, and acceptance criteria for materials manufactured in space. The overall objective of the TIM was to leverage MSFC's shared experiences and collective knowledge in advanced manufacturing and materials development to construct a path forward for the establishment of baseline material properties, standards development, and certification activities related to ISM. Participants were asked to help identify research and development activities that will (1) accelerate acceptance and adoption of ISM techniques among the aerospace design community; (2) benefit future NASA programs, commercial technology developments, and national needs; and (3) provide opportunities and avenues for further collaboration.

  8. Irradiation embrittlement and mitigation. V. 1. Working material. Proceedings of a specialists meeting held in Espoo, Finland 23-26 October 1995

    International Nuclear Information System (INIS)

    1995-01-01

    The purpose of the meeting was to provide an international forum for discussion on recent results in research and utility experience on radiation damage and its surveillance, annealing and re-embrittlement of PWR, WWER and BWR reactor pressure vessel materials. The scope included: mechanism of radiation damage; effects of operating parameters (flux, temperature, time, etc.); results from surveillance programmes and their analysis; fracture mechanics testing and evaluation; annealing and optimization of the process; re-embrittlement after annealing. Presentations were aimed at better understanding of radiation damage, annealing and re-irradiation behaviour of reactor pressure vessels materials, at providing guidance and recommendations for optimization of annealing and surveillance programmes and directions for further investigations. Refs, figs and tabs

  9. Irradiation embrittlement and mitigation. V. 1. Working material. Proceedings of a specialists meeting held in Espoo, Finland 23-26 October 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-12-31

    The purpose of the meeting was to provide an international forum for discussion on recent results in research and utility experience on radiation damage and its surveillance, annealing and re-embrittlement of PWR, WWER and BWR reactor pressure vessel materials. The scope included: mechanism of radiation damage; effects of operating parameters (flux, temperature, time, etc.); results from surveillance programmes and their analysis; fracture mechanics testing and evaluation; annealing and optimization of the process; re-embrittlement after annealing; Presentations were aimed at better understanding of radiation damage, annealing and re-irradiation behaviour of reactor pressure vessels materials, at providing guidance and recommendations for optimization of annealing and surveillance programmes and directions for further investigations. Refs, figs and tabs.

  10. Consultants Group Meeting on Development of Cost-Effective Diets for Use in Mass Production of Tsetse Flies. Working Material

    International Nuclear Information System (INIS)

    2000-10-01

    The increasing demand for employing tsetse SIT for area-wide tsetse and trypanosomosis management programmes on mainland Africa has compelled the IAEA to concentrate on the development of semi-automated processes for standardising laborious and quality sensitive components of the sterile male mass production. The size of facilities required to produce the sterile males will continue to increase with time and demand. The current diet for tsetse is decontaminated vertebrate blood and it will need to be supplied to centres without access to a suitable local blood source. In view of the increasing demand for sterile male tsetse and uncertainty of obtaining high quality decontaminated blood locally, ways need to be explored to ensure availability of inexpensive, standard quality diets. Towards this goal a consultants group meeting on the development of cost-effective diets for tsetse was held at the IAEA headquarters in Vienna, Austria from 17 to 21 July 2000. The major objective of the consultants group meeting was to identify research that is needed to ensure the availability of large quantities of high quality diet for tsetse mass production. Seven papers were presented and discussed. A visit was made to the Entomology Unit, at the FAO/IAEA Agriculture and Biotechnology Laboratories, Seibersdorf to see the present tsetse rearing facility and the various steps of blood processing and quality assurance used in the evaluation of blood quality before use for colony feeding. The meeting noted that commercially available products are used to prepare standard diets for screwworm mass production. These products have not yet been adequately evaluated for tsetse. However, it is necessary to improve the current procedure applied to the use fresh blood. Possibilities of utilising commercially available dietary ingredients should also be explored. A three-step approach was proposed: Improvement and optimisation of the current blood collection, processing etc.; Use of additives

  11. Remedial action programs annual meeting: Meeting notes

    International Nuclear Information System (INIS)

    1987-01-01

    The US Department of Energy Grand Junction Projects Office was pleased to host the 1987 Remedial Action programs Annual Meeting and herein presents notes from that meeting as prepared (on relatively short notice) by participants. These notes are a summary of the information derived from the workshops, case studies, and ad hoc committee reports rather than formal proceedings. The order of the materials in this report follows the actual sequence of presentations during the annual meeting

  12. Pharmaceuticals as Groundwater Tracers - Applications and Limitations

    Science.gov (United States)

    Scheytt, T. J.; Mersmann, P.; Heberer, T.

    2003-12-01

    Pharmaceutically active substances and metabolites are found at concentrations up to the microgram/L-level in groundwater samples from the Berlin (Germany) area and from several other places world wide. Among the compounds detected in groundwater are clofibric acid, propyphenazone, diclofenac, ibuprofen, and carbamazepine. Clofibric acid, the active metabolite of clofibrate and etofibrate (blood lipid regulators) is detected in groundwater at maximum concentrations of 7300 ng/L. Among the most important input paths of drugs are excretion and disposal into the sewage system. Groundwater contamination is likely to be due to leaky sewage systems, influent streams, bank filtration, and irrigation with effluent water from sewage treatment plants. There are no known natural sources of the above mentioned pharmaceuticals. The use of pharmaceuticals as tracers may include: (a) Quantification of infiltration from underground septic tanks (b) Detection of leaky sewage systems / leaky sewage pipes (c) Estimation of the effectiveness of sewage treatment plants (d) Identification of transport pathways of other organic compounds (e) Quantification of surface water / groundwater interaction (f) Characterization of the biodegradation potential. The use of pharmaceuticals as tracers is limited by variations in input. These variations depend on the amount of drugs prescribed and used in the study area, the social structure of the community, the amount of hospital discharge, and temporal concentration variations. Furthermore, the analysis of trace amounts of pharmaceuticals is sophisticated and expensive and may therefore limit the applicability of pharmaceuticals as tracers. Finally, the transport and degradation behavior of pharmaceuticals is not fully understood. Preliminary experiments in the laboratory were conducted using sediment material and groundwater from the Berlin area to evaluate the transport and sorption behavior of selected drugs. Results of the column experiments

  13. Space optical materials and space qualification of optics; Proceedings of the Meeting, Orlando, FL, Mar. 30, 31, 1989

    Science.gov (United States)

    Hale, Robert R.

    1989-10-01

    The present conference on space optical materials discusses current metals and nonmetals-related processing R&D efforts, investigations of space optical effects, and the spaceborne qualification of optical components and systems. Attention is given to CVD SiC for optical applications, optical materials for space-based lasers, the high-efficiency acoustooptic and optoelectronic crystalline material Tl3AsSe3, HIPed Be for low-scatter cryogenic optics, durable solar-reflective surfacing for Be optics, thermal effects on Be mirrors, contamination effects on optical surfaces in the monolayer regime, and IR background signature survey experiment results. Also discussed are the contamination-control program for the EUE instrument, an optical multipass radiation system for the heating of levitated samples, optical sample-position sensing for electrostatic levitation, and the qualification of space lighting systems.

  14. Advisory group meeting on safeguards related to final disposal of nuclear material in waste and spent fuel (AGM-660)

    International Nuclear Information System (INIS)

    1988-12-01

    The Advisory Group was asked to advise the Agency on the circumstances under which the Agency might logically implement Section 11 of INFCIRC/153, or the comparable Section 26c of INFCIRC/66/rev2, which provides for a determination that nuclear material is 'practicably irrecoverable', and that therefore safeguards could be terminated. This advice was sought, and in the paragraphs that follow is given, in two areas. One relates to 'waste', which the Group understands as referring to material which contains nuclear material that the State/facility operator believes has no economically recoverable value and for which no further use is foreseen. The other relates to spent fuel, which in some cases may be placed in geological 'permanent repositories'

  15. Consultants' report on meeting for development of technical criteria for termination of safeguards for material categorized as measured discards

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1990-03-15

    The following view is held by the consultants. The Agency should have criteria which can be used in the field and which can be used by an inspector to answer the question of whether a particular batch of material presented for termination of safeguards does, in fact, qualify for the termination of safeguards. To maintain the credibility of safeguards, the criteria of termination should be such that termination of waste is not the weak link in the safeguards system. That is, that given a choice, a potential diverter would choose to obtain nuclear material he needs from a source other than recovery from waste upon which safeguards has been terminated

  16. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.

    Science.gov (United States)

    de Wilde, Sofieke; de Jong, Maria G H; Le Brun, Paul P H; Guchelaar, Henk-Jan; Schimmel, Kirsten J M

    2018-01-01

    Most medicinal products dispensed to patients have marketing authorization (MA) to ensure high quality of the product, safety, and efficacy. However, in daily practice, to treat patients adequately, there is a medical need for drugs that do not hold MA. To meet this medical need, medicinal products are used in clinical care without MA (unlicensed), such as products prepared by (local) pharmacies: the pharmaceutical preparations. Three types of pharmaceutical preparations are distinguished: (i) reconstitution in excess of summary of product characteristics; (ii) adaptation of a licensed medicinal product (outside its official labeling); (iii) medicinal products from an active pharmaceutical ingredient. Although unlicensed, patients may expect the same quality for these unlicensed pharmaceutical preparations as for the licensed medicinal products. To assure this quality, a proper risk-benefit assessment and proper documentation in (centralized) patient registries and linking to a national pharmacovigilance database should be in place. Based on a risk assessment matrix, requirements for quality assurance can be determined, which has impact on the level of documentation of a pharmaceutical preparation. In this paper, the approach for good documentation including quality assurance and benefit-risk assessment will be discussed and possibilities for patient registries are described to make these crucial preparations available for regular patient care. KEY POINTS Ensuring pharmaceutical quality and performing a proper benefit-risk assessment will guarantee safe use of pharmaceutical preparations. Good documentation of (ultra-)orphan treatments can be collected in centralized patient registries and should be combined with existing information in (inter)national databases and self-reflection of patients. Linking patient registries to a centralized database for adverse drug events is highly recommended as it increases safety control of the (ultra) orphan pharmaceutical

  17. Annual meeting 1997 - Nondestructive materials evaluation: NDT as a service in a changed industrial environment. Proceedings, book of posters

    International Nuclear Information System (INIS)

    1997-01-01

    The second volume of the proceedings presents the contributions of the poster session, devoted to the following subject fields of main interest: ultrasonic testing methods, magnetic testing methods, industrial radiography, materials characterization, NDT in the building trade, aspects of vocational training. Fifteen of the contributions were analysed and indexed for separate retrieval from the ENERGY database [de

  18. 40 CFR 63.7886 - What are the general standards I must meet for my affected remediation material management units?

    Science.gov (United States)

    2010-07-01

    ... refinery) is no longer subject to this subpart. (3) If the remediation material management unit is also... emissions limitations and work practice standards under the other subpart (e.g., you install and operate the required air pollution controls or have implemented the required work practice to reduce HAP emissions to...

  19. Annual meeting 1997 - Nondestructive materials evaluation: NDT as a service in a changed industrial environment. Proceedings, book of papers

    International Nuclear Information System (INIS)

    1997-01-01

    Volume 1 of the conference proceedings presents the full papers. They discuss aspects of the following subjects of main interest: NDT services, ultrasonic testing, industrial radiography, eddy current testing, materials characterization, NDT in the building trade, acoustic emission analysis. Eighteen of the papers were analysed and indexed for separate retrieval from the ENERGY database. (MM) [de

  20. Materialism.

    Science.gov (United States)

    Melnyk, Andrew

    2012-05-01

    Materialism is nearly universally assumed by cognitive scientists. Intuitively, materialism says that a person's mental states are nothing over and above his or her material states, while dualism denies this. Philosophers have introduced concepts (e.g., realization and supervenience) to assist in formulating the theses of materialism and dualism with more precision, and distinguished among importantly different versions of each view (e.g., eliminative materialism, substance dualism, and emergentism). They have also clarified the logic of arguments that use empirical findings to support materialism. Finally, they have devised various objections to materialism, objections that therefore serve also as arguments for dualism. These objections typically center around two features of mental states that materialism has had trouble in accommodating. The first feature is intentionality, the property of representing, or being about, objects, properties, and states of affairs external to the mental states. The second feature is phenomenal consciousness, the property possessed by many mental states of there being something it is like for the subject of the mental state to be in that mental state. WIREs Cogn Sci 2012, 3:281-292. doi: 10.1002/wcs.1174 For further resources related to this article, please visit the WIREs website. Copyright © 2012 John Wiley & Sons, Ltd.

  1. NMR imaging and pharmaceutical sciences

    International Nuclear Information System (INIS)

    Beall, P.T.; Good, W.R.

    1986-01-01

    Described is the technique of NMR-imaging in diagnostic medicine. Proton and phosphorus NMR in diagnosis of abnormal tissue pathology. Discussed is the value of NMR to the pharmaceutical sciences. NMR may play an important role in monitoring the response of tissues to drugs, determining the localization of drugs, performing real time pharmacokinetics and testing the use of NMR contrast pharmaceuticals

  2. PSE in Pharmaceutical Process Development

    DEFF Research Database (Denmark)

    Gernaey, Krist; Cervera Padrell, Albert Emili; Woodley, John

    2011-01-01

    The pharmaceutical industry is under growing pressure to increase efficiency, both in production and in process development. This paper will discuss the use of Process Systems Engineering (PSE) methods in pharmaceutical process development, and searches for answers to questions such as: Which PSE...

  3. Radiation sterilization of pharmaceuticals and polymers

    International Nuclear Information System (INIS)

    Gopal, N.G.S.

    1978-01-01

    Radiation, in the form of high energy electrons as well as gamma radiation, has featured in the last 15 yr as a promising sterilization agent for many heat sensitive and ethylene oxide incompatible pharmaceuticals and polymers of medical usage. This article deals with (i) a comparison of the various methods of sterilization and their shortcomings, (ii) modes of interaction of radiation with matter, (iii) the types of radiation sources in common use, (iv) dosimetry, (v) dose rate effect, (vi) a literature survey of the radiation effect on pharmaceuticals in solid form as well as in aqueous solution and on polymers in the form of plastic medical products and (vii) the evaluation of the irradiated products. The effect of dose rate on the stability of these materials is emphasized. Either very little work has been done on the dose rate effect or the published information is scanty. The literature survey covers the recent period of 5 to 6 years. (author)

  4. Pharmaceutical applications of magnetic resonance imaging (MRI).

    Science.gov (United States)

    Richardson, J Craig; Bowtell, Richard W; Mäder, Karsten; Melia, Colin D

    2005-06-15

    Magnetic resonance imaging (MRI) is a powerful imaging modality that provides internal images of materials and living organisms on a microscopic and macroscopic scale. It is non-invasive and non-destructive, and one of very few techniques that can observe internal events inside undisturbed specimens in situ. It is versatile, as a wide range of NMR modalities can be accessed, and 2D and 3D imaging can be undertaken. Despite widespread use and major advances in clinical MRI, it has seen limited application in the pharmaceutical sciences. In vitro studies have focussed on drug release mechanisms in polymeric delivery systems, but isolated studies of bioadhesion, tablet properties, and extrusion and mixing processes illustrate the wider potential. Perhaps the greatest potential however, lies in investigations of pharmaceuticals in vivo, where pilot human and animal studies have demonstrated we can obtain unique insights into the behaviour of gastrointestinal, topical, colloidal, and targeted drug delivery systems.

  5. Materials processing using supercritical fluids

    Directory of Open Access Journals (Sweden)

    Orlović Aleksandar M.

    2005-01-01

    Full Text Available One of the most interesting areas of supercritical fluids applications is the processing of novel materials. These new materials are designed to meet specific requirements and to make possible new applications in Pharmaceuticals design, heterogeneous catalysis, micro- and nano-particles with unique structures, special insulating materials, super capacitors and other special technical materials. Two distinct possibilities to apply supercritical fluids in processing of materials: synthesis of materials in supercritical fluid environment and/or further processing of already obtained materials with the help of supercritical fluids. By adjusting synthesis parameters the properties of supercritical fluids can be significantly altered which further results in the materials with different structures. Unique materials can be also obtained by conducting synthesis in quite specific environments like reversed micelles. This paper is mainly devoted to processing of previously synthesized materials which are further processed using supercritical fluids. Several new methods have been developed to produce micro- and nano-particles with the use of supercritical fluids. The following methods: rapid expansion of supercritical solutions (RESS supercritical anti-solvent (SAS, materials synthesis under supercritical conditions and encapsulation and coating using supercritical fluids were recently developed.

  6. DOE-DARPA High-Performance Corrosion-Resistant Materials (HPCRM), Annual HPCRM Team Meeting & Technical Review

    Energy Technology Data Exchange (ETDEWEB)

    Farmer, J; Brown, B; Bayles, B; Lemieux, T; Choi, J; Ajdelsztajn, L; Dannenberg, J; Lavernia, E; Schoenung, J; Branagan, D; Blue, C; Peter, B; Beardsley, B; Graeve, O; Aprigliano, L; Yang, N; Perepezko, J; Hildal, K; Kaufman, L; Lewandowski, J; Perepezko, J; Hildal, K; Kaufman, L; Lewandowski, J; Boudreau, J

    2007-09-21

    The overall goal is to develop high-performance corrosion-resistant iron-based amorphous-metal coatings for prolonged trouble-free use in very aggressive environments: seawater & hot geothermal brines. The specific technical objectives are: (1) Synthesize Fe-based amorphous-metal coating with corrosion resistance comparable/superior to Ni-based Alloy C-22; (2) Establish processing parameter windows for applying and controlling coating attributes (porosity, density, bonding); (3) Assess possible cost savings through substitution of Fe-based material for more expensive Ni-based Alloy C-22; (4) Demonstrate practical fabrication processes; (5) Produce quality materials and data with complete traceability for nuclear applications; and (6) Develop, validate and calibrate computational models to enable life prediction and process design.

  7. Using containerless methods to develop amorphous pharmaceuticals.

    Science.gov (United States)

    Weber, J K R; Benmore, C J; Suthar, K J; Tamalonis, A J; Alderman, O L G; Sendelbach, S; Kondev, V; Yarger, J; Rey, C A; Byrn, S R

    2017-01-01

    Many pipeline drugs have low solubility in their crystalline state and require compounding in special dosage forms to increase bioavailability for oral administration. The use of amorphous formulations increases solubility and uptake of active pharmaceutical ingredients. These forms are rapidly gaining commercial importance for both pre-clinical and clinical use. Synthesis of amorphous drugs was performed using an acoustic levitation containerless processing method and spray drying. The structure of the products was investigated using in-situ high energy X-ray diffraction. Selected solvents for processing drugs were investigated using acoustic levitation. The stability of amorphous samples was measured using X-ray diffraction. Samples processed using both spray drying and containerless synthesis were compared. We review methods for making amorphous pharmaceuticals and present data on materials made by containerless processing and spray drying. It was shown that containerless processing using acoustic levitation can be used to make phase-pure forms of drugs that are known to be difficult to amorphize. The stability and structure of the materials was investigated in the context of developing and making clinically useful formulations. Amorphous compounds are emerging as an important component of drug development and for the oral delivery of drugs with low solubility. Containerless techniques can be used to efficiently synthesize small quantities of pure amorphous forms that are potentially useful in pre-clinical trials and for use in the optimization of clinical products. Developing new pharmaceutical products is an essential enterprise to improve patient outcomes. The development and application of amorphous pharmaceuticals to increase absorption is rapidly gaining importance and it provides opportunities for breakthrough research on new drugs. There is an urgent need to solve problems associated with making formulations that are both stable and that provide high

  8. Pharmaceutical advertising in emergency departments.

    Science.gov (United States)

    Marco, Catherine A

    2004-04-01

    Promotion of prescription drugs represents a growing source of pharmaceutical marketing expenditures. This study was undertaken to identify the frequency of items containing pharmaceutical advertising in clinical emergency departments (EDs). In this observational study, emergency physician on-site investigators quantified a variety of items containing pharmaceutical advertising present at specified representative times and days, in clinical EDs. Measurements were obtained by 65 on-site investigators, representing 22 states. Most EDs in this study were community EDs (87% community and 14% university or university affiliate), and most were in urban settings (50% urban, 38% suburban, and 13% rural). Investigators measured 42 items per ED (mean = 42; median = 31; interquartile range of 14-55) containing pharmaceutical advertising in the clinical area. The most commonly observed items included pens (mean 15 per ED; median 10), product brochures (mean 5; median 3), stethoscope labels (mean 4; median 2), drug samples (mean 3; median 0), books (mean 3.4), mugs (mean 2.4), and published literature (mean 3.1). EDs with a policy restricting pharmaceutical representatives in the ED had significantly fewer items containing pharmaceutical advertising (median 7.5; 95% CI = 0 to 27) than EDs without such a policy (median 35; 95% CI = 27 to 47, p = 0.005, nonparametric Wilcoxon two-sample test). There were no differences in quantities of pharmaceutical advertising for EDs in community compared with university settings (p = 0.5), rural compared with urban settings (p = 0.3), or annual ED volumes (p = 0.9). Numerous items containing pharmaceutical advertising are frequently observed in EDs. Policies restricting pharmaceutical representatives in the ED are associated with reduced pharmaceutical advertising.

  9. [Pharmaceutical logistic in turnover of pharmaceutical products of Azerbaijan].

    Science.gov (United States)

    Dzhalilova, K I

    2009-11-01

    Development of pharmaceutical logistic system model promotes optimal strategy for pharmaceutical functioning. The goal of such systems is organization of pharmaceutical product's turnover in required quantity and assortment, at preset time and place, at a highest possible degree of consumption readiness with minimal expenses and qualitative service. Organization of the optimal turnover chain in the region is offered to start from approximate classification of medicaments by logistic characteristics. Supplier selection was performed by evaluation of timeliness of delivery, quality of delivered products (according to the minimum acceptable level of quality) and time-keeping of time spending for orders delivery.

  10. Research coordination meeting of the coordinated research project on analytical and experimental benchmark analyses of accelerator driven systems. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2006-07-01

    The Technical Meeting hosted at the Belarus National Academy of Sciences in Minsk by the Joint Institute of Power Engineering and Nuclear Research 'SOSNY' from 5-9 December 2005 was the kick-off Research Coordination Meeting (RCM) of the IAEA Coordinated Research Project (CRP) on 'Analytical and Experimental Benchmark Analyses of Accelerator Driven Systems (ADS)'. The CRP had received proposals for research agreements and contracts from scientists representing the following 25 institutions: Centro Atomico Bariloche, SCK CEN Mol, Instituto de Pesquisas Energeticas e Nucleares Sao Paulo, Joint Institute of Power Engineering and Nuclear Research SOSNY Minsk, China Institute of Atomic Energy, CEA Cadarache, CNRS Paris, FZ Rossendorf, FZ Karlsruhe, Budapest University of Technology and Economics, Politecnico di Torino, Japan Atomic Energy Agency, Nuclear Research and Consultancy Group (NRG) Petten, Pakistan Institute of Nuclear Science and Technology, AGH-University of Science and Technology Krakow, Institute of Atomic Energy Otwock/Swierk, ITEP Moscow, MEPHI Moscow, Kurchatov Institute, JINR Dubna, Universidad Politecnica de Madrid, CIEMAT Madrid, Royal Institute of Technology Stockholm, National Science Center 'Kharkov Institute and Technology', and Argonne National Laboratory). These institutions represent 18 IAEA Member States (i.e., Argentina, Belarus, Belgium, Brazil, China, France, Germany, Hungary, Italy, Japan, Netherlands, Pakistan, Poland, Russia, Spain, Sweden, Ukraine, USA), and one International Organization (JINR Dubna). The overall objective of the CRP is contributing to the generic R and D efforts in various fields common to innovative fast neutron system development, i.e., heavy liquid metal thermal hydraulics, dedicated transmutation fuels and associated core designs, theoretical nuclear reaction models, measurement and evaluation of nuclear data for transmutation, and development and validation of calculational methods and codes. Ultimately, the CRP

  11. The fourth research co-ordination meeting (RCM) on 'Updated codes and methods to reduce the calculational uncertainties of liquid metal fast reactors reactivity effects'. Working material

    International Nuclear Information System (INIS)

    2003-01-01

    The fourth Research Co-ordination Meeting (RCM) of the Co-ordinated Research Project (CRP) on 'Updated Codes and Methods to Reduce the Calculational Uncertainties of the LMFR Reactivity Effect' was held during 19-23 May, 2003 in Obninsk, Russian Federation. The general objective of the CRP is to validate, verify and improve methodologies and computer codes used for the calculation of reactivity coefficients in fast reactors aiming at enhancing the utilization of plutonium and minor actinides. The first RCM took place in Vienna on 24 - 26 November 1999. The meeting was attended by 19 participants from 7 Member States and one from an international organization (France, Germany, India, Japan, Rep. of Korea, Russian Federation, the United Kingdom, and IAEA). The participants from two Member States (China and the U.S.A.) provided their results and presentation materials even though being absent at the meeting. The results for several relevant reactivity parameters obtained by the participants with their own state-of-the-art basic data and codes, were compared in terms of calculational uncertainty, and their effects on the ULOF transient behavior of the hybrid BN- 600 core were evaluated. Contributions of the participants in the benchmark analyses is shown. This report first addresses the benchmark definitions and specifications given for each Phase and briefly introduces the basic data, computer codes, and methodologies applied to the benchmark analyses by various participants. Then, the results obtained by the participants in terms of calculational uncertainty and their effect on the core transient behavior are intercompared. Finally it addresses some conclusions drawn in the benchmarks

  12. WATER QUALITY MONITORING OF PHARMACEUTICALS ...

    Science.gov (United States)

    The demand on freshwater to sustain the needs of the growing population is of worldwide concern. Often this water is used, treated, and released for reuse by other communities. The anthropogenic contaminants present in this water may include complex mixtures of pesticides, prescription and nonprescription drugs, personal care and common consumer products, industrial and domestic-use materials and degradation products of these compounds. Although, the fate of these pharmaceuticals and personal care products (PPCPs) in wastewater treatment facilities is largely unknown, the limited data that does exist suggests that many of these chemicals survive treatment and some others are returned to their biologically active form via deconjugation of metabolites.Traditional water sampling methods (i.e., grab or composite samples) often require the concentration of large amounts of water to detect trace levels of PPCPs. A passive sampler, the polar organic chemical integrative sampler (POCIS), has been developed to integratively concentrate the trace levels of these chemicals, determine the time-weighted average water concentrations, and provide a method of estimating the potential exposure of aquatic organisms to these complex mixtures of waterborne contaminants. The POCIS (U.S. Patent number 6,478,961) consists of a hydrophilic microporous membrane, acting as a semipermeable barrier, enveloping various solid-phase sorbents that retain the sampled chemicals. Sampling rates f

  13. Outline in 1997 Japan compound material academic meeting technological prize winning technology. Kenchiku, doboku kozobutsu no hoshu[center dot]hokyo yo forukatousito no kaihatsu

    Energy Technology Data Exchange (ETDEWEB)

    Iba, Yoshitomo.; Uemura, Masahiko.; Murakami, Shinkichi.; Saito, Makoto.; Kobayashi, Akira. (Nittetsu Composite Corp., Tokyo (Japan))

    1999-03-15

    That function declines in the sutra time target, and it is finally destroyed, or a construction structure thing bears putting off that life by managing efficient maintenance it is possible. The factor of the function decline of the structure thing, the degree of the decline, and so on are grasped quantitatively, and efficient repair reinforcement time and a method of construction are chosen, and you must carry it out for that. It is paying attention to the development of the method of construction to reinforce the maintenance repair of the construction structure thing by using the tip compound factor from such a viewpoint. In the beginning, a material cost was very expensive, and the recognition not to use it was very general in such a construction field. In such recognition, in Tonen Corp. incorporated company, it has paid attention to the use possibility in the construction field of the tip compound factor since early, research and development have been done continuously from 1980, that It succeeds in, and it is the method of construction that a repair reinforces a concrete structure thing by the tip material that the method of construction which got the technological prize of the Japan compound material academic meeting in 1997 moved carbon fiber to the center. (NEDO)

  14. Outline in 1997 Japan compound material academic meeting technological prize winning technology; Kenchiku, doboku kozobutsu no hoshu{center_dot}hokyo yo forukatousito no kaihatsu

    Energy Technology Data Exchange (ETDEWEB)

    Iba, Yoshitomo.; Uemura, Masahiko.; Murakami, Shinkichi.; Saito, Makoto.; Kobayashi, Akira. [Nittetsu Composite Corp., Tokyo (Japan)

    1999-03-15

    That function declines in the sutra time target, and it is finally destroyed, or a construction structure thing bears putting off that life by managing efficient maintenance it is possible. The factor of the function decline of the structure thing, the degree of the decline, and so on are grasped quantitatively, and efficient repair reinforcement time and a method of construction are chosen, and you must carry it out for that. It is paying attention to the development of the method of construction to reinforce the maintenance repair of the construction structure thing by using the tip compound factor from such a viewpoint. In the beginning, a material cost was very expensive, and the recognition not to use it was very general in such a construction field. In such recognition, in Tonen Corp. incorporated company, it has paid attention to the use possibility in the construction field of the tip compound factor since early, research and development have been done continuously from 1980, that It succeeds in, and it is the method of construction that a repair reinforces a concrete structure thing by the tip material that the method of construction which got the technological prize of the Japan compound material academic meeting in 1997 moved carbon fiber to the center. (NEDO)

  15. Creative scientific research international session of 2nd meeting on advanced pulsed-neutron research on quantum functions in nano-scale materials

    International Nuclear Information System (INIS)

    Itoh, Shinichi

    2005-06-01

    1 MW-class pulsed-neutron sources will be constructed in Japan, United State and United Kingdom in a few years. Now is the time for a challenge to innovate on neutron science and extend new science fields. Toward the new era, we develop new pulsed-neutron technologies as well as new neutron devices under the international collaborations with existing pulsed-neutron facilities, such as the UK-Japan collaboration program on neutron scattering. At the same time, the new era will bring international competitions to neutron researchers. We aim to create new neutron science toward the new pulsed-neutron era by introducing the new technologies developed here. For this purpose, we have started the research project, 'Advanced pulsed-neutron research on quantum functions in nano-scale materials,' in the duration between JFY2004 and JFY2008. The 2nd meeting of this project was held on 22-24 February 2005 to summarize activities in FY2004 and to propose research projects in the coming new fiscal year. In this international session as a part of this meeting, the scientific results and research plans on the UK-Japan collaboration program, the research plans on the collaboration between IPNS (Intense Pulsed Neutron Source, Argonne National Laboratory) and KENS (Neutron Science Laboratory, KEK), also the recent scientific results arisen form this project were presented. (author)

  16. [Hospital pharmaceutical practice in prison].

    Science.gov (United States)

    Harcouët, L

    2010-09-01

    Since 1994, hospital pharmaceutical teams have been in charge of pharmaceutical tasks in "unités de consultation et de soins ambulatoires" (UCSA), which are hospital consulting care units in French prisons. In 2008, pharmaceutical team in Parisian prisons received 6500 prescriptions and prepared 85,000 nominative bags containing drugs. Prisoners were 1.3% to receive treatments against HIV, 8.2% cardiovascular drugs, 7.2% opioid substitution treatments, and 52.9% psychoactive drugs, including 39.3% hypnotics, 40.5% anxiolytics, 11.3% antidepressants and 12.2% neuroleptics. In prison, the dichotomy between somatic and mental care is marked, attitudes of prisoners about their medicines are complex (important claims, embezzlement, etc.) and it is difficult for law defendants to maintain treatment confidentiality and to prepare prison outing in terms of health. To attenuate the heterogeneity of drug distribution systems in French prisons, we propose pharmaceutical analysis of prescriptions and nominative dispensation, computerization in UCSA in coordination with hospitals, a better contribution of prison medical and pharmaceutical staff in hospital "drug committees" and the redaction of pharmaceutical guidelines. Acting in concert with multidisciplinary medical staff in UCSA, pharmaceutical teams have to develop epidemiological studies to improve knowledge in prisoner's health and also prevention and health care in prison. Copyright © 2010 Elsevier Masson SAS. All rights reserved.

  17. Polymers for Pharmaceutical Packaging and Delivery Systems

    DEFF Research Database (Denmark)

    Fristrup, Charlotte Juel

    materials of interest for pharmaceutical packaging and delivery systems. Confocal fluorescence microscopy studies and stability studies with insulin aspart (AspB28 insulin) were conducted to evaluate the impact of modified PP compared to unmodified PP. In contrast to PEEK, PP did not contain any functional....... In order to decrease the amount of catalyst residual in the modified materials, activator regenerated by electron transfer (ARGET) SI-ATRP was applied in the second experimental round. Two poly(ethylene glycol)methyl ether methacrylate (MPEGMA) monomers with 4 and 23 ethylene oxide units in the side chain......Selection of polymer materials which will be exposed to protein drugs in either containers or medical devices is often very challenging due to the demands on the polymers. Suitable polymer materials should comply with requirements like compatibility with proteins, sterilisability, good barrier...

  18. Materials

    CSIR Research Space (South Africa)

    Van Wyk, Llewellyn V

    2009-02-01

    Full Text Available . It is generally included as part of a structurally insulated panel (SIP) where the foam is sandwiched between external skins of steel, wood or cement. Cement composites Cement bonded composites are an important class of building materials. These products... for their stone buildings, including the Egyptians, Aztecs and Inca’s. As stone is a very dense material it requires intensive heating to become warm. Rocks were generally stacked dry but mud, and later cement, can be used as a mortar to hold the rocks...

  19. Challenges in Translational Development of Pharmaceutical Cocrystals.

    Science.gov (United States)

    Kale, Dnyaneshwar P; Zode, Sandeep S; Bansal, Arvind K

    2017-02-01

    The last 2 decades have witnessed increased research in the area of cocrystals resulting in deeper scientific understanding, increase in intellectual property landscape, and evolution in the regulatory environment. Pharmaceutical cocrystals have received significant attention as a new solid form on account of their ability to modulate poor physicochemical properties of drug molecules. However, pharmaceutical development of cocrystals could be challenging, thus limiting their translation into viable drug products. In the present commentary, the role of cocrystals in the modulation of material properties and challenges involved in the pharmaceutical development of cocrystals have been discussed. The major hurdles encountered in the development of cocrystals such as safety of coformers, unpredictable performance during dissolution and solubility in different media, difficulties in establishing in vitro-in vivo correlation, and polymorphism have been extensively discussed. The influence of selecting appropriate formulation and process design on these challenges has been discussed. Finally, a brief outline of cocrystals that are undergoing clinical development has also been presented. Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

  20. The accumulation and management of pharmaceutical waste in the community pharmacy

    OpenAIRE

    Latožienė, Rima

    2017-01-01

    The Accumulation and Management of Pharmaceutical Waste in the Community Pharmacy Authors: students Diana Patašienė and Rima Latožienė, pharmacy master program at Vilnius University Faculty of Medicine, Department of Pathology, Forensic Medicine and Pharmacology. Work Leader: Dr. Kristina Garuolienė. The aim of the study: to determine pharmaceutical waste formation causes and to assess pharmaceutical waste management problems at community pharmacies. Materials and methods: The study was condu...

  1. Biricodar. Vertex Pharmaceuticals.

    Science.gov (United States)

    Dey, Saibal

    2002-05-01

    Vertex is developing biricodar as a chemosensitizing agent designed to restore the effectiveness of chemotherapeutic agents in tumor multidrug resistance. By November 1998, phase II trials had commenced for biricodar, in combination with chemotherapy, for five common cancer indications: breast, ovarian, soft-tissue sarcomas, small cell lung cancer and prostate cancer. Phase II trials were ongoing in January 2002. By March 2000, Vertex was the sole developer of biricodar, as an agreement made in 1996 with BioChem Pharma (now Shire Pharmaceuticals), for the development and marketing of biricodar in Canada was terminated. Biricodar is the free base compound, which also has a citrate salt analog known as VX-710-3. Vertex has published three patents, WO-09615101, WO-09636630 and WO-09736869, disclosing derivatives of biricodar that are claimed for the treatment of multidrug resistant protein and P-glycoprotein-mediated multidrug resistant tumors. In January 2002, a Banc of America analyst report forecast that biricodar had a 30% chance of reaching the market with a launch date in the second half of 2005, with peak sales estimated at $250 million.

  2. Pharmaceutical applications of graphene

    Directory of Open Access Journals (Sweden)

    Justyna Żwawiak

    2017-02-01

    Full Text Available Nowadays, dynamic development in nanotechnological sciences is observed. Nanoparticles are frequently used in medicine and pharmacy as delivery systems for different kinds of active substances. One of the latest developed substances, with an unusually wide scope of utility, is graphene. The ways of its use in different fields of industry, not only pharmaceutical and medical, have been a subject of study for many research groups since the moment of its development in 2004. Graphene in pure form is highly hydrophobic. However, the presence of defects on its surface allows chemical modifications to be made, e.g. introduction of oxygen groups by covalent bonding. Also, non-covalent modifications are extensively used, including van der Waals forces, hydrogen bonding, coordination bonds, electrostatic and π-π stacking interactions. Due to the large surface area, graphene can be used in combination therapy, consisting in simultaneous administration of two or more pharmacologically active agents. Another interesting approach is gene therapy. Application of the PEI-graphene oxide system increased the efficacy of transfection. Possibilities of graphene and graphene oxide are not limited to their use as active substance delivery systems. These compounds by themselves were also found to be bacteriostatic and antibacterial agents.

  3. ECONOMIC AND FINANCIAL IMPLICATIONS OF THE PHARMACEUTICAL INDUSTRY IN ROMANIA

    Directory of Open Access Journals (Sweden)

    Georgiana Daniela Minculete Piko

    2014-09-01

    Full Text Available In the wake of the financial crisis, most industries witnessed an economic downturn also boosted by the austerity measures imposed by the state. The pharmaceutical sector is one of the few sectors that followed an upward trend. Although the economic and financial crisis has long taken hold of the entire world, the domino theory did not apply to this industry; instead, the “butterfly effect” became evident. The phrase refers to the fact that the wings of a butterfly create small changes that may finally alter the route of certain elements. In the pharmaceutical industry, minor changes in research and development finally led to spectacular innovations. At present, there are no such big investments in research and development in Romania as there are in Europe; yet, due to mergers and acquisitions between Romanian and foreign companies, the pharmaceutical sector in Romania significantly contributes to the creation of added value in terms of economic development. The added value of the pharmaceutical industry in our country has increased significantly in recent years. The purpose of this article is to highlight the financial and economic significance of the pharmaceutical industry in Romania. This industry is one with an average degree of concentration; thus, the average liquidity and solvency indicators in this sector were calculated with a view to emphasizing its financial independence. The findings of this research indicate a high level of financial independence in this industry, as pharmaceutical companies are able to meet payment deadlines. This study highlights the importance of such an industry in times of economic crisis, the financial stability of the pharmaceutical sector reinforcing the need for massive investment in research and development.

  4. New Materials Developed To Meet Regulatory And Technical Requirements Associated With In-Situ Decommissioning Of Nuclear Reactors And Associated Facilities

    International Nuclear Information System (INIS)

    Blankenship, J.; Langton, C.; Musall, J.; Griffin, W.

    2012-01-01

    For the 2010 ANS Embedded Topical Meeting on Decommissioning, Decontamination and Reutilization and Technology, Savannah River National Laboratory's Mike Serrato reported initial information on the newly developed specialty grout materials necessary to satisfy all requirements associated with in-situ decommissioning of P-Reactor and R-Reactor at the U.S. Department of Energy's Savannah River Site. Since that report, both projects have been successfully completed and extensive test data on both fresh properties and cured properties has been gathered and analyzed for a total of almost 191,150 m 3 (250,000 yd 3 ) of new materials placed. The focus of this paper is to describe the (1) special grout mix for filling the P-Reactor vessel (RV) and (2) the new flowable structural fill materials used to fill the below grade portions of the facilities. With a wealth of data now in hand, this paper also captures the test results and reports on the performance of these new materials. Both reactors were constructed and entered service in the early 1950s, producing weapons grade materials for the nation's defense nuclear program. R-Reactor was shut down in 1964 and the P-Reactor in 1991. In-situ decommissioning (ISD) was selected for both facilities and performed as Comprehensive Environmental Response, Compensations and Liability Act actions (an early action for P-Reactor and a removal action for R-Reactor), beginning in October 2009. The U.S. Department of Energy concept for ISD is to physically stabilize and isolate intact, structurally robust facilities that are no longer needed for their original purpose of producing (reactor facilities), processing (isotope separation facilities), or storing radioactive materials. Funding for accelerated decommissioning was provided under the American Recovery and Reinvestment Act. Decommissioning of both facilities was completed in September 2011. ISD objectives for these CERCLA actions included: (1) Prevent industrial worker exposure to

  5. Papers about coated particles, graphitic and metallic materials for progressive high-temperature reactors at the Reactor Meeting 1978

    International Nuclear Information System (INIS)

    Rottmann, J.

    1978-09-01

    In the contributions, questions on the development, the radiation and the high-temperature behaviour and the characterization of fuel element particles are treated. Furthermore the resistance and radiation behaviour of graphitic materials are discussed. Finally, questions on the choice of high-temperature alloys for nuclear process heat facilities are discussed and the testing-equipment of the Nuclear Research Centre as well as first results of the long-time experiments are presented. The work was performed within the frame of the projects 'HTR-Fuel Element Cycle' and 'Prototype Nuclear Process Heat', which are sponsored by the Federal Ministry of Research and Technology of the Federal Republic of Germany and of the state of North-Rhine-Westfalia. Partner firms, who participate in the two projects are Gelsenberg AG, Gesellschaft fuer Hochtemperaturreaktor-Technik mbH, Hochtemperaturreaktor-Brennelement GmbH, Hochtemperatur-Reaktorbau GmbH, Kernforschungsanlage Juelich GmbH, NUKEM GmbH, SIGRI Elektrographit GmbH/Ringsdorff-Werke GmbH, Bergbauforschung GmbH und Rheinische Braunkohlenwerke AG. (orig./UA) [de

  6. Recognizing misleading pharmaceutical marketing online.

    Science.gov (United States)

    De Freitas, Julian; Falls, Brian A; Haque, Omar S; Bursztajn, Harold J

    2014-01-01

    In light of decision-making psychology, this article details how drug marketing operates across established and novel web domains and identifies some common misleading trends and influences on prescribing and patient-initiated medication requests. The Internet has allowed pharmaceutical marketing to become more salient than ever before. Although the Internet's growth has improved the dissemination of pharmaceutical information, it has also led to the increased influence of misleading pharmaceutical marketing. Such mismarketing is of concern, especially in psychiatry, since psychotropics generate considerable revenue for drug companies. In a climate of resource-limited drug regulation and time-strapped physicians, we recommend improving both independent monitoring and consumer awareness of Internet-enabled, potentially misleading, pharmaceutical marketing influences. © 2014 American Academy of Psychiatry and the Law.

  7. [PICS: pharmaceutical inspection cooperation scheme].

    Science.gov (United States)

    Morénas, J

    2009-01-01

    The pharmaceutical inspection cooperation scheme (PICS) is a structure containing 34 participating authorities located worldwide (October 2008). It has been created in 1995 on the basis of the pharmaceutical inspection convention (PIC) settled by the European free trade association (EFTA) in1970. This scheme has different goals as to be an international recognised body in the field of good manufacturing practices (GMP), for training inspectors (by the way of an annual seminar and experts circles related notably to active pharmaceutical ingredients [API], quality risk management, computerized systems, useful for the writing of inspection's aide-memoires). PICS is also leading to high standards for GMP inspectorates (through regular crossed audits) and being a room for exchanges on technical matters between inspectors but also between inspectors and pharmaceutical industry.

  8. Marketing orientation in pharmaceutical industry

    Directory of Open Access Journals (Sweden)

    Prošić Danica

    2006-01-01

    Full Text Available Pharmaceutical companies are major stakeholders in the global health agenda Virtually all drugs used by patients in Europe reach markets through the promotion tactics of a small number of corporations with a tremendous impact on global health. The sector is both fast growing and highly profitable. Effective marketing strategies are a crucial ingredient in making sure pharmaceutical products and profits flow in a virtuous cycle. At first glance, the relationship between doctors and drug companies, as well as advertising practices for over-the-counter medication, appears tightly regulated. According to many consumer organizations, drug promotion in Europe today can be characterized as nice and friendly marketing. This refers to the creation of a false sense of trust that consumers associate with branded pharmaceutical products, as a result of pharmaceutical marketing efforts disguised as genuine corporate responsibility.

  9. in Leafy Vegetable and Pharmaceutical

    African Journals Online (AJOL)

    Bheema

    successfully employed for the determination of copper (II) in leafy vegetable and pharmaceutical samples. ... Our previous studies of transition metal ions such as zinc, cobalt and ..... A new method for extractive photometric determination of.

  10. Tropical Journal of Pharmaceutical Research

    African Journals Online (AJOL)

    Tropical Journal of Pharmaceutical Research. Journal Home · ABOUT THIS JOURNAL · Advanced Search · Current Issue · Archives · Journal Home > Vol 12, No 6 (2013) >. Log in or Register to get access to full text downloads.

  11. Nanocrystals Technology for Pharmaceutical Science.

    Science.gov (United States)

    Cheng, Zhongyao; Lian, Yumei; Kamal, Zul; Ma, Xin; Chen, Jianjun; Zhou, Xinbo; Su, Jing; Qiu, Mingfeng

    2018-05-17

    Nanocrystals technology is a promising method for improving the dissolution rate and enhancing the bioavailability of poorly soluble drugs. In recent years, it has been developing rapidly and applied to drug research and engineering. Nanocrystal drugs can be formulated into various dosage forms. This review mainly focused on the nanocrystals technology and its application in pharmaceutical science. Firstly, different preparation methods of nanocrystal technology and the characterization of nanocrystal drugs are briefly described. Secondly, the application of nanocrystals technology in pharmaceutical science is mainly discussed followed by the introduction of sustained release formulations. Then, the scaling up process, marketed nanocrystal drug products and regulatory aspects about nanodrugs are summarized. Finally, the specific challenges and opportunities of nanocrystals technology for pharmaceutical science are summarized and discussed. This review will provide a comprehensive guide for scientists and engineers in the field of pharmaceutical science and biochemical engineering. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

  12. Salvia officinalis used in pharmaceutics

    Science.gov (United States)

    Lemle, K. L.

    2018-01-01

    The paper presents some pharmaceutical properties of Salvia officinalis, a plant belonging the Lamiaceae family, one of the oldest medicinal plants, which play an important role in improving the state of health.

  13. Tropical Journal of Pharmaceutical Research

    African Journals Online (AJOL)

    We seek to encourage pharmaceutical and allied research of tropical and ... and related disciplines (including biotechnology, cell and molecular biology, drug ... with ibrutinib reduces proliferation, migration and invasion of lung cancer cells ...

  14. PARTICULARITIES OF MODERN PHARMACEUTICAL PROMOTION

    Directory of Open Access Journals (Sweden)

    Юрий Владимирович Тарасов

    2014-02-01

    Full Text Available Pharmaceutical products market is one of the most saturated consumers’ markets. Characteristic features of it are: high competition, fierce struggle for the customer, specific technologies of promotion. In conditions of globalization and increase in competition both in world pharmaceutical market and in the market of medicines and goods of medical purpose in Russia modern marketing techniques of promotion of the products to the end consumers are the key tools for strengthening market positions – both of producers of pharmaceutical goods and their suppliers, distributors, big whole-sale companies. Among main tools of promotion are: advertising, public relations, stimulation of sales on the market of medicines, personal sales, computer technologies. The article describes different technologies of promotion of medicines: indoor-advertising, hot lines, pharmaceutical exhibitions, packing. DOI: http://dx.doi.org/10.12731/2218-7405-2013-12-1

  15. [Pharmaceutical product quality control and good manufacturing practices].

    Science.gov (United States)

    Hiyama, Yukio

    2010-01-01

    This report describes the roles of Good Manufacturing Practices (GMP) in pharmaceutical product quality control. There are three keys to pharmaceutical product quality control. They are specifications, thorough product characterization during development, and adherence to GMP as the ICH Q6A guideline on specifications provides the most important principles in its background section. Impacts of the revised Pharmaceutical Affairs Law (rPAL) which became effective in 2005 on product quality control are discussed. Progress of ICH discussion for Pharmaceutical Development (Q8), Quality Risk Management (Q9) and Pharmaceutical Quality System (Q10) are reviewed. In order to reconstruct GMP guidelines and GMP inspection system in the regulatory agencies under the new paradigm by rPAL and the ICH, a series of Health Science studies were conducted. For GMP guidelines, product GMP guideline, technology transfer guideline, laboratory control guideline and change control system guideline were written. For the GMP inspection system, inspection check list, inspection memo and inspection scenario were proposed also by the Health Science study groups. Because pharmaceutical products and their raw materials are manufactured and distributed internationally, collaborations with other national authorities are highly desired. In order to enhance the international collaborations, consistent establishment of GMP inspection quality system throughout Japan will be essential.

  16. Use of atypical antipsychotics in nursing homes and pharmaceutical marketing.

    Science.gov (United States)

    Pimentel, Camilla B; Donovan, Jennifer L; Field, Terry S; Gurwitz, Jerry H; Harrold, Leslie R; Kanaan, Abir O; Lemay, Celeste A; Mazor, Kathleen M; Tjia, Jennifer; Briesacher, Becky A

    2015-02-01

    To describe the current extent and type of pharmaceutical marketing in nursing homes (NHs) in one state and to provide preliminary evidence for the potential influence of pharmaceutical marketing on the use of atypical antipsychotics in NHs. Nested mixed-methods, cross-sectional study of NHs in a cluster randomized trial. Forty-one NHs in Connecticut. NH administrators, directors of nursing, and medical directors (n = 93, response rate 75.6%). Quantitative data, including prescription drug dispensing data (September 2009-August 2010) linked with Nursing Home Compare data (April 2011), were used to determine facility-level prevalence of atypical antipsychotic use, facility-level characteristics, NH staffing, and NH quality. Qualitative data, including semistructured interviews and surveys of NH leaders conducted in the first quarter of 2011, were used to determine encounters with pharmaceutical marketing. Leadership at 46.3% of NHs (n = 19) reported pharmaceutical marketing encounters, consisting of educational training, written and Internet-based materials, and sponsored training. No association was detected between level of atypical antipsychotic prescribing and reports of any pharmaceutical marketing by at least one NH leader. NH leaders frequently encounter pharmaceutical marketing through a variety of ways, although the impact on atypical antipsychotic prescribing is unclear. © 2015, Copyright the Authors Journal compilation © 2015, The American Geriatrics Society.

  17. Titanium Alloys for Critical Ordnance Components. Producers Coordination Meeting on Titanium Materials for Davy Crockett and Other Weapon Systems Held at Watertown Arsenal, Watertown 72, Mass., 14 Apr 60 and Fabricators Coordination Meeting on Titanium Materials for Davy Crockett and Other Weapon Systems Held at Watervliet Arsenal, Watervliet, NY, 15 Apr 1960

    Science.gov (United States)

    1960-01-01

    Title Agenda and AV^stracts - Watertown Arsenal, Watnrtovm, Mass. llj April i960 - Producers Coordination Meeting, "Titanium Materials for Davy...u.nd J.i’.l~.Jhr!l’ Scicnti~’ic Comp::1.~1y1 Chlc::-.~~o, IJ~~nois. oth :r c~tUl’ll~nt and 1Jl’Occ1t.G.~cn !.Jn.y be uoed if :J..CCC:t.> td )le to

  18. Pharmaceutical compounds in drinking water

    Directory of Open Access Journals (Sweden)

    Vikas Chander

    2016-06-01

    Full Text Available Pharmaceutical products and their wastes play a major role in the degradation of environment. These drugs have positive as well as negative consequences on different environmental components including biota in different ways. Many types of pharmaceutical substances have been detected with significant concentrations through various advanced instrumental techniques in surface water, subsurface water, ground water, domestic waste water, municipal waste water and industrial effluents. The central as well as state governments in India are providing supports by creating excise duty free zones to promote the pharmaceutical manufacturers for their production. As a result, pharmaceutical companies are producing different types of pharmaceutical products at large scale and also producing complex non-biodegradable toxic wastes byproducts and releasing untreated or partially treated wastes in the environment in absence of strong regulations. These waste pollutants are contaminating all types of drinking water sources. The present paper focuses on water quality pollution by pharmaceutical pollutants, their occurrences, nature, metabolites and their fate in the environment.

  19. Technical meeting on development of 'Deep Burn' concepts using coated particle fuel for incineration of nuclear waste, surplus fissile materials and plutonium without recourse to multiple reprocessing. Meeting report

    International Nuclear Information System (INIS)

    2013-01-01

    Summary report of the technical meeting. The purpose of this meeting is to explore various Deep-Burn options and concepts being developed in Member States and to appraise the progress made towards the maturity of Deep-Burn concepts based on HTGR designs. The meeting will also identify technology development challenges towards the realization of Deep-Burn concepts and propose collaborative ways to address them

  20. PHARMACEUTICAL PARTNERSHIPS IN THE DEVELOPMENT OF NEW PHARMACEUTICALS

    Directory of Open Access Journals (Sweden)

    A. L. Bulgakov

    2018-01-01

    Full Text Available This article examines the causes for creating alliances between manufacturers and drug developers. The attention has also been paid to the classification of such partnerships depending on the level of integration. The classification is necessary for further study of relations in the alliances. It is important to understand how economically effective and justified such partnerships are. The aim of the study is to determine the reasons for creating partnerships between drug developers and manufacturers, and to work out a classification of partnerships in the field of pharmacology. Materials and methods. The study analyzes existing alliances, partnerships of Big Pharma companies such as Bayer AG, Merck & Co, Pfizer. Results and discussion. The variety of forms of partnerships allows all participants in this market to get from cooperation the benefits they need. Some seek to reduce risk, others look forward to gaining access to new research opportunities, the third seek to share knowledge for greater productivity. However, there is always the opposite side, they have to sacrifice something to get a market advantage. For example, increased integration leads to a reduction in the risk of drug creation, but also leads to a decrease in the company’s independence. Conclusion. The results of this study can be used later in the study of the financial effectiveness of pharmaceutical partnerships, as well as in exploring the causes of alliances’ collapses. Any partnership has its value and can be considered as an intangible asset of the company. However, at the moment, there is no universal way of assessing this type of active assets, therefore, classification is a key step in creating a model for determining the value of a partnership. 

  1. A strategy to improve skills in pharmaceutical supply management in East Africa: the regional technical resource collaboration for pharmaceutical management

    Directory of Open Access Journals (Sweden)

    Minzi Omary

    2008-12-01

    Full Text Available Abstract Background International initiatives such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, the President's Emergency Plan for AIDS Relief and the President's Malaria Initiative have significantly increased availability and access to medicines in some parts of the developing world. Despite this, however, skills remain limited on quantifying needs for medications and ordering, receiving and storing medications appropriately; recording medications inventories accurately; distributing medications for use appropriately; and advising patients on how to use medications appropriately. The Regional Technical Resource Collaboration for Pharmaceutical Management (RTRC has been established to help address the problem of skills shortage in pharmaceutical management in East Africa. Methods The initiative brings together academic institutions from four East African countries to participate in skills-building activities in pharmaceutical supply management. The initiative targeted the institutions' ability to conduct assessments of pharmaceutical supply management systems and to develop and implement effective skills-building programmes for pharmaceutical supply chain management. Results Over a two-year period, the RTRC succeeded in conducting assessments of pharmaceutical supply management systems and practices in Kenya, Rwanda, Tanzania and Uganda. In 2006, the RTRC participated in a materials-development workshop in Kampala, Uganda, and contributed to the development of comprehensive HIV/AIDS pharmaceutical management training materials; these materials are now widely available in all four countries. In Tanzania and Uganda the RTRC has been involved with the training of health care workers in HIV/AIDS pharmaceutical management. In Kenya, Tanzania and Uganda the RTRC has been conducting operations research to find solutions to their countries' skills-shortage problems. Some of the interventions tested include applying and evaluating the

  2. Ethical pharmaceutical promotion and communications worldwide: codes and regulations

    Science.gov (United States)

    2014-01-01

    The international pharmaceutical industry has made significant efforts towards ensuring compliant and ethical communication and interaction with physicians and patients. This article presents the current status of the worldwide governance of communication practices by pharmaceutical companies, concentrating on prescription-only medicines. It analyzes legislative, regulatory, and code-based compliance control mechanisms and highlights significant developments, including the 2006 and 2012 revisions of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice. Developments in international controls, largely built upon long-established rules relating to the quality of advertising material, have contributed to clarifying the scope of acceptable company interactions with healthcare professionals. This article aims to provide policy makers, particularly in developing countries, with an overview of the evolution of mechanisms governing the communication practices, such as the distribution of promotional or scientific material and interactions with healthcare stakeholders, relating to prescription-only medicines. PMID:24679064

  3. Ethical pharmaceutical promotion and communications worldwide: codes and regulations.

    Science.gov (United States)

    Francer, Jeffrey; Izquierdo, Jose Zamarriego; Music, Tamara; Narsai, Kirti; Nikidis, Chrisoula; Simmonds, Heather; Woods, Paul

    2014-03-29

    The international pharmaceutical industry has made significant efforts towards ensuring compliant and ethical communication and interaction with physicians and patients. This article presents the current status of the worldwide governance of communication practices by pharmaceutical companies, concentrating on prescription-only medicines. It analyzes legislative, regulatory, and code-based compliance control mechanisms and highlights significant developments, including the 2006 and 2012 revisions of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice.Developments in international controls, largely built upon long-established rules relating to the quality of advertising material, have contributed to clarifying the scope of acceptable company interactions with healthcare professionals. This article aims to provide policy makers, particularly in developing countries, with an overview of the evolution of mechanisms governing the communication practices, such as the distribution of promotional or scientific material and interactions with healthcare stakeholders, relating to prescription-only medicines.

  4. Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs

    OpenAIRE

    Anna Karagianni; Maria Malamatari; Kyriakos Kachrimanis

    2018-01-01

    Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an overview of pharmaceutical cocrystals will be presented, with an emphasis on the intermolecular interactions in cocrystals and the methods for their preparation. Furthermore, cocrystals of direct phar...

  5. 77 FR 16262 - Importer of Controlled Substances, Notice of Registration; Johnson Matthey, Inc., Pharmaceutical...

    Science.gov (United States)

    2012-03-20

    ... DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances, Notice of Registration; Johnson Matthey, Inc., Pharmaceutical Materials By Notice dated December 2, 2011, and published in the Federal Register on December 12, 2011, 76 FR 77253, Johnson Matthey, Inc., Pharmaceutical...

  6. Development of Problem Sets for K-12 and Engineering on Pharmaceutical Particulate Systems

    Science.gov (United States)

    Savelski, Mariano J.; Slater, C. Stewart; Del Vecchio, Christopher A.; Kosteleski, Adrian J.; Wilson, Sarah A.

    2010-01-01

    Educational problem sets have been developed on structured organic particulate systems (SOPS) used in pharmaceutical technology. The sets present topics such as particle properties and powder flow and can be integrated into K-12 and college-level curricula. The materials educate students in specific areas of pharmaceutical particulate processing,…

  7. New materials

    International Nuclear Information System (INIS)

    Joshi, S.K.; Rao, C.N.R.; Tsuruta, T.

    1992-01-01

    The book contains the state-of-the art lectures delivered at the discussion meeting on new materials, a field in which rapid advances are taking place. The main objective of the meeting was to bring active scientists in this area from Japan and India together. The topics covered diverse aspects of modern materials including high temperature superconducting compounds. (M.G.B.)

  8. Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs

    Directory of Open Access Journals (Sweden)

    Anna Karagianni

    2018-01-01

    Full Text Available Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an overview of pharmaceutical cocrystals will be presented, with an emphasis on the intermolecular interactions in cocrystals and the methods for their preparation. Furthermore, cocrystals of direct pharmaceutical interest, along with their in vitro properties and available in vivo data and characterization techniques are discussed, highlighting the potential of cocrystals as an attractive route for drug development.

  9. Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

    Science.gov (United States)

    Karagianni, Anna; Malamatari, Maria; Kachrimanis, Kyriakos

    2018-01-25

    Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an overview of pharmaceutical cocrystals will be presented, with an emphasis on the intermolecular interactions in cocrystals and the methods for their preparation. Furthermore, cocrystals of direct pharmaceutical interest, along with their in vitro properties and available in vivo data and characterization techniques are discussed, highlighting the potential of cocrystals as an attractive route for drug development.

  10. MODERN METHODS OF PRICING IN THE STRATEGIC ACTIVITIES PLANNING OF PHARMACEUTICAL COMPANIES IN UKRAINE

    Directory of Open Access Journals (Sweden)

    N. Slushaenko

    2015-04-01

    Full Text Available This article investigated the role of pricing for strategic activities of pharmaceutical companies. It has been modified Bass diffusion model for new products, and it has been conducted empirical testing of the model on the sample of the products of the Ukrainian pharmaceutical market. Among the analyzed pricing models for new product allocated to one that meets the needs of the pharmaceutical industry and is based on available statistics. Formed a clear selection algorithm pricing policy of the company to the new product.

  11. Science meeting. Abstracts

    International Nuclear Information System (INIS)

    2000-01-01

    the document is a collection of the science meeting abstracts in the fields of nuclear physics, medical sciences, chemistry, agriculture, environment, engineering, material sciences different aspects of energy and presents research done in 2000 in these fields

  12. Access to medicines: relations with the institutionalization of pharmaceutical services

    Directory of Open Access Journals (Sweden)

    Rafael Damasceno de Barros

    2017-11-01

    Full Text Available ABSTRACT OBJETIVE To analyze the relationship between access to medicines by the population and the institutionalization of pharmaceutical services in Brazilian primary health care. METHODS This study is part of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos – Serviços 2015 (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines – Services 2015, a cross-sectional, exploratory, and evaluative study composed of an information survey in a representative sample of cities, stratified by Brazilian regions. Access was defined based on the acquisition of medicines reported by the patient, ranging between: total, partial, or null. The institutionalization of pharmaceutical services was analyzed based on information provided by pharmaceutical services providers and by those responsible for medicines delivery. Chi-square test and multinomial logistic regression were used in the statistical analysis. RESULTS Full access to medicines was greater when professionals affirmed there were the following aspects of the dimensions: “management tools,” “participation and social control,” “financing,” and “personnel structure,” with significant associations in the bivariate analysis. The “pharmaceutical care” dimension did not achieve such an association. After multinomial logistic regression, full access was more prevalent when those in charge of pharmaceutical services stated that: they always or repeatedly attend meetings of the Municipal Health Council, OR = 3.3 (95%CI 1.5-7.3; there are protocols for medicines delivery, OR = 2.7 (95%CI 1.2-6.1; there is computerized system for managing pharmaceutical services, OR = 3.9 (95%CI 1.9-8.0; those responsible for medicines delivery reported having participated in a course or training for professionals in the past two years, OR = 2.0 (95%CI 1.1-3.5; there is computerized system for pharmaceutical services management, OR

  13. An Overview of Pharmaceutical Validation and Process Controls in ...

    African Journals Online (AJOL)

    It has always been known that the processes involved in pharmaceutical production impact significantly on the quality of the products The processes include raw material and equipment inspections as well as in-process controls. Process controls are mandatory in good manufacturing practice (GMP). The purpose is to ...

  14. Radiation protection in the pharmaceutical-chemical industry

    International Nuclear Information System (INIS)

    Griesser, R.

    1992-01-01

    Some aspects of the use of ionizing radiation in research in the pharmaceutical and chemical industries will be discussed, the emphasis being placed on the handling of open radioactive materials in research laboratories. The compliance with official regulations and the preparation of company internal radiation protection regulations are described. 1 tab., 9 refs

  15. Bulk characterization of pharmaceutical powders by low-pressure compression

    DEFF Research Database (Denmark)

    Sørensen, A.H.; Sonnergaard, Jørn; Hovgaard, L.

    2005-01-01

    Low-pressure compression of pharmaceutical powders using small amounts of sample (50 mg) was evaluated as an alternative to traditional bulk powder characterization by tapping volumetry. Material parameters were extrapolated directly from the compression data and by fitting with the Walker...

  16. [Bioequivalence studies of pharmaceutical preparations].

    Science.gov (United States)

    Vetchý, D; Frýbortová, K; Rabisková, M; Danecková, H

    2007-01-01

    Bioequivalence studies are very important for the development of a pharmaceutical preparation in the pharmaceutical industry. Their rationale is the monitoring of pharmacokinetic and pharmacodynamic parameters after the administration of tested drugs. The target of such study is to evaluate the therapeutic compatibility of tested drugs (pharmaceutical equivalents or pharmaceutical alternatives). The importance of bioequivalence studies is increasing also due to the large growth of the production and consumption of generic products. Generic products represent approximately 50 % of the whole consumption in many European countries and USA. The search output of bioequivalence study is together with the pharmaceutical quality data of medical product one of the main part of the registration file submitted to a national regulatory authorities. The registration of generic products does not demand complicated and expensive clinical study contrary to original product. The comparison of the original and the generic product via bioequivalence study is suggested as sufficient. The aim of this article is to provide to a medical public a summary about the types of bioequivalence studies, their range, rules of their practise and let them gain their own attitude to this question.

  17. Pharmaceutical policies in European countries.

    Science.gov (United States)

    Barros, Pedro Pita

    2010-01-01

    Pharmaceutical expenditures have an important role in Europe. The attempts to control expenditure have used a wide range of policy measures. We reviewed the main measures adopted by the European Union countries, especially in countries where governments are the largest third-party payers. To complement a literature review on the topic, data was gathered from national reviews of health systems and direct inquiries to several government bodies. Almost all countries regulate prices of pharmaceutical products. Popular policy measures include international referencing to set prices (using as benchmark countries that have set lower prices), internal reference pricing systems to promote price competition in domestic markets, and positive lists for reimbursement to promote consumption of generics (including in some cases substitution by pharmacists of drugs prescribed by physicians). Despite the wide range of policy measures, it is not possible to identify a "silver bullet" to control pharmaceutical expenditures. We also identified two main policy challenges: policy coordination among countries within the European Union to maintain incentives for R&D at the global level, and the development of new relationships with the pharmaceutical industry; namely, the so-called risk-sharing agreements between the pharmaceutical industry and governments/regulators (or large third-party payers).

  18. IAEA meeting: International conference of national regulatory authorities with competence in the safety of radiation sources and the security of radioactive materials

    Energy Technology Data Exchange (ETDEWEB)

    Englefield, Chris [UK INTERPOL Environmental Crime (Radioactive Substances) Sub-Group, Environment Agency (United Kingdom)

    2001-06-01

    The meeting was the outcome of one of the actions arising from an IAEA sponsored meeting held in Dijon in 1998 on these issues. The action plan included inter alia the production of a 'Code of Conduct' (published December 2000), the production of a scheme for the 'Categorisation of Sources' (published December 2000) and a meeting to share experience and knowledge about the issues of illicit or inadvertent movements of radioactive materials across international borders. This was the major focus of the meeting held in Buenos Aires. The meeting was attended by 130 delegates representing 70 countries, the EU and the IAEA. This means that over half of the 131 IAEA Member States were present, a measure of the level of significance that is attached to the initiating issue of 'illicit trafficking'.The meeting was chaired by Dan Beninson (Argentina) and the Technical Secretariat was led by Alfonso Bilbao of IAEA. I attended as the UK delegate, in my capacity as Chairman of the UK INTERPOL Environmental Crime (Radioactive Substances) Sub-Group. The national papers were so numerous that it is not practicable to try to summarise them all here. However, a general impression will be given. The majority of papers submitted explained the regulatory structures extant in the speakers' home countries. It was useful to understand the level of development of regulatory arrangements in the Member States represented. These ranged from the highly developed such as those of EU Member States, the US and some South American states, to the very simple. In some cases, speakers frankly admitted that regulatory systems were virtually non-existent, but that as IAEA Members, their countries were ready and willing to improve their arrangements, with the assistance of IAEA . Some general conclusions may be derived: (i) A personal view is that IAEA and Member States have not clarified their risk assessment thinking: as RP practitioners we tend to concentrate on

  19. US/Japan collaborative program on fusion reactor materials: Summary of the tenth DOE/JAERI Annex I technical progress meeting on neutron irradiation effects in first wall and blanket structural materials

    International Nuclear Information System (INIS)

    Rowcliffe, A.F.

    1989-01-01

    This meeting was held at Oak Ridge National Laboratory on March 17, 1989, to review the technical progress on the collaborative DOE/JAERI program on fusion reactor materials. The purpose of the program is to determine the effects of neutron irradiation on the mechanical behavior and dimensional stability of US and Japanese austenitic stainless steels. Phase I of the program focused on the effects of high concentrations of helium on the tensile, fatigue, and swelling properties of both US and Japanese alloys. In Phase II of the program, spectral and isotropic tailoring techniques are fully utilized to reproduce the helium:dpa ratio typical of the fusion environment. The Phase II program hinges on a restart of the High Flux Isotope Reactor by mid-1989. Eight target position capsules and two RB* position capsules have been assembled. The target capsule experiments will address issues relating to the performance of austenitic steels at high damage levels including an assessment of the performance of a variety of weld materials. The RB* capsules will provide a unique and important set of data on the behavior of austenitic steels irradiated under conditions which reproduce the damage rate, dose, temperature, and helium generation rate expected in the first wall and blanket structure of the International Thermonuclear Experimental Reactor

  20. Management of pharmaceutical services in the Brazilian primary health care.

    Science.gov (United States)

    Gerlack, Letícia Farias; Karnikowski, Margô Gomes de Oliveira; Areda, Camila Alves; Galato, Dayani; Oliveira, Aline Gomes de; Álvares, Juliana; Leite, Silvana Nair; Costa, Ediná Alves; Guibu, Ione Aquemi; Soeiro, Orlando Mario; Costa, Karen Sarmento; Guerra, Augusto Afonso; Acurcio, Francisco de Assis

    2017-11-13

    To identify limiting factors in the management of pharmaceutical services in the primary health care provided by the Brazilian Unified Health System (SUS). This study was based on the data from the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos no Brasil (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines), and it was conducted by interviews with professionals responsible for pharmaceutical services in Brazilian cities, in 2015. To identify the management limiting factors, we considered the organizational, operational, and sustainability indicators of the management. For the analyses, we included the weights and structure of analysis plan for complex samples. The results were expressed by frequencies and measures of central tendency with 95% confidence interval, considering the Brazilian geographic regions. We identified the following limiting factors: lack of pharmaceutical services in the Municipal Health Secretariat organization chart (24%) and in the health plan (18%); lack of participation of managers in the Health Board and the absence of reference to this topic in the agenda of meetings (58.4%); lack of financial autonomy (61.5%) and lack of knowledge on the available values (81.7%); lack of adoption of operational procedures (about 50%) for selection, scheduling, and acquisition; and the fact that most professionals evaluate the organization of pharmaceutical services as good and great (58.8%), despite the worrisome indicators. Pharmaceutical services management is currently supported by a legal and political framework that should guide and contribute to improve the pharmaceutical services in the Brazilian Unified Health System primary health care. However, there is a mismatch between the goals established by these guidelines and what is actually happening.

  1. The Pharmaceutical Industry Beamline of Pharmaceutical Consortium for Protein Structure Analysis

    International Nuclear Information System (INIS)

    Nishijima, Kazumi; Katsuya, Yoshio

    2002-01-01

    The Pharmaceutical Industry Beamline was constructed by the Pharmaceutical Consortium for Protein Structure Analysis which was established in April 2001. The consortium is composed of 22 pharmaceutical companies affiliating with the Japan Pharmaceutical Manufacturers Association. The beamline is the first exclusive on that is owned by pharmaceutical enterprises at SPring-8. The specification and equipments of the Pharmaceutical Industry Beamline is almost same as that of RIKEN Structural Genomics Beamline I and II. (author)

  2. Big Pharma on the Farm: Students Are Exposed to Pharmaceutical Marketing More Often in Rural Clinics.

    Science.gov (United States)

    Evans, David V; Keys, Toby; Desnick, Laurel; A Andrilla, C Holly; Bienz, Danielle; Rosenblatt, Roger

    2016-07-01

    Pharmaceutical marketing techniques are effective in changing the behavior of health care providers in ways that deviate from evidence-based practices. To mitigate the influence of pharmaceutical marketing on learners, academic medical centers (AMCs) have adopted policies to limit student/industry interaction. Many clinical experiences occur outside of the AMC. The purpose of this study was to compare medical students' exposure to pharmaceutical marketing in off-campus rural and urban underserved clinical sites. The University of Washington School of Medicine Rural and Underserved Opportunities Program (RUOP) places rising second-year medical students in underserved clinical sites in five northwestern states. We surveyed RUOP students to evaluate their exposure to pharmaceutical marketing. Of 120 students, 86 (72%) completed surveys. Sixty-five (76%) did their RUOP rotation in rural areas. Students in rural locations were more likely to report exposure to pharmaceutical marketing. Distribution of free drug samples was reportedly three times higher in rural than urban sites (54% versus 15%). Doctors meeting with sales representatives were reported as four times higher in rural clinics (40% versus 10%). Students at rural sites reported exposure to pharmaceutical marketing more than those in urban settings. Rural medical educators should provide faculty development for community clinicians on the influences of pharmaceutical marketing on learners. Medical schools must review local clinic and institution-wide policies to limit pharmaceutical marketing exposure to learners in the rural learning environment.

  3. Pharmaceutical Public-Private Partnerships

    DEFF Research Database (Denmark)

    Bagley, Constance; Tvarnø, Christina D.

    2014-01-01

    This article provides a game theory and law-and-management analysis of for- profit pharmaceutical public-private partnerships, a complex type of legal arrangement in the highly regulated pharmaceutical industry. A pharmaceutical public-private partnership (PPPP) agreement is a legally binding...... and a practical perspective on how properly crafted PPPP arrangements can promote innovation more efficiently than traditional self-optimizing contracts. In particular, a properly framed binding contract, coupled with respect for positive incentives, can move the parties away from an inefficient prisoners...... systems to build and share innovation. When coupled with appropriate attention to the difficult task of coordinating the actions of interdependent actors, a PPPP arrangement can enhance the likelihood of successful commercialization of pharmacological discoveries by flipping the par- ties’ incentives...

  4. Abstracts of the works presented to the meeting day: UPPA/firms on materials; Resumes des travaux presentes a la journee de rencontres UPPA/entreprises sur les materiaux

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2001-07-01

    This document provides the abstracts of the papers presented at the conference 'UPPA/firms meeting day on materials', held April 5, 2001 in Pau (France). The main topics presented were: 1)fabrication of new materials (1 paper) (polymers, resins, materials for electrodes) 2)analysis and characterization of materials (8 papers) (ESCA, FTIR, UV-Visible, Raman, electro-osmometry, near-field microscopy) 3)treatment of materials (1 paper) (cold plasmas) 4)behavior of materials (1 paper) (vitreous membranes for chemical sensors). The applications of these materials are: the petroleum industry, the petrochemistry, the air and water cleansing, the electric powered vehicles or hybrid electric powered vehicles. (O.M.)

  5. Technical meeting (TM) to 'Review of national programmes on fast reactors and accelerator driven systems (ADS)'. Technical Working Group on Fast Reactors (TWG-FR) (37th annual meeting). Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2004-07-01

    The objectives of the 37th Annual Meeting of the Technical Working Group on Fast Reactors, were to: 1) exchange information on the national programmes on Fast Reactors (FR) and Accelerator Driven Systems (ADS); 2) review the progress since the 36th TWG-FR Annual Meeting, including the status of the actions; 3) consider meeting arrangements for 2004 and 2005; 4) review the Agency's co-ordinated research activities in the field of FRs and ADS, as well as co-ordination of the TWG-FR's activities with other organizations. The participants made presentations on the status of the respective national programmes on FR and ADS development. A summary of the highlights for the period since the 36th TWG-FR Annual Meeting is included in this proceedings. Annex IV contains the Review of National Programs on Fast Reactors and Accelerator Driven Systems (ADS), and the TWG-FR Activity Report for the Period May 2003-April 2004.

  6. The future of the pharmaceutical, biological and medical device industry

    Directory of Open Access Journals (Sweden)

    Burgess LJ

    2011-09-01

    Full Text Available Lesley J Burgess, Marli TerblancheTREAD Research/Cardiology Unit, Department of Internal Medicine, Tygerberg Hospital and University of Stellenbosch, Parow, South AfricaAbstract: Numerous factors contribute to the declining pharmaceutical industry on the one hand and the rapidly growing generic industry together with the growing importance of medical devices and biologicals on the other. It is clear that the pharmaceutical industry is going to undergo a change in the next decade in order to meet the current challenges facing it and ultimately sustain its profitability and growth. This paper aims to identify a number of fairly obvious trends that are likely to have a significant impact on the product development pipeline in the next decade. It is more than clear that the current production pipeline for pharmaceutical, biotechnology and medical device industries is no longer sustainable and that urgent interventions are required in order to maintain its current level of profitability.Keywords: pharmaceutical industry, personalized medicine, trends, generics, biotechnology

  7. Core competencies for pharmaceutical physicians and drug development scientists

    Science.gov (United States)

    Silva, Honorio; Stonier, Peter; Buhler, Fritz; Deslypere, Jean-Paul; Criscuolo, Domenico; Nell, Gerfried; Massud, Joao; Geary, Stewart; Schenk, Johanna; Kerpel-Fronius, Sandor; Koski, Greg; Clemens, Norbert; Klingmann, Ingrid; Kesselring, Gustavo; van Olden, Rudolf; Dubois, Dominique

    2013-01-01

    Professional groups, such as IFAPP (International Federation of Pharmaceutical Physicians and Pharmaceutical Medicine), are expected to produce the defined core competencies to orient the discipline and the academic programs for the development of future competent professionals and to advance the profession. On the other hand, PharmaTrain, an Innovative Medicines Initiative project, has become the largest public-private partnership in biomedicine in the European Continent and aims to provide postgraduate courses that are designed to meet the needs of professionals working in medicines development. A working group was formed within IFAPP including representatives from PharmaTrain, academic institutions and national member associations, with special interest and experience on Quality Improvement through education. The objectives were: to define a set of core competencies for pharmaceutical physicians and drug development scientists, to be summarized in a Statement of Competence and to benchmark and align these identified core competencies with the Learning Outcomes (LO) of the PharmaTrain Base Course. The objectives were successfully achieved. Seven domains and 60 core competencies were identified and aligned accordingly. The effective implementation of training programs using the competencies or the PharmaTrain LO anywhere in the world may transform the drug development process to an efficient and integrated process for better and safer medicines. The PharmaTrain Base Course might provide the cognitive framework to achieve the desired Statement of Competence for Pharmaceutical Physicians and Drug Development Scientists worldwide. PMID:23986704

  8. Influence of pharmaceutical marketing on prescription practices of physicians.

    Science.gov (United States)

    Narendran, Roshni; Narendranathan, M

    2013-01-01

    In India same drug molecules are sold under different brand names by different pharmaceuticals. To persuade the physicians to prescribe their brands pharmaceuticals engage in marketing techniques like giving samples, gifts, sponsoring travel etc. Many countries are striving to reduce the impact of incentives on prescription behaviour. This study explores the influence of pharmaceutical marketing on the prescription practices of doctors in India. There were 103 study subjects - 50 doctors and 53 sales personnel. Data collection was done by a self administered questionnaire. Data were collected on 36 variables which were supposed to influence prescription. The effectiveness of the promotional strategies on prescription behaviour was marked in a seven point Likert scale ranging from "not at all effective" (score=1) to "extremely effective" (score=7). Open ended questions were used to collect qualitative data. Good rapport with the doctor, launch meetings, reputation of the company, quality of the drug and brand names significantly influenced prescription behaviour, while direct mailers, advertisements in journals and giving letter pads and other brand reminders were less effective. Commonly used method of giving samples was not among the twenty most effective methods influencing prescription. Product quality and good company are still factors that influence prescription. Pharmaceutical marketing influences the choice of brands by a physician. The more expensive strategies involved in public relations are more effective. Sending mails and journal advertisements are less effective strategies. How expensive marketing strategies affect cost of the medicines has to be explored further.

  9. Core Competencies for Pharmaceutical Physicians and Drug Development Scientists

    Directory of Open Access Journals (Sweden)

    Honorio eSilva

    2013-08-01

    Full Text Available Professional groups, such as IFAPP (International Federation of Pharmaceutical Physicians and Pharmaceutical Medicine, are expected to produce the defined core competencies to orient the discipline and the academic programs for the development of future competent professionals and to advance the profession. On the other hand, PharmaTrain, an Innovative Medicines Initiative project, has become the largest public-private partnership in biomedicine in the European Continent and aims to provide postgraduate courses that are designed to meet the needs of professionals working in medicines development. A working group was formed within IFAPP including representatives from PharmaTrain, academic institutions and national member associations, with special interest and experience on Quality Improvement through education. The objectives were: to define a set of core competencies for pharmaceutical physicians and drug development scientists, to be summarized in a Statement of Competence and to benchmark and align these identified core competencies with the Learning Outcomes of the PharmaTrain Base Course. The objectives were successfully achieved. Seven domains and 60 core competencies were identified and aligned accordingly. The effective implementation of training programs using the competencies or the PharmaTrain Learning Outcomes anywhere in the world may transform the drug development process to an efficient and integrated process for better and safer medicines. The PharmaTrain Base Course might provide the cognitive framework to achieve the desired Statement of Competence for Pharmaceutical Physicians and Drug Development Scientists worldwide.

  10. Salt forms of the pharmaceutical amide dihydrocarbamazepine.

    Science.gov (United States)

    Buist, Amanda R; Kennedy, Alan R

    2016-02-01

    Carbamazepine (CBZ) is well known as a model active pharmaceutical ingredient used in the study of polymorphism and the generation and comparison of cocrystal forms. The pharmaceutical amide dihydrocarbamazepine (DCBZ) is a less well known material and is largely of interest here as a structural congener of CBZ. Reaction of DCBZ with strong acids results in protonation of the amide functionality at the O atom and gives the salt forms dihydrocarbamazepine hydrochloride {systematic name: [(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)(hydroxy)methylidene]azanium chloride, C15H15N2O(+)·Cl(-)}, dihydrocarbamazepine hydrochloride monohydrate {systematic name: [(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)(hydroxy)methylidene]azanium chloride monohydrate, C15H15N2O(+)·Cl(-)·H2O} and dihydrocarbamazepine hydrobromide monohydrate {systematic name: [(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)(hydroxy)methylidene]azanium bromide monohydrate, C15H15N2O(+)·Br(-)·H2O}. The anhydrous hydrochloride has a structure with two crystallographically independent ion pairs (Z' = 2), wherein both cations adopt syn conformations, whilst the two hydrated species are mutually isostructural and have cations with anti conformations. Compared to neutral dihydrocarbamazepine structures, protonation of the amide group is shown to cause changes to both the molecular (C=O bond lengthening and C-N bond shortening) and the supramolecular structures. The amide-to-amide and dimeric hydrogen-bonding motifs seen for neutral polymorphs and cocrystalline species are replaced here by one-dimensional polymeric constructs with no direct amide-to-amide bonds. The structures are also compared with, and shown to be closely related to, those of the salt forms of the structurally similar pharmaceutical carbamazepine.

  11. Pharmaceutical aerosols. Study of their gamma radiation sterilization

    International Nuclear Information System (INIS)

    Sebert, P.

    1984-10-01

    The gamma radiation sterilization of pharmaceutical aerosols was studied. The following topics were investigated: radiosterilization of nitrogen protoxide used as a propellant; radiosterilization of packaging materials (aluminium containers, plastics valves); radio-sterilization of excipients and active ingredients. Most of the investigated materials proved to be stable to irradiation (2,5 Mrads) from pharmacopoeial aspect. Stability tests of the preparations packaged showed no change in the parameters investigated [fr

  12. Tropical Journal of Pharmaceutical Research, June 2002; 1 (1): 63-22

    African Journals Online (AJOL)

    Clinical Phamacy

    Development and in-vitro Evaluation of a Topical Drug ... The present study was carried out to exploit the feasibility of using polymeric ... Materials. Betamethazone. (Glaxo. SmithKline. Pharmaceuticals Ltd), Ethyl cellulose .... A dialysis tubing.

  13. Pharmaceutical care in smoking cessation.

    Science.gov (United States)

    Marín Armero, Alicia; Calleja Hernandez, Miguel A; Perez-Vicente, Sabina; Martinez-Martinez, Fernando

    2015-01-01

    As a determining factor in various diseases and the leading known cause of preventable mortality and morbidity, tobacco use is the number one public health problem in developed countries. Facing this health problem requires authorities and health professionals to promote, via specific programs, health campaigns that improve patients' access to smoking cessation services. Pharmaceutical care has a number of specific characteristics that enable the pharmacist, as a health professional, to play an active role in dealing with smoking and deliver positive smoking cessation interventions. The objectives of the study were to assess the efficacy of a smoking cessation campaign carried out at a pharmaceutical care center and to evaluate the effects of pharmaceutical care on patients who decide to try to stop smoking. The methodology was an open, analytical, pre-post intervention, quasi-experimental clinical study performed with one patient cohort. The results of the study were that the promotional campaign for the smoking cessation program increased the number of patients from one to 22, and after 12 months into the study, 43.48% of the total number of patients achieved total smoking cessation. We can conclude that advertising of a smoking cessation program in a pharmacy increases the number of patients who use the pharmacy's smoking cessation services, and pharmaceutical care is an effective means of achieving smoking cessation.

  14. Financing pharmaceuticals in transition economies.

    Science.gov (United States)

    Kanavos, P

    1999-06-01

    This paper (a) provides a methodological taxonomy of pricing, financing, reimbursement, and cost containment methodologies for pharmaceuticals; (b) analyzes complex agency relationships and the health versus industrial policy tradeoff; (c) pinpoints financing measures to balance safety and effectiveness of medicines and their affordability by publicly funded systems in transition; and (d) highlights viable options for policy-makers for the financing of pharmaceuticals in transition. Three categories of measures and their implications for pharmaceutical policy cost containing are analyzed: supply-side measures, targeting manufacturers, proxy demand-side measures, targeting physicians and pharmacists, and demand-side measures, targeting patients. In pursuing supply side measures, we explore free pricing for pharmaceuticals, direct price controls, cost-plus and cost pricing, average pricing and international price comparisons, profit control, reference pricing, the introduction of a fourth hurdle, positive and negative lists, and other price control measures. The analysis of proxy-demand measures includes budgets for physicians, generic policies, practice guidelines, monitoring the authorizing behavior of physicians, and disease management schemes. Demand-side measures explore the effectiveness of patient co-payments, the impact of allowing products over-the-counter and health promotion programs. Global policies should operate simultaneously on the supply, the proxy demand, and the demand-side. Policy-making needs to have a continuous long-term planning. The importation of policies into transition economy may require extensive and expensive adaptation, and/or lead to sub-optimal policy outcomes.

  15. The argument for pharmaceutical policy

    DEFF Research Database (Denmark)

    Traulsen, Janine Morgall; Almarsdóttir, Anna Birna

    2005-01-01

    and the involvement of pharmacists in this endeavour. The aim of the authors is to stimulate an informed and critical appreciation of this field. The authors begin with an introduction to the field of pharmaceutical policy, introducing several important concepts and current trends including: medicines regulation; how...

  16. Probing Pharmaceutical Mixtures during Milling

    DEFF Research Database (Denmark)

    Walker, Greg; Römann, Philipp; Poller, Bettina

    2017-01-01

    interpret the spectral changes. Overall, this study demonstrates the potential of low-frequency Raman spectroscopy, which has several practical advantages over XRPD, for probing (dis-)order during pharmaceutical processing, showcasing its potential for future development, and implementation as an in...

  17. UV imaging in pharmaceutical analysis

    DEFF Research Database (Denmark)

    Østergaard, Jesper

    2018-01-01

    UV imaging provides spatially and temporally resolved absorbance measurements, which are highly useful in pharmaceutical analysis. Commercial UV imaging instrumentation was originally developed as a detector for separation sciences, but the main use is in the area of in vitro dissolution...

  18. Patrick Couvreur: inspiring pharmaceutical innovation.

    Science.gov (United States)

    Stanwix, Hannah

    2014-05-01

    Patrick Couvreur speaks to Hannah Stanwix, Managing Comissioning Editor: Professor Patrick Couvreur received his pharmacy degree from the Université Catholique de Louvain (Louvain-la-Neuve, Belgium) in 1972. He holds a PhD in pharmaceutical technology from the same university and completed a postdoctoral fellowship at the Eidgenössische Technische Hochschule (Zürich, Switzerland). Since 1984, Professor Couvreur has been Full Professor of Pharmacy at the Paris-Sud University (Paris, France) and was holder of the Chair of Innovation Technologique at the prestigious Collège de France (Paris, France). He has published more than 450 peer-reviewed articles and has an H-index of 73, with over 19,000 citations. Professor Coureur has been recognized by numerous national and international awards, including the 2004 Pharmaceutical Sciences World Congress Award, the prestigious Host Madsen Medal, the Prix Galien, the European Pharmaceutical Scientist Award 2011 from the European Federation of Pharmaceutical Sciences, the Médaille de l'Innovation from the Centre National de la Recherche Scientifique, and recently the European Inventor Award 2013 from the European Patent Office.

  19. Archives: Tropical Journal of Pharmaceutical Research

    African Journals Online (AJOL)

    Items 1 - 50 of 97 ... Archives: Tropical Journal of Pharmaceutical Research. Journal Home > Archives: Tropical Journal of Pharmaceutical Research. Log in or Register to get access to full text downloads.

  20. Quality Systems Implementation in the Pharmaceutical Industry

    African Journals Online (AJOL)

    Nafiisah

    quality standards imposed on local pharmaceutical manufacturers. Keywords: Quality/ .... GMP is concerned with both production and quality control. It is aimed ... in the European pharmaceutical industry in designing their quality systems:.

  1. Archives: Nigerian Journal of Pharmaceutical Research

    African Journals Online (AJOL)

    Items 1 - 9 of 9 ... Archives: Nigerian Journal of Pharmaceutical Research. Journal Home > Archives: Nigerian Journal of Pharmaceutical Research. Log in or Register to get access to full text downloads.

  2. Toward a Regional Research Agenda on Pharmaceutical ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    African policymakers are pushing for local pharmaceutical manufacturing as a ... Africa Development Community Pharmaceutical Business Plan (2007-2013) and ... IDRC congratulates first cohort of Women in Climate Change Science Fellows.

  3. Pharmaceutical and Medicine Manufacturing Sector (NAICS 3254)

    Science.gov (United States)

    Find environmental regulatory and compliance information for the pharmaceutical manufacturing sector, including essential uses of CFCs, NESHAP for pharmaceutical production, effluent guidelines for wastewater and management of hazardous waste.

  4. Technical meeting on development of 'Deep Burn' concepts using coated particle fuel for incineration of nuclear waste, surplus fissile materials and plutonium without recourse to multiple reprocessing. Presentations

    International Nuclear Information System (INIS)

    2013-01-01

    The purpose of this meeting is to explore various Deep-Burn options and concepts being developed in Member States and to appraise the progress made towards the maturity of Deep-Burn concepts based on HTGR designs. The meeting will also identify technology development challenges towards the realization of Deep-Burn concepts and propose collaborative ways to address them

  5. International working group on life management of nuclear power plants (IWG-LMNPP). Regular meeting. 30 August - 1 September 1995. Working material. V. 2

    International Nuclear Information System (INIS)

    1995-01-01

    This meeting of the International Working Group on Life Management of Nuclear Power Plants (IWG-LMNPP) was organized to review the national programmes of the countries and to advise the IAEA on its technical meetings and activities in the subject areas taking into consideration current progress, problems and operating experience. Refs, figs and tabs

  6. International working group on life management of nuclear power plants (IWG-LMNPP). Regular meeting. 30 August - 1 September 1995. Working material. V. 1

    International Nuclear Information System (INIS)

    1995-01-01

    This meeting of the International Working Group on Life Management of Nuclear Power Plants (IWG-LMNPP) was organized to review the national programmes of the countries and to advise the IAEA on its technical meetings and activities in the subject areas taking into consideration current progress, problems and operating experience. Refs, figs and tabs

  7. The coefficient of rolling resistance (CoRR) of some pharmaceutical tablets.

    Science.gov (United States)

    Ketterhagen, William R; Bharadwaj, Rahul; Hancock, Bruno C

    2010-06-15

    Experiments have been conducted to measure the coefficient of rolling resistance (CoRR) of some pharmaceutical tablets and several common materials, such as glass beads and steel ball bearings. CoRR values are required as inputs for discrete element method (DEM) models which can be used to model particulate flows and solid dosage form manufacturing processes. Until now there have been no CoRR data reported for pharmaceutical materials, and thus these new data will help to facilitate more accurate modeling of pharmaceutical systems. Copyright 2010 Elsevier B.V. All rights reserved.

  8. Pharmaceutical care in smoking cessation

    Directory of Open Access Journals (Sweden)

    Marín Armero A

    2015-01-01

    Full Text Available Alicia Marín Armero,1 Miguel A Calleja Hernandez,2 Sabina Perez-Vicente,3 Fernando Martinez-Martinez4 1Community Pharmacy, Murcia, Spain; 2Hospital Pharmacy, University Hospital Virgen de las Nieves, Granada, Spain; 3Result Evaluation Unit, Institute of Biomedicine, Sevilla, Spain; 4Research Unit in Pharmaceutical Care, University of Granada, Granada, Spain Abstract: As a determining factor in various diseases and the leading known cause of preventable mortality and morbidity, tobacco use is the number one public health problem in developed countries. Facing this health problem requires authorities and health professionals to promote, via specific programs, health campaigns that improve patients’ access to smoking cessation services. Pharmaceutical care has a number of specific characteristics that enable the pharmacist, as a health professional, to play an active role in dealing with smoking and deliver positive smoking cessation interventions. The objectives of the study were to assess the efficacy of a smoking cessation campaign carried out at a pharmaceutical care center and to evaluate the effects of pharmaceutical care on patients who decide to try to stop smoking. The methodology was an open, analytical, pre–post intervention, quasi-experimental clinical study performed with one patient cohort. The results of the study were that the promotional campaign for the smoking cessation program increased the number of patients from one to 22, and after 12 months into the study, 43.48% of the total number of patients achieved total smoking cessation. We can conclude that advertising of a smoking cessation program in a pharmacy increases the number of patients who use the pharmacy’s smoking cessation services, and pharmaceutical care is an effective means of achieving smoking cessation. Keywords: community pharmacy, health campaign, tobacco cessation, nicotine replacement therapy

  9. Final draft consultants report. Consultants' meeting on requirements for reference materials and intercomparison runs - IAEA programme on Analytical Quality Control Services (AQCS), 17-21 April 1994, Kona, HI, USA

    International Nuclear Information System (INIS)

    2002-01-01

    The purpose of the meeting was to define the aims of the Agency's Analytical Quality Control Services (AQCS) programme in view of its uniqueness as an international programme and to establish objectives for the organization of intercomparison runs and production of reference materials and the Agency's services to Member States in future years. This draft report contains the meeting agenda and recommendations made by the consultants. The recommendations are grouped as follows: Mission Statement; Laboratory Qualification; Training and Development; Resources and Technical Concepts; Standing Group of Experts

  10. A vision of the pharmaceutical industry.

    Science.gov (United States)

    Muñio, S

    1998-01-01

    As the financial resources available for looking after the health of an aging population are limited, generic drugs (drugs that are no longer covered by a patent and marketed at a lower price) have come to be used in western countries as a means for meeting growing demand while leaving resources in the health budget for new drugs. In Spain, a law on product patents was introduced in 1992, which is much later than in other countries, and created difficulties in the definition and procedure for gaining approval for generic drugs. Circular 3/97 from the Ministry of Health finally resolved these issues. In this circular, generic pharmaceutical products (GPPs) are clearly defined and identified with a positive commitment towards guaranteeing the ability to interchange original drugs for other cheaper generic products and towards clarifying the Spanish vade mecum. The position of the pharmaceutical industry on generic drugs varies widely and consequently, it is impossible to make a general statement on the view of the industry. However, the commitment of Novartis, given the issues described above and in line with the company's global strategy, is to offer innovation and services to society. This is perfectly compatible with offering health professionals both innovative drugs and generic drugs of a high quality at a lower price, given that registering genetics requires less investment in research and development. In any case, GPPs face an uncertain future in Spain and market forecasts also differ widely, ranging from 15 billion to 80 billion pesetas in the year 2000. It will be necessary to get doctors and pharmacists positively involved, to set up fast structural measures, and to avoid rejection by patients through successful information and marketing.

  11. Advanced Continuous Flow Platform for On-Demand Pharmaceutical Manufacturing.

    Science.gov (United States)

    Zhang, Ping; Weeranoppanant, Nopphon; Thomas, Dale A; Tahara, Kohei; Stelzer, Torsten; Russell, Mary Grace; O'Mahony, Marcus; Myerson, Allan S; Lin, Hongkun; Kelly, Liam P; Jensen, Klavs F; Jamison, Timothy F; Dai, Chunhui; Cui, Yuqing; Briggs, Naomi; Beingessner, Rachel L; Adamo, Andrea

    2018-02-21

    As a demonstration of an alternative to the challenges faced with batch pharmaceutical manufacturing including the large production footprint and lengthy time-scale, we previously reported a refrigerator-sized continuous flow system for the on-demand production of essential medicines. Building on this technology, herein we report a second-generation, reconfigurable and 25 % smaller (by volume) continuous flow pharmaceutical manufacturing platform featuring advances in reaction and purification equipment. Consisting of two compact [0.7 (L)×0.5 (D)×1.3 m (H)] stand-alone units for synthesis and purification/formulation processes, the capabilities of this automated system are demonstrated with the synthesis of nicardipine hydrochloride and the production of concentrated liquid doses of ciprofloxacin hydrochloride, neostigmine methylsulfate and rufinamide that meet US Pharmacopeia standards. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

  12. Third working meeting on radiation interaction. 1

    International Nuclear Information System (INIS)

    Schmidt, J.; Brede, O.; Doellstaedt, R.; Mehnert, R.

    1984-12-01

    The following topics have been discussed during the meeting: elementary processes in radiation chemistry and physics (theory, inorganic and organic systems); applied radiation chemistry and radiation processing; techniques, methods and instrumentation used in radiation chemistry and radiation processing; and irradiation of food, agricultural products, pharmaceutical products, domestic and industrial wastes. 52 papers are included in part 1

  13. Third working meeting on radiation interaction. 2

    International Nuclear Information System (INIS)

    Schmidt, J.; Brede, O.; Doellstaedt, R.; Mehnert, R.

    1984-12-01

    The following topics have been discussed during the meeting: elementary processes in radiation chemistry and physics (theory, inorganic and organic systems); applied radiation chemistry and radiation processing; techniques, methods and instrumentation used in radiation chemistry and radiation processing; and irradiation of food, agricultural products, pharmaceutical products, domestic and industrial wastes. 55 papers are included in part 2

  14. [Application of microwave irradiation technology to the field of pharmaceutics].

    Science.gov (United States)

    Zhang, Xue-Bing; Shi, Nian-Qiu; Yang, Zhi-Qiang; Wang, Xing-Lin

    2014-03-01

    Microwaves can be directly transformed into heat inside materials because of their ability of penetrating into any substance. The degree that materials are heated depends on their dielectric properties. Materials with high dielectric loss are more easily to reach a resonant state by microwaves field, then microwaves can be absorbed efficiently. Microwave irradiation technique with the unique heating mechanisms could induce drug-polymer interaction and change the properties of dissolution. Many benefits such as improving product quality, increasing energy efficiency and reducing times can be obtained by microwaves. This paper summarized characteristics of the microwave irradiation technique, new preparation techniques and formulation process in pharmaceutical industry by microwave irradiation technology. The microwave technology provides a new clue for heating and drying in the field of pharmaceutics.

  15. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.

    Science.gov (United States)

    Seay, Melicia; Varma, Priya

    2005-12-31

    The enactment of the Omnibus Budget Reconciliation Act of 1990 (OBRA '90) gave states the option of offering pharmaceutical benefits within their Medicaid programs. But the law placed restrictions on states' flexibility to control what prescriptions they would cover and required the states to reimburse outpatient prescription drugs from manufacturers that signed rebate agreements with the U.S. Department of Health and Human Services. Forty-nine states--Arizona is excluded, based on its program structure--and the District of Columbia currently offer prescription drug coverage under the Medicaid Drug Rebate Program. During the past four years, states all over the country have been plagued with revenue shortfalls in their state Medicaid budgets. While the fiscal situation improved for most states in the 2004 legislative session, many states still face budget pressures in 2005. Compounding existing budget pressures are threats from the Bush Administration to shift increased costs of the Medicaid program on to the states. All things considered, the economic pressure of funding Medicaid is at the top of legislative agendas in 2005. As in previous years, states are attempting to reduce costs to their Medicaid programs by seeking savings in their pharmaceutical programs. Prescription drug costs are highly attributed as a contributing factor to the fiscal climate of state Medicaid programs. Currently, prescription drug spending outpaces that of every other category of health care and drug prices are rising faster than inflation. In response, states are instituting a variety of pharmaceutical cost control measures such as creating preferred drug lists (PDLs), negotiating supplemental rebates, forming bulk purchasing pools, promoting generic drug substitution and implementing price controls. As prescription drug cost containment tools have gained acceptance and momentum, they continue to be controversial. This issue brief explores the debate, history, methodology, utilization

  16. Modernization of instrumentation and control systems in nuclear power plants. Working materials. Proceedings of a specialists` meeting held in Garching, Germany, 4-7 July 1995

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-12-31

    The Specialists` Meeting on ``Modernization of Instrumentation and Control Systems in Nuclear Power Plants`` was organized by the IAEA (jointly by Division of Nuclear Power and Division of Nuclear Safety) in co-operation with Institute for Safety Technology (ISTec) and held in Garching, Germany from 4 to 7 July 1995 (The Meeting Chairman - Dr. W. Bastl). The meeting brought together experts on power plant operation with experts on application of today`s instrumentation and control technology. In this way, a match was made between those knowing the industry needs and requirements and those knowing the potentials of the technology. Refs, figs and tabs.

  17. A survey of pharmaceutical company representative interactions with doctors in Libya

    Directory of Open Access Journals (Sweden)

    Mustafa A. Alssageer

    2012-09-01

    Full Text Available Objectives: To examine the frequency of pharmaceutical company representative (PCR interactions with doctors in Libya and review possible associations between these interactions and the personal and practice setting characteristics of doctors. Method: An anonymous survey questionnaire was circulated to 1,000 Libyan doctors in selected public and private practice settings in Tripoli, Benghazi and Sebha. Results: A questionnaire return rate of 61% (608 returned questionnaires was achieved. Most respondents (94% reported that they had been visited by PCRs at least ‘once’ in the last year. Fifty per cent of respondents met with PCRs at least once a month, and 20% at least once a week. The following characteristics were significantly associated with meeting with a representative more than once a week: age, gender (male > female, years of practice, being a specialist (other than an anaesthesiologist or working in private practice. Ninety-one per cent of doctors reported that they had received at least one kind of relationship gift during the last year. Printed materials (79%, simple gifts (73% and drug samples (69% were the most common relationship products given to respondents. Reimbursements or sponsored items were reported by 33% of respondents. Physician specialists were more likely to receive drug samples or sponsored items than residents, general practitioners, anaesthesiologists or surgeons (P<0.01. Participants working in private practice alone or in both sectors were more likely to receive printed materials, simple gifts or free samples from PCRs than doctors working in the public sector (P<0.05. Conclusion: Libyan doctors are frequently visited by PCRs. Doctors, working in private practice or specialist practice, are especially targeted by promotional activities. An agreed code of conduct for pharmaceutical promotion in Libya between doctors and PCRs should be created.

  18. Code of ethics for the national pharmaceutical system: Codifying and compilation.

    Science.gov (United States)

    Salari, Pooneh; Namazi, Hamidreza; Abdollahi, Mohammad; Khansari, Fatemeh; Nikfar, Shekoufeh; Larijani, Bagher; Araminia, Behin

    2013-05-01

    Pharmacists as one of health-care providers face ethical issues in terms of pharmaceutical care, relationship with patients and cooperation with the health-care team. Other than pharmacy, there are pharmaceutical companies in various fields of manufacturing, importing or distributing that have their own ethical issues. Therefore, pharmacy practice is vulnerable to ethical challenges and needs special code of conducts. On feeling the need, based on a shared project between experts of the ethics from relevant research centers, all the needs were fully recognized and then specified code of conduct for each was written. The code of conduct was subject to comments of all experts involved in the pharmaceutical sector and thus criticized in several meetings. The prepared code of conduct is comprised of professional code of ethics for pharmacists, ethics guideline for pharmaceutical manufacturers, ethics guideline for pharmaceutical importers, ethics guideline for pharmaceutical distributors, and ethics guideline for policy makers. The document was compiled based on the principles of bioethics and professionalism. The compiling the code of ethics for the national pharmaceutical system is the first step in implementing ethics in pharmacy practice and further attempts into teaching the professionalism and the ethical code as the necessary and complementary effort are highly recommended.

  19. The role of cocrystals in pharmaceutical science.

    Science.gov (United States)

    Shan, Ning; Zaworotko, Michael J

    2008-05-01

    Pharmaceutical cocrystals, a subset of a long known but little-studied class of compounds, represent an emerging class of crystal forms in the context of pharmaceutical science. They are attractive to pharmaceutical scientists because they can significantly diversify the number of crystal forms that exist for a particular active pharmaceutical ingredient (API), and they can lead to improvements in physical properties of clinical relevance. In this article we address pharmaceutical cocrystals from the perspective of design (crystal engineering) and present a series of case studies that demonstrate how they can enhance the solubility, bioavailability, and/or stability of API crystal forms.

  20. Operating procedures for nuclear power plants and their presentation. Working material. Proceedings of a specialists meeting held in Vienna, 31 March - 2 April 1992

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1994-12-31

    With a view to exchanging information on most recent development of technology in the field the IAEA International Working Group on Nuclear Power Plant control and Instrumentation suggested to organize a Specialists` Meeting on ``Operating Procedures for Nuclear Power Plants and their Presentation``. The meeting was held in Vienna, at IAEA Headquarters from March 31 to April 2, 1992 and provided an opportunity to: share operators experience; discuss the different techniques of presenting the information; identify further trends of technology and needs of the industry. The meeting was attended by 46 participants representing 12 Member States and 3 international organizations. The present volume contains summary of the meeting, session summaries and papers of the national participants. Refs, figs and tabs.

  1. Operating procedures for nuclear power plants and their presentation. Working material. Proceedings of a specialists meeting held in Vienna, 31 March - 2 April 1992

    International Nuclear Information System (INIS)

    1993-01-01

    With a view to exchanging information on most recent development of technology in the field the IAEA International Working Group on Nuclear Power Plant control and Instrumentation suggested to organize a Specialists' Meeting on ''Operating Procedures for Nuclear Power Plants and their Presentation''. The meeting was held in Vienna, at IAEA Headquarters from March 31 to April 2, 1992 and provided an opportunity to: share operators experience; discuss the different techniques of presenting the information; identify further trends of technology and needs of the industry. The meeting was attended by 46 participants representing 12 Member States and 3 international organizations. The present volume contains summary of the meeting, session summaries and papers of the national participants. Refs, figs and tabs

  2. Strategic imperatives for globalization of industries in developing countries: an Indian pharmaceutical industry example.

    Science.gov (United States)

    Srivastava, Rajesh; Chandra, Ashish; Kumar, Girish

    2004-01-01

    The annual global pharmaceutical sales have grown over 466 billion dollars, almost 50% of which comes from North America. Among developing countries, India, with 16% of the world population, accounts for only a small percentage of the global pharmaceutical industry. Until recently, India has had virtually no pharmaceutical industry worth the name producing drugs from basic raw materials and it used to rely mostly on the imports from countries like the USA and England for all its requirements of drugs. On the other hand, India has seen a plethora of multinational pharmaceutical companies come and do business in India. This paper develops a matrix which provides a broad guidance to the mid- to large-size Indian pharmaceutical domestic companies, which should embark on the path to global expansion to establish their might as well.

  3. Modern principles of public administration of pharmaceutical supply for the population in emergency situations

    Directory of Open Access Journals (Sweden)

    P. V. Olіynуk

    2015-08-01

    Full Text Available In conditions of the emergency situations’ amount increasing the readiness of the state to provide affected people and all other segments of the population with full pharmaceutical provision is important. The aim of research is an analysis of the state of the legislative and regulatory framework of governmental administration by pharmaceutical provision of the population in the conditions of emergency situations. Materials and methods. We used methods of observation and synthesis, generalization and formalization, analysis of content. The object of the study were regulations, government pharmaceutical providing of population in emergency situations. Results. Studies show the need to develop methods and principles of public administration process to ensure people with pharmaceutical and specific methodological approaches in emergency situations. Conclusions. It has been established, that it is necessary to develop scientifically based methods of governance by the process of pharmaceutical providing the affected population.

  4. Sex, gender, and pharmaceutical politics: From drug development to marketing.

    Science.gov (United States)

    Fisher, Jill A; Ronald, Lorna M

    2010-08-01

    Biological sex differences and sociocultural gender norms affect the provision of health care products and services, but there has been little explicit analysis of the impact of sex differences and gender norms on the regulation of pharmaceutical development and marketing. This article provides an overview of the regulation of pharmaceuticals and examines the ways that regulatory agencies account for sex and gender in their review of scientific data and marketing materials. The primary focus is on the US context, but information is also included about regulatory models in Europe, Canada, and Japan for comparative purposes. Specific examples show how sex differences and gender norms influence scientific and policy decisions about pharmaceuticals. The United States and Canada were found to be the only countries that have explicit requirements to include women in clinical trials and to perform sex-based subgroup analysis on study results. The potential influence of politics on regulatory decisions may have led to an uneven application of standards, as seen through the examples of mifepristone (for abortion) and sildenafil citrate (for erectile dysfunction). Three detailed case studies illustrate the importance of considering sex and gender in pharmaceutical development and marketing: Phase I clinical trials; human papillomavirus quadrivalent vaccine; and tegaserod, a drug for irritable bowel syndrome. Sex and gender play important roles in pharmaceutical regulation, from the design of clinical trials and the approval of new drugs to advertising and postmarketing surveillance. However, regulatory agencies pay insufficient attention to both biological sex differences and sociocultural gender norms. This disregard perpetuates inequalities by ignoring drug safety problems that predominate in women and by allowing misleading drug marketing that reinforces gender stereotypes. Recommendations have been made to improve the regulation of pharmaceuticals in regard to sex and

  5. International research networks in pharmaceuticals

    DEFF Research Database (Denmark)

    Cantner, Uwe; Rake, Bastian

    2014-01-01

    of scientific publications related to pharmaceutical research and applying social network analysis, we find that both the number of countries and their connectivity increase in almost all disease group specific networks. The cores of the networks consist of high income OECD countries and remain rather stable......Knowledge production and scientific research have become increasingly more collaborative and international, particularly in pharmaceuticals. We analyze this tendency in general and tie formation in international research networks on the country level in particular. Based on a unique dataset...... over time. Using network regression techniques to analyze the network dynamics our results indicate that accumulative advantages based on connectedness and multi-connectivity are positively related to changes in the countries' collaboration intensity whereas various indicators on similarity between...

  6. Report of 6th research meeting on basic process of fuel cycle for nuclear fusion reactors, Yayoi Research Group; 3rd expert committee on research of nuclear fusion fuel material correlation basis

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-03-01

    In this report, the lecture materials of Yayoi Research Group, 6th research meeting on basic process of fuel cycle for nuclear fusion reactors which was held at the University of Tokyo on March 25, 1996, are collected. This workshop was held also as 3rd expert committee on research of nuclear fusion fuel material correlation basis of Atomic Energy Society of Japan. This workshop has the character of the preparatory meeting for the session on `Interface effect in nuclear fusion energy system` of the international workshop `Interface effect in quantum energy system`, and 6 lectures and one comment were given. The topics were deuterium transport in Mo under deuterium ion implantation, the change of the stratum structure of graphite by hydrogen ion irradiation, the tritium behavior in opposing materials, the basic studies of the irradiation effects of solid breeding materials, the research on the behavior of hydroxyl group on the surface of solid breeding materials, the sweep gas effect on the surface of solid breeding materials, and the dynamic behavior of ion-implanted deuterium in proton-conductive oxides. (K.I.)

  7. Phytoremediation of Pharmaceuticals - Preliminary Study

    OpenAIRE

    Kotyza, J. (Jan); Soudek, P. (Petr); Kafka, Z.; Vaněk, T. (Tomáš)

    2010-01-01

    Phytoremediation of selected pharmaceuticals (diclofenac, ibuprofen, and acetaminophen) using Armoracia rusticana and Linum usitatissimum cell cultures and by hydroponically cultivated Lupinus albus, Hordeum vulgaris, and Phragmites australis plants in laboratory conditions is described. During in vitro experiments, the best results for acetaminophen were achieved using Armoracia rusticana hairy root cultures, where 100% of the starting amount was removed from the media during eight days. To...

  8. Pharmaceutical cocrystals: walking the talk.

    Science.gov (United States)

    Bolla, Geetha; Nangia, Ashwini

    2016-06-28

    Pharmaceutical cocrystals belong to a sub-class of cocrystals wherein one of the components is a drug molecule (or an active pharmaceutical ingredient, API) and the second is a benign food or drug grade additive (generally regarded as safe, GRAS). The two components are hydrogen-bonded in a fixed stoichiometric ratio in the crystal lattice. In the past decade, pharmaceutical cocrystals have demonstrated significant promise in their ability to modify the physicochemical and pharmacokinetic properties of drug substances, such as the solubility and dissolution rate, bioavailability, particle morphology and size, tableting and compaction, melting point, physical form, biochemical and hydration stability, and permeability. In this feature review, we highlight some prominent examples of drug cocrystals which exhibit variable hardness/softness and elasticity/plasticity depending on coformer selection, improvement of solubility and permeability in the same cocrystal, increase of the melting point for solid formulation, enhanced color performance, photostability and hydration stability, and a longer half-life. Cocrystals of flavanoids and polyphenols can make improved pharmaceuticals and also extend to the larger class of nutraceuticals. The application of crystal engineering to assemble ternary cocrystals expands this field to drug-drug cocrystals which may be useful in multi-drug resistance, mitigating side effects of drugs, or attenuating/enhancing drug action synergistically by rational selection. The advent of new techniques for structural characterization beyond the standard X-ray diffraction will provide a better understanding of drug phases which are at the borderline of crystalline-amorphous nature and even newer opportunities in the future.

  9. Pharmaceutical microparticle engineering with electrospraying

    DEFF Research Database (Denmark)

    Bohr, Adam; Wan, Feng; Kristensen, Jakob

    2015-01-01

    Microparticles of Celecoxib, dispersed in a matrix of poly(lactic-co-glycolic acid) (PLGA), were prepared by electrospraying using different solvent mixtures to investigate the influence upon particle formation and the resulting particle characteristics. Mixtures consisting of a good solvent, ace...... demonstrated by the increasingly higher drug release rates. The results demonstrate the importance of solvent composition in particle preparation and indicate potential for exploiting this dependence to improve pharmaceutical particle design and performance....

  10. Health risks of counterfeit pharmaceuticals.

    Science.gov (United States)

    ten Ham, Martijn

    2003-01-01

    Pharmaceutical products are not exempt from the practice of counterfeiting. In recent years, many reports have become available demonstrating the presence of fake medicines on the market. Several studies have demonstrated that they are quite often of bad quality. It is estimated that 5% of all world trade in branded goods is counterfeit, leading to huge financial losses for the pharmaceutical industry. But much more important, from a public health point of view, is that history has shown that such products may lead to a great health risk. The essence of counterfeit products and the reason they are so dangerous is the complete absence of quality control, since they are often indistinguishable from the genuine product. The existence of counterfeit drugs has long been ignored both by the pharmaceutical industry and by drug regulatory authorities. At present initiatives are being taken, nationally and internationally, to curb counterfeiting. It is now realised that a strong regulatory agency is essential, but the initiatives can only be successful if all parties concerned actively co-operate.

  11. [E-commerce of pharmaceuticals].

    Science.gov (United States)

    Shani, Segev

    2003-05-01

    The emergence of the Internet as a new communications and information technology caused major social and cultural changes. The dramatic increase in accessibility and availability of information empowered the consumer by closing the information gap between the consumer and different suppliers. The objective of this article is to review many new internet-supported applications related to the pharmaceutical market. E-commerce is divided into two major components: Business to Consumer (B to C), and Business to Business (B to B). The main applications in B to C are dissemination of medical and drug information, and the sale of drugs through the Internet. Medical information on the Internet is vast and very helpful for patients, however, its reliability is not guaranteed. Online pharmacies increase the accessibility and availability of drugs. Nevertheless, several obstacles such as security of the data provided (both financial and clinical) prevent the widespread use of online pharmacies. Another risk is the health authorities' inability to regulate Internet sites effectively. Therefore, unregulated sale of prescription drugs, fake or substandard, often occurs on the Internet. B to B relates to physicians, clinics, hospitals, HMO's and pharmaceutical companies. There is a vast number of applications ranging from clinical research, marketing and sales promotion, to drug distribution and logistics. In conclusion, the Internet is dynamic and has contributed to the development of numerous new applications in the field of pharmaceuticals. Regulatory authorities should be active in developing new policies that will deal with those new Internet-based applications.

  12. Stability of Pharmaceuticals in Space

    Science.gov (United States)

    Nguyen, Y-Uyen

    2009-01-01

    Stability testing is a tool used to access shelf life and effects of storage conditions for pharmaceutical formulations. Early research from the International Space Station (ISS) revealed that some medications may have degraded while in space. This potential loss of medication efficacy would be very dangerous to Crew health. The aim of this research project, Stability of Pharmacotherapeutic Compounds, is to study how the stability of pharmaceutical compounds is affected by environmental conditions in space. Four identical pharmaceutical payload kits containing medications in different dosage forms (liquid for injection, tablet, capsule, ointment and suppository) were transported to the ISS aboard a Space Shuttle. One of the four kits was stored on that Shuttle and the other three were stored on the ISS for return to Earth at various time intervals aboard a pre-designated Shuttle flight. The Pharmacotherapeutics laboratory used stability test as defined by the United States Pharmacopeia (USP), to access the degree of degradation to the Payload kit medications that may have occurred during space flight. Once these medications returned, the results of stability test performed on them were compared to those from the matching ground controls stored on Earth. Analyses of the results obtained from physical and chemical stability assessments on these payload medications will provide researchers additional tools to promote safe and efficacious medications for space exploration.

  13. Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination.

    Science.gov (United States)

    Kasprzyk-Hordern, Barbara; Dinsdale, Richard M; Guwy, Alan J

    2009-06-01

    This manuscript is part two of a two-part study aiming to provide a better understanding and application of environmental data not only for environmental aims but also to meet forensic objectives. In this paper pharmaceuticals were investigated as potential chemical indicators of water contamination with sewage. The monitoring program carried out in Wales revealed that some pharmaceuticals are particularly persistent and/or ubiquitous in contaminated river water and therefore might be considered as potential conservative or labile wastewater indicators. In particular, these include some anti-inflammatory/analgesics, antiepileptics, beta-blockers, some H2-receptor antagonists and antibacterial drugs.

  14. Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer.

    Science.gov (United States)

    Anyakora, Chimezie; Ekwunife, Obinna; Alozie, Faith; Esuga, Mopa; Ukwuru, Jonathan; Onya, Steve; Nwokike, Jude

    2017-09-18

    Pharmaceutical companies in Africa need to invest in both facilities and quality management systems to achieve good manufacturing practice (GMP) compliance. Compliance to international GMP standards is important to the attainment of World Health Organization (WHO) prequalification. However, most of the local pharmaceutical manufacturing companies may be deterred from investing in quality because of many reasons, ranging from financial constraints to technical capacity. This paper primarily evaluates benefits against the cost of investing in GMP, using a Nigerian pharmaceutical company, Chi Pharmaceuticals Limited, as a case study. This paper also discusses how to drive more local manufacturers to invest in quality to attain GMP compliance; and proffers practical recommendations for local manufacturers who would want to invest in quality to meet ethical and regulatory obligations. The cost benefit of improving the quality of Chi Pharmaceuticals Limited's facilities and system to attain WHO GMP certification for the production of zinc sulfate 20-mg dispersible tablets was calculated by dividing the annual benefits derived from quality improvement interventions by the annual costs of implementing quality improvement interventions, referred to as a benefit-cost ratio (BCR). Cost benefit of obtaining WHO GMP certification for the production of zinc sulfate 20-mg dispersible tablets was 5.3 (95% confidence interval of 5.0-5.5). Investment in quality improvement intervention is cost-beneficial for local manufacturing companies. Governments and regulators in African countries should support pharmaceutical companies striving to invest in quality. Collaboration of local manufacturing companies with global companies will further improve quality. Local pharmaceutical companies should be encouraged to key into development opportunities available for pharmaceutical companies in Africa.

  15. Pharmaceutical and analytical evaluation of triphalaguggulkalpa tablets

    OpenAIRE

    Savarikar, Shreeram S.; Barbhind, Maneesha M.; Halde, Umakant K.; Kulkarni, Alpana P.

    2011-01-01

    Aim of the Study: Development of standardized, synergistic, safe and effective traditional herbal formulations with robust scientific evidence can offer faster and more economical alternatives for the treatment of disease. The main objective was to develop a method of preparation of guggulkalpa tablets so that the tablets meet the criteria of efficacy, stability, and safety. Materials and Methods: Triphalaguggulkalpa tablet, described in sharangdharsanhita and containing guggul and triphala p...

  16. Meeting Disorders.

    Science.gov (United States)

    Yager, Joel; Katzman, Jeffrey W

    2017-12-01

    Although meetings are central to organizational work, considerable time devoted to meetings in Academic Health Centers appears to be unproductively spent. The primary purposes of this article are to delineate and describe Meeting Disorders, pathological processes resulting in these inefficient and ineffective scenarios, and Meeting Fatigue Disorder (MFD), a clinical syndrome. The paper also offers preliminary approaches to remedies. The authors integrate observations made during tens of thousands of hours in administrative meetings in academic medical settings with information in the literature regarding the nature, causes and potential interventions for dysfunctional groups and meetings. Meeting Disorders, resulting from distinct pathologies of leadership and organization, constitute prevalent subgroups of the bureaucrapathologies, pathological conditions caused by dysfunctional bureaucratic processes that generate excesses of wasted time, effort, and other resources. These disorders also generate frustration and demoralization among participants, contributing to professional burnout. Meeting Fatigue Disorder (MFD) is a subjective condition that develops in individuals who overdose on these experiences and may reflect one manifestation of burnout. Meeting disorders and Meeting Fatigue Disorder occur commonly in bureaucratic life. Resources and potential remedies are available to help ameliorate their more deleterious effects.

  17. Materials Characterization and Microelectronic Implementation of Metal-insulator Transition Materials and Phase Change Materials

    Science.gov (United States)

    2015-03-26

    materials like crystalline semiconductors, graphene , and composites, the materials discussed here could have a significant impact. This thesis investigates...diagnosis [124], crystallinity of pharmaceutical materials [125], materials diagnosis for restoration of paintings [126], and materials research [127...temperature dots and paint were placed on samples on the substrate. Temperature dots are typically used in the transportation of goods such as food in order

  18. STAFF MEETING

    CERN Document Server

    2003-01-01

    I should like to invite all members of the CERN Personnel to a meeting on Wednesday 25th June 2003 at 11.00 hrs - Auditorium, bldg. 500 to give a report on the outcome of the June Meetings of Council and its Committees. Closed-circuit transmission of the meeting will be available in the AB Auditorium (Prévessin), the AB Auditorium (Meyrin - bldg. 6), the IT Auditorium (bldg. 31) and the AT Auditorium (bldg. 30). Luciano Maiani Director General

  19. Nuclear power plant control and instrumentation 1991. Working material. Proceedings of the regular meeting held in Vienna, 6-8 May 1991

    International Nuclear Information System (INIS)

    1992-01-01

    The meeting of the IWG-NPPCI was organized in order to summarize operating experience of nuclear power plant control systems, gain a general overview of activities in development of modern control systems and receive recommendations on the further directions and particular measures within the Agency's programme. The meeting was held at the IAEA Headquarters in Vienna and was attended by twenty four national delegates and observers from 19 countries. The present volume contains: report on the meeting of the IWG-NPPCI, Vienna, 6 to 8 May 1991; report of the scientific secretary on th major activities of IAEA during 1989-91 in the NPPCI area; and reports of the national representatives to the International Working Group on NPPCI. The papers and discussions with practical experience and described actual problems encountered. Emphasis was placed on technical, industrial and economic aspects of the introduction of modern control systems and on the improvement of plant availability and safety. Refs, figs and tabs

  20. 78 FR 9430 - Sunshine Act Meeting Notice

    Science.gov (United States)

    2013-02-08

    ... Corporation's Institutional Advancement Committee will meet telephonically on February 13, 2013. The meeting... will be made of the closed session of the Board and Institutional Advancement Committee meetings. The... Rehabilitation Act. Upon request, meeting notices and materials will be made available in alternative formats to...

  1. 78 FR 67201 - Sunshine Act Meeting

    Science.gov (United States)

    2013-11-08

    ... Institutional Advancement Committee will meet telephonically on November 22, 2013. The meeting will commence at... of the closed session meeting of the Institutional Advancement Committee. The transcript of any... 1973 Rehabilitation Act. Upon request, meeting notices and materials will be made available in...

  2. 78 FR 59374 - Sunshine Act Meeting

    Science.gov (United States)

    2013-09-26

    ... Institutional Advancement Committee will meet telephonically on October 1, 2013. The meeting will commence at 4... meeting of the Institutional Advancement Committee. The transcript of any portion of the closed session... the 1973 Rehabilitation Act. Upon request, meeting notices and materials will be made available in...

  3. 78 FR 45568 - Sunshine Act Meeting Notice

    Science.gov (United States)

    2013-07-29

    ... Corporation's Institutional Advancement Committee will meet telephonically on August 6, 2013. The meeting will... transcript will be made of the closed session meeting of the Institutional Advancement Committee. The... Disabilities Act and Section 504 of the 1973 Rehabilitation Act. Upon request, meeting notices and materials...

  4. 78 FR 40515 - Sunshine Act Meeting Notice

    Science.gov (United States)

    2013-07-05

    ... Corporation's Institutional Advancement Committee will meet telephonically on July 9, 2013. The meeting will... transcript will be made of the closed session meeting of the Institutional Advancement Committee. The... the 1973 Rehabilitation Act. Upon request, meeting notices and materials will be made available in...

  5. 78 FR 33862 - Sunshine Act Meeting; Notice

    Science.gov (United States)

    2013-06-05

    ... Corporation's Institutional Advancement Committee will meet telephonically on June 11, 2013. The meeting will... transcript will be made of the closed session meeting of the Institutional Advancement Committee. The... and Section 504 of the 1973 Rehabilitation Act. Upon request, meeting notices and materials will be...

  6. 78 FR 12365 - Sunshine Act Meeting

    Science.gov (United States)

    2013-02-22

    ... Institutional Advancement Committee will meet telephonically on February 26, 2013. The meeting will commence at... made of the closed session of the Board and Institutional Advancement Committee meetings. The... Rehabilitation Act. Upon request, meeting notices and materials will be made available in alternative formats to...

  7. 78 FR 53480 - Sunshine Act Meeting

    Science.gov (United States)

    2013-08-29

    ... Institutional Advancement Committee will meet telephonically on September 3, 2013. The meeting will commence at... session meeting of the Institutional Advancement Committee. The transcript of any portion of the closed... Disabilities Act and Section 504 of the 1973 Rehabilitation Act. Upon request, meeting notices and materials...

  8. 78 FR 20356 - Sunshine Act Meeting

    Science.gov (United States)

    2013-04-04

    ... Institutional Advancement Committee will meet telephonically on April 9, 2013. The meeting will commence at 4:00... verbatim written transcript will be made of each closed session meeting of the Institutional Advancement... Rehabilitation Act. Upon request, meeting notices and materials will be made available in alternative formats to...

  9. 78 FR 14839 - Sunshine Act Meeting

    Science.gov (United States)

    2013-03-07

    ... Institutional Advancement Committee will meet telephonically on March 12, 2013 and March 26, 2013. Each meeting... session meeting of the Institutional Advancement Committee. The transcript of any portion of the closed... Act and Section 504 of the 1973 Rehabilitation Act. Upon request, meeting notices and materials will...

  10. 78 FR 21978 - Sunshine Act Meeting

    Science.gov (United States)

    2013-04-12

    ... Institutional Advancement Committee will meet telephonically on April 23, 2013. The meeting will commence at 4... written transcript will be made of each closed session meeting of the Institutional Advancement Committee... the 1973 Rehabilitation Act. Upon request, meeting notices and materials will be made available in...

  11. 28 CFR 16.202 - Open meetings.

    Science.gov (United States)

    2010-07-01

    ... 28 Judicial Administration 1 2010-07-01 2010-07-01 false Open meetings. 16.202 Section 16.202 Judicial Administration DEPARTMENT OF JUSTICE PRODUCTION OR DISCLOSURE OF MATERIAL OR INFORMATION Public Observation of Parole Commission Meetings § 16.202 Open meetings. (a) Every portion of every meeting of the...

  12. Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics.

    Science.gov (United States)

    Shan, Ning; Perry, Miranda L; Weyna, David R; Zaworotko, Michael J

    2014-09-01

    Pharmaceutical cocrystallization has emerged in the past decade as a new strategy to enhance the clinical performance of orally administered drugs. A pharmaceutical cocrystal is a multi-component crystalline material in which the active pharmaceutical ingredient is in a stoichiometric ratio with a second compound that is generally a solid under ambient conditions. The resulting cocrystal exhibits different solid-state thermodynamics, leading to changes in physicochemical properties that offer the potential to significantly modify drug pharmacokinetics. The impact of cocrystallization upon drug pharmacokinetics has not yet been well delineated. Herein, we compile previously published data to address two salient questions: what effect does cocrystallization impart upon physicochemical properties of a drug substance and to what degree can those effects impact its pharmacokinetics. Cocrystals can impact various aspects of drug pharmacokinetics, including, but not limited to, drug absorption. The diversity of solid forms offered through cocrystallization can facilitate drastic changes in solubility and pharmacokinetics. Therefore, it is unsurprising that cocrystal screening is now a routine step in early-stage drug development. With the increasing recognition of pharmaceutical cocrystals from clinical, regulatory and legal perspectives, the systematic commercialization of cocrystal containing drug products is just a matter of time.

  13. Recent trends in the impurity profile of pharmaceuticals

    Directory of Open Access Journals (Sweden)

    Kavita Pilaniya

    2010-01-01

    Full Text Available Various regulatory authorities such as the International Conference on Harmonization (ICH, the United States Food and Drug administration (FDA, and the Canadian Drug and Health Agency (CDHA are emphasizing on the purity requirements and the identification of impurities in Active Pharmaceutical Ingredients (APIs. The various sources of impurity in pharmaceutical products are - reagents, heavy metals, ligands, catalysts, other materials like filter aids, charcoal, and the like, degraded end products obtained during \\ after manufacturing of bulk drugs from hydrolysis, photolytic cleavage, oxidative degradation, decarboxylation, enantiomeric impurity, and so on. The different pharmacopoeias such as the British Pharmacopoeia, United State Pharmacopoeia, and Indian Pharmacopoeia are slowly incorporating limits to allowable levels of impurities present in APIs or formulations. Various methods are used to isolate and characterize impurities in pharmaceuticals, such as, capillary electrophoresis, electron paramagnetic resonance, gas-liquid chromatography, gravimetric analysis, high performance liquid chromatography, solid-phase extraction methods, liquid-liquid extraction method, Ultraviolet Spectrometry, infrared spectroscopy, supercritical fluid extraction column chromatography, mass spectrometry, Nuclear magnetic resonance (NMR spectroscopy, and RAMAN spectroscopy. Among all hyphenated techniques, the most exploited techniques for impurity profiling of drugs are Liquid Chromatography (LC-Mass Spectroscopy (MS, LC-NMR, LC-NMR-MS, GC-MS, and LC-MS. This reveals the need and scope of impurity profiling of drugs in pharmaceutical research.

  14. Electrochemical biosensors in pharmaceutical analysis

    Directory of Open Access Journals (Sweden)

    Eric de Souza Gil

    2010-09-01

    Full Text Available Given the increasing demand for practical and low-cost analytical techniques, biosensors have attracted attention for use in the quality analysis of drugs, medicines, and other analytes of interest in the pharmaceutical area. Biosensors allow quantification not only of the active component in pharmaceutical formulations, but also the analysis of degradation products and metabolites in biological fluids. Thus, this article presents a brief review of biosensor use in pharmaceutical analysis, focusing on enzymatic electrochemical sensors.Em virtude do aumento da demanda por técnicas analíticas simples e de baixo custo, os biossensores têm atraído a atenção para a análise de fármacos, medicamentos e outros analitos de interesse em controle de qualidade de medicamentos. Os biossensores permitem a quantificação não somente de princípio ativo em formulações farmacêuticas, mas também de produtos de degradação e metabólitos em fluídos biológicos, bem como análise de amostras de interesse clínico e industrial, além de possibilitar a determinação de enantiômeros. Desta forma, este artigo objetiva fazer uma breve revisão a respeito do emprego de biossensores em análise farmacêutica, com ênfase em sensores eletroquímicos enzimáticos.

  15. Introduction: Institutional corruption and the pharmaceutical policy.

    Science.gov (United States)

    Rodwin, Marc A

    2013-01-01

    Today, the goals of pharmaceutical policy and medical practice are often undermined due to institutional corruption - that is, widespread or systemic practices, usually legal, that undermine an institution's objectives or integrity. In this symposium, 16 articles investigate the corruption of pharmaceutical policy, each taking a different look at the sources of corruption, how it occurs, and what is corrupted. We will see that the pharmaceutical industry's own purposes are often undermined. Furthermore, pharmaceutical industry funding of election campaigns and lobbying skews the legislative process that sets pharmaceutical policy. Moreover, certain practices have corrupted medical research, the production of medical knowledge, the practice of medicine, drug safety, the Food and Drug Administration's oversight of the pharmaceutical market, and the trustworthiness of patient advocacy organizations. © 2013 American Society of Law, Medicine & Ethics, Inc.

  16. Tria Pharmaceuticals in the Baltics

    DEFF Research Database (Denmark)

    Kratochvil, Renate; Nell, Phillip C.

    2016-01-01

    Linda, a management consultant, had to solve a tricky problem regarding difficulties with the 'Baltic region subsidiary' of a global pharmaceutical company. She was hired by their Regional Headquarters (RHQ) for Central and Eastern Europe to disentangle this multifaceted challenge (eg sales down...... on the topic were the cultural misunderstandings between the employees of the various countries, or the company’s outdated products. Linda was challenged to, first, get a clear and comprehensive picture of the situation, and, second, propose a well-conceived solution to the RHQ. This case is written as a two...

  17. International Conference Nuclear Energy in Central Europe 99, V. 2. Proceedings. Embedded Meeting Neutron Imaging Methods to Detect Defects in Materials

    International Nuclear Information System (INIS)

    Gortnar, O.; Stritar, A.

    1999-01-01

    International Conference Nuclear Energy in Central Europe is an annual meeting of the Nuclear Society of Slovenia. The second book of proceedings contain 14 articles from Slovenia, surrounding countries and countries of the Central and Eastern European Region. Topics cover Neutron Imaging Methods

  18. Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates

    Directory of Open Access Journals (Sweden)

    Ramesh N. Patel

    2004-01-01

    Full Text Available The production of single enantiomers of drug intermediates has become increasingly important in the pharmaceutical industry. Chiral intermediates and fine chemicals are in high demand from both the pharmaceutical and agrochemical industries for the preparation of bulk drug substances and agricultural products. The enormous potential of microorganisms and enzymes for the transformation of synthetic chemicals with high chemo-, regio- and enantioselectivities has been demonstrated. In this article, biocatalytic processes are described for the synthesis of chiral pharmaceutical intermediates.

  19. Novel methodology for pharmaceutical expenditure forecast

    OpenAIRE

    Vataire, Anne-Lise; Cetinsoy, Laurent; Aball?a, Samuel; R?muzat, C?cile; Urbinati, Duccio; Kornfeld, ?sa; Mzoughi, Olfa; Toumi, Mondher

    2014-01-01

    Background and objective: The value appreciation of new drugs across countries today features a disruption that is making the historical data that are used for forecasting pharmaceutical expenditure poorly reliable. Forecasting methods rarely addressed uncertainty. The objective of this project was to propose a methodology to perform pharmaceutical expenditure forecasting that integrates expected policy changes and uncertainty (developed for the European Commission as the ‘EU Pharmaceutical e...

  20. Bioremediation Kinetics of Pharmaceutical Industrial Effluent

    OpenAIRE

    M. Šabić; M. Vuković Domanovac; Z. Findrik Blažević; E. Meštrović

    2015-01-01

    In recent years, concerns about the occurrence and fate of pharmaceuticals that could be present in water and wastewater has gained increasing attention. With the public’s enhanced awareness of eco-safety, environmentally benign methods based on microorganisms have become more accepted methods of removing pollutants from aquatic systems. This study investigates bioremediation of pharmaceutical wastewater from pharmaceutical company Pliva Hrvatska d.o.o., using activated sludge and bioaugmente...

  1. Supply Chain Management in Zhendong Pharmaceutical Company

    OpenAIRE

    Li, Yan

    2011-01-01

    Medicines are special commodity related to people’s lives and health, therefore, pharmaceutical distribution is an industry affecting the national economy and the people's livelihood. With health care reform, changeable pharmaceutical policy and fiercely increasing competition in the medical industry, pharmaceutical distribution companies should improve their level of logistics operations and reduce overall logistics management costs in order to gain a leading position in the competition. In ...

  2. Nanotechnology tools in pharmaceutical R&D

    OpenAIRE

    Challa S.S.R. Kumar

    2010-01-01

    Nanotechnology is a new approach to problem solving and can be considered as a collection of tools and ideas which can be applied in pharmaceutical industry. Application of nanotechnology tools in pharmaceutical R&D is likely to result in moving the industry from ‘blockbuster drug’ model to ‘personalized medicine’. There are compelling applications in pharmaceutical industry where inexpensive nanotechnology tools can be utilized. The review explores the possibility of categorizing various nan...

  3. Status of national programmes on fast breeder reactors. Twenty-fifth annual meeting of the International Working Group on Fast Reactors. Summary report. Working material

    International Nuclear Information System (INIS)

    1992-01-01

    'burning' of the associated extremely long-life transuranic waste, particularly actinides, thus reducing the required isolation time for high level waste from tens of thousands of years to hundreds of years for fission products only. This additional important mission for the LMFBR is gaining worldwide interest. In the framework of disarmament of nuclear weapons and the utilization of the nuclear material for peaceful purposes a role for fast reactors can be also considered. Over the past 25 years, the IAEA has actively encouraged and advocated international cooperation in Fast Breeder Reactor Technology. At the present time the Working Group on Fast Reactors is the oldest and one of the most active groups in the Division of Nuclear Power. The present document contains information on the status of fast breeder reactor development and on worldwide activities in this advanced nuclear power technology during 1991, as reported at the 25th jubilee Annual Meeting of the IWGFR in Vienna, 27-30 April 1992. The publication is intended to provide information regarding the current status of LMFBR development in IAEA Member States and CEC

  4. Status of national programmes on fast breeder reactors. Twenty-fifth annual meeting of the International Working Group on Fast Reactors. Summary report. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1992-07-01

    'burning' of the associated extremely long-life transuranic waste, particularly actinides, thus reducing the required isolation time for high level waste from tens of thousands of years to hundreds of years for fission products only. This additional important mission for the LMFBR is gaining worldwide interest. In the framework of disarmament of nuclear weapons and the utilization of the nuclear material for peaceful purposes a role for fast reactors can be also considered. Over the past 25 years, the IAEA has actively encouraged and advocated international cooperation in Fast Breeder Reactor Technology. At the present time the Working Group on Fast Reactors is the oldest and one of the most active groups in the Division of Nuclear Power. The present document contains information on the status of fast breeder reactor development and on worldwide activities in this advanced nuclear power technology during 1991, as reported at the 25th jubilee Annual Meeting of the IWGFR in Vienna, 27-30 April 1992. The publication is intended to provide information regarding the current status of LMFBR development in IAEA Member States and CEC.

  5. Logic Meeting

    CERN Document Server

    Tugué, Tosiyuki; Slaman, Theodore

    1989-01-01

    These proceedings include the papers presented at the logic meeting held at the Research Institute for Mathematical Sciences, Kyoto University, in the summer of 1987. The meeting mainly covered the current research in various areas of mathematical logic and its applications in Japan. Several lectures were also presented by logicians from other countries, who visited Japan in the summer of 1987.

  6. A validated high performance thin layer chromatography method for determination of yohimbine hydrochloride in pharmaceutical preparations

    OpenAIRE

    Jihan M Badr

    2013-01-01

    Background: Yohimbine is an indole alkaloid used as a promising therapy for erectile dysfunction. A number of methods were reported for the analysis of yohimbine in the bark or in pharmaceutical preparations. Materials and Method: In the present work, a simple and sensitive high performance thin layer chromatographic method is developed for determination of yohimbine (occurring as yohimbine hydrochloride) in pharmaceutical preparations and validated according to International Conference of Ha...

  7. Sorption, Uptake, and Translocation of Pharmaceuticals across Multiple Interfaces in Soil Environment

    Science.gov (United States)

    Zhang, W.; Liu, C. H.; Bhalsod, G.; Zhang, Y.; Chuang, Y. H.; Boyd, S. A.; Teppen, B. J.; Tiedje, J. M.; Li, H.

    2015-12-01

    Pharmaceuticals are contaminants of emerging concern frequently detected in soil and water environments, raising serious questions on their potential impact on human and ecosystem health. Overuse and environmental release of antibiotics (i.e., a group of pharmaceuticals extensively used in human medicine and animal agriculture) pose enormous threats to the health of human, animal, and the environment, due to proliferation of antibiotic resistant bacteria. Recently, we have examined interactions of pharmaceuticals with soil geosorbents, bacteria, and vegetable crops in order to elucidate pathways of sorption, uptake, and translocation of pharmaceuticals across the multiple interfaces in soils. Sorption of pharmaceuticals by biochars was studied to assess the potential of biochar soil amendment for reducing the transport and bioavailability of antibiotics. Our preliminary results show that carbonaceous materials such as biochars and activated carbon had strong sorption capacities for antibiotics, and consequently decreased the uptake and antibiotic resistance gene expression by an Escherichia coli bioreporter. Thus, biochar soil amendment showed the potential for reducing selection pressure on antibiotic resistant bacteria. Additionally, since consumption of pharmaceutical-tainted food is a direct exposure pathway for humans, it is important to assess the uptake and accumulation of pharmaceuticals in food crops grown in contaminated soils or irrigated with reclaimed water. Therefore, we have investigated the uptake and accumulations of pharmaceuticals in greenhouse-grown lettuce under contrasting irrigation practices (i.e., overhead or surface irrigations). Preliminary results indicate that greater pharmaceutical concentrations were measured in overhead irrigated lettuce than in surface irrigated lettuce. This could have important implications when selecting irrigation scheme to use the reclaimed water for crop irrigation. In summary, proper soil and water management

  8. Evaluation of P-Listed Pharmaceutical Residues in Empty Pharmaceutical Containers

    Science.gov (United States)

    Under the Resource Conservation and Recovery Act (RCRA), some pharmaceuticals are considered acute hazardous wastes because their sole active pharmaceutical ingredients are P-listed commercial chemical products (40 CFR 261.33). Hospitals and other healthcare facilities have stru...

  9. Entrepreneurial patent management in pharmaceutical startups.

    Science.gov (United States)

    Holgersson, Marcus; Phan, Tai; Hedner, Thomas

    2016-07-01

    Startups fill an increasingly important role as innovators in the pharmaceutical industry, and patenting is typically central to their success. This article aims to explore patent management in pharmaceutical startups. The results show that startups need to deal with several challenges related to patenting and an 'entrepreneurial' approach to patent management is called for. Resource constraints, venture capital provision, exits and other conditions and events must be readily considered in the patent management process to build a successful pharmaceutical venture, something that could benefit the pharmaceutical industry as a whole. Copyright © 2016 Elsevier Ltd. All rights reserved.

  10. Organic Colouring Agents in the Pharmaceutical Industry

    Directory of Open Access Journals (Sweden)

    Šuleková M.

    2017-09-01

    Full Text Available Food dyes are largely used in the process of manufacturing pharmaceutical products. The aim of such a procedure is not only to increase the attractiveness of products, but also to help patients distinguish between pharmaceuticals. Various dyes, especially organic colouring agents, may in some cases have a negative impact on the human body. They are incorporated into pharmaceutical products including tablets, hard gelatine capsules or soft gelatine capsules, lozenges, syrups, etc. This article provides an overview of the most widely used colouring agents in pharmaceuticals, their characteristics and the EU legislation which regulates their use.

  11. Joint ICFRM-14 (14. international conference on fusion reactor materials) and IAEA satellite meeting on cross-cutting issues of structural materials for fusion and fission applications. PowerPoint presentations

    International Nuclear Information System (INIS)

    2009-01-01

    The Conference was devoted to the challenges in the development of new materials for advanced fission, fusion and hybrid reactors. The topics discussed include fuels and materials research under the high neutron fluence; post-irradiation examination; development of radiation resistant structural materials utilizing fission research reactors; core materials development for the advanced fuel cycle initiative; qualification of structural materials for fission and fusion reactor systems; application of charged particle accelerators for radiation resistance investigations of fission and fusion structural materials; microstructure evolution in structural materials under irradiation; ion beams and ion accelerators

  12. Cyclodextrins and their pharmaceutical applications.

    Science.gov (United States)

    Loftsson, Thorsteinn; Duchêne, Dominique

    2007-02-01

    Cyclodextrins were first described by Villiers in 1891. Schardinger laid the foundation of the cyclodextrin chemistry in 1903-1911 and identified both alpha- and beta-cyclodextrin. In the 1930s, Freudenberg identified gamma-cyclodextrin and suggested that larger cyclodextrins could exist. Freudenberg and co-workers showed that cyclodextrins were cyclic oligosaccharides formed by glucose units and somewhat later Cramer and co-workers described their ability to form inclusion complexes. By the early 1950s the basic physicochemical characteristics of cyclodextrins had been discovered, including their ability to solubilize and stabilize drugs. The first cyclodextrin-related patent was issued in 1953 to Freudenberg, Cramer and Plieninger. However, pure cyclodextrins that were suitable for pharmaceutical applications did not come available until about 25 years later and at the same time the first cyclodextrin-containing pharmaceutical product was marketed in Japan. Later cyclodextrin-containing products appeared on the European market and in 1997 also in the US. New cyclodextrin-based technologies are constantly being developed and, thus, 100 years after their discovery cyclodextrins are still regarded as novel excipients of unexplored potential.

  13. MARKETING STRATEGIES OF PHARMACEUTICAL ORGANIZATION

    Directory of Open Access Journals (Sweden)

    N. M. Sergeeva

    2015-01-01

    Full Text Available Strategy of pharmaceutical goods (PG promotion is a working out of methods of goods realization stimulation. To make PG promotion maximum effective, and to receive a sufficient result for pharmaceutical organization (PO it is necessary to conduct marketing studies (MS, to work out a marketing plan for PG promotion and to offer marketing strategies for goods promotion. To resolve these problems we have formed a concept of marketing promotion of PG system for one of big retail PO of Kursk and Kursk oblast (code name “A”. With this purpose we have identified a problem of PG promotion organization, studied an influence of external and internal environment on the PO “A” activity, determined strong and weak sides of PO activity. We have systematized the results in SWOT-analysis, and formed the strategies of PO for the improvement of work efficiency on the market. On the basis of the results received we have worked out the recommendations for the marketing strategies of PG promotion for the certain PO.

  14. Materials modified by irradiation

    International Nuclear Information System (INIS)

    Chmielewski, A.G.

    2007-01-01

    Application of radiation in pharmaceutical sciences and cosmetology, polymer materials, food industry, environment, health camre products and packing production is described. Nano-technology is described more detailed, because it is less known as irradiation using technology. Economic influence of the irradiation on the materials value addition is shown

  15. Development of methodologies for optimization of surveillance testing and maintenance of safety related equipment at NPPs. Report of a research coordination meeting. Working material

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1997-09-01

    This report summarizes the results of the first meeting of the Coordinated Research Programme (CRP) on Development of Methodologies for Optimization of Surveillance Testing and Maintenance of Safety Related Equipment at NPPs, held at the Agency Headquarters in Vienna, from 16 to 20 December 1996. The purpose of this Research Coordination Meeting (RCM) was that all Chief Scientific Investigators of the groups participating in the CRP presented an outline of their proposed research projects. Additionally, the participants discussed the objective, scope, work plan and information channels of the CRP in detail. Based on these presentations and discussions, the entire project plan was updated, completed and included in this report. This report represents a common agreed project work plan for the CRP. Refs, figs, tabs.

  16. Pharmaceutical care in Kuwait: hospital pharmacists' perspectives.

    Science.gov (United States)

    Katoue, Maram G; Awad, Abdelmoneim I; Schwinghammer, Terry L; Kombian, Samuel B

    2014-12-01

    Pharmaceutical care practice has been championed as the primary mission of the pharmacy profession, but its implementation has been suboptimal in many developing countries including Kuwait. Pharmacists must have sufficient knowledge, skills, and positive attitudes to practise pharmaceutical care, and barriers in the pharmacy practice model must be overcome before pharmaceutical care can be broadly implemented in a given healthcare system. To investigate hospital pharmacists' attitudes towards pharmaceutical care, perceptions of their preparedness to provide pharmaceutical care, and the barriers to its implementation in Kuwait. Six general hospitals, eight specialized hospitals and seven specialized health centers in Kuwait. A descriptive, cross-sectional survey was distributed to all pharmacists working in the governmental hospitals in Kuwait (385 pharmacists). Data were collected via a pre-tested self-administered questionnaire. Descriptive statistics including percentages, medians and means Likert scale rating (standard deviations) were calculated and compared using statistical package for social sciences, version 20. Statistical significance was accepted at a p value of Kuwait. Completed surveys were received from 250 (64.9%) of the 385 pharmacists. Pharmacists expressed overall positive attitudes towards pharmaceutical care. They felt well prepared to implement the various aspects of pharmaceutical care, with the least preparedness in the administrative/management aspects. Pharmacists with more practice experience expressed significantly more positive attitudes towards pharmaceutical care (p = 0.001) and they felt better prepared to provide pharmaceutical care competencies (p Kuwait advocate implementation of pharmaceutical care while also appreciating the organizational, technical and professional barriers to its widespread adoption. Collaborative efforts between health authorities and educational institutions, and the integration of innovative approaches in

  17. Proceedings of the IAEA research coordination meeting on methods for the calculations of neutron nuclear data for structural materials, Bologna, Italy, 7-10 October 1986

    International Nuclear Information System (INIS)

    Goulo, V.

    1988-01-01

    The Meeting presentations were divided into 5 sessions devoted to the following aspects of nuclear theory for evaluation of fast neutron data: Development of Multistep Compound Reaction Models (3 papers), Exiton, Hybrid, Unified Pre-equilibrium Models (4 papers), Description of Direct Processes (3 papers), Parametrization of Optical Model, Level Density Functions, Gamma-Ray Strength Functioning (3 papers) and Methods of Cross Section Evaluation (5 papers). A separate abstract was prepared for each of these papers. Refs, figs and tabs

  18. Workshop on Design Loads for Advanced Fighters: Meeting of the Structures and Materials Panel of AGARD (64th) Held in Madrid (Spain) on 27 April-1 May 1987.

    Science.gov (United States)

    1988-02-01

    artificial intelligence system. It is posited that combining such a system, referred to informally as "Guardian", with a system incorporating aircraft...Proceedings of the Aerospace Medical Association Annual Scientific Meeting, 1976. 13. Van Patten, R. E. Current research on an artificial intelligence ...avions qui l’ont suivi (MIRAGE 4000, MIR. III NG et RAFALE) avec leur syst~me de commande de vol electrique et leur stabilite artificielle , a achev

  19. An Evidence Framework for Off-Patent Pharmaceutical Review (EFOR) for Health Technology Assessment in Emerging Markets.

    Science.gov (United States)

    Brixner, Diana; Kaló, Zoltán; Maniadakis, Nikos; Kim, Kyoo; Wijaya, Kalman

    2018-03-29

    This article introduces an Evidence Framework for Off-Patent Pharmaceutical Review (EFOR), which establishes value-based criteria in a template that manufacturers use to provide evidence showing how their products meet those criteria. Health authorities in emerging markets can then use the evidence presented in the EFOR to evaluate off-patent pharmaceuticals (OPPs) in a consistent, transparent, and evidence-based manner to support policy decisions, including pricing, reimbursement, formulary listing, and drug procurement. A literature search found no multi-criteria evidence framework for evaluating OPPs in emerging markets. An International Outcomes Research Board (IORB) of academia and industry experts conducted extensive research, meetings, and workshops to define high-priority criteria to incorporate into an evidence-based health technology assessment (HTA) tool using the multi-criteria decision analysis (MCDA) technique. The resulting framework was further tailored for country-specific needs in workshops in three emerging countries (Kazakhstan, Vietnam, and Indonesia). The IORB defined nine criteria four categories (Product, Manufacturing, Service, and Value Assessment), which OPP manufacturers can use to provide evidence for reimbursement and health policy decision making. Then the IORB developed the EFOR as a base case document, which can be adapted and used as a template by health authorities in emerging countries. Emerging countries have a significant need for an HTA tool that balances affordability with accurate evidence showing the value differentiation of OPPs. The value attributes in this setting often are different from those in developed markets, which emphasize new products and have high regulation and manufacturing standards. The EFOR is an easy-to-use, adaptable framework that emerging countries can use to increase the consistency, transparency, and effectiveness of drug decision making. The open source EFOR is available as Supplemental Materials

  20. Nuclear power plant control and instrumentation 1991. Working material. Proceedings of the regular meeting held in Vienna, 6-8 May 1991

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1993-12-31

    The meeting of the IWG-NPPCI was organized in order to summarize operating experience of nuclear power plant control systems, gain a general overview of activities in development of modern control systems and receive recommendations on the further directions and particular measures within the Agency`s programme. The meeting was held at the IAEA Headquarters in Vienna and was attended by twenty four national delegates and observers from 19 countries. The present volume contains: report on the meeting of the IWG-NPPCI, Vienna, 6 to 8 May 1991; report of the scientific secretary on th major activities of IAEA during 1989-91 in the NPPCI area; and reports of the national representatives to the International Working Group on NPPCI. The papers and discussions with practical experience and described actual problems encountered. Emphasis was placed on technical, industrial and economic aspects of the introduction of modern control systems and on the improvement of plant availability and safety. Refs, figs and tabs.